
<html lang="en"     class="pb-page"  data-request-id="cffcd76a-ca6f-4635-b055-8caebfa7afc7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-13;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00873;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors" /></meta><meta name="dc.Creator" content="Mohammed&#xA;I.  El-Gamal" /></meta><meta name="dc.Creator" content="Shahad K.  Al-Ameen" /></meta><meta name="dc.Creator" content="Dania M.  Al-Koumi" /></meta><meta name="dc.Creator" content="Mawadda G.  Hamad" /></meta><meta name="dc.Creator" content="Nouran A.  Jalal" /></meta><meta name="dc.Creator" content="Chang-Hyun  Oh" /></meta><meta name="dc.Description" content="Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is overstimulated by its lig..." /></meta><meta name="Description" content="Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is overstimulated by its lig..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 2, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00873" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00873" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00873" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00873" /></link>
        
    
    

<title>Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00873" /></meta><meta property="og:title" content="Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0009.jpeg" /></meta><meta property="og:description" content="Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is overstimulated by its ligand, CSF-1. Innate immunity, as well as macrophage differentiation and survival, are regulated by the stimulation of the CSF-1R. Another ligand, interlukin-34 (IL-34), was recently reported to activate the CSF-1R receptor in a different manner. The relationship between CSF-1R and microglia has been reviewed. Both CSF-1 antibodies and small molecule CSF-1R kinase inhibitors have now been tested in animal models and in humans. In this Perspective, we discuss the role of CSF-1 and IL-34 in producing cancer, bone disorders, and inflammation. We also review the newly discovered and improved small molecule kinase inhibitors and monoclonal antibodies that have shown potent activity toward CSF-1R, reported from 2012 until 2017." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is overstimulated by its ligand, CSF-1. Innate immunity, as well as macrophage differentiation and survival, are regulated by the stimulation of the CSF-1R. Another ligand, interlukin-34 (IL-34), was recently reported to activate the CSF-1R receptor in a different manner. The relationship between CSF-1R and microglia has been reviewed. Both CSF-1 antibodies and small molecule CSF-1R kinase inhibitors have now been tested in animal models and in humans. In this Perspective, we discuss the role of CSF-1 and IL-34 in producing cancer, bone disorders, and inflammation. We also review the newly discovered and improved small molecule kinase inhibitors and monoclonal antibodies that have shown potent activity toward CSF-1R, reported from 2012 until 2017." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0009.jpeg" /></meta><meta name="twitter:title" content="Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00873"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00873">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00873&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00873&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00873&amp;href=/doi/10.1021/acs.jmedchem.7b00873" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5450-5466</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00739" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b01370" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Mohammed I. El-Gamal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mohammed I. El-Gamal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</div><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mohammed%0AI.++El-Gamal">Mohammed I. El-Gamal</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4269-5264" title="Orcid link">http://orcid.org/0000-0002-4269-5264</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shahad K. Al-Ameen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shahad K. Al-Ameen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shahad+K.++Al-Ameen">Shahad K. Al-Ameen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dania M. Al-Koumi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dania M. Al-Koumi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dania+M.++Al-Koumi">Dania M. Al-Koumi</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mawadda G. Hamad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mawadda G. Hamad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mawadda+G.++Hamad">Mawadda G. Hamad</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nouran A. Jalal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nouran A. Jalal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nouran+A.++Jalal">Nouran A. Jalal</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Chang-Hyun Oh</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chang-Hyun Oh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Biomaterials, Korea Institute of Science and Technology, P.O. Box 131, Cheongryang, Seoul 130-650, Republic of Korea</div><div class="loa-info-affiliations-info">Department of Biomolecular Science, University of Science and Technology, 113 Gwahangno, Yuseong-gu, Daejeon 305-333, Republic of Korea</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +82 2 958 5160. E-mail: <a href="/cdn-cgi/l/email-protection#80e3e8efe8c0ebe9f3f4aef2e5aeebf2"><span class="__cf_email__" data-cfemail="ea89828582aa8183999ec4988fc48198">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chang-Hyun++Oh">Chang-Hyun Oh</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00873&amp;href=/doi/10.1021%2Facs.jmedchem.7b00873" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5450–5466</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 2, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 June 2017</li><li><span class="item_label"><b>Published</b> online</span>2 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00873" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00873</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5450%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMohammed%250AI.%2BEl-Gamal%252C%2BShahad%2BK.%2BAl-Ameen%252C%2BDania%2BM.%2BAl-Koumi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D13%26contentID%3Dacs.jmedchem.7b00873%26title%3DRecent%2BAdvances%2Bof%2BColony-Stimulating%2BFactor-1%2BReceptor%2B%2528CSF-1R%2529%2BKinase%2Band%2BIts%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5466%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00873"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4390</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00873" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mohammed\nI.&quot;,&quot;last_name&quot;:&quot;El-Gamal&quot;},{&quot;first_name&quot;:&quot;Shahad&quot;,&quot;last_name&quot;:&quot;K. Al-Ameen&quot;},{&quot;first_name&quot;:&quot;Dania&quot;,&quot;last_name&quot;:&quot;M. Al-Koumi&quot;},{&quot;first_name&quot;:&quot;Mawadda&quot;,&quot;last_name&quot;:&quot;G. Hamad&quot;},{&quot;first_name&quot;:&quot;Nouran&quot;,&quot;last_name&quot;:&quot;A. Jalal&quot;},{&quot;first_name&quot;:&quot;Chang-Hyun&quot;,&quot;last_name&quot;:&quot;Oh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5450-5466&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00873&quot;},&quot;abstract&quot;:&quot;Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is overstimulated by its ligand, CSF-1. Innate immunity, as well as macrophage differentiation and survival, are regulated by the stimulation of the CSF-1R. Another ligand, interlukin-34 (IL-34), was recently reported to activate the CSF-1R receptor in a different manner. The relationship between CSF-1R and microglia has been reviewed. Both CSF-1 antibodies and small molecule CSF-1R kinase inhibitors have now been tested in animal models and in humans. In this Perspective, we discuss the role of CSF-1 and IL-34 in producing cancer, bone disorders, and inflammation. We also review the newly discovered and improved small molecule kinase inhibitors and monoclonal antibodies that have shown potent activity toward CSF-1R, reported from 2012 until 2017.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00873&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00873" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00873&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00873" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00873&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00873" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00873&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00873&amp;href=/doi/10.1021/acs.jmedchem.7b00873" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00873" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00873" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00873%26sid%3Dliteratum%253Aachs%26pmid%3D29293000%26genre%3Darticle%26aulast%3DEl-Gamal%26date%3D2018%26atitle%3DRecent%2BAdvances%2Bof%2BColony-Stimulating%2BFactor-1%2BReceptor%2B%2528CSF-1R%2529%2BKinase%2Band%2BIts%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D13%26spage%3D5450%26epage%3D5466%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/13" title="Go to Volume 61, Issue 13"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/jmcmar.2018.61.issue-13/20180712/jmcmar.2018.61.issue-13.largecover.jpg" alt="Go to Volume 61, Issue 13"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is overstimulated by its ligand, CSF-1. Innate immunity, as well as macrophage differentiation and survival, are regulated by the stimulation of the CSF-1R. Another ligand, interlukin-34 (IL-34), was recently reported to activate the CSF-1R receptor in a different manner. The relationship between CSF-1R and microglia has been reviewed. Both CSF-1 antibodies and small molecule CSF-1R kinase inhibitors have now been tested in animal models and in humans. In this Perspective, we discuss the role of CSF-1 and IL-34 in producing cancer, bone disorders, and inflammation. We also review the newly discovered and improved small molecule kinase inhibitors and monoclonal antibodies that have shown potent activity toward CSF-1R, reported from 2012 until 2017.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Receptor tyrosine kinases (RTKs) play a major role in maintaining homeostasis as they provide important pathways for signal transduction that allow cell communication, maintain normal cellular processes, and provide surface receptors for many hormones and growth factors. These trans-membrane proteins contain extracellular domains to which ligands bind and initiate intracellular signaling via activation of their attached TK moieties.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The human genome includes 58 RTKs including including fibroblast growth factor receptor (FGFRs), epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and others, along with 32 nonreceptor TKs, many of which are tightly linked to receptors. RTKs are classified into different groups depending on the homology of their active sites and the similarity of their ligands.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> They contribute to the initiation, development, and progression of several types of cancers, inflammations, and bone osteolysis due to the effects of mutations on receptor function or to receptor or ligand overexpression, so they are very promising therapeutic targets. One of the most important receptors among type III RTKs is CSF-1R (FMS, c-FMS, CD115, or M-CSFR) kinase, a member of the PDGFR class of RTKs that was reported initially to be an oncogene for feline McDonough sarcoma.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> CSF-1R is expressed on hematopoietic stem cells (HSCs) at low levels and at higher levels on monocytes, macrophages, myeloid dendritic cells, microglia, and osteoclasts. It plays an important role in regulating their development. CSF-1R is also found in other cells such as oocytes (immature egg cell), preimplantation embryos, epithelial cells, and colonic epithelial cells. It binds to macrophage colony-stimulating factor (M-CSF or CSF-1) and interleukin-34 (IL-34). IL-34 has generally similar biological properties to CSF-1, with the main differences arising from their different spatiotemporal regulation and the fact that CSF-1 acts both in an autocrine and paracrine fashion, whereas IL-34 acts purely locally, Activation of CSF-1R promotes the survival, differentiation, and proliferation of macrophage and monocyte lineages, yet their overexpression is associated with disorders.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> As a result, inhibitors that regulate their functions are of high interest.</div><div class="NLM_p last">We have previously reviewed the biology of CSF-1R kinase and its related diseases as well as the CSF-1R kinase inhibitors and antibodies published in the literature until the end of 2011.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Herein, we reviewed the role of CSF-1R in cancers, bone osteolysis, and inflammatory disorders, as well as IL-34 and its role as a second ligand for the CSF-1 receptor and potential inhibitors or antibodies targeting CSF-1R. This article covers the period from 2012 until 2017.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  CSF-1 and Bone Osteolysis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bone cells can be divided into three main types: osteoclasts (OCs), osteoblasts (OBs), and osteocytes (OSs). Each one of them is responsible for a particular function in maintaining the bone structure. OBs form the bone while OCs destroy it, and osteocytes keep the balance between OBs and OCs.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Bone tissues are continuously going through a process called bone remodeling or coupling in which they are destroyed and rebuilt again over time. This process is regulated by cross talk between OBs and OCs.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> OBs are cells with a single nucleus that arise from a mesenchymal precursor,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and they can be differentiated in vitro with the addition of ascorbic acid (vitamin C), dexamethasone, or β-glycerol phosphate.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> OBs cells are responsible for initial bone buildup and for later remodeling.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Osteoclasts, the cells responsible for bone destruction, are multinucleated cells that are developed with the help of CSF-1 and receptor-activated nuclear factor κ-B (RANK) ligand (RANKL) from osteoclast progenitor cells (OPs), which in turn derive from hematopoietic stem cells (HSCs) or blood stem cells.<a onclick="showRef(event, 'ref6 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref9 ref10">(6,9,10)</a> The ability of bones to renew themselves gives these types of tissues a unique dynamic structure that can adapt to the surrounding environment. Any abnormality in the process of bone remodeling results in different disease conditions that affect bone density and structure such as osteoporosis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Mice lacking CSF-1 (op/op) were found to be underweight and toothless and to have a weak skeletal structure<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and a defect in osteocyte proliferation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Until recently, it was believed that OBs controlled OCs, but recently mutual cross-regulation of the two has been demonstrated. OC formation in the body occurs through a particular pathway. First, CSF-1 is produced in the bone marrow by OB cells and binds to CSF-1R located on the surface of osteoclast precursors (OCPs). After that, RANKL expression is stimulated in response to CSF-1R signals. Lastly, OCPs fuse together to form multinucleated OC cells.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The relationship between CSF-1 and OC cells was demonstrated by a study done using the Meox2-Cre line to generate mice lacking CSF-1 (CSF-KO). This type of mouse showed a defect in osteocyte survival and function which resulted in poor bone structure.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">Some growth factors such as insulin-like growth factor (IGF) and bone morphogenetic protein (BMP), which are released during bone resorption, can stimulate OB differentiation and bone buildup. These growth factors are secreted in the presence of an acid generated by osteoclasts.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> CSF-1 maintains appropriate levels of OCPs in the bone marrow. It also increases RANK expression in OCPs.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Polarization of hematopoietic stem cells (HSCs) occurs in the presence of CSF-1, while RANKL is present in the differentiation process.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Mice lacking RANK-L or CSF-1 are unable to generate OB cells, which leads to low bone density and osteoporosis.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> When CSF-1 is administered to op/op mice, the bone marrow cavity starts to form again, and that is an important step in curing osteoporosis.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  CSF-1 and Cancer</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Macrophages play an essential role in innate defense mechanism. Macrophages arise from monocytes, which normally differentiate into M1 proinflammatory macrophages, but under certain circumstances, such as in many tumor microenvironments, they can differentiate into antiinflammatory M2 macrophages, also called tumor-associated macrophages (TAMs), that allow for cancer cell growth, metastasis, angiogenesis, and especially localized immunosuppression. Overexpression of CSF-1, which is a monocyte chemoattractant, by tumor cells has been associated with their recruitment and differentiation into TAMs (M2) in various kinds of cancers.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> TAMs are related to macrophages and are derived from monocytes that circulate in the bloodstream and situate themselves at the tumor site.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Tumors release CSF-1, which is a cytokine responsible for the proliferation, survival, and differentiation of the macrophages after it binds to the CSF-1R. Overexpression of CSF-1 has been associated with activation and recruitment of TAMs in various types of cancers.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> TAMs also tend to accumulate in low oxygen conditions and allow the expression of other growth factors, such as VEGF. VEGF stimulates the formation of blood vessels and endothelial cell proliferation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> High CSF-1 levels were reported in breast, prostate, pancreas, renal, ovary, and many other types of cancer. Overexpression of CSF-1 and its receptor, CSF-1R, in tumors has been linked to poor prognosis.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">CSF-1/CSF-1R inhibitors are clinically developed to control protein overexpression and are classified as either:<table class="listgroup" border="0" width="95%" id="list1" list-type="label"><tr class="li1"><td valign="top">1</td><td colspan="5" valign="top" class="paragraph"><p class="last">Kinase domain inhibitors.</p></td></tr><tr class="li1"><td valign="top">2</td><td colspan="5" valign="top" class="paragraph"><p class="last">Protein–protein interaction inhibitors (protein–ligand or receptor dimerization inhibitors).</p></td></tr></table></div><div id="sec3-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">3.1.  CSF-1 and Breast Cancer</h3><div class="NLM_p">CSF-1 and CSF-1R are normally expressed in breast tissue during puberty, pregnancy, and lactation. However, their overexpression or the repeated stimulation of CSF-1R by released CSF-1 is exhibited in several cancers including breast cancer. Additionally, the co-expression of both CSF-1 and CSF-1R in neoplastic epithelial cells of breast cancer patients correlates with poor prognosis and predicts ipsilateral recurrence. A study was carried out on patients with breast cancer that showed a link between high levels of CSF-1 and tumor progression.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p last">Another study on macrophage-deficient (MMTV-PYT) mice lacking the CSF-1 gene was conducted to observe the role of CSF-1 in metastasis, as it is regulated by TAMs. The results of this study showed that TAMs were incapable of accumulation in the tumor, and they reduced cancer growth and lung metastasis. Because the tumor will attract TAMs by the secreted CSF-1, this cytokine migrates with the collagen fibers and invades locally or moves to reach the blood vessels, causing metastasis. Inhibiting TAMs by targeting the CSF-1/CSF-1R may be one of the most effective ways to stop tumor progression and improve cancer outcomes. Such inhibition can decrease metastasis to organs such as the lungs and bones, and the inhibition of TAMs increases neutrophil numbers at some sites.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a></div></div><div id="sec3-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.2.  CSF-1 and Renal Cell Carcinoma</h3><div class="NLM_p">Renal cell carcinoma (RCC) is the seventh most common cancer in men and the ninth most common in women. It appears mostly in patients with end-stage renal failure, acquired renal cystic disease, obesity, and tuberous sclerosis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">After a renal injury (transient renal ischemia/reperfusion), CSF-1/CSF-1R are co-expressed on tubular epithelial cells (TECs), resulting in high proliferative and antiapoptotic behavior to replenish the injured TECs and promote healing. CSF-1R is expressed in epithelial cells in some cancers, such as prostate and breast cancer, which makes it likely that CSF-1 and CSF-1R are co-expressed in RCC. To test this hypothesis, several studies have been done to determine whether CSF-1R is limited only to RCC; by observing TECs near to and away from cancerous cells that detected a high expression of CSF-1R close to the RCC, CSF-1R expression decreased with increasing distance from RCC. Because CSF-1 and CSF-1R are mostly expressed on cells adjacent to the tumor, this explains the co-expression of CSF-1 and CSF-1R on TECs near the RCC and their role in tumor propagation and proliferation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">CSF-1-induced activation of M2 macrophages contributes to the immune dysfunction evident in RCC. CSF-1 regulates TAM production in the RCC microenvironment, encouraging cellular migration and tumor growth. TAMs also play a role in the epithelial–mesenchymal transition of RCC and its resistance to inhibitors. Suppression of TAM recruitment is an important target because the presence of TAMs indicates poor prognosis in patients with RCC.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec3-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.3.  CSF-1 and Pancreatic Cancer</h3><div class="NLM_p last">Pancreatic cancer (PC) is an aggressive type of cancer with a high death rate due to the late diagnosis of the disease. Its overall survival rate in patients with metastasis is approximately 12 months, while in patients with local advanced PC, it is 24 months.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The main cause of the tumor microenvironment is the contribution of TAMs, granulocytic myeloid-derived suppressor cells (GMDSC), and myeloid-derived suppressor cells (MDSCs) as they promote the proliferation of tumor cells, ease tumor cells metastasis, and cause cytotoxic resistance, which leads to poor prognosis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> MDSCs, which express two markers CD11b and Gr-1, are precursors to macrophages, granulocytes, and dendritic cells. Their high expression and accumulation in tumor cells is driven by GM-CSF, which is a type of colony stimulating factor. Consequently, this leads to an inhibition of the antitumor function of CD8<sup>+</sup> T-cells.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Furthermore, CSF-1 is highly expressed in the epithelial cells of pancreatic ductal adenocarcinoma (PDAC), which promotes the production of cytokines by M1 and M2 macrophages, allowing tumor migration.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In animal tumor models, blockage of CSF-1R enhances antitumor activity only in tumors with high levels of MDSCs, which makes it a pretreatment biomarker for pancreatic cancer patients.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec3-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.4.  CSF-1 and Lung Cancer</h3><div class="NLM_p last">Lung cancer is one of the most fatal cancers. It has high mortality and metastasis rates; 60–70% of patients experience bone metastases.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Late diagnosis in advanced stage IV lung cancer means that 5-year survival is only 16%. Most of these patients experience chest pain, coughing, dyspnea, weight loss, and chronic obstructive pulmonary disease (COPD).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> There are two major types of lung cancer, nonsmall cell lung cancer (NSCLC) that affects 85% of patients and small cell lung cancer (SCLC) which accounts for the rest (15%).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> CSF-1 secretion, which is localized in lung cancer, contributes to a poor prognosis. Moreover, CSF-1 stimulates TAMs that exhibit tumorous effects by enhancing tumor expansion and angiogenesis and supporting the production of pro-angiogenic factors such as VEGF, IL-10, TNF-α, or others.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In the A549 adenocarcinoma cell line model of NSCLC, CSF-1/CSF-1R are expressed and associated with high proliferation, lung cancer bone metastasis, and promotion of chemotherapy resistance.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Treatment A549 cells with a CSF-1 inhibitor reduces tumor prevalence and bone metastases. Inhibition of CSF-1/CSF-1R signaling causes a rapid reduction in TAMs within 48 h.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">4.  CSF-1 and Inflammation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Rheumatoid arthritis (RA) is a systemic chronic inflammatory condition that results in joint destruction, scars, and deformity. One percent of all age groups globally are affected by RA. This autoimmune disease is caused by a disruption of bone homeostasis which is regulated by the balance between osteoclast and osteoblast.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Manifestations of RA, such as bone loss, are mediated by an immune response which involves pro-inflammatory cytokines including TNF-α and several other immune cells.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> TNF-α, which is secreted from activated macrophages, helps regulate the immune response and the production of RANKL and CSF-1 from osteoblasts.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> The involvement of immune cells in inflammation and bone loss was studied to examine the effect of inhibiting CSF-1R and its ligands (CSF-1 and IL- 34) in RA patients and models of RA.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">The level of synovial macrophages and their release of inflammatory cytokines were found to affect the progression and the activity of RA. Compounds that are able to inhibit the survival, activation, or differentiation of macrophages through inhibiting CSF-1R or its ligands may have a therapeutic efficacy in treating RA.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> CSF-1R is expressed in different cells involved in RA progression such as tissue macrophages, immature dendritic cells (DCs), OCs, and OBs. CSF-1 and IL-34 play a major role in osteoclastogenesis and are expressed in synovial endothelial cells and are highly expressed in the serum and synovial fluid of RA patients. In vitro data showed that CSF-1 can also be produced by synovial fibroblasts and chondrocytes after the induction effect of TNF-α and IL-1β.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> CSF-1 signaling was found to increase the numbers of DCs, and also it is required for their differentiation.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p last">Animal studies on mice have shown that the administration of CSF-1 increased the severity of collagen-induced arthritis (CIA) in contrast to mice deficient in CSF-1R that had less disease severity. Pharmacological inhibition of CSF-1R, administration of antibodies against CSF-1, or genetical deletion of CSF-1 reduced synovial inflammation and joint erosion in animal models of RA.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> Clinical studies found an elevation of CSF-1 levels in the synovium of patients with RA while in healthy individuals no CSF-1 overexpression was noticed.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Using antihuman CSF-1R antibody (huAb1), which inhibits the binding of CSF-1R to its ligands, reduced the production of different chemokines and IL-6 in the synovial explant. In vivo studies on murine models with CIA showed that the administration of antimouse CSF-1R antibody (muAb5) reduced the joint deformity in models with RA compared to control.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">5.  Interleukin-34</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Interleukin-34 (IL-34) was found to signal through CSF-1R along with CSF-1 on cells of mononuclear phagocyte system after examination using a human monocyte proliferation screening assay.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> This signaling causes receptor dimerization, autophosphorylation, activation of extracellular signal-regulated kinase 1/2 (ERK1/2) signaling, and expression of genes that play a role in the mononuclear phagocyte cells viability.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> This explains the more severe phenotype of mice deficient in CSF-1R (CSF-1R–/−) compared to those deficient in CSF-1 (CSF-1op/op).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> CSF-1op/op mice experienced a severe loss of bone osteoclasts, reduced levels of macrophages (which partially increased as the mice aged) in some tissues, a moderate reduction of microglia, and a relatively normal level of Langerhans cell development in the skin. In contrast, CSF-1R–/– mice are profoundly depleted of macrophages and deficient in osteoclasts, microglia, and Langerhans cells throughout their lifetimes. This suggests that CSF-1R is activated by IL-34 independently of CSF-1. When IL-34 was tested using different assays, it showed a high specificity to monocytes and macrophages, which was supported by the lack of binding of IL-34 to 28 other cell types and the lack of significant sequence similarity between it and any other cytokine or protein.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Despite the functional similarity between IL-34 and CSF-1, there are some notable differences between them. Cell culture studies show that both ligands are equally important for primary human monocytes viability and for the formation of macrophage colonies from human bone marrow. CSF-1 can be replaced by IL-34 to promote RANKL-induced osteoclastogenesis.<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37,40)</a> The helical cytokine fold in the crystal structure of dimeric IL-34 is similar to that in CSF-1; both of them are short-chain, helical cytokines and belong to the same class.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Moreover, IL-34 has more restricted expression than CSF-1, and upon binding CSF-1R produces more efficient receptor activation and internalization.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> In addition, IL-34 showed a more potent binding and a stronger activation of CSF-1R than CSF-1 but a more transient tyrosine phosphorylation of the receptor. One of the most observed differences between IL-34 and CSF-1 is their expression in embryonic and adult tissues, leading to a complementary, but not redundant activation of CSF-1R.<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37,40)</a></div><div class="NLM_p">A research group tested several biopsies from osteosarcoma patients and observed high IL-34 expression levels.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> This increases the progression of osteosarcoma and facilitates lung metastases. IL-34 mRNA could be observed in nonstimulated cells, as could dose-dependent upregulation of IL-34 mRNA expression by TNF-α and IL-1β; this result was confirmed using confocal microscopy analysis, showing an increase of IL-34 in osteosarcoma cells treated with TNF-α and IL-1β, in contrast to no such upregulation by the cytokines in normal cells. Immunohistochemical analysis of human osteosarcoma biopsies revealed that most osteosarcoma cells showed positive nuclear and/or cytoplasmic immunostaining for IL-34. The involvement of IL-34 in the progression of osteosarcoma was studied by modifying the human osteosarcoma cell line (HOS), which normally expresses a small amount of IL-34, to overexpress IL-34 and by then implanting in nude mice to observe the tumor progression. Overexpression of IL-34 significantly increased (by 57%) tumor volume and the establishment of lung metastases compared to the control group.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">The role of IL-34 and disease progression was investigated in patients with RA.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The results of this study showed production of IL-34 in the synovium, synovial fluid, and fibroblast-like synovial cells of patients with RA in similar levels as those for CSF-1, suggesting a role of IL-34 in RA pathogenesis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p last">The formation of OCs in mouse models is stimulated by IL-34 and RANKL in a dose-dependent fashion. Systemic IL-34 administration to the mouse bloodstream increases the number of CD11b+ cells and decreases bone density, while in humans, IL-34 and RANKL regulate OC differentiation.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">6.  CSF-1R and Microglia</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Development of CNS microglia depends on several growth factors including CSF-1R kinase, and CSF-1R is expressed by microglia.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> CSF-1R is very essential for microglia cell viability, and it was reported that mice with knocked out CSF-1R had no microglia.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> CSF-1R kinase inhibitors such as PLX3397 inhibited EOC 20 microglial cell growth in vitro and eliminated almost all microglia from the adult CNS with no negative effect on cognition or behavior. So microglia are physiologically dependent on CSF-1R signaling, and they are not necessary for cognitive or behavioral tasks. When the inhibitor was withdrawn, rapid repopulation occurred and new cells differentiated into microglia in mice in a week. Elimination of the microglia did not compromise the BBB integrity.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> On the other hand, mice with engineered overexpression of CSF-1R in astrocytes exhibit increased microglial proliferation.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">Microglia are the first cells that respond to intracerebral hemorrhage. As CSF-1R inhibition has a negative impact on microglia, PLX3397 attenuated neurodeficits, and brain edema in vivo in intracerebral hemorrhage models. In these models, intracerebral hemorrhage was induced by injection of collagenase or autologous blood. CSF-1R inhibition ablates microglia and helps protect the brain through reduction of leukocyte infiltration in brain and improvement of BBB integrity. So CSF-1R inhibition helps attenuate brain injury after intracerebral hemorrhage.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p last">It was reported that microglial loss due to CSF-1R inhibition disrupted brain development and caused olfactory deficits.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> It was reported also that CSF-1R gene mutations caused adult-onset leukoencephalopathy, which is an autosomal-dominant neurodegenerative disease. Many neurological disorders such as Alzheimer’s disease, Krabbe’s disease, Charcot–Marie–Tooth disease, glioma, and multiple sclerosis can be modulated by CSF-1R ligands and inhibitors.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">7.  CSF-1 and CSF-1R Antibodies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Monoclonal antibodies (mAb) have been developed to block the CSF-1/CSF-1R pathway, inhibit CSF-1 dependent colony formation, and prevent the activities of CSF-1 and CSF-1R. Several studies have backed this method of inhibition. To determine CSF-1R expression in RA patients and the effectiveness of an anti-CSF-1R antibody in different animals with RA, the expression of CSF-1R was inspected in the synovium, bone, and blood samples from RA, osteoarthritis (OA), and healthy humans. CSF-1R expression was increased in the synovium of RA patients compared with OA patients and healthy people. In mice, blockage of CSF-1R stopped cartilage damage, systemic bone loss, and bone erosion. This was associated with reduction of osteoclast in both models.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Another study was performed to determine the influence of lipopolysaccharide (LPS), an effective inflammatory inducer of bone loss or bone resorption and an anti-CSF-1R antibody on osteoclastogenesis. Mice injected with a combination of LPS and anti-CSF-1R antibody had greater decrease in osteoclast number than mice injected with only LPS.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Anti-CSF-1R antibodies also stopped further bone destruction, which aids in cancer-induced weight loss in a breast cancer model of bone metastasis.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In addition, mice with unilateral knee arthritis induced by complete Freund’s adjuvant (CFA) injections, the administration of an intra-articular injection of monoclonal antibody, and recombinant human CSF-1 therapy, alone or in combination with other cytokines, successfully increases the number and viability of monocytes/macrophages, improves antibody-dependent cellular cytotoxicity (ADCC), enhances antimicrobial responses, decreased platelet and cholesterol levels, and is a therapeutic target in LPS-induced osteoclastogenesis as it inhibits inflammation-induced bone erosion. Therefore, CSF-1 and the inhibition of its receptor is a promising target and therapeutic alternative for different conditions.<a onclick="showRef(event, 'ref36 ref54'); return false;" href="javascript:void(0);" class="ref ref36 ref54">(36,54)</a></div><div id="sec7-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">7.1.  H27K15</h3><div class="NLM_p last">H27K15 is a new monoclonal antibody that has been developed to overcome the issue of increased CSF-1 expression caused by treatment with mAb. Blockage of the formation of CSF-1/CSF-1R complex results in a rebound effect on treated patients due to disturbance of CSF-1 degradation and internalization.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> H27K15 is a nonligand competitive anti-CSF-1 mAb that exerts its activity by affecting signal transduction and partially inhibiting CSF-1R. This antibody prevents the differentiation of monocytes into CD163+CD64+ M2-polarized macrophages and moves them toward CD14–CD1a+ dendritic cells. It inhibits the secretion of monocyte chemotactic protein-1 and reduces interleukin-6 production, which are involved in M2 macrophage recruitment. H27K15 is derived from an IgG2a antibody called CXIIG6, which is an antihuman CSF-1R mAb that stains a CSF-1R-transfected NIH/3T3 cell line but not untransfected cells. The mAb recognizes an epitope on the N-terminal domain of the protein to induce a dose-dependent decrease in MMP-9 production by monocyte-derived osteoclasts and a decrease in dependent CSF-1 phosphorylation of the CSF-1R intracellular tyrosine (Tyr 708) in NIH/3T3-CSF-1R cells. H27K15 was generated to be evaluated as a cancer immunotherapy. It exhibits a similar effect to CXIIG6, which decreases CSF-1-dependent phosphorylation of CSF-1R. ELISA data showed that H27K15 targets human CSF-1R and has no cross reactions with other tyrosine kinases.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> H27K15 is a promising drug candidate for cancer immunotherapy that could help in preventing rebound effects and toxicity in treated patients.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div></div><div id="sec7-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">7.2.  RG7155</h3><div class="NLM_p">Emactuzumab (RG7155) is a recombinant, humanized monoclonal antibody that exhibits its activity directly against the CSF-1R expressed on macrophages by binding to the receptor surface and blocking its activity. It decreases TAMs, induced by cancer, which suppress the anticancer immune response in the body.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> The RG7155 monoclonal antibody inhibits CSF-1R (IC<sub>50</sub> = 0.3 nM), causing cell death and inhibiting CD68/CD163 macrophages. RG7155 is selective for CSF-1R, inhibits dimerization of the receptor, and prevents formation of the ligand/receptor complex. Consequently, the antibody inhibits CSF-1R and blocks ligand-dependent and ligand-independent receptor activation.</div><div class="NLM_p">Inhibition of CSF-1R by the mAb resulted in a reduction of F4/80+ TAMs and an increase in the CD8/CD4 ratio in tumor cells across various solid malignancies. This was reflected by RG7155 treatment where T cell infiltrate dominated by CD4 T cells was switched to CD8 predominated lymphocyte infiltrate.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> RG7155 activity and safety in patients with advanced local diffuse-type, tenosynovial giant cell tumor (Dt-GCT) was supported preclinically by animal models and patients.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Dt-GCT is a tumor characterized by cytogenetic abnormalities of a chromosomal translocation in the gene encoding CSF-1, and this results in an overexpression of CSF-1 and activation of CSF-1R. This allows the recruitment of macrophages that associated with the tumor mass in Dt-GCT. Targeting CSF-1R with emactuzumab is highly effective in patients with Dt-GCT even when used as a short course therapy in patients who cannot undergo surgery.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p last">In conclusion, RG7155 shows many promising activities in treating Dt-GCT, as it is not only limited to TAMs but also increases tumor immune effector cells, as reflected by the CD4/CD8 T-cell ratio.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div></div><div id="sec7-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">7.3.  FPA008</h3><div class="NLM_p last">Cabiralizumab (FPA008) is a monoclonal antibody developed by the FivePrime Company. FPA008 blocks the binding of both CSF-1 and the IL-34 ligand to CSF-1R in patients with RA, as shown in preclinical models of RA, which results in a decrease in CD14+/CD16++ nonclassical monocytes.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> Inhibition of CSF-1R resulted in a dose-dependent increase in the levels of CSF-1R and IL34. FPA008 safety profiling shows that a dose of 1 or 3 mg/kg has adverse effects such as facial swelling, headache, pruritus, fatigue, and eyelid edema; those adverse events are self-limited.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> FPA008 is currently being evaluated in phase Ia/Ib of a clinical trial and targets immune cells, macrophages, and monocytes in many advanced solid tumors and RA that are activated in the disease settings. FPA008 blocks the binding of CSF-1R to CSF-1 and IL-34, thus inhibiting the survival and activity of these cells.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div></div><div id="sec7-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">7.4.  TG3003</h3><div class="NLM_p last">TG3003 acts against CD115, a CSF-1 cell surface receptor. TG3003 does not block CSF-1/CSF-1R binding but downmodulates CD115 signaling. Compared to other anti-CSF-1 antibodies, TG3003 does not show any cytotoxic activity in normal myeloid cells. In in vitro studies, TG3003 deprives monocyte differentiation from M2-type macrophages to CD14- CDa+ cells, dendritic cells that are able to stimulate T cell responses. Because it inhibits M2-TAMs, it will enhance a patient’s immune response and affect tumor progression.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> It also inhibits the secretion of MCP-1/CCL2 and the production of IL-6, which are associated with M2-macrophage polarization. Moreover, TG3003 maintains CSF-1 circulatory levels as it does not inhibit the physiological pathway of its degradation, in contrast to other mAbs, which helps prevent the toxic and rebound effect in treated individuals.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">8.  CSF-1R Kinase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">8.1.  Cyanoimidazolecarboxamides</h3><div id="sec8-1-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">8.1.1.  JNJ-40346527</h4><div class="NLM_p">JNJ-40346527 (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is an oral CSF-1R kinase inhibitor (IC<sub>50</sub> = 3.2 nM in cell-free kinase assay) that selectively binds to CSF-1R in RA patients. A phase II clinical study on patients with active RA was carried out based on a phase I study that found high efficacy of compound <b>1</b> on inhibition of CSF-1 and expected a more than 90% decrease in CSF-1R activity, suggesting compound <b>1</b> as a possible treatment of RA. The phase II study demonstrated no significant difference in efficacy between the compound <b>1</b>-treated group and the placebo-treated group. Higher levels of CSF-1 and lower levels of CD16+ monocytes indicates that compound <b>1</b> binds to the CSF-1 receptor and inhibits the response of macrophages to CSF-1 at a concentration of less than 10 nM. Despite the effective binding of the drug to CSF-1R, the drug was not effective in treating DMARD-refractory RA patients.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Adverse effects were related to its mechanism of action; inhibition of liver-derived macrophages, called Kupffer cells, which account for approximately 90% of tissue macrophages in the body and acts to clear liver enzymes, resulted in an increase of liver enzymes.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a> Other preclinical studies showed that compound <b>1</b> could be used in the treatment of relapsed or refractory classical Hodgkin lymphoma (cHL).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cyanoimidazolecarboxamide and cyanofurancarboxamide CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>1</b> was found to inhibit macrophages in animal models and to decrease proliferation of Hodgkin lymphoma (HL) cell lines in vitro. This compound affects cHL by two pathways, targeting TAMs and regulating tumor cells in Hodgkin lymphoma.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> CSF-1R bound to the ligand was found in samples taken from patients with cHL. A reduction of HL cell viability was observed following treatment with the CSF-1R inhibitor, suggesting a role for the CSF-1R pathway in the activity of the disease. A phase I/II, multicenter study showed that compound <b>1</b> is relatively safe and well-tolerated by cHL patients but had a limited activity as a monotherapy for cHL treatment. Absorption of compound <b>1</b> was fast according to a single-dose phase I study where doses ranged from 10 mg daily to 450 mg twice daily with a <i>t</i><sub>max</sub> of 1–3.5 h and a <i>C</i><sub>max</sub> increasing with the dose up to 450 mg daily. A multiple-dose study of doses ranging from 50 mg daily to 300 mg twice daily for 14 successive days showed a proportional increase between the dose and <i>C</i><sub>max</sub> following daily dosing. Plasma CSF-1R levels 4 h postdose were more than 80–90% inhibited in most patients and all treatment schedules, confirmed the binding of compound <b>1</b> to the receptor. The 24 h postdosing analysis showed a decrease in the inhibition of plasma CSF-1R for the daily doses, while the 150 mg twice daily dose showed a sustained inhibition (peak and trough analysis), making it a more suitable dose for the phase II study according to the PK and PD analyses. One patient with multiply relapsed disease had the best overall response, which is a complete remission after a treatment with 150 mg daily for approximately one year. Other patients showed a stable or progressive disease state. In vivo pharmacological activity showing an inhibition of the phosphorylation of CSF-1R by 95% was observed following a dose of 450 mg in the single-dose study and a dose of 150 mg daily in the multiple-dose study. Dose ranges from 150 to 600 mg/day showed acceptable safety and tolerability in healthy volunteers. Although the percentage of CSF-1R inhibition and targeting in the tumor cells was high, this phase II study reported no noticeable efficacy in patients with late stage cHL who had tried other treatments before trying compound <b>1</b>. This could be due to the ability of HL cells to differentiate and activate other signaling mechanisms or messengers in the tumor cells of these patients, making it difficult for single-target molecules to be effective on them and leading to resistance of these molecules. Further assessment of these single-target molecules in combination with other agents is required for optimal cancer treatment.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div></div><div id="sec8-1-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">8.1.2.  Other Cyanoimidazolecarboxamide and Cyanofurancarboxamide Derivatives</h4><div class="NLM_p last">Numerous arylamides are CSF-1R inhibitors. The main core structure, 1,2,4-phenylenetriamine, exhibits excellent potency and good efficacy in vivo. However, it may form reactive quinone diimine metabolites that cause tissue damage due to glutathione depletion and protein toxicity. That is why the structure has had several modifications made to it, especially to the C-2 and C-4 located in the aryl group as they have an impact on the activity. The best activity occurred when the methylpiperidine at the C-2 position was replaced with a cyclohexene ring. Replacing piperazine with a piperidine group on C-4 showed potency retention (compounds <b>3</b> and <b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> They demonstrated good activity against CSF-1R as well as CSF-1 in a cell-based assay. However, they had low efficacy in a pharmacodynamics assay and poor pharmacokinetics properties that produced disappointing results in vivo. In the case of more basic piperazine derivative (compound <b>3</b>), this compound showed the cons of off-target activity and bonded strongly to sodium and calcium channels, which led to increased risk of adverse cardiovascular effects. As a result of these modifications, a new compound JNJ-28312141 (<b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) with reduced basicity compared to compound <b>2</b>, an acceptable solubility, better PD and PK properties, and great efficacy in a rodent model of RA progressed to clinical trials. Compound <b>5</b> exhibited reasonable selectivity against four kinases (FLT3, AXL, KIT, and TRKA) in addition to CSF-1R. Further testing of this compound against these kinases in cell-based assays resulted in a 16-fold selectivity for KIT over CSF-1R, which appeared to cause bone marrow suppression issue. Despite the fact that KIT inhibition can be beneficial in inflammation as it suppresses the function of dendritic and mast cells, other evidence shows that KIT inhibition may cause bone marrow suppression, anemia, hypospermia, and pigment loss. In vivo studies of compound <b>5</b> and its analogues show a reduction in reticulocyte counts and hypocellularity of the bone marrow, which relates its inhibition to unwanted adverse effects. Consequently, additional optimization is underway to improve the selectivity of compound <b>5</b> and its analogues to CSF-1R instead of KIT. Modeling shows small differences between CSF-1R and KIT close to the C-2 position that may enhance selectivity toward CSF-1R, while the difference near the C-4 position was less defined due to low resolution in the CSF-1R area. However, because it is close to solvent, this allowed for high flexibility in the variation of the structure without affecting the potency of the compound toward CSF-1R, allowing for optimization in these regions. The addition of 4,4-dimethyl groups to cyclohexene enhanced selectivity of these compounds toward CSF-1R. In the ATP binding site of CSF-1R, compound <b>5</b> and its analogues extended from the hinge zone and bound at the ribose pocket because Phe797 is shifted away from the region in CSF-1R, whereas in KIT, Phe is already forced into that space, preventing the dimethylcyclohexene from binding and causing a steric clash, leading to low potency as determined in a Mo7e cell assay (this assay was utilized here to investigate the inhibitory effect of the compound at cellular level). This also enhanced the potency of the compounds against CSF-1R by 1.8-fold compared with KIT by increasing selectivity toward CSF-1R. Although compound <b>5</b> showed good potency, it showed limited stability in human, mouse, and rat liver microsomes due to oxidation of the 4-position benzylic methine. Methyl substituents there increase metabolic stability, but only compound <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), possessing a 4-(HO (CH<sub>2</sub>)<sub>2</sub>)-piperazin-1-yl moiety, exhibited a good in vivo PD activity and reasonable potency against CSF-1R (IC<sub>50</sub> = 0.7 nM in cell-free kinase assay), BMDM assay (IC<sub>50</sub> = 6.1 nM) and Mo7e (IC<sub>50</sub> = 13 nM), allowing it to be considered for further evaluation. The PK properties of the compound <b>6</b> hydrochloride salt were evaluated in rats. After injection with 1 mg/kg iv of compound <b>6</b> mixed with 20% 2-hydroxypropyl-β-cyclodextrin (HPbCD), the volume of distribution was 7.6 L/kg. The systemic clearance of compound <b>6</b> was 55 mL/min/kg, which is moderate; the mean <i>C</i><sub>max</sub> after 5 mg/kg oral dose values was 88 ng/mL (210 nM), and the elimination <i>t</i><sub>1/2</sub> was 6.5 h. Furthermore, it showed acceptable systemic exposure (<i>F</i> = 31%, AUC = 690 ng·h/mL). These results encouraged conducting further in vivo studies. Compound <b>6</b> was tested in a streptococcal cell wall (SCW)-induced arthritis model of RA and proven to be efficacious in fully and partly inhibiting the progression of ankle swelling progression at doses of 40 and 10 mg/kg, respectively.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div></div><div id="sec8-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">8.2.  Aminopyrimidine Derivatives</h3><div id="sec8-2-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">8.2.1.  ENMD-2076</h4><div class="NLM_p">ENMD-2076 (<b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) is an orally active multitarget kinase inhibitor developed by CASI Pharmaceuticals.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> In addition to CSF-1R inhibition, it inhibits several other kinases, including Aurora A and B, angiogenesis enzymes (VEGFR and FGFR), and growth factors (CSF-1R, FIT-3, KIT). ENMD-2076 activity has been tested on MV4-11 cells that express CSF-1R and results in the inhibition of CSF-1 signals stimulating CSF-1R and reduction in mammary gland cancer growth (IC<sub>50</sub> = 600 nM), which shows that it has an antiangiogenic and antiproliferative profile that make it a potential therapeutic candidate for treating human cancers.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Compound <b>7</b> has been evaluated in phase I clinical trials in different types of tumors including liver and breast tumors and leukemia, and in phase II clinical trials in ovarian cancer.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> It will be tested in phase 2 clinical trials for treatment of ovarian clear cell carcinoma.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Aminopyrimidine CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8-2-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">8.2.2.  SB1578</h4><div class="NLM_p">SB1578 (<b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) is a macrocyclic JAK2 inhibitor that also has potent activity against the CSF-1R kinase. It plays an essential role in the initiation and pathogenesis of RA. It also has useful effects on bone and cartilage damage.</div><div class="NLM_p">Compound <b>8</b> possesses unique activities such as stopping the inflammatory response by preventing the diffusion of neutrophils and macrophages to affected joints, which reflects its great role in managing autoimmune diseases. This compound was discovered through a kinase inhibitor program by the S*BIO company, and it was produced from a pyrimidine-containing, low molecular weight series. It is a potent multikinase inhibitor, with IC<sub>50</sub> values of 69 nM for CSF-1R, 62 nM for FLT3, 46 nM for JAK2, and 230 nM for TYK2 in cell-free kinase assays. In monocytes isolated from peripheral blood, SB1578 has an IC<sub>50</sub> of 277 nM. It also has an inhibitory effect on THP-1 cells, which are stimulated with CSF-1 to induce autophosphorylation of CSF-1R.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p last">Compound <b>8</b> was also tested using a Micro-Equilibrium Dialyzer (Harvard Apparatus) to measure the amount of plasma protein binding to compound <b>8</b> in plasma obtained from five different species (human, rat, mouse, dog, and monkey). A high amount of SB1578 bound to human plasma (99%) and monkey plasma (98.7%) proteins, but lower amounts of compound <b>8</b> were bound by plasma proteins in the other species (87.3–87.5%).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div></div><div id="sec8-2-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">8.2.3.  GW 2580</h4><div class="NLM_p">GW 2580 (<b>9</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) is an oral bioavailable diaminopyrimidine derivative and a selective CSF-1R inhibitor in vitro with an IC<sub>50</sub> of 60 nM in cell-free kinase assay. Compound <b>9</b> completely inhibited the growth of CSF-1R dependent M-NFS-60 tumor cells and human monocytes in the peritoneal cavity. It also inhibited joint connective tissue formation and bone destruction in human osteoclast cultures. It is as effective as imatinib in reducing the severity of arthritis in CIA. After oral administation of the drug, the ability of CSF-1R to increase LPS-induced IL-6 production in mice was blocked by compound <b>9</b>. In addition, it inhibited the growth of M-NFS-60 mouse myeloid cells expressing CSF-1R kinase.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p last">One study was carried out to determine the role of M2 macrophage using a specific CSF-1R signaling inhibition approach to inhibit these macrophages; the results showed that the administration of compound <b>9</b> to M2 macrophages for 1 week decreased the numbers of M2 macrophages in the heart and decreased expression of cardiac arginase-1 and CD206, genes indicative of M2 macrophage activity.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div></div><div id="sec8-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">8.3.  Pyridines</h3><div id="sec8-3-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">8.3.1.  BLZ945</h4><div class="NLM_p">BLZ945 (<b>10</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) is a CSF-1R kinase inhibitor that has a great impact on OCs function and macrophage precursors and can be used in preventing some diseases associated with abnormalities in these cells.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75,76)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of BLZ945 and its active metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Some research has been done on compound <b>10</b> and its active metabolite (<b>11</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) to determine their effectiveness. The active metabolite, which is a structural isomer of the parent compound, is formed via oxidation by P450 followed by reduction of the ketone group. This metabolite is 4 times less potent than its parent drug. Using the equilibrium dialysis method, the amounts of plasma protein binding for compound <b>10</b> (96.3% ± 0.18) was slightly lower than that of its metabolite (96.9% ± 0.24).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">An in vitro kinase assay used to determine pharmacological activity with a murine AML cell line showed that their proliferation depended on CSF-1; the test was used to determine proliferation and viability due to blockage of CSF-1R phosphorylation. The IC<sub>50</sub> values of BLZ945 and its metabolite against CSF-1R kinase in cell-free kinase assay were 1.2 and 5.5 nM, respectively.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Compound <b>10</b> was more than 3200 times more selective against CSF-1R than the other types of tyrosine kinase receptors.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The antiproliferative activity of BLZ945 and its metabolite were significant against the CSF-1-expressing cell line M-NFS-60 (EC50 of 71 and 140 nM, respectively).</div><div class="NLM_p last">Compound <b>10</b> inhibition of CSF-1R reduced the TAM turnover rate and increased the number of cytotoxic T cells in some types of cancer such as cervical and breast cancer. Moreover, a study on keratin 14-expressing human papillomavirus type 16 (K14-HPV-16) cells showed that compound <b>10</b> prevented tumor development. Another study was done on mouse mammary tumor virus driven by the polyomavirus middle T antigen (MMTV-PyMT) and showed that compound <b>10</b> decreased mutant cell growth.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div></div><div id="sec8-3-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">8.3.2.  PLX647</h4><div class="NLM_p">PLX647 (<b>14</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) is a selective and potent CSF-1R kinase inhibitor (IC<sub>50</sub> = 28 nM in cell-free kinase assay) that also inhibits KIT (IC<sub>50</sub> = 16 nM in cell-free kinase assay) and FLT3-ITD in vitro. 7-Azaindole (<b>12</b>) was identified as a kinase inhibitor scaffold in the scaffold-based discovery of PLX647. Introducing a 3-methoxy substituent onto 3-benzylpyrrolo[2,3-<i>b</i>]pyridine gave PLX070 (<b>13</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Replacing the methoxyphenyl moiety of PLX070 with (trifluoromethyl)benzylaminopyridyl led to PLX-647 (<b>14</b>, R = H, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Addition of a 5-methoxy gave <b>15</b> (R = OMe, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), which is more polar and more soluble in aqueous solutions (molar solubility = 77 μM) than compound <b>14</b> (molar solubility = 14 μM), according to a turbidity-based assay, but it is a less potent CSF-1R inhibitor (IC<sub>50</sub> = 62 nM in cell-free kinase assay) than PLX647. PLX647 was efficacious in animal models and in the inhibition of macrophages, osteoclasts, and mast cells stimulated by CSF-1R and KIT.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78,79)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of the 7-azaindole-containing pyridine analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>14</b> controls inflammation, cancer progression, and bone osteolysis by inhibiting the CSF-1R and KIT kinases. The effect of CSF-1R inhibition was determined by LPS-induced cytokine release, mast cell activation, kidney inflammation, collagen-induced arthritis, cancer-induced bone pain, and osteolysis. The preclinical results were used to characterize compound <b>14</b> pharmacology. In vivo, compound <b>14</b> was used to determine the effect of CSF-1R inhibition on LPS-induced cytokine stimulation. Injecting mice with LPS increases the levels of the inflammatory cytokines. Mice given an oral dose of compound <b>14</b> before an LPS injection had an 85% reduced serum TNF-α level and a 75% inhibition in IL-6 release. Compound <b>14</b> also inhibits mast cell activation in the skin by inhibiting the PCA reaction, which is a result of the inhibition of KIT. In mice with renal inflammation induced by unilateral ureter obstruction (UUO), PLX647 reduced the levels of F4/80+ macrophages by 77%, suggesting that compound <b>14</b> is sufficiently effective in preventing the accumulation of macrophages in renal inflammation caused by UUO. In a CIA mouse model, compound <b>14</b> decreased the signs of arthritis after 31 days. Currently, compound <b>14</b> is in clinical trials to reprogram the immune microenvironment in tumors for the improvement of anticancer treatment.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div></div><div id="sec8-3-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">8.3.3.  Pexidartinib (PLX3397)</h4><div class="NLM_p">PLX3397 (<b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) is an orally active and potent CSF-1R inhibitor (IC<sub>50</sub> = 13 nM in cell-free kinase assay) that exhibits an activity on other kinases such as KIT and FLT3.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> compound <b>16</b> was developed based on the structure of compound <b>14</b>. The phenyl ring in the (trifluoromethyl)phenyl tail of compound <b>14</b> was replaced with pyridine to enhance its polarity. In addition, a chloro group was introduced to position 5 of the azaindole scaffold. In its autoinhibited state, part of the juxtamembrane of CSF-1R binds into its ATP-binding site. Compound <b>16</b> binds in the ATP-binding site of CSF-1R but has interactions with residues in the juxtamembrane inhibitory loop, which prevents the loop from exiting the ATP-binding cleft upon ligand binding. It makes hydrogen bonds with tyrosine residue 546 (Tyr546) and tryptophan residue 550 (Trp550) in the juxtamembrane region of the kinase. In the presence of water, in addition to π stacking between pyridine and Trp550, the pyridine nitrogen atom is involved in a network of hydrogen bonds that keep the juxtamembrane domain in its inactive state (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). When testing compounds <b>14</b> and <b>16</b> on cells that depend on CSF-1R for their growth, compound <b>16</b> showed a significantly higher potency than compound <b>14</b>. Preclinical studies in animals showed promising PK properties including enhanced oral bioavailability and a proportional relationship between the effect of compound <b>16</b> and its dose. Compound <b>16</b> was tested on various animals to evaluate its efficacy. Administration of compound <b>16</b> in a CIA mouse model improved the condition of the joints. In patients with tenosynovial giant-cell tumors, 52% of those treated with compound <b>16</b> responded significantly to the treatment with more than 8 months of disease control. These results were better than those obtained from imatinib. In most patients, the administration of compound <b>16</b> showed a reduction in tumor volume for longer periods.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Conformation-specific inhibition of CSF-1R kinase by PLX3397 (<b>16</b>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Reprinted with permission from <span class="references__authors"><span class="NLM_string-name">Tap, W. D.</span></span>   <cite><i>New England Journal of Medicine</i></cite> <span class="NLM_year">2015</span>, <em>373</em>, 428–437.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Copyright 2015 Massachusetts Medical Socieity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>16</b> was also used on glioblastoma (GB), a deadly cancer that is usually treated by surgical removal followed by radiation therapy in addition to other chemotherapies (Temozolomide) with a survival time of approximately 14 months. compound <b>16</b> prolonged the survival time and slowed the disease progression rate. Microglia, macrophages, and other tumor microenvironments, which affect the biology of GB, are regulated by CSF-1R and KIT. This makes compound <b>16</b> a possible treatment option for GB because of the relationship between high levels of microglia and low survival rates in GB patients. In addition, GB patient samples had high levels of CSF-1R and KIT ligands that activate surrounding microglia, the resident macrophages of the central nervous system (CNS), leading to increased tumor invasion. Another reason for testing compound <b>16</b> activity is the slowing of tumor progression after depletion of microglia in orthotopic GB models.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> An in vitro study using normal microglia obtained from C57Bl/6J mice to examine the effect of microglia on glioma 261 (GL261) glioblastoma cell invasion found an 8-fold increase in GL261 glioblastoma cell invasion. The same study showed that the inhibition of CSF-1R signaling inhibited the invasion of breast cancer cells, which are stimulated by macrophages both in vitro and in vivo. For this reason, CSF-1R kinase domain ATP binding site inhibitors were tested on GB.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> In a Matrigel invasion assay on mouse GL261 GB cells cultured with microglia, a dose of 1 μM of <b>16</b> caused a significant inhibition of metastasis. Compound <b>16</b> crosses the normal blood–brain barrier (BBB) readily and reaches the CNS in rats without being actively transported which indicates that compound <b>16</b> can reach GB and stromal tumor tissues.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> In wild-type C57 mice injected with GL261 cells, the cells showed extensive CSF-1 expression and infiltration of microglia. Administration of compound <b>16</b> resulted in reduced microglia/macrophages numbers and significantly inhibited the invasiveness of the tumor cells.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Studies on PK/PD models, which were obtained from tumor tissue samples taken from patients who took compound <b>16</b> for 7 days, showed that the concentration achieved by compound <b>16</b> in half of the tumor tissue samples was equal to or more than 100 nM and that was sufficient to inhibit CSF-1R. Phase I studies analyzed CSF-1 plasma levels and confirmed the inhibition of CSF-1R. These data made compound <b>16</b> a good candidate for phase II clinical trials. A phase II study was conducted on patients with recurrent GB by giving them a daily dose of 1000 mg of compound <b>16</b>, which was well-tolerated and resulted in an increase of CSF-1 and a decrease in the number of monocytes of the CD14dim/CD16+ subset in plasma compared with pretreatment values. In addition, compound <b>16</b> sufficiently penetrated tumor tissues, leading to an inhibition of CSF-1R and a decrease in the number of TAMs. A median drug level of 5500 ng/g was detected in the tumor cells after 7 days of administering compound <b>16</b>. Despite these significant effects, compound <b>16</b> showed an increase in CSF-1 and reduced CD14(dim)/CD16+ monocytes in plasma compared with their values before treatment. So the compound is well tolerated and is able to cross the blood–cancer barrier, but no efficacy was seen in this heavily pretreated population.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div></div></div><div id="sec8-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">8.4.  Quinoline and Cinnoline derivatives</h3><div id="sec8-4-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">8.4.1.  AZ683 and AZD7505</h4><div class="NLM_p">AZ683 (<b>17</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) is a compound that belongs to the 3-amido-4-anilinoquinoline class. It is a potent and highly selective CSF-1R inhibitor, allowing a reduction of TAMs and inhibiting tumor growth. It has a good oral bioavailability, an IC<sub>50</sub> of 230 nM in vitro in cell-free kinase assay, and promising biological properties as it was tested on 85 kinases and found to inhibit two specific receptors by more than 20% (CSF-1R 96% and ARK5 51%, at 1 μM concentration).<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> This compound was linked with serious cardiovascular side effects when tested in dog cardiomyocytes, as it produced a dose-dependent reduction on the action potential (10 and 30 μM) and inhibited cardiac Na<sub>v</sub>1 channels in humans (IC<sub>50</sub> = 14 μM). As a result, compound <b>17</b> did not proceed to further development phases. A new class of highly related cinnolines, 3-amido-4-anilinocinnolines (compounds <b>18</b> and <b>19</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), were discovered to be selective CSF-1 inhibitors with excellent pharmacokinetic properties, and their IC<sub>50</sub> values in 3T3 cell-based assay (stimulated with CSF-1 and engineered to express CSF-1R kinase) were 13 and 25 nM, respectively. However, compound <b>18</b> still showed a dose-dependent prolonging of AV conduction and the QRS duration, similar to AZ683. Therefore, further modifications were made to both classes of compounds, and the aniline substituent and 7-alkoxy groups were combined to produce a new potential CSF-1R inhibitor with a lesser cardiotoxic effect.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The new compound AZD7507 (<b>19</b>) (32 nM cell activity), in which the <i>N</i>-methylpiperazine at position 6 was replaced with a hydroxyethylpiperazine, had a big impact as it produced a 7 mL/min/kg in vivo clearance, a bioavailability of 42%, and an IC<sub>50</sub> > 20 μM in a canine L-type Ca channel assay in contrast with AZ683 (3.5 μM). In addition, dog myocytes treated with 30 μM AZD7507 had no significant effects, and the maximum dose had no effect on the AV conduction time or QRS duration. In epithelial cells with cholangiocarcinoma (CC), compound <b>19</b> treatment significantly reduced the number of CD68+ macrophages and minimized tumor volume and mass.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of the quinoline and cinnoline derivatives reported as CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, AZD7507 (<b>19</b>) is considered a promising compound as it retained the desired potency and oral pharmacokinetic properties of AZ683. Moreover, in a telemetry study in dogs given a single oral dose, there was no cardiovascular toxicity, no elevation of troponin related to the treatment, and no alteration in the ECG.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> It has not been investigated in clinical trials yet.</div></div></div><div id="sec8-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">8.5.  Miscellaneous</h3><div id="sec8-5-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">8.5.1.  AC708</h4><div class="NLM_p">AC708 (structure not disclosed) is a potent compound that inhibits CSF-1R and targets TAMs as it prevents CSF-1-mediated phosphorylation of CSF-1R.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> It shows significant selectivity for CSF-1R compared with other protein kinases. In cell-based assays, the cells were stimulated with either CSF-1 or IL-34, resulting in IC<sub>50</sub> values of 26 and 33 nM, respectively. In cultured, growth factor-dependent cells, it has an IC<sub>50</sub> = 38 nM for CSF-1 and an IC<sub>50</sub> = 40 nM for IL-34, and it prevented the differentiation and survival of human OCs mediated by CSF-1 (IC<sub>50</sub> = 15 nM). Further studies were done to assess the compound’s efficacy on different types of cells. AC708 prevented the growth of M-NFS-60 cells intraperitoneally in a dose-dependent manner; a 100 mg/kg dose of AC708 produced a more than 80% reduction in cell number, which is a similar effect to that of Ki-20227. In human monocytes stimulated by both ligands, AC708 caused inhibition of MCP-1 release with CSF-1 (IC<sub>50</sub> = 93 nM) and IL-34 (IC<sub>50</sub> = 88 nM), which are lower IC<sub>50</sub> values compared with those obtained from compound <b>9</b>, a benchmark compound [CSF-1 (IC<sub>50</sub> = 148 nM) and IL-34 (IC<sub>50</sub> = 140 nM)].<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><div class="NLM_p">In vivo studies have been done to test the efficacy of AC708 on immune-competent and nude mice with the use of the F4/80 macrophage marker. The animals were injected with an anti-VEGF antibody repeatedly to develop resistance, followed by full immune profiling. The results showed a significant increase of macrophage infiltration in tumor with anti-VEGF antibody resistance in contrast to the tumors of anti-VEGF antibody-sensitive mice (<i>p</i> > 0.0001).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Another study shows the effect of the compound on anti-VEGF antibody-resistant mice when it is combined with another chemotherapy (paclitaxel). The results showed a restoration of the angiogenic therapy, which caused a reduction of 82% in the tumor load and a decrease in macrophage infiltration compared to when paclitaxel was administered alone.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p last">Two models were developed to assess the ability of the compound to control endogenous CSF-1R. In the first model, recombinant parathyroid hormone-related protein (PTHrP) was injected, and plasma levels of tartrate-resistant acid phosphatase (TRAP5b) were measured. PTHrP-induced elevation of plasma TRAP5b was decreased in a dose-dependent manner when a 100 mg/kg dose of AC708 was administered. In the second model, CSF-1-mediated MCP-1 release stimulation was inhibited by 60% after a 100 mg/kg dose of AC708 was administered.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div></div><div id="sec8-5-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">8.5.2.  ARRY-382</h4><div class="NLM_p">ARRY-382 is a CSF-1R kinase inhibitor developed by ARRAY Biopharma, and its chemical structure has not been disclosed yet. The compound is still in phase I clinical trials.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> It is a potent and selective inhibitor of CSF-1R (IC<sub>50</sub> = 9 nM in cell-free kinase assay). In vitro tests of ARRY-382 prove that it has a potent inhibitory effect on OC differentiation (IC<sub>50</sub> = 4 nM) and bone resorption (IC<sub>50</sub> = 58 nM). In an HEK-293 cell-induced tumor model in mice, its ED<sub>50</sub> value was 3 mg/kg.</div><div class="NLM_p last">The safety of ARRY-382 was tested in 26 patients with advanced or metastatic cancers at doses of 25– 500 mg, and no significant major side effects were reported. The maximum tolerated dose with biological effect was 400 mg QD.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div></div><div id="sec8-5-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">8.5.3.  PLX 5622</h4><div class="NLM_p">PLX 5622 (structure not disclosed) is a CSF-1R inhibitor with potent activity (<i>K</i><sub>i</sub> = 5.9 nM) and high selectivity (50-fold for four tyrosine kinases and over 100-fold for 230 different kinases). In a study carried out on wild-type mice to test the inhibitory effect of PLX5622 on microglia in adult human brains, mice were tested with two different doses, 300 or 1200 mg/kg. The results showed that microglia were eliminated by inhibiting CSF-1R and that a higher dose of PLX5622 (1200 mg/kg) resulted in nearly complete elimination (98%) of microglia.<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91,92)</a></div><div class="NLM_p last">In another study on inflammatory monocytes (Ly6C-high) and patrolling monocytes (Ly6C-low), both high and low doses of PLX5622 resulted in the depletion of Ly6C-high within the blood and an unchanged effect on the number of Ly6C-low.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></div></div><div id="sec8-5-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">8.5.4.  DCC-3014</h4><div class="NLM_p last">DCC-3014 (structure not disclosed) is a potent inhibitor of CSF-1R (IC<sub>50</sub> = 5 nM in cell-free kinase assay). It is a type 2 DFG loop-out kinase inhibitor with the typical slow binding kinetics of that class, with a small molecular weight that was tested in over 300 human kinases including CSF-1R and kinases related to it, such as FLT3 and KIT. DCC-3014 inhibited CSF-1R by more than 100-fold compared with its inhibitory effects on FLT3, KIT, PDGFRα, and PDGFRβ, and by more than 1000-fold compared with other kinases. DCC-3014 is a highly specific inhibitor of CSF-1R and keeps the receptor in an inactivated conformation.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Preclinical studies showed promising pharmacokinetic and optimized biopharmaceutical properties of DCC-3014. In vivo, DCC-3014 was tested in the murine cFOS PK/PD model and resulted in a more than 90% inhibition of CSF-1R at 15 mg/kg 24 h after the dose. A dose of 3 mg/kg administered for 6 days until it reached a steady state resulted in a strong inhibition of CSF-1R. In the MC38 colorectal cancer model, which has a high level of infiltrating TAMs, a dose of 10 mg/kg of DCC-3014 resulted in an inhibition of TAMs, repolarization of the adaptive immune cells (converting them to antitumor cells), and depletion of circulating CD16+ monocytes. DCC-3014 was also tested in THP-1 and MNFS-60 monocyte cell lines, a human whole blood assay, and in a human osteoclast TRAP assay. The results of these studies showed that the inhibition of CSF-1R in THP-1 monocytes (IC<sub>50</sub> = 11 nM), MNFS-60 monocytes (IC<sub>50</sub> = 4 nM), human osteoclasts (IC<sub>50</sub> = 9 nM), and in a human whole blood monocyte/pERK assay (IC<sub>50</sub> = 260 nM) was resilient to 10–1000 ng/mL CSF-1 because DCC-3014 binds CSF-1R for a long time and keeps it in its inactive conformation. The combination of DCC-3014 and the murine anti-PD1 antibody in the MC38 colorectal cancer model showed an improvement in the inhibitory effect and a synergistic immunomodulatory activity by the added blocking of macrophage immune checkpoints compared with other treatment alone.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> DCC-3014 is currently in phase I clinical trials in patients with advanced malignancies to assess its safety, PK, and PD using different doses.<a onclick="showRef(event, 'ref94 ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref94 ref95 ref96">(94−96)</a></div></div><div id="sec8-5-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">8.5.5.  4-Arylamido-5-methylisoxazole derivatives</h4><div class="NLM_p">Compound <b>20a</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) is a 4-arylamido-5-methylisoxazole derivative recently discovered as a potent inhibitor of CSF-1R and other kinases. <b>20a</b> is a derivative of a highly potent and selective CSF-1R inhibitor.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> While screening a library of protein kinase inhibitors in U937 (human histiocytic lymphoma) and A375P (human melanoma) cells, the methylisoxazole group was discovered to be a hinge binder that exhibited high activity toward U937 cells. Data showed that 2-methyl-<i>N</i>-(5-methylisoxazol-4-yl)benzamide (<b>21</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) was selective for CSF-1R (IC<sub>50</sub> = 216 nM in cell-free kinase assay). The structure–activity relationship showed that, in U937 cells, the amide linker was better for activity than the urea analogues. The middle phenyl ring with its substituents also has a great impact on the CSF-1R activity, where the number, position, and type of the substituents affect their antiproliferative effect. The tested compounds were more potent against U937 cells than A375P cells. On the basis of the IC<sub>50</sub> values, only four of the compounds demonstrated high inhibitory activity <b>20a</b>–<b>d</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) with GI<sub>50</sub> values against U937 hematopoietic cell line as follows: 16, 19, 26, and 49 nM, respectively. An introduction of disubstituted benzamide at positions 3 and 5 increases the activity, especially if the substituent is alkylpiperazine, alkylimidazole, or morpholine. On the other hand, the substitution of a bulky aromatic acid lowers inhibitor activity. When comparing the activity of the four potent compounds in U937 cells, compound <b>20a</b>, with trifluoromethyl and methylpiperazinyl groups at positions 3 and 5, exhibited the most potent activity.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of the 4-arylamido-5-methylisoxazole analogues reported as CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the selectivity index, the compounds were tested against HS27 cells (human normal cell line). The IC<sub>50</sub> ranges were >30 μM. All the tested derivatives displayed weak cytotoxicity against HS27 and great selectivity indexes toward cancer cells rather than normal cells. After determining <b>20a</b> as the most potent antiproliferative compound, it was screened against a selected panel of kinases to determine its kinase inhibitory profile. It showed an excellent inhibitory effect on CSF-1R (IC<sub>50</sub> = 9.95 nM in cell-free kinase assay) and a less potent inhibitory effect against B-RAF, B-RAF/V600E, Lyn, and C-RAF with IC<sub>50</sub> values of 5590, 668, 65.9, and 44.8 nM, respectively.</div><div class="NLM_p">To understand how compound <b>20a</b> binds to CSF-1R, a molecular docking study was done. The docking binding mode of compound <b>20a</b> to the ATP-binding site of CSF-1R is shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding mode of compound <b>20a</b> docked into CSF-1R (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCO">3LCO</a>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Reprinted with permission from <span class="references__authors"><span class="NLM_string-name">Im, D.</span></span>,   <cite><i>European Journal of Medicinal Chemistry</i></cite> <span class="NLM_year">2015</span>, <em>102</em>, 600.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Copyright 2015 Elsevier Masson SAS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">9.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17151" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17151" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this article, we reviewed different CSF-1R inhibitors that were recently reported in the literature reported from 2012 until the present. Most of the reviewed inhibitors are potent inhibitors of CSF-1R and its ligands (CSF-1 and/or IL-34).</div><div class="NLM_p">Anti-CSF-1 monoclonal antibodies are currently under investigation to be used in macrophage-committed progenitor cells purification in mice and help in identification of human blood monocytes. Moreover, their functions can be studied in human or animals as their activity depends on CSF-1 signaling. Here, we reviewed several monoclonal antibodies with different properties and characteristics that make them unique as chemotherapies. H27K1 was developed to overcome the increase in CSF-1 caused by other mAbs. Emactuzumab was effective in treating patients with Dt-GCT cancer, which makes it a promising drug candidate. Another antibody, FPA008, was generated to target immune cells, macrophages, and monocytes in many tumors. Lastly, TG3003 showed great activity in preventing cytotoxicity compared with the other mAbs. The main advantage of cancer immunotherapy over kinase inhibitors is higher selectivity and safety. The antibody binds to a specific antigen on the cancer cell. But kinase inhibitory chemotherapeutic agents most probably inhibit several kinases, especially if they mimic the ATP structure and bind to the kinase hinge region. Conjugated mAbs (antibody–drug conjugates) can be a very useful approach to target the chemotherapeutic agent to the cancer cell using a specific mAb that interacts selectively with a specific antigen on the cancer cell. Future research should focus on this approach to maximize the therapeutic effects and minimize the side effects.</div><div class="NLM_p">Oral CSF-1R kinase inhibitors such as JNJ-40346527 showed a significant effect in treating patients with RA (passed phase 2) or in cHL (passed phase 1). ENMD-2076 is effective in some types of cancer such as ovarian cancer, fallopian cancer, peritoneal cancer, multiple myeloma, and triple-negative breast cancer (passed phase 2 studies). GW 2580 can be a promising anticancer candidate (in preclinical studies). It is also effective in reducing collagen-induced arthritis, and a new study showed that it may play a role in lowering the levels of M2 within the heart. BLZ945 is also effective in preclinical studies against cancer because it decreases the TAM turnover rate and the growth of mutant cells. ARRY-382 has a great effect on osteoclast cell differentiation, and in patients with metastatic cancer, a high dose showed 28-fold increase in activity compared with lower dose. AZD7505 has the same potency as AZ683. AZ683 produces cardiovascular side effects that disappear when using the modified compound, AZD7505. PLX 5622 is another CSF-1R inhibitor that resulted in elimination of microglia from the brain. In addition, it was tested in phase 1b clinical trials in RA patients taking methotrexate (<a href="https://clinicaltrials.gov/ct2/show/NCT01329991?term=PLX+5622&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01329991?term=PLX+5622&rank=2</a>, accessed Dec. 18, 2017).</div><div class="NLM_p last">The structures of some of these inhibitors are still not disclosed, and some have recently entered clinical trials. Targeting CSF-1R is a fast-growing field. These trials will be closely watched for their outcomes. Combinations of monoclonal antibodies and CSF-1R inhibitors could produce synergistic therapeutic effects and may be a successful avenue for more efficient treatment of cancer and inflammatory disorders. According to the <a href="http://clinicaltrials.gov" class="ext-link">clinicaltrials.gov</a> web site, clinical trials will be conducted for emactuzumab in combination with paclitaxel or atezolimumab for advanced solid tumors (<a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=emactuzumab&amp;cntry1=&amp;state1=&amp;recrs=" class="extLink">https://clinicaltrials.gov/ct2/results?cond=&term=emactuzumab&cntry1=&state1=&recrs=</a>, accessed Dec. 18, 2017). Cabiralizumab will be tested also in combination with nivolumab for treatment of advanced cancers (<a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=Cabiralizumab&amp;cntry1=&amp;state1=&amp;recrs=" class="extLink">https://clinicaltrials.gov/ct2/results?cond=&term=Cabiralizumab&cntry1=&state1=&recrs=</a>, accessed Dec. 18, 2017), and ARRY-382 will be tested in combination with pembrolizumab in phases 1 and 2 for treatment of advanced solid tumors (<a href="https://clinicaltrials.gov/ct2/show/NCT02880371?term=pembrolizumab+AND+arry&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02880371?term=pembrolizumab+AND+arry&rank=1</a>, accessed Dec. 18, 2017).</div></div><div class="NLM_back"><div class="NLM_notes" id="notes1"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00873" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chang-Hyun Oh</span> - <span class="hlFld-Affiliation affiliation">Center
for Biomaterials, Korea Institute of Science
and Technology, P.O. Box 131, Cheongryang, Seoul 130-650, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biomolecular Science, University of Science
and Technology, 113 Gwahangno,
Yuseong-gu, Daejeon 305-333, Republic of Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d0b3b8bfb890bbb9a3a4fea2b5febba2"><span class="__cf_email__" data-cfemail="debdb6b1b69eb5b7adaaf0acbbf0b5ac">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammed
I. El-Gamal</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4269-5264" title="Orcid link">http://orcid.org/0000-0002-4269-5264</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shahad K. Al-Ameen</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dania M. Al-Koumi</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mawadda G. Hamad</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nouran A. Jalal</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Mohammed
I. El-Gamal</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=BIO-d348e1605-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mohammed I. El-Gamal</b> earned the Bachelor Degree of Pharmaceutical Sciences from Faculty of Pharmacy, University of Mansoura, Egypt, in 2003 as the first achiever (excellent with honors). In January 2008, he earned his M.Sc. degree in Medicinal Chemistry from the same university, Department of Medicinal Chemistry. He received his Ph.D. degree in 2012 at the University of Science and Technology, Korea Institute of Science and Technology, Republic of Korea. He is currently an assistant professor of medicinal chemistry. He has reported and published some articles related to CSF-1R kinase and its inhibitors. His research interests involve kinase inhibitors, other anticancer agents, antiinflammatory agents, radiolabeled imaging agents, prodrugs, antibiotics, and pharmacokinetic properties optimization.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Shahad K. Al-Ameen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=BIO-d348e1610-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Shahad K. Al-Ameen</b> is a recently graduated pharmacist. She graduated in June 2017 at the College of Pharmacy, University of Sharjah, United Arab Emirates. She is among the best students at her college. She participated in this Perspective to fulfill her graduation requirements.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Dania M. Al-Koumi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=BIO-d348e1615-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dania M. Al-Koumi</b> is a recently graduated pharmacist. She graduated in June 2017 at the College of Pharmacy, University of Sharjah, United Arab Emirates. She is among the best students at her college. She participated in this Perspective to fulfill her graduation requirements.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Mawadda G. Hamad</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=BIO-d348e1620-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mawadda G. Hamad</b> is a recently graduated pharmacist. She graduated in June 2017 at the College of Pharmacy, University of Sharjah, United Arab Emirates. She is among the best students at her college. She participated in this Perspective to fulfill her graduation requirements.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Nouran A. Jalal</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=BIO-d348e1625-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nouran A. Jalal</b> is a recently graduated pharmacist. She graduated in June 2017 at the College of Pharmacy, University of Sharjah, United Arab Emirates. She is among the best students at her college. She participated in this Perspective to fulfill her graduation requirements.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Chang-Hyun Oh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=BIO-d348e1630-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chang-Hyun Oh</b> received his Ph.D. degree in medicinal chemistry from Hanyang University, Republic of Korea, in 1994. He is working as a principal researcher of medicinal chemistry at the Korea Institute of Science and Technology, Republic of Korea. His research interests focused on the development of novel therapeutic agents for the treatment of cancer, prodrugs, carbapenem antibiotics, and radiolabeled imaging agents. He has been interested in the field of kinase inhibitors and has published several articles related to kinase inhibitors such as CSF-1R kinase inhibitors.</p></figure></div><div class="ack" id="ACK-d348e1598-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful for Korea Institute of Science and Technology (KIST, Seoul, Republic of Korea) for financial support (grant No. E26900).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADCC</td><td class="NLM_def"><p class="first last">antibody-dependent cellular cytotoxicity</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">Anti-PD</td><td class="NLM_def"><p class="first last">antiprogrammed death</p></td></tr><tr><td class="NLM_term">AV</td><td class="NLM_def"><p class="first last">atrioventricular node</p></td></tr><tr><td class="NLM_term">BMDM</td><td class="NLM_def"><p class="first last">bone marrow-derived macrophages</p></td></tr><tr><td class="NLM_term">BMP</td><td class="NLM_def"><p class="first last">bone morphogenetic protein</p></td></tr><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">cholangiocarcinoma</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete Freund’s adjuvant</p></td></tr><tr><td class="NLM_term">CHL</td><td class="NLM_def"><p class="first last">classical Hodgkin lymphoma</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">collagen-induced arthritis</p></td></tr><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myeloid leukemia</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">CSF-1</td><td class="NLM_def"><p class="first last">colony-stimulating factor-1</p></td></tr><tr><td class="NLM_term">CSF-1R</td><td class="NLM_def"><p class="first last">colony-stimulating factor-1 receptor</p></td></tr><tr><td class="NLM_term">DC</td><td class="NLM_def"><p class="first last">dendritic cells</p></td></tr><tr><td class="NLM_term">DMARD</td><td class="NLM_def"><p class="first last">disease-modifying antirheumatic drug</p></td></tr><tr><td class="NLM_term">Dt-GCT</td><td class="NLM_def"><p class="first last">diffuse-type tenosynovial giant cell tumor</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">ERK1/2</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase-1 and -2</p></td></tr><tr><td class="NLM_term">FGFR</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">FMS-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">FMS</td><td class="NLM_def"><p class="first last">kinase first discovered as the oncogene responsible for feline McDonough sarcoma</p></td></tr><tr><td class="NLM_term">GMDSC</td><td class="NLM_def"><p class="first last">granulocytic myeloid-derived suppressor cells</p></td></tr><tr><td class="NLM_term">GM-CSF</td><td class="NLM_def"><p class="first last">granulocyte macrophage colony-stimulating factor</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HOS</td><td class="NLM_def"><p class="first last">human osteosarcoma</p></td></tr><tr><td class="NLM_term">HPV</td><td class="NLM_def"><p class="first last">human papilloma virus</p></td></tr><tr><td class="NLM_term">HSC</td><td class="NLM_def"><p class="first last">hematopoietic stem cell</p></td></tr><tr><td class="NLM_term">HuAB</td><td class="NLM_def"><p class="first last">human antibody</p></td></tr><tr><td class="NLM_term">IGF</td><td class="NLM_def"><p class="first last">insulin-like growth factor</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">ITD</td><td class="NLM_def"><p class="first last">internal tandem duplication</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">M-CSF</td><td class="NLM_def"><p class="first last">macrophage or monocyte colony-stimulating factor</p></td></tr><tr><td class="NLM_term">M-CSFR</td><td class="NLM_def"><p class="first last">macrophage colony-stimulating factor receptor</p></td></tr><tr><td class="NLM_term">MCP</td><td class="NLM_def"><p class="first last">monocyte chemoattractant protein</p></td></tr><tr><td class="NLM_term">MDSCs</td><td class="NLM_def"><p class="first last">myeloid-derived suppressor cells</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">MMTV-PyMT</td><td class="NLM_def"><p class="first last">mouse mammary tumor virus driven polyomavirus middle T antigen</p></td></tr><tr><td class="NLM_term">MuAb</td><td class="NLM_def"><p class="first last">murine antibody</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">NaV1</td><td class="NLM_def"><p class="first last">sodium channel, voltage-gated, type I</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">OB</td><td class="NLM_def"><p class="first last">osteoblast</p></td></tr><tr><td class="NLM_term">OC</td><td class="NLM_def"><p class="first last">osteoclast</p></td></tr><tr><td class="NLM_term">OCPs</td><td class="NLM_def"><p class="first last">osteoclast precursors</p></td></tr><tr><td class="NLM_term">OP</td><td class="NLM_def"><p class="first last">osteoclast progenitor</p></td></tr><tr><td class="NLM_term">OS</td><td class="NLM_def"><p class="first last">osteocyte</p></td></tr><tr><td class="NLM_term">PC</td><td class="NLM_def"><p class="first last">pancreatic cancer</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PDAK</td><td class="NLM_def"><p class="first last">pancreatic ductal adenocarcinoma</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PDGFR</td><td class="NLM_def"><p class="first last">platelet-derived growth factor receptor</p></td></tr><tr><td class="NLM_term">pERK</td><td class="NLM_def"><p class="first last">phospho-extracellular signal-related kinase</p></td></tr><tr><td class="NLM_term">PTHrp</td><td class="NLM_def"><p class="first last">parathyroid hormone-related protein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">RANKL</td><td class="NLM_def"><p class="first last">receptor activator of nuclear factor kappa B ligand</p></td></tr><tr><td class="NLM_term">RCC</td><td class="NLM_def"><p class="first last">renal cell carcinoma</p></td></tr><tr><td class="NLM_term">RTKs</td><td class="NLM_def"><p class="first last">receptor tyrosine kinases</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SCLC</td><td class="NLM_def"><p class="first last">small cell lung cancer</p></td></tr><tr><td class="NLM_term">SCW</td><td class="NLM_def"><p class="first last">streptococcal cell wall</p></td></tr><tr><td class="NLM_term">TAM</td><td class="NLM_def"><p class="first last">tumor-associated macrophages</p></td></tr><tr><td class="NLM_term">TBW</td><td class="NLM_def"><p class="first last">total body washout</p></td></tr><tr><td class="NLM_term">TEC</td><td class="NLM_def"><p class="first last">tubular epithelial cell</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TRAP</td><td class="NLM_def"><p class="first last">tartrate-resistant acid phosphatase</p></td></tr><tr><td class="NLM_term">TRKA</td><td class="NLM_def"><p class="first last">tropomyosin receptor kinase A</p></td></tr><tr><td class="NLM_term">TYK2</td><td class="NLM_def"><p class="first last">tyrosine kinase 2</p></td></tr><tr><td class="NLM_term">UUO</td><td class="NLM_def"><p class="first last">unilateral ureter obstruction</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">VEGFR</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 96 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. T.</span></span> <span> </span><span class="NLM_article-title">Receptor tyrosine kinases: mechanisms of activation and signaling</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2007.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ceb.2007.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=17306972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=117-123&author=S.+R.+Hubbardauthor=W.+T.+Miller&title=Receptor+tyrosine+kinases%3A+mechanisms+of+activation+and+signaling&doi=10.1016%2Fj.ceb.2007.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases: mechanisms of activation and signaling</span></div><div class="casAuthors">Hubbard, Stevan R.; Miller, W. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases (RTKs) are essential components of signal transduction pathways that mediate cell-to-cell communication.  These single-pass transmembrane receptors, which bind polypeptide ligands - mainly growth factors - play key roles in processes such as cellular growth, differentiation, metab. and motility.  Recent progress has been achieved towards an understanding of the precise (and varied) mechanisms by which RTKs are activated by ligand binding and by which signals are propagated from the activated receptors to downstream targets in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg3ej9ekC3hLVg90H21EOLACvtfcHk0ljI86_IG1NdGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D&md5=254110135c0f1a5642441c551d379bef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2007.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2007.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26atitle%3DReceptor%2520tyrosine%2520kinases%253A%2520mechanisms%2520of%2520activation%2520and%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2007%26volume%3D19%26spage%3D117%26epage%3D123%26doi%3D10.1016%2Fj.ceb.2007.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebaï, A.</span></span> <span> </span><span class="NLM_article-title">Receptor tyrosine kinases: from biology to pathology</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.3109/10799893.2011.625425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3109%2F10799893.2011.625425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22040163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbot1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=387-394&author=M.+Chouraauthor=A.+Reba%C3%AF&title=Receptor+tyrosine+kinases%3A+from+biology+to+pathology&doi=10.3109%2F10799893.2011.625425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases: from biology to pathology</span></div><div class="casAuthors">Choura Mouna; Rebai Ahmed</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">387-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Receptor tyrosine kinases (RTKs) are transmembrane proteins involved in the control of fundamental cellular processes in metazoans.  RTKs possess a general structure that includes an extracellular domain, a transmembrane domain and a highly conserved tyrosine kinase domain.  RTKs are classified according to their variable extracellular ligand-binding domain.  Studies of human RTK members have yielded a wealth of information elucidating their importance.  Improper functioning of these enzymes due to mutations, mainly in the kinase domain, is often manifested in various human diseases and is known to be involved in several types of cancer.  Here we summarize most of human RTKs, their cognate ligands, as well as related diseases and discuss the eventual use of certain RTKs as new therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQs7acWT79Owg5nADWVYHg1fW6udTcc2eb5AFVxxUzEoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbot1KhsQ%253D%253D&md5=ba6dc2f354598801af9a8f2947a6f1cb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3109%2F10799893.2011.625425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2011.625425%26sid%3Dliteratum%253Aachs%26aulast%3DChoura%26aufirst%3DM.%26aulast%3DReba%25C3%25AF%26aufirst%3DA.%26atitle%3DReceptor%2520tyrosine%2520kinases%253A%2520from%2520biology%2520to%2520pathology%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2011%26volume%3D31%26spage%3D387%26epage%3D394%26doi%3D10.3109%2F10799893.2011.625425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hah, J. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ejmech.2015.08.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2015&pages=600-610&author=D.+Imauthor=K.+Jungauthor=S.+Yangauthor=W.+Amanauthor=J.+M.+Hah&title=Discovery+of+4-arylamido+3-methyl+isoxazole+derivatives+as+novel+FMS+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2015.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAman%26aufirst%3DW.%26aulast%3DHah%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%25204-arylamido%25203-methyl%2520isoxazole%2520derivatives%2520as%2520novel%2520FMS%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D102%26spage%3D600%26epage%3D610%26doi%3D10.1016%2Fj.ejmech.2015.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitu, V.</span></span> <span> </span><span class="NLM_article-title">CSF-1 receptor signaling in myeloid cells</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">a021857</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a021857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1101%2Fcshperspect.a021857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24890514" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=a021857&author=E.+R.+Stanleyauthor=V.+Chitu&title=CSF-1+receptor+signaling+in+myeloid+cells&doi=10.1101%2Fcshperspect.a021857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a021857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a021857%26sid%3Dliteratum%253Aachs%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DChitu%26aufirst%3DV.%26atitle%3DCSF-1%2520receptor%2520signaling%2520in%2520myeloid%2520cells%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2014%26volume%3D6%26spage%3Da021857%26doi%3D10.1101%2Fcshperspect.a021857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Gamal, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbar, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.-H.</span></span> <span> </span><span class="NLM_article-title">FMS kinase inhibitors: current status and future prospects</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1002/med.21258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fmed.21258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22434539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVyrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=599-636&author=M.+I.+El-Gamalauthor=H.+S.+Anbarauthor=K.+H.+Yooauthor=C.-H.+Oh&title=FMS+kinase+inhibitors%3A+current+status+and+future+prospects&doi=10.1002%2Fmed.21258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FMS Kinase Inhibitors: Current Status and Future Prospects</span></div><div class="casAuthors">El-Gamal, Mohammed I.; Anbar, Hanan S.; Yoo, Kyung Ho; Oh, Chang-Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">599-636</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  FMS, first discovered as the oncogene responsible for Feline McDonough Sarcoma, is a type III receptor tyrosine kinase that binds to the macrophage or monocyte colony-stimulating factor (M-CSF or CSF-1).  Signal transduction through that binding results in survival, proliferation, and differentiation of monocyte/macrophage lineage.  Overexpression of CSF-1 and/or FMS has been implicated in a no. of disease states such as the growth of metastasis of certain types of cancer, in promoting osteoclast proliferation in bone osteolysis, and many inflammatory disorders.  Inhibition of CSF-1 and/or FMS may help treat these pathol. conditions.  This article reviews FMS gene, FMS kinase, CSF-1, IL-34, and their roles in bone osteolysis, cancer biol., and inflammation.  Monoclonal antibodies, FMS crystal structure, and small mol. FMS kinase inhibitors of different chem. scaffolds are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqclLKowsJFbVg90H21EOLACvtfcHk0lj6x4wP7s3W3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVyrsbs%253D&md5=779bb21f27a2d89670b0ac1655c1d47b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fmed.21258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21258%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Gamal%26aufirst%3DM.%2BI.%26aulast%3DAnbar%26aufirst%3DH.%2BS.%26aulast%3DYoo%26aufirst%3DK.%2BH.%26aulast%3DOh%26aufirst%3DC.-H.%26atitle%3DFMS%2520kinase%2520inhibitors%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D599%26epage%3D636%26doi%3D10.1002%2Fmed.21258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khol, M. P.</span></span> <span> </span><span class="NLM_article-title">The effects of recombinant osteoactivin on murine osteoclastogenesis</span>. Thesis. <span class="NLM_publisher-name">Northeast Ohio Medical University</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+P.+Khol&title=The+effects+of+recombinant+osteoactivin+on+murine+osteoclastogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhol%26aufirst%3DM.%2BP.%26atitle%3DThe%2520effects%2520of%2520recombinant%2520osteoactivin%2520on%2520murine%2520osteoclastogenesis%26pub%3DNortheast%2520Ohio%2520Medical%2520University%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, R.</span>; <span class="NLM_string-name">Feldman, D.</span>; <span class="NLM_string-name">Dempster, D. W.</span>; <span class="NLM_string-name">Luckey, M.</span>; <span class="NLM_string-name">Cauley, J. A.</span></span> <i>Osteoporosis</i>, <span class="NLM_edition">4th</span> ed., <span class="NLM_year">2014</span>; <a href="https://www.elsevier.com/books/osteoporosis/marcus/978-0-12-415853-5" class="extLink">https://www.elsevier.com/books/osteoporosis/marcus/978-0-12-415853-5</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+Marcus&author=D.+Feldman&author=D.+W.+Dempster&author=M.+Luckey&author=J.+A.+Cauley&title=Osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMarcus%26aufirst%3DR.%26btitle%3DOsteoporosis%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chockalingam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S. S.</span></span> <span> </span><span class="NLM_article-title">Macrophage colony stimulating factor and cancer: a review</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">10635</span>– <span class="NLM_lpage">10644</span>, <span class="refDoi"> DOI: 10.1007/s13277-014-2627-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1007%2Fs13277-014-2627-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=10635-10644&author=S.+Chockalingamauthor=S.+S.+Ghosh&title=Macrophage+colony+stimulating+factor+and+cancer%3A+a+review&doi=10.1007%2Fs13277-014-2627-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage colony-stimulating factor and cancer: a review</span></div><div class="casAuthors">Chockalingam, S.; Ghosh, Siddhartha Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10635-10644</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor growth is influenced by a wide variety of external and internal factors.  One of the most important mediators of tumor development is our immune system.  The nonstop surveillance of the immune system was originally expected to clear the transformed cells from the body and guard against the development of tumor.  But contradictory evidences are reported to show the involvement of immune system in supporting the growth and spread of tumor.  Tumor infiltrating immune cells, in addn. to harboring immunosuppressive activities, also promote angiogenesis and metastasis of tumor.  Many growth factors and cytokines are involved in shaping this complex immune microenvironment of the tumor.  Macrophage colony-stimulating factor (MCSF) is one such growth factor which is overexpressed in many tumors.  In this review, we summarize the basic biol. of MCSF, its role in cancer and discuss the involvement of tumor-assocd. macrophages (TAMs) in tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonrRt-ocMfhrVg90H21EOLACvtfcHk0lj6x4wP7s3W3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM&md5=01055b227ccf55ef96e8d9a4a3ec1277</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs13277-014-2627-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-014-2627-0%26sid%3Dliteratum%253Aachs%26aulast%3DChockalingam%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DS.%2BS.%26atitle%3DMacrophage%2520colony%2520stimulating%2520factor%2520and%2520cancer%253A%2520a%2520review%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D10635%26epage%3D10644%26doi%3D10.1007%2Fs13277-014-2627-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeengar, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramavat, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, V. G.</span></span> <span> </span><span class="NLM_article-title">Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.phrs.2015.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26022736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt12ht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2015&pages=63-73&author=D.+Thummuriauthor=M.+K.+Jeengarauthor=S.+Shrivastavaauthor=H.+Nemaniauthor=R.+N.+Ramavatauthor=P.+Chaudhariauthor=V.+G.+Naidu&title=Thymoquinone+prevents+RANKL-induced+osteoclastogenesis+activation+and+osteolysis+in+an+in+vivo+model+of+inflammation+by+suppressing+NF-KB+and+MAPK+Signalling&doi=10.1016%2Fj.phrs.2015.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling</span></div><div class="casAuthors">Thummuri, Dinesh; Jeengar, Manish Kumar; Shrivastava, Shweta; Nemani, Harishankar; Ramavat, Ravindar Naik; Chaudhari, Pradip; Naidu, V. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Osteoclasts are multinuclear giant cells responsible for bone resorption in inflammatory bone diseases such as osteoporosis, rheumatoid arthritis and periodontitis.  Because of deleterious side effects with currently available drugs the search continues for novel effective and safe therapies.  Thymoquinone (TQ), the major bioactive component of Nigella sativa has been investigated for its anti-inflammatory, antioxidant and anticancer activities.  However, its effects in osteoclastogenesis have not been reported.  In the present study we show for the first time that TQ inhibits nuclear factor-KB ligand (RANKL) induced osteoclastogenesis in RAW 264.7 and primary bone marrow derived macrophages (BMMs) cells.  RANKL induced osteoclastogenesis is assocd. with increased expression of multiple transcription factors via activation of NF-KB, MAPKs signalling and reactive oxygen species (ROS).  Mechanistically TQ blocked the RANKL induced NF-KB activation by attenuating the phosphorylation of IkB kinase (IKKα/β).  Interestingly, in RAW 264.7 cells TQ inhibited the RANKL induced phosphorylation of MAPKs and mRNA expression of osteoclastic specific genes such as TRAP, DC-STAMP, NFATc1 and c-Fos.  In addn., TQ also decreased the RANKL stimulated ROS generation in macropahges (RAW 264.7) and H2O2 induced ROS generation in osteoblasts (MC-3T3-E1).  Consistent with in vitro results, TQ inhibited lipopolysaccharide (LPS) induced bone resorption by suppressing the osteoclastogenesis.  Indeed, micro-CT anal. showed that bone mineral d. (BMD) and bone architecture parameters were pos. modulated by TQ.  Taken together our data demonstrate that TQ has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-KB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre7jXayHxqlbVg90H21EOLACvtfcHk0lhOOyqVgGOMiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt12ht74%253D&md5=3bb4cd59e7dc807794a2dc296d510687</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DJeengar%26aufirst%3DM.%2BK.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DNemani%26aufirst%3DH.%26aulast%3DRamavat%26aufirst%3DR.%2BN.%26aulast%3DChaudhari%26aufirst%3DP.%26aulast%3DNaidu%26aufirst%3DV.%2BG.%26atitle%3DThymoquinone%2520prevents%2520RANKL-induced%2520osteoclastogenesis%2520activation%2520and%2520osteolysis%2520in%2520an%2520in%2520vivo%2520model%2520of%2520inflammation%2520by%2520suppressing%2520NF-KB%2520and%2520MAPK%2520Signalling%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D99%26spage%3D63%26epage%3D73%26doi%3D10.1016%2Fj.phrs.2015.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Papp, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, L. T.</span></span> <span> </span><span class="NLM_article-title">The osteoclast, bone remodelling and treatment of metabolic bone disease</span>. <i>Eur. J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1341</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2362.2012.02717.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1111%2Fj.1365-2362.2012.02717.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1332-1341&author=B.+F.+Boyceauthor=E.+Rosenbergauthor=A.+E.+de+Pappauthor=L.+T.+Duong&title=The+osteoclast%2C+bone+remodelling+and+treatment+of+metabolic+bone+disease&doi=10.1111%2Fj.1365-2362.2012.02717.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2362.2012.02717.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2362.2012.02717.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DB.%2BF.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3Dde%2BPapp%26aufirst%3DA.%2BE.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26atitle%3DThe%2520osteoclast%252C%2520bone%2520remodelling%2520and%2520treatment%2520of%2520metabolic%2520bone%2520disease%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D42%26spage%3D1332%26epage%3D1341%26doi%3D10.1111%2Fj.1365-2362.2012.02717.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodruff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebel, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fajardo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluhak-Heinrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud Werner, S.</span></span> <span> </span><span class="NLM_article-title">Abboud Werner, S.. Meox2Cre-mediated disruption of CSF-1 leads to osteopetrosis and osteocyte defects</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2011.09.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bone.2011.09.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=42-53&author=S.+E.+Harrisauthor=M.+Macdougallauthor=D.+Hornauthor=K.+Woodruffauthor=S.+N.+Zimmerauthor=V.+I.+Rebelauthor=R.+Fajardoauthor=J.+Q.+Fengauthor=J.+Gluhak-Heinrichauthor=M.+A.+Harrisauthor=S.+Abboud+Werner&title=Abboud+Werner%2C+S..+Meox2Cre-mediated+disruption+of+CSF-1+leads+to+osteopetrosis+and+osteocyte+defects&doi=10.1016%2Fj.bone.2011.09.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DS.%2BE.%26aulast%3DMacdougall%26aufirst%3DM.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DWoodruff%26aufirst%3DK.%26aulast%3DZimmer%26aufirst%3DS.%2BN.%26aulast%3DRebel%26aufirst%3DV.%2BI.%26aulast%3DFajardo%26aufirst%3DR.%26aulast%3DFeng%26aufirst%3DJ.%2BQ.%26aulast%3DGluhak-Heinrich%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DM.%2BA.%26aulast%3DAbboud%2BWerner%26aufirst%3DS.%26atitle%3DAbboud%2520Werner%252C%2520S..%2520Meox2Cre-mediated%2520disruption%2520of%2520CSF-1%2520leads%2520to%2520osteopetrosis%2520and%2520osteocyte%2520defects%26jtitle%3DBone%26date%3D2012%26volume%3D50%26spage%3D42%26epage%3D53%26doi%3D10.1016%2Fj.bone.2011.09.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegal, G. P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms modulating inflammatory osteolysis: A review with insights into therapeutic targets</span>. <i>Pathol., Res. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1016/j.prp.2008.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.prp.2008.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=18757139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOku7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2008&pages=695-706&author=S.+Weiauthor=G.+P.+Siegal&title=Mechanisms+modulating+inflammatory+osteolysis%3A+A+review+with+insights+into+therapeutic+targets&doi=10.1016%2Fj.prp.2008.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets</span></div><div class="casAuthors">Wei, Shi; Siegal, Gene P.</div><div class="citationInfo"><span class="NLM_cas:title">Pathology, Research and Practice</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">695-706</span>CODEN:
                <span class="NLM_cas:coden">PARPDS</span>;
        ISSN:<span class="NLM_cas:issn">0344-0338</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Inflammatory osteolysis is a relatively frequent and incapacitating complication of rheumatoid arthritis and multiple other inflammation-assocd. bone diseases.  It is thought to operate through an ultimate common pathway of accelerated osteoclast recruitment and activation under the control of cytokines produced in the inflammatory environment.  Over the past decade, there have been major advances in our understanding of the mechanisms of osteoclastogenesis.  It is now clear that the interaction of receptor activator NF-κB (RANK) and its ligand, RANKL, plays a central role in osteoclast formation and activity.  Therefore, understanding osteoclastogenesis offers new pathways for potential therapeutic intervention in inflammatory osteolysis.  The success of anti-tumor necrosis factor-α and interleukin-1 therapy highlights the central role that these specific cytokines play in this disease.  This review outlines our current understanding of the mechanisms mediating inflammatory osteolysis and highlights potential therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojz5UoKcSsvrVg90H21EOLACvtfcHk0lhOOyqVgGOMiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOku7fO&md5=a245bf8522c9b35081325e461b2b3b4a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.prp.2008.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prp.2008.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%26aulast%3DSiegal%26aufirst%3DG.%2BP.%26atitle%3DMechanisms%2520modulating%2520inflammatory%2520osteolysis%253A%2520A%2520review%2520with%2520insights%2520into%2520therapeutic%2520targets%26jtitle%3DPathol.%252C%2520Res.%2520Pract.%26date%3D2008%26volume%3D204%26spage%3D695%26epage%3D706%26doi%3D10.1016%2Fj.prp.2008.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimoldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Macrophages polarization in tumor progression</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.semcancer.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=18467122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=349-355&author=A.+Sicaauthor=P.+Larghiauthor=A.+Mancinoauthor=L.+Rubinoauthor=C.+Portaauthor=M.+G.+Totaroauthor=M.+Rimoldiauthor=S.+K.+Biswasauthor=P.+Allavenaauthor=A.+Mantovani&title=Macrophages+polarization+in+tumor+progression&doi=10.1016%2Fj.semcancer.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage polarization in tumour progression</span></div><div class="casAuthors">Sica, Antonio; Larghi, Paola; Mancino, Alessandra; Rubino, Luca; Porta, Chiara; Totaro, Maria Grazia; Rimoldi, Monica; Biswas, Subhra Kumar; Allavena, Paola; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Macrophages are a fundamental part of the innate defense mechanisms, which can promote specific immunity by inducing T cell recruitment and activation.  Despite this, their presence within the tumor microenvironment has been assocd. with enhanced tumor progression and shown to promote cancer cell growth and spread, angiogenesis and immunosuppression.  This paradoxical role of macrophages in cancer finds an explanation in their functional plasticity, that may result in the polarized expression of either pro- or anti-tumoral functions.  Key players in the setting of their phenotype are the microenvironmental signals to which macrophages are exposed, which selectively tune their functions within a functional spectrum encompassing the M1 and M2 extremes.  Here, we discuss recent findings suggesting that targeting tumor-assocd. macrophages (TAMs) polarization may represent a novel therapeutic strategy against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphZcYy9ySqx7Vg90H21EOLACvtfcHk0liyULAUL_yEDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D&md5=a786b03442ac65bb774e8b87ea84e0b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DLarghi%26aufirst%3DP.%26aulast%3DMancino%26aufirst%3DA.%26aulast%3DRubino%26aufirst%3DL.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DTotaro%26aufirst%3DM.%2BG.%26aulast%3DRimoldi%26aufirst%3DM.%26aulast%3DBiswas%26aufirst%3DS.%2BK.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DMacrophages%2520polarization%2520in%2520tumor%2520progression%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2008%26volume%3D18%26spage%3D349%26epage%3D355%26doi%3D10.1016%2Fj.semcancer.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schioppa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span> <span> </span><span class="NLM_article-title">Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2006.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ejca.2006.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=16520032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Grt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=717-727&author=A.+Sicaauthor=T.+Schioppaauthor=A.+Mantovaniauthor=P.+Allavena&title=Tumour-associated+macrophages+are+a+distinct+M2+polarised+population+promoting+tumour+progression%3A+Potential+targets+of+anti-cancer+therapy&doi=10.1016%2Fj.ejca.2006.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy</span></div><div class="casAuthors">Sica, Antonio; Schioppa, Tiziana; Mantovani, Alberto; Allavena, Paola</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAM) represent the major inflammatory component of the stroma of many tumors, and can affect different aspects of the neoplastic tissue.  Many observations indicate that TAM express several M2-assocd. pro-tumoral functions, including promotion of angiogenesis, matrix remodelling and suppression of adaptive immunity.  The pro-tumoral role of TAM in cancer is further supported by clin. studies that found a correlation between the high macrophage content of tumors and poor patient prognosis.  Evidence is presented here supporting the view that TAM represent a unique and distinct M2-skewed myeloid population and are a potential target for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2BRvs8GA_9bVg90H21EOLACvtfcHk0liyULAUL_yEDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Grt78%253D&md5=5df82a5fe77ad15b687a31aeda826205</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2006.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2006.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DSchioppa%26aufirst%3DT.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAllavena%26aufirst%3DP.%26atitle%3DTumour-associated%2520macrophages%2520are%2520a%2520distinct%2520M2%2520polarised%2520population%2520promoting%2520tumour%2520progression%253A%2520Potential%2520targets%2520of%2520anti-cancer%2520therapy%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26spage%3D717%26epage%3D727%26doi%3D10.1016%2Fj.ejca.2006.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achkova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span> <span> </span><span class="NLM_article-title">Role of the colony stimulating factor 1 (CSF-1)/CSF-1 receptor axis in cancer</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1042/BST20150245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1042%2FBST20150245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27068937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslyqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=333-341&author=D.+Achkovaauthor=J.+Maher&title=Role+of+the+colony+stimulating+factor+1+%28CSF-1%29%2FCSF-1+receptor+axis+in+cancer&doi=10.1042%2FBST20150245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer</span></div><div class="casAuthors">Achkova, Daniela; Maher, John</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-341</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Cancer cells employ a variety of mechanisms to evade apoptosis and senescence.  Pre-eminent among these is the aberrant co-expression of growth factors and their ligands, forming an autocrine growth loop that promotes tumor formation and progression.  One growth loop whose transforming potential has been repeatedly demonstrated is the CSF-1/CSF-1R axis.  Expression of CSF-1 and/or CSF-1R has been documented in a no. of human malignancies, including breast, prostate and ovarian cancer and classical Hodgkin's lymphoma (cHL).  This review summarizes the large body of work undertaken to study the role of this cytokine receptor system in malignant transformation.  These studies have attributed a key role to the CSF-1/CSF-1R axis in supporting tumor cell survival, proliferation and enhanced motility.  Moreover, increasing evidence implicates paracrine interactions between CSF-1 and its receptor in defining a tumor-permissive and immunosuppressive tumor-assocd. stroma.  Against this background, we briefly consider the prospects for therapeutic targeting of this system in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohsPnqZfR7n7Vg90H21EOLACvtfcHk0liyULAUL_yEDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslyqs7w%253D&md5=3155b29184a36c189f8704e25e896cc1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2FBST20150245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150245%26sid%3Dliteratum%253Aachs%26aulast%3DAchkova%26aufirst%3DD.%26aulast%3DMaher%26aufirst%3DJ.%26atitle%3DRole%2520of%2520the%2520colony%2520stimulating%2520factor%25201%2520%2528CSF-1%2529%252FCSF-1%2520receptor%2520axis%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2016%26volume%3D44%26spage%3D333%26epage%3D341%26doi%3D10.1042%2FBST20150245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riverso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dello Sbarba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovida, E.</span></span> <span> </span><span class="NLM_article-title">The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e27450</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0027450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0027450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27450&author=A.+Morandiauthor=V.+Barbettiauthor=M.+Riversoauthor=P.+Dello+Sbarbaauthor=E.+Rovida&title=The+colony-stimulating+factor-1+%28CSF-1%29+receptor+sustains+ERK1%2F2+activation+and+proliferation+in+breast+cancer+cell+lines&doi=10.1371%2Fjournal.pone.0027450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0027450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0027450%26sid%3Dliteratum%253Aachs%26aulast%3DMorandi%26aufirst%3DA.%26aulast%3DBarbetti%26aufirst%3DV.%26aulast%3DRiverso%26aufirst%3DM.%26aulast%3DDello%2BSbarba%26aufirst%3DP.%26aulast%3DRovida%26aufirst%3DE.%26atitle%3DThe%2520colony-stimulating%2520factor-1%2520%2528CSF-1%2529%2520receptor%2520sustains%2520ERK1%252F2%2520activation%2520and%2520proliferation%2520in%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De27450%26doi%3D10.1371%2Fjournal.pone.0027450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swierczak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, J. A.</span></span> <span> </span><span class="NLM_article-title">The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-13-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F2326-6066.CIR-13-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25005824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSrur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=765-776&author=A.+Swierczakauthor=A.+Cookauthor=J.+Lenzoauthor=C.+Restallauthor=J.+Dohertyauthor=R.+Andersonauthor=J.+A.+Hamilton&title=The+promotion+of+breast+cancer+metastasis+caused+by+inhibition+of+CSF-1R%2FCSF-1+signaling+is+blocked+by+targeting+the+G-CSF+receptor&doi=10.1158%2F2326-6066.CIR-13-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor</span></div><div class="casAuthors">Swierczak, Agnieszka; Cook, Andrew D.; Lenzo, Jason C.; Restall, Christina M.; Doherty, Judy P.; Anderson, Robin L.; Hamilton, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-776</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Swierczak and colleagues show that blockade of CSF-1R signaling promoted metastasis in two mouse mammary tumor models, with increases in serum G-CSF and neutrophils, which can be overcome by anti-G-CSFR antibodies, raising concerns about targeting CSF-1R as breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJjtH5QPlxgbVg90H21EOLACvtfcHk0lj1kGXYagl30w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSrur7J&md5=d22a84794043ca0337187af822aa7107</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-13-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-13-0190%26sid%3Dliteratum%253Aachs%26aulast%3DSwierczak%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DA.%26aulast%3DLenzo%26aufirst%3DJ.%26aulast%3DRestall%26aufirst%3DC.%26aulast%3DDoherty%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DR.%26aulast%3DHamilton%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520promotion%2520of%2520breast%2520cancer%2520metastasis%2520caused%2520by%2520inhibition%2520of%2520CSF-1R%252FCSF-1%2520signaling%2520is%2520blocked%2520by%2520targeting%2520the%2520G-CSF%2520receptor%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2014%26volume%3D2%26spage%3D765%26epage%3D776%26doi%3D10.1158%2F2326-6066.CIR-13-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pixley, F. J.</span></span> <span> </span><span class="NLM_article-title">CSF-1R signaling in health and disease: a focus on the mammary gland</span>. <i>J. Mammary Gland Biol. Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1007/s10911-014-9320-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1007%2Fs10911-014-9320-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24912655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC2cfgslWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=149-159&author=A.+R.+Sullivanauthor=F.+J.+Pixley&title=CSF-1R+signaling+in+health+and+disease%3A+a+focus+on+the+mammary+gland&doi=10.1007%2Fs10911-014-9320-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">CSF-1R signaling in health and disease: a focus on the mammary gland</span></div><div class="casAuthors">Sullivan Amy Renee; Pixley Fiona Jane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of mammary gland biology and neoplasia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colony-stimulating factor-1 (CSF-1), also known as macrophage-colony stimulating factor (M-CSF), is the primary growth factor regulating survival, proliferation and differentiation of macrophages.  It is also a potent chemokine for macrophages and monocytes.  Signaling via the CSF-1 receptor (CSF-1R) is necessary for the production of almost all tissue resident macrophage populations and these macrophages participate, via trophic mechanisms, in the normal development and homeostasis of tissues and organs in which they reside, including the mammary gland.  The drawback of this close interaction between macrophages and parenchymal cells is that dysregulation of macrophage trophic functions assists in the development and progression of many cancers, including breast cancer.  Furthermore, tumour cells secrete CSF-1 to attract more macrophages to the tumour microenvironment where CSF-1R signaling frequently drives the behaviour of these tumour-associated macrophages (TAMs) to promote tumour progression and metastasis.  Evidence is mounting that treated tumours secrete more CSF-1 and the increased recruitment of TAMs limits treatment efficacy.  Thus, therapeutic targeting of the CSF-1R to inhibit TAM function is likely to enhance tumour response and improve patient outcomes in the treatment of cancer, including breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwf4vn3sGFXS-bLEOO4dYpfW6udTcc2eYZm9PYA50CFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfgslWkug%253D%253D&md5=26e33f74139721dccff408dbf8b86e62</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs10911-014-9320-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10911-014-9320-1%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DA.%2BR.%26aulast%3DPixley%26aufirst%3DF.%2BJ.%26atitle%3DCSF-1R%2520signaling%2520in%2520health%2520and%2520disease%253A%2520a%2520focus%2520on%2520the%2520mammary%2520gland%26jtitle%3DJ.%2520Mammary%2520Gland%2520Biol.%2520Neoplasia%26date%3D2014%26volume%3D19%26spage%3D149%26epage%3D159%26doi%3D10.1007%2Fs10911-014-9320-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Escudier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux-Leclercq, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruenvald, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwich, A.</span></span> <span> </span><span class="NLM_article-title">Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">v58</span>– <span class="NLM_lpage">v68</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdw328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1093%2Fannonc%2Fmdw328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27664262" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=v58-v68&author=B.+Escudierauthor=C.+Portaauthor=M.+Schmidingerauthor=N.+Rioux-Leclercqauthor=A.+Bexauthor=V.+Khooauthor=V.+Gruenvaldauthor=A.+Horwich&title=Renal+cell+carcinoma%3A+ESMO+clinical+practice+guidelines+for+diagnosis%2C+treatment+and+follow-up&doi=10.1093%2Fannonc%2Fmdw328"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdw328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdw328%26sid%3Dliteratum%253Aachs%26aulast%3DEscudier%26aufirst%3DB.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DSchmidinger%26aufirst%3DM.%26aulast%3DRioux-Leclercq%26aufirst%3DN.%26aulast%3DBex%26aufirst%3DA.%26aulast%3DKhoo%26aufirst%3DV.%26aulast%3DGruenvald%26aufirst%3DV.%26aulast%3DHorwich%26aufirst%3DA.%26atitle%3DRenal%2520cell%2520carcinoma%253A%2520ESMO%2520clinical%2520practice%2520guidelines%2520for%2520diagnosis%252C%2520treatment%2520and%2520follow-up%26jtitle%3DAnn.%2520Oncol.%26date%3D2016%26volume%3D27%26spage%3Dv58%26epage%3Dv68%26doi%3D10.1093%2Fannonc%2Fmdw328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriegsmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimanski, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, V. R.</span></span> <span> </span><span class="NLM_article-title">Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F0008-5472.CAN-11-1232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=187-200&author=J.+Menkeauthor=J.+Kriegsmannauthor=C.+C.+Schimanskiauthor=M.+M.+Schwartzauthor=A.+Schwartingauthor=V.+R.+Kelley&title=Autocrine+CSF-1+and+CSF-1+receptor+coexpression+promotes+renal+cell+carcinoma+growth&doi=10.1158%2F0008-5472.CAN-11-1232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1232%26sid%3Dliteratum%253Aachs%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DKriegsmann%26aufirst%3DJ.%26aulast%3DSchimanski%26aufirst%3DC.%2BC.%26aulast%3DSchwartz%26aufirst%3DM.%2BM.%26aulast%3DSchwarting%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DV.%2BR.%26atitle%3DAutocrine%2520CSF-1%2520and%2520CSF-1%2520receptor%2520coexpression%2520promotes%2520renal%2520cell%2520carcinoma%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D187%26epage%3D200%26doi%3D10.1158%2F0008-5472.CAN-11-1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burattini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montironi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascinu, S.</span></span> <span> </span><span class="NLM_article-title">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1007/s00262-013-1487-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1007%2Fs00262-013-1487-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24132754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1757-1768&author=M.+Santoniauthor=F.+Massariauthor=C.+Amantiniauthor=M.+Nabissiauthor=F.+Mainesauthor=L.+Burattiniauthor=R.+Berardiauthor=G.+Santoniauthor=R.+Montironiauthor=G.+Tortoraauthor=S.+Cascinu&title=Emerging+role+of+tumor-associated+macrophages+as+therapeutic+targets+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1007%2Fs00262-013-1487-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Santoni, Matteo; Massari, Francesco; Amantini, Consuelo; Nabissi, Massimo; Maines, Francesca; Burattini, Luciano; Berardi, Rossana; Santoni, Giorgio; Montironi, Rodolfo; Tortora, Giampaolo; Cascinu, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1757-1768</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAMs) derived from peripheral blood monocytes recruited into the renal cell carcinoma (RCC) microenvironment.  In response to inflammatory stimuli, macrophages undergo M1 (classical) or M2 (alternative) activation.  M1 cells produce high levels of inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-12, IL-23 and IL-6, while M2 cells produce anti-inflammatory cytokines, such as IL-10, thus contributing to RCC-related immune dysfunction.  The presence of extensive TAM infiltration in RCC microenvironment contributes to cancer progression and metastasis by stimulating angiogenesis, tumor growth, and cellular migration and invasion.  Moreover, TAMs are involved in epithelial-mesenchymal transition of RCC cancer cells and in the development of tumor resistance to targeted agents.  Interestingly, macrophage autophagy seems to play an important role in RCC.  Based on this scenario, TAMs represent a promising and effective target for cancer therapy in RCC.  Several strategies have been proposed to suppress TAM recruitment, to deplete their no., to switch M2 TAMs into antitumor M1 phenotype and to inhibit TAM-assocd. mols.  In this review, we summarize current data on the essential role of TAMs in RCC angiogenesis, invasion, impaired anti-tumor immune response and development of drug resistance, thus describing the emerging TAM-centered therapies for RCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolZG976wpuQbVg90H21EOLACvtfcHk0lj1kGXYagl30w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF&md5=1160c0890450df83400121069c437a24</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00262-013-1487-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-013-1487-6%26sid%3Dliteratum%253Aachs%26aulast%3DSantoni%26aufirst%3DM.%26aulast%3DMassari%26aufirst%3DF.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMaines%26aufirst%3DF.%26aulast%3DBurattini%26aufirst%3DL.%26aulast%3DBerardi%26aufirst%3DR.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DMontironi%26aufirst%3DR.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DCascinu%26aufirst%3DS.%26atitle%3DEmerging%2520role%2520of%2520tumor-associated%2520macrophages%2520as%2520therapeutic%2520targets%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2013%26volume%3D62%26spage%3D1757%26epage%3D1768%26doi%3D10.1007%2Fs00262-013-1487-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. H.</span></span> <span> </span><span class="NLM_article-title">Optimal dose reduction of Folfirinox for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2017.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ejca.2017.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=125-133&author=J.+C.+Leeauthor=J.+W.+Kimauthor=S.+Ahnauthor=H.+W.+Kimauthor=J.+Leeauthor=Y.+H.+Kimauthor=K.+H.+Paikauthor=J.+Kimauthor=J.+H.+Hwang&title=Optimal+dose+reduction+of+Folfirinox+for+preserving+tumour+response+in+advanced+pancreatic+cancer%3A+Using+cumulative+relative+dose+intensity&doi=10.1016%2Fj.ejca.2017.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2017.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2017.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DPaik%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DJ.%2BH.%26atitle%3DOptimal%2520dose%2520reduction%2520of%2520Folfirinox%2520for%2520preserving%2520tumour%2520response%2520in%2520advanced%2520pancreatic%2520cancer%253A%2520Using%2520cumulative%2520relative%2520dose%2520intensity%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2017%26volume%3D76%26spage%3D125%26epage%3D133%26doi%3D10.1016%2Fj.ejca.2017.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knolhoff, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nywening, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang-Gillam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedegebuure, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linehan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNardo, D. G.</span></span> <span> </span><span class="NLM_article-title">CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">5057</span>– <span class="NLM_lpage">5069</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-3723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F0008-5472.CAN-13-3723" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5057-5069&author=Y.+Zhuauthor=B.+L.+Knolhoffauthor=M.+A.+Meyerauthor=T.+M.+Nyweningauthor=B.+L.+Westauthor=J.+Luoauthor=A.+Wang-Gillamauthor=S.+P.+Goedegebuureauthor=D.+C.+Linehanauthor=D.+G.+DeNardo&title=CSF1%2FCSF1R+blockade+reprograms+tumor-infiltrating+macrophages+and+improves+response+to+T-cell+checkpoint+immunotherapy+in+pancreatic+cancer+models&doi=10.1158%2F0008-5472.CAN-13-3723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-3723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-3723%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DKnolhoff%26aufirst%3DB.%2BL.%26aulast%3DMeyer%26aufirst%3DM.%2BA.%26aulast%3DNywening%26aufirst%3DT.%2BM.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DWang-Gillam%26aufirst%3DA.%26aulast%3DGoedegebuure%26aufirst%3DS.%2BP.%26aulast%3DLinehan%26aufirst%3DD.%2BC.%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26atitle%3DCSF1%252FCSF1R%2520blockade%2520reprograms%2520tumor-infiltrating%2520macrophages%2520and%2520improves%2520response%2520to%2520T-cell%2520checkpoint%2520immunotherapy%2520in%2520pancreatic%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D5057%26epage%3D5069%26doi%3D10.1158%2F0008-5472.CAN-13-3723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanger, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonderheide, R. H.</span></span> <span> </span><span class="NLM_article-title">Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ccr.2012.04.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=822-835&author=L.+J.+Bayneauthor=G.+L.+Beattyauthor=N.+Jhalaauthor=C.+E.+Clarkauthor=A.+D.+Rhimauthor=B.+Z.+Stangerauthor=R.+H.+Vonderheide&title=Tumor-derived+granulocyte-macrophage+colony-stimulating+factor+regulates+myeloid+inflammation+and+T+cell+immunity+in+pancreatic+cancer&doi=10.1016%2Fj.ccr.2012.04.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DBayne%26aufirst%3DL.%2BJ.%26aulast%3DBeatty%26aufirst%3DG.%2BL.%26aulast%3DJhala%26aufirst%3DN.%26aulast%3DClark%26aufirst%3DC.%2BE.%26aulast%3DRhim%26aufirst%3DA.%2BD.%26aulast%3DStanger%26aufirst%3DB.%2BZ.%26aulast%3DVonderheide%26aufirst%3DR.%2BH.%26atitle%3DTumor-derived%2520granulocyte-macrophage%2520colony-stimulating%2520factor%2520regulates%2520myeloid%2520inflammation%2520and%2520T%2520cell%2520immunity%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D822%26epage%3D835%26doi%3D10.1016%2Fj.ccr.2012.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louzoun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesinski, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span> <span> </span><span class="NLM_article-title">A mathematical model for pancreatic cancer growth and treatments</span>. <i>J. Theor. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.jtbi.2014.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.jtbi.2014.02.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=74-82&author=Y.+Louzounauthor=C.+Xueauthor=G.+B.+Lesinskiauthor=A.+Friedman&title=A+mathematical+model+for+pancreatic+cancer+growth+and+treatments&doi=10.1016%2Fj.jtbi.2014.02.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jtbi.2014.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtbi.2014.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DLouzoun%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DC.%26aulast%3DLesinski%26aufirst%3DG.%2BB.%26aulast%3DFriedman%26aufirst%3DA.%26atitle%3DA%2520mathematical%2520model%2520for%2520pancreatic%2520cancer%2520growth%2520and%2520treatments%26jtitle%3DJ.%2520Theor.%2520Biol.%26date%3D2014%26volume%3D351%26spage%3D74%26epage%3D82%26doi%3D10.1016%2Fj.jtbi.2014.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmgaard, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamarin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesokhin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merghoub, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolchok, J. D.</span></span> <span> </span><span class="NLM_article-title">Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2, 3-dioxygenase-expressing tumors</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2016.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ebiom.2016.02.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=50-58&author=R.+B.+Holmgaardauthor=D.+Zamarinauthor=A.+Lesokhinauthor=T.+Merghoubauthor=J.+D.+Wolchok&title=Targeting+myeloid-derived+suppressor+cells+with+colony+stimulating+factor-1+receptor+blockade+can+reverse+immune+resistance+to+immunotherapy+in+indoleamine+2%2C+3-dioxygenase-expressing+tumors&doi=10.1016%2Fj.ebiom.2016.02.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2016.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2016.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgaard%26aufirst%3DR.%2BB.%26aulast%3DZamarin%26aufirst%3DD.%26aulast%3DLesokhin%26aufirst%3DA.%26aulast%3DMerghoub%26aufirst%3DT.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26atitle%3DTargeting%2520myeloid-derived%2520suppressor%2520cells%2520with%2520colony%2520stimulating%2520factor-1%2520receptor%2520blockade%2520can%2520reverse%2520immune%2520resistance%2520to%2520immunotherapy%2520in%2520indoleamine%25202%252C%25203-dioxygenase-expressing%2520tumors%26jtitle%3DEBioMedicine%26date%3D2016%26volume%3D6%26spage%3D50%26epage%3D58%26doi%3D10.1016%2Fj.ebiom.2016.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodruff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prihoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeSaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud-Werner, S. L.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor 1 potentiates lung cancer bone metastasis</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2014.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1038%2Flabinvest.2014.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=371-381&author=J.+Y.+Hungauthor=D.+Hornauthor=K.+Woodruffauthor=T.+Prihodaauthor=C.+LeSauxauthor=J.+Petersauthor=F.+Tioauthor=S.+L.+Abboud-Werner&title=Colony-stimulating+factor+1+potentiates+lung+cancer+bone+metastasis&doi=10.1038%2Flabinvest.2014.1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2014.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2014.1%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DJ.%2BY.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DWoodruff%26aufirst%3DK.%26aulast%3DPrihoda%26aufirst%3DT.%26aulast%3DLeSaux%26aufirst%3DC.%26aulast%3DPeters%26aufirst%3DJ.%26aulast%3DTio%26aufirst%3DF.%26aulast%3DAbboud-Werner%26aufirst%3DS.%2BL.%26atitle%3DColony-stimulating%2520factor%25201%2520potentiates%2520lung%2520cancer%2520bone%2520metastasis%26jtitle%3DLab.%2520Invest.%26date%3D2014%26volume%3D94%26spage%3D371%26epage%3D381%26doi%3D10.1038%2Flabinvest.2014.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ettinger, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheney, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirieac, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demmy, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganti, A. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grannis, F. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanzeb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kris, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennes, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Malley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osarogiagbon, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otterson, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinder-Schenck, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisters, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reckamp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riely, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HUghes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. M.</span></span> <span> </span><span class="NLM_article-title">Non-small cell lung cancer clinical practice guidelines in oncology</span>. <i>J. Natl. Compr. Cancer Network</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.6004/jnccn.2012.0130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.6004%2Fjnccn.2012.0130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23054877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslynsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1236-1271&author=D.+S.+Ettingerauthor=W.+Akerleyauthor=H.+Borghaeiauthor=A.+C.+Changauthor=R.+T.+Cheneyauthor=L.+R.+Chirieacauthor=T.+A.+D%E2%80%99Amicoauthor=T.+L.+Demmyauthor=A.+K.+P.+Gantiauthor=R.+Govindanauthor=F.+W.+Grannisauthor=L.+Hornauthor=T.+M.+Jahanauthor=M.+Jahanzebauthor=A.+Kessingerauthor=R.+Komakiauthor=F.-M.+Kongauthor=M.+G.+Krisauthor=L.+M.+Krugauthor=I.+T.+Lennesauthor=B.+W.+Looauthor=R.+Martinsauthor=J.+O%27Malleyauthor=R.+U.+Osarogiagbonauthor=G.+A.+Ottersonauthor=J.+D.+Patelauthor=M.+C.+Pinder-Schenckauthor=K.+M.+Pistersauthor=K.+Reckampauthor=G.+J.+Rielyauthor=E.+Rohrenauthor=S.+J.+Swansonauthor=D.+E.+Woodauthor=S.+C.+Yangauthor=M.+HUghesauthor=K.+M.+Gregory&title=Non-small+cell+lung+cancer+clinical+practice+guidelines+in+oncology&doi=10.6004%2Fjnccn.2012.0130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Non-small cell lung cancer: clinical practice guidelines in oncology</span></div><div class="casAuthors">Ettinger, David S.; Akerley, Wallace; Borghaei, Hossein; Chang, Andrew C.; Cheney, Richard T.; Chirieac, Lucian R.; D'Amico, Thomas A.; Demmy, Todd L.; Ganti, Apar Kishor P.; Govindan, Ramaswamy; Grannis, Frederic W., Jr.; Horn, Leora; Jahan, Thierry M.; Jahanzeb, Mohammad; Kessinger, Anne; Komaki, Ritsuko; Kong, Feng-Ming; Kris, Mark G.; Krug, Lee M.; Lennes, Inga T.; Loo, Billy W., Jr.; Martins, Renato; O'Malley, Janis; Osarogiagbon, Raymond U.; Otterson, Gregory A.; Patel, Jyoti D.; Pinder-Schenck, Mary C.; Pisters, Katherine M.; Reckhamp, Karen; Riely, Gregory J.; Rohren, Eric; Swanson, Scott J.; Wood, Douglas E.; Yang, Stephen C.; Hughes, Miranda; Gregory, Kristina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Comprehensive Cancer Network</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1236-1271</span>CODEN:
                <span class="NLM_cas:coden">JNCCA4</span>;
        ISSN:<span class="NLM_cas:issn">1540-1405</span>.
    
            (<span class="NLM_cas:orgname">Harborside Press</span>)
        </div><div class="casAbstract">A review.  Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer.  These guidelines only include information about stage IV NSCLC.  Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clin. trials, and/or palliative treatment.  The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment.  If metastatic disease is discovered during surgery, then extensive surgery is often aborted.  Decisions about treatment should be based on multidisciplinary discussion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGPB2lS5HTrVg90H21EOLACvtfcHk0liJlQbSE4EZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslynsrrL&md5=7c12bc6563fb96f5ce5515a068394eeb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.6004%2Fjnccn.2012.0130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6004%252Fjnccn.2012.0130%26sid%3Dliteratum%253Aachs%26aulast%3DEttinger%26aufirst%3DD.%2BS.%26aulast%3DAkerley%26aufirst%3DW.%26aulast%3DBorghaei%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DA.%2BC.%26aulast%3DCheney%26aufirst%3DR.%2BT.%26aulast%3DChirieac%26aufirst%3DL.%2BR.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DT.%2BA.%26aulast%3DDemmy%26aufirst%3DT.%2BL.%26aulast%3DGanti%26aufirst%3DA.%2BK.%2BP.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DGrannis%26aufirst%3DF.%2BW.%26aulast%3DHorn%26aufirst%3DL.%26aulast%3DJahan%26aufirst%3DT.%2BM.%26aulast%3DJahanzeb%26aufirst%3DM.%26aulast%3DKessinger%26aufirst%3DA.%26aulast%3DKomaki%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DF.-M.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DKrug%26aufirst%3DL.%2BM.%26aulast%3DLennes%26aufirst%3DI.%2BT.%26aulast%3DLoo%26aufirst%3DB.%2BW.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DO%2527Malley%26aufirst%3DJ.%26aulast%3DOsarogiagbon%26aufirst%3DR.%2BU.%26aulast%3DOtterson%26aufirst%3DG.%2BA.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DPinder-Schenck%26aufirst%3DM.%2BC.%26aulast%3DPisters%26aufirst%3DK.%2BM.%26aulast%3DReckamp%26aufirst%3DK.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26aulast%3DRohren%26aufirst%3DE.%26aulast%3DSwanson%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DD.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DHUghes%26aufirst%3DM.%26aulast%3DGregory%26aufirst%3DK.%2BM.%26atitle%3DNon-small%2520cell%2520lung%2520cancer%2520clinical%2520practice%2520guidelines%2520in%2520oncology%26jtitle%3DJ.%2520Natl.%2520Compr.%2520Cancer%2520Network%26date%3D2012%26volume%3D10%26spage%3D1236%26epage%3D1271%26doi%3D10.6004%2Fjnccn.2012.0130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adah, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2016.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.phrs.2016.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27157248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFemtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=25-34&author=D.+Adahauthor=M.+Hussainauthor=L.+Qinauthor=L.+Qinauthor=J.+Zhangauthor=X.+Chen&title=Implications+of+MDSCs-targeting+in+lung+cancer+chemo-immunotherapeutics&doi=10.1016%2Fj.phrs.2016.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics</span></div><div class="casAuthors">Adah, Dickson; Hussain, Muzammal; Qin, Limei; Qin, Li; Zhang, Jiancun; Chen, Xiaoping</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite advances in chemotherapy and immunotherapy, advanced lung cancer remains an incurable disease.  Novel trends in anticancer therapeutics focus on harnessing the therapeutically-targeted tumor-related immune suppression.  In this respect, myeloid-derived suppressor cells (MDSCs) have captured considerable attention in the last few years, as they are vividly implicated in tumor immune escape mechanisms.  In this review, we specifically discuss the multifaceted roles of MDSCs in lung tumor microenvironment, encompassing lung tumor growth and progression via suppression of anti-tumor immunity, assocn. with worse prognosis, and hampering the efficacy of lung cancer chemotherapy and immunotherapy.  In addn., we also discuss that therapeutic manipulation of MDSCs-targeting, either alone or in combination with chemo- and/or immune-therapeutic regimens, may not only have tumor growth inhibition, anti-angiogenesis and anti-metastasis effects, but may also have the potential to enhance the efficacy of lung cancer chemotherapy and immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobpVR72xV93rVg90H21EOLACvtfcHk0liJlQbSE4EZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFemtL0%253D&md5=79630ef8a0be79ae52e7fb38049fcbcb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DAdah%26aufirst%3DD.%26aulast%3DHussain%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DImplications%2520of%2520MDSCs-targeting%2520in%2520lung%2520cancer%2520chemo-immunotherapeutics%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D110%26spage%3D25%26epage%3D34%26doi%3D10.1016%2Fj.phrs.2016.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span> <span> </span><span class="NLM_article-title">MiR-1207–5p suppresses lung cancer growth and metastasis by targeting CSF1</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">32421</span>– <span class="NLM_lpage">32432</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.18632%2Foncotarget.8718" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=32421-32432&author=W.+Dangauthor=Z.+Qinauthor=S.+Fanauthor=Q.+Wenauthor=Y.+Luauthor=J.+Wangauthor=X.+Zhangauthor=L.+Weiauthor=W.+Heauthor=Q.+Yeauthor=Q.+Yanauthor=G.+Liauthor=J.+Ma&title=MiR-1207%E2%80%935p+suppresses+lung+cancer+growth+and+metastasis+by+targeting+CSF1&doi=10.18632%2Foncotarget.8718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8718%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DJ.%26atitle%3DMiR-1207%25E2%2580%25935p%2520suppresses%2520lung%2520cancer%2520growth%2520and%2520metastasis%2520by%2520targeting%2520CSF1%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D32421%26epage%3D32432%26doi%3D10.18632%2Foncotarget.8718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panni, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linehan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNardo, D. G.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor-infiltrating macrophages to combat cancer</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.2217/imt.13.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.2217%2Fimt.13.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24088077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCrtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1075-1087&author=R.+Z.+Panniauthor=D.+C.+Linehanauthor=D.+G.+DeNardo&title=Targeting+tumor-infiltrating+macrophages+to+combat+cancer&doi=10.2217%2Fimt.13.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor-infiltrating macrophages to combat cancer</span></div><div class="casAuthors">Panni, Roheena Z.; Linehan, David C.; DeNardo, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1075-1087</span>CODEN:
                <span class="NLM_cas:coden">IMMUCO</span>;
        ISSN:<span class="NLM_cas:issn">1750-743X</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages are one of the major constituents of tumor stroma in many solid tumors and there is compelling preclin. and clin. evidence that macrophages promote cancer initiation and malignant progression.  Therefore, these cells represent potential targets for therapeutic benefit.  In this review, we will summarize macrophage phenotypic heterogeneity, the current understanding of how tumors take advantage of macrophage plasticity to generate immunosuppression, and how manipulation of specific macrophage populations can be used for therapeutic purposes through translational approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhoXbRjxrVErVg90H21EOLACvtfcHk0lijkrigZQXlUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCrtr7K&md5=c1be67329f872a65c7d326233cc225e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2217%2Fimt.13.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt.13.102%26sid%3Dliteratum%253Aachs%26aulast%3DPanni%26aufirst%3DR.%2BZ.%26aulast%3DLinehan%26aufirst%3DD.%2BC.%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26atitle%3DTargeting%2520tumor-infiltrating%2520macrophages%2520to%2520combat%2520cancer%26jtitle%3DImmunotherapy%26date%3D2013%26volume%3D5%26spage%3D1075%26epage%3D1087%26doi%3D10.2217%2Fimt.13.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J. H.</span></span> <span> </span><span class="NLM_article-title">Cytokine-mediated bone destruction in rheumatoid arthritis</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">263625</span>, <span class="refDoi"> DOI: 10.1155/2014/263625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1155%2F2014%2F263625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25295284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC2M3msVOmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=263625&author=S.+M.+Jungauthor=K.+W.+Kimauthor=C.-W.+Yangauthor=S.-H.+Parkauthor=J.+H.+Ju&title=Cytokine-mediated+bone+destruction+in+rheumatoid+arthritis&doi=10.1155%2F2014%2F263625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine-mediated bone destruction in rheumatoid arthritis</span></div><div class="casAuthors">Jung Seung Min; Park Sung-Hwan; Kim Kyoung Woon; Yang Chul-Woo; Ju Ji Hyeon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">263625</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bone homeostasis, which involves formation and resorption, is an important process for maintaining adequate bone mass in humans.  Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation and bone loss, leading to joint destruction and deformity, and is a representative disease of disrupted bone homeostasis.  The bone loss and joint destruction are mediated by immunological insults by proinflammatory cytokines and various immune cells.  The connection between bone and immunity has been intensely studied and comprises the emerging field of osteoimmunology.  Osteoimmunology is an interdisciplinary science investigating the interplay between the skeletal and the immune systems.  The main contributors in osteoimmunology are the bone effector cells, such as osteoclasts or osteoblasts, and the immune cells, particularly lymphocytes and monocytes.  Physiologically, osteoclasts originate from immune cells, and immune cells regulate osteoblasts and vice versa.  Pathological conditions such as RA might affect these interactions, thereby altering bone homeostasis, resulting in the unfavorable outcome of bone destruction.  In this review, we describe the osteoclastogenic roles of the proinflammatory cytokines and immune cells that are important in the pathophysiology of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdPpzEjzv6SLHHuJhbyicZfW6udTcc2ebd5D2m8LbffLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3msVOmtA%253D%253D&md5=b710905e9cdf0315fba9b9410681a2d6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1155%2F2014%2F263625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F263625%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DYang%26aufirst%3DC.-W.%26aulast%3DPark%26aufirst%3DS.-H.%26aulast%3DJu%26aufirst%3DJ.%2BH.%26atitle%3DCytokine-mediated%2520bone%2520destruction%2520in%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2014%26volume%3D2014%26spage%3D263625%26doi%3D10.1155%2F2014%2F263625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. R.</span></span> <span> </span><span class="NLM_article-title">Treatment options for rheumatoid arthritis</span>. <i>Drug Topics</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1999&pages=53-62&author=D.+R.+Miller&title=Treatment+options+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BR.%26atitle%3DTreatment%2520options%2520for%2520rheumatoid%2520arthritis%26jtitle%3DDrug%2520Topics%26date%3D1999%26volume%3D143%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkamp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malvar-Fernandez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanghi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masteller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radstake, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedquist, K. A.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.1186/s13075-016-0973-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1186%2Fs13075-016-0973-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27036883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=75&author=S.+Garciaauthor=L.+Hartkampauthor=B.+Malvar-Fernandezauthor=I.+E.+van+Esauthor=H.+Linauthor=J.+Wongauthor=L.+Longauthor=J.+A.+Zanghiauthor=A.+L.+Rankinauthor=E.+L.+Mastellerauthor=B.+R.+Wongauthor=T.+R.+Radstakeauthor=P.+P.+Takauthor=K.+A.+Reedquist&title=Colony-stimulating+factor+%28CSF%29+1+receptor+blockade+reduces+inflammation+in+human+and+murine+models+of+rheumatoid+arthritis&doi=10.1186%2Fs13075-016-0973-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis</span></div><div class="casAuthors">Garcia, Samuel; Hartkamp, Linda M.; Malvar-Fernandez, B.; van Es, Inge E.; Lin, Haishan; Wong, Justin; Long, Li; Zanghi, James A.; Rankin, Andrew L.; Masteller, Emma L.; Wong, Brian R.; Radstake, Timothy R. D. J.; Tak, Paul P.; Reedquist, Kris A.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75/1-75/14</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: CSF-1 or IL-34 stimulation of CSF1R promotes macrophage differentiation, activation and osteoclastogenesis, and pharmacol. inhibition of CSF1R is beneficial in animal models of arthritis.  The objective of this study was to det. the relative contributions of CSF-1 and IL-34 signaling to CSF1R in RA.  Methods: CSF-1 and IL-34 were detected by immunohistochem. and digital image anal. in synovial tissue from 15 biol.-naive rheumatoid arthritis (RA), 15 psoriatic arthritis (PsA) and 7 osteoarthritis (OA) patients.  Gene expression in CSF-1- and IL-34-differentiated human macrophages was assessed by FACS anal. and quant. PCR.  RA synovial explants were incubated with CSF-1, IL-34, control antibody (Ab), or neutralizing/blocking Abs targeting CSF-1, IL-34, or CSF1R.  The effect of a CSF1R-blocking Ab was examd. in murine collagen-induced arthritis (CIA).  Results: CSF-1 (also known as M-CSF) and IL-34 expression was similar in RA and PsA synovial tissue, but lower in controls (P < 0.05).  CSF-1 expression was obsd. in the synovial sublining, and IL-34 in the sublining and the intimal lining layer.  CSF-1 and IL-34 differentially regulated the expression of 17 of 336 inflammation-assocd. genes in macrophages, including chemokines, extra-cellular matrix components, and matrix metalloproteinases.  Exogenous CSF-1 or IL-34, or their independent neutralization, had no effect on RA synovial explant IL-6 prodn.  Anti-CSF1R Ab significantly reduced IL-6 and other inflammatory mediator prodn. in RA synovial explants, and paw swelling and joint destruction in CIA.  Conclusions: Simultaneous inhibition of CSF1R interactions with both CSF-1 and IL-34 suppresses inflammatory activation of RA synovial tissue and pathol. in CIA, suggesting a novel therapeutic strategy for RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeozGQWNoAnLVg90H21EOLACvtfcHk0lhqC9aDMG6pwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyjsbY%253D&md5=12c52f2156d063843efe928153dcd22c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1186%2Fs13075-016-0973-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-016-0973-6%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DS.%26aulast%3DHartkamp%26aufirst%3DL.%26aulast%3DMalvar-Fernandez%26aufirst%3DB.%26aulast%3Dvan%2BEs%26aufirst%3DI.%2BE.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DL.%26aulast%3DZanghi%26aufirst%3DJ.%2BA.%26aulast%3DRankin%26aufirst%3DA.%2BL.%26aulast%3DMasteller%26aufirst%3DE.%2BL.%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DRadstake%26aufirst%3DT.%2BR.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DReedquist%26aufirst%3DK.%2BA.%26atitle%3DColony-stimulating%2520factor%2520%2528CSF%2529%25201%2520receptor%2520blockade%2520reduces%2520inflammation%2520in%2520human%2520and%2520murine%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2016%26volume%3D18%26spage%3D75%26doi%3D10.1186%2Fs13075-016-0973-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemmour, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thioudellet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehnert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmerjahn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span> <span> </span><span class="NLM_article-title">Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3000</span>, <span class="refDoi"> DOI: 10.1002/art.38624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fart.38624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24623505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVOhtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=2989-3000&author=M.+L.+Tohauthor=J.+Y.+Bonnefoyauthor=N.+Accartauthor=S.+Cochinauthor=S.+Pohleauthor=H.+Haegelauthor=M.+De+Meyerauthor=C.+Zemmourauthor=X.+Previlleauthor=C.+Guillenauthor=C.+Thioudelletauthor=P.+Ancianauthor=A.+Luxauthor=B.+Sehnertauthor=F.+Nimmerjahnauthor=R.+E.+Vollauthor=G.+Schett&title=Bone-+and+cartilage-protective+effects+of+a+monoclonal+antibody+against+colony-stimulating+factor+1+receptor+in+experimental+arthritis&doi=10.1002%2Fart.38624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis</span></div><div class="casAuthors">Toh, Myew-Ling; Bonnefoy, Jean-Yves; Accart, Nathalie; Cochin, Sandrine; Pohle, Sandy; Haegel, Helene; De Meyer, Micael; Zemmour, Christophe; Preville, Xavier; Guillen, Christine; Thioudellet, Christine; Ancian, Philippe; Lux, Anja; Sehnert, Bettina; Nimmerjahn, Falk; Voll, Reinhard E.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2989-3000</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Colony-stimulating factor 1 receptor (CSF-1R) essentially modulates monocyte proliferation, migration, and activation, which are considered important for the pathogenesis of rheumatoid arthritis (RA).  We undertook this study to det. CSF-1R expression in human RA as well as the efficacy of a specific anti-CSF-1R monoclonal antibody (AFS98) in 2 different animal models of RA.  Methods: CSF-1R expression was examd. in blood, synovium, and bone samples from RA patients, osteoarthritis (OA) patients, and healthy subjects.  The efficacy of AFS98 was examd. by clin. assessment, histol., and bone histomorphometry in collagen-induced arthritis (CIA) and serum-transfer arthritis.  Results: CSF-1R expression was increased in the synovium of RA patients compared to OA patients and healthy controls in fibroblast-like synoviocytes, follicular dendritic cells, macrophages, and osteoclasts.  Circulating RA monocytes and neutrophils but not lymphocytes were CSF-1R+.  In mice, blockade of CSF-1R abrogated cartilage damage, bone erosion, and systemic bone loss, and this was assocd. with the depletion of osteoclasts in both models.  While blockade of CSF-1R did not affect inflammation in passive serum-transfer arthritis, it significantly reduced inflammation in CIA, and this was assocd. with the absence of synovial macrophages and reduced splenic CD11b+Gr-1-monocytes.  Conclusion: CSF-1R was broadly expressed in human RA.  Blockade of CSF-1R protected against bone and cartilage destruction in both mouse models and also showed significant antiinflammatory effects in the CIA model.  These data provide evidence for CSF-1R as a therapeutic target in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8ZxPzKmL4rVg90H21EOLACvtfcHk0lhqC9aDMG6pwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVOhtbnF&md5=4ba72d8cf97bc11a568026c2a480e1dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fart.38624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.38624%26sid%3Dliteratum%253Aachs%26aulast%3DToh%26aufirst%3DM.%2BL.%26aulast%3DBonnefoy%26aufirst%3DJ.%2BY.%26aulast%3DAccart%26aufirst%3DN.%26aulast%3DCochin%26aufirst%3DS.%26aulast%3DPohle%26aufirst%3DS.%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DDe%2BMeyer%26aufirst%3DM.%26aulast%3DZemmour%26aufirst%3DC.%26aulast%3DPreville%26aufirst%3DX.%26aulast%3DGuillen%26aufirst%3DC.%26aulast%3DThioudellet%26aufirst%3DC.%26aulast%3DAncian%26aufirst%3DP.%26aulast%3DLux%26aufirst%3DA.%26aulast%3DSehnert%26aufirst%3DB.%26aulast%3DNimmerjahn%26aufirst%3DF.%26aulast%3DVoll%26aufirst%3DR.%2BE.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DBone-%2520and%2520cartilage-protective%2520effects%2520of%2520a%2520monoclonal%2520antibody%2520against%2520colony-stimulating%2520factor%25201%2520receptor%2520in%2520experimental%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2014%26volume%3D66%26spage%3D2989%26epage%3D3000%26doi%3D10.1002%2Fart.38624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado-Vazquez, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morado-Urbina, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castãneda-Corral, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta-Gonzalez, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano-Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Andrade, J. M.</span></span> <span> </span><span class="NLM_article-title">Intra-articular administration of an antibody against CSF-1 receptor reduces pain-related behaviors and inflammation in CFA-induced knee arthritis</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>584</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2014.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.neulet.2014.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2015&pages=39-44&author=P.+A.+Alvarado-Vazquezauthor=C.+E.+Morado-Urbinaauthor=G.+Cast%C3%A3neda-Corralauthor=R.+I.+Acosta-Gonzalezauthor=H.+Kitauraauthor=K.+Kimuraauthor=T.+Takano-Yamamotoauthor=J.+M.+Jim%C3%A9nez-Andrade&title=Intra-articular+administration+of+an+antibody+against+CSF-1+receptor+reduces+pain-related+behaviors+and+inflammation+in+CFA-induced+knee+arthritis&doi=10.1016%2Fj.neulet.2014.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2014.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2014.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarado-Vazquez%26aufirst%3DP.%2BA.%26aulast%3DMorado-Urbina%26aufirst%3DC.%2BE.%26aulast%3DCast%25C3%25A3neda-Corral%26aufirst%3DG.%26aulast%3DAcosta-Gonzalez%26aufirst%3DR.%2BI.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DTakano-Yamamoto%26aufirst%3DT.%26aulast%3DJim%25C3%25A9nez-Andrade%26aufirst%3DJ.%2BM.%26atitle%3DIntra-articular%2520administration%2520of%2520an%2520antibody%2520against%2520CSF-1%2520receptor%2520reduces%2520pain-related%2520behaviors%2520and%2520inflammation%2520in%2520CFA-induced%2520knee%2520arthritis%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D584%26spage%3D39%26epage%3D44%26doi%3D10.1016%2Fj.neulet.2014.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stawicki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhyala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.str.2012.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=676-687&author=X.+Maauthor=W.+Y.+Linauthor=Y.+Chenauthor=S.+Stawickiauthor=K.+Mukhyalaauthor=Y.+Wuauthor=F.+Martinauthor=J.+F.+Bazanauthor=M.+A.+Starovasnik&title=Structural+basis+for+the+dual+recognition+of+helical+cytokines+IL-34+and+CSF-1+by+CSF-1R&doi=10.1016%2Fj.str.2012.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DW.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DStawicki%26aufirst%3DS.%26aulast%3DMukhyala%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DF.%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26atitle%3DStructural%2520basis%2520for%2520the%2520dual%2520recognition%2520of%2520helical%2520cytokines%2520IL-34%2520and%2520CSF-1%2520by%2520CSF-1R%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D676%26epage%3D687%26doi%3D10.1016%2Fj.str.2012.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garceau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapetanovic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sester, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fici, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelly, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, D. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and expression of porcine colony stimulating factor-1 (CSF-1) and colony stimulating factor-1 receptor (CSF-1R) and analysis of the species specificity of stimulation by CSF-1 and Interleukin 34</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2012.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.cyto.2012.08.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=793-805&author=D.+J.+Gowauthor=V.+Garceauauthor=R.+Kapetanovicauthor=D.+P.+Sesterauthor=G.+J.+Ficiauthor=J.+A.+Shellyauthor=T.+L.+Wilsonauthor=D.+A.+Hume&title=Cloning+and+expression+of+porcine+colony+stimulating+factor-1+%28CSF-1%29+and+colony+stimulating+factor-1+receptor+%28CSF-1R%29+and+analysis+of+the+species+specificity+of+stimulation+by+CSF-1+and+Interleukin+34&doi=10.1016%2Fj.cyto.2012.08.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2012.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2012.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DGow%26aufirst%3DD.%2BJ.%26aulast%3DGarceau%26aufirst%3DV.%26aulast%3DKapetanovic%26aufirst%3DR.%26aulast%3DSester%26aufirst%3DD.%2BP.%26aulast%3DFici%26aufirst%3DG.%2BJ.%26aulast%3DShelly%26aufirst%3DJ.%2BA.%26aulast%3DWilson%26aufirst%3DT.%2BL.%26aulast%3DHume%26aufirst%3DD.%2BA.%26atitle%3DCloning%2520and%2520expression%2520of%2520porcine%2520colony%2520stimulating%2520factor-1%2520%2528CSF-1%2529%2520and%2520colony%2520stimulating%2520factor-1%2520receptor%2520%2528CSF-1R%2529%2520and%2520analysis%2520of%2520the%2520species%2520specificity%2520of%2520stimulation%2520by%2520CSF-1%2520and%2520Interleukin%252034%26jtitle%3DCytokine%26date%3D2012%26volume%3D60%26spage%3D793%26epage%3D805%26doi%3D10.1016%2Fj.cyto.2012.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garceau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pridans, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gow, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, D. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and expression of feline colony stimulating factor receptor (CSF-1R) and analysis of the species specificity of stimulation by colony stimulating factor-1 (CSF-1) and interleukin-34 (IL-34)</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2012.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.cyto.2012.11.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=630-638&author=D.+J.+Gowauthor=V.+Garceauauthor=C.+Pridansauthor=A.+G.+Gowauthor=K.+E.+Simpsonauthor=D.+Gunn-Mooreauthor=D.+A.+Hume&title=Cloning+and+expression+of+feline+colony+stimulating+factor+receptor+%28CSF-1R%29+and+analysis+of+the+species+specificity+of+stimulation+by+colony+stimulating+factor-1+%28CSF-1%29+and+interleukin-34+%28IL-34%29&doi=10.1016%2Fj.cyto.2012.11.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2012.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2012.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DGow%26aufirst%3DD.%2BJ.%26aulast%3DGarceau%26aufirst%3DV.%26aulast%3DPridans%26aufirst%3DC.%26aulast%3DGow%26aufirst%3DA.%2BG.%26aulast%3DSimpson%26aufirst%3DK.%2BE.%26aulast%3DGunn-Moore%26aufirst%3DD.%26aulast%3DHume%26aufirst%3DD.%2BA.%26atitle%3DCloning%2520and%2520expression%2520of%2520feline%2520colony%2520stimulating%2520factor%2520receptor%2520%2528CSF-1R%2529%2520and%2520analysis%2520of%2520the%2520species%2520specificity%2520of%2520stimulation%2520by%2520colony%2520stimulating%2520factor-1%2520%2528CSF-1%2529%2520and%2520interleukin-34%2520%2528IL-34%2529%26jtitle%3DCytokine%26date%3D2013%26volume%3D61%26spage%3D630%26epage%3D638%26doi%3D10.1016%2Fj.cyto.2012.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masteller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. R.</span></span> <span> </span><span class="NLM_article-title">Targeting IL-34 in chronic inflammation</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1212</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.drudis.2014.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24906044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1212-1216&author=E.+L.+Mastellerauthor=B.+R.+Wong&title=Targeting+IL-34+in+chronic+inflammation&doi=10.1016%2Fj.drudis.2014.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-34 in chronic inflammation</span></div><div class="casAuthors">Masteller, Emma L.; Wong, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1212-1216</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  A second ligand for colony-stimulating factor-1 receptor (CSF-1R) with distinct biol. activities had long been implicated but not appreciated until the recent discovery of interleukin (IL)-34.  IL-34 and CSF-1 signal through this common receptor to mediate the biol. of mononuclear phagocytic cells.  Aberrant macrophage activation by CSF-1 and/or IL-34 is assocd. with numerous diseases, and clin. therapies targeting this pathway are being tested.  Although IL-34 and CSF-1 have distinct activities under physiol. conditions, they appear functionally redundant in various disease states.  Thus, blocking the activity of both might be necessary for maximal efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRSYJn2BakBbVg90H21EOLACvtfcHk0lhQyhCKFb6Dlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShur3I&md5=e673220555f583d447e5e8585ba869f3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMasteller%26aufirst%3DE.%2BL.%26aulast%3DWong%26aufirst%3DB.%2BR.%26atitle%3DTargeting%2520IL-34%2520in%2520chronic%2520inflammation%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1212%26epage%3D1216%26doi%3D10.1016%2Fj.drudis.2014.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ségaliny, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dizier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokajczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisson-Vidal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymann, D.</span></span> <span> </span><span class="NLM_article-title">Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1002/ijc.29376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fijc.29376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25471534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyjt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=73-85&author=A.+I.+S%C3%A9galinyauthor=A.+Mohamadiauthor=B.+Dizierauthor=A.+Lokajczykauthor=R.+Brionauthor=R.+Lanelauthor=J.+Amiaudauthor=C.+Charrierauthor=C.+Boisson-Vidalauthor=D.+Heymann&title=Interleukin-34+promotes+tumor+progression+and+metastatic+process+in+osteosarcoma+through+induction+of+angiogenesis+and+macrophage+recruitment&doi=10.1002%2Fijc.29376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment</span></div><div class="casAuthors">Segaliny, Aude I.; Mohamadi, Amel; Dizier, Blandine; Lokajczyk, Anna; Brion, Regis; Lanel, Rachel; Amiaud, Jerome; Charrier, Celine; Boisson-Vidal, Catherine; Heymann, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Interleukin-34 (IL-34) was recently characterized as the M-CSF "twin" cytokine, regulating the proliferation/differentiation/survival of myeloid cells.  The implication of M-CSF in oncol. was initially suspected by the reduced metastatic dissemination in knock-out mice, due to angiogenesis impairment.  Based on this observation, our work studied the involvement of IL-34 in the pathogenesis of osteosarcoma.  The in vivo effects of IL-34 were assessed on tissue vasculature and macrophage infiltration in a murine preclin. model based on a paratibial inoculation of human osteosarcoma cells overexpressing or not IL-34 or M-CSF.  In vitro investigations using endothelial cell precursors and mature HUVEC cells were performed to analyze the involvement of IL-34 in angiogenesis and myeloid cell adhesion.  The data revealed that IL-34 overexpression was assocd. with the progression of osteosarcoma (tumor growth, lung metastases) and an increase of neo-angiogenesis.  In vitro analyses demonstrated that IL-34 stimulated endothelial cell proliferation and vascular cord formation.  Pre-treatment of endothelial cells by chondroitinases/heparinases reduced the formation of vascular tubes and abolished the assocd. cell signalling.  In addn., IL-34 increased the in vivo recruitment of M2 tumor-assocd. macrophages into the tumor tissue.  IL-34 increased in vitro monocyte/CD34+ cell adhesion to activated HUVEC monolayers under physiol. shear stress conditions.  This work also demonstrates that IL-34 is expressed by osteosarcoma cells, is regulated by TNF-α, IL-1β, and contributes to osteosarcoma growth by increasing the neo-angiogenesis and the recruitment of M2 macrophages.  By promoting new vessel formation and extravasation of immune cells, IL-34 may play a key role in tumor development and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroMj1wADvl57Vg90H21EOLACvtfcHk0lhQyhCKFb6Dlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyjt73E&md5=065a3257b00a059065c35812033be8ab</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fijc.29376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29376%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A9galiny%26aufirst%3DA.%2BI.%26aulast%3DMohamadi%26aufirst%3DA.%26aulast%3DDizier%26aufirst%3DB.%26aulast%3DLokajczyk%26aufirst%3DA.%26aulast%3DBrion%26aufirst%3DR.%26aulast%3DLanel%26aufirst%3DR.%26aulast%3DAmiaud%26aufirst%3DJ.%26aulast%3DCharrier%26aufirst%3DC.%26aulast%3DBoisson-Vidal%26aufirst%3DC.%26aulast%3DHeymann%26aufirst%3DD.%26atitle%3DInterleukin-34%2520promotes%2520tumor%2520progression%2520and%2520metastatic%2520process%2520in%2520osteosarcoma%2520through%2520induction%2520of%2520angiogenesis%2520and%2520macrophage%2520recruitment%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D137%26spage%3D73%26epage%3D85%26doi%3D10.1002%2Fijc.29376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. J.</span></span> <span> </span><span class="NLM_article-title">Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R14</span>, <span class="refDoi"> DOI: 10.1186/ar3693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1186%2Far3693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22264405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlSmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R14&author=S.-J.+Hwangauthor=B.+Choiauthor=S.-S.+Kangauthor=J.-H.+Changauthor=Y.-G.+Kimauthor=Y.-H.+Chungauthor=D.+H.+Sohnauthor=M.+W.+Soauthor=C.+K.+Leeauthor=W.+H.+Robinsonauthor=E.+J.+Chang&title=Interleukin-34+produced+by+human+fibroblast-like+synovial+cells+in+rheumatoid+arthritis+supports+osteoclastogenesis&doi=10.1186%2Far3693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis</span></div><div class="casAuthors">Hwang, Seung-Jun; Choi, Bongkun; Kang, Soon-Suk; Chang, Jae-Ho; Kim, Yong-Gil; Chung, Yeon-Ho; Sohn, Dong Hyun; So, Min Wook; Lee, Chang-Keun; Robinson, William H.; Chang, Eun-Ju</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">R14</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: Interleukin-34 (IL-34) is a recently defined cytokine, showing a functional overlap with macrophage colony stimulating factor (M-CSF).  This study was undertaken to address the expression of IL-34 in rheumatoid arthritis (RA) patients and to investigate its regulation and pathogenic role in RA.  Methods: IL-34 levels were detd. in the RA synovium, synovial fluid (SF) and fibroblast-like synovial cells (FLS) by immunohistochem., real-time PCR, ELISA and immunoblotting.  RA activity was assessed using Disease Activity Score 28 (DAS28) activity in the plasma collected at baseline and one year after treatment.  Conditioned media (CM) were prepd. from RA FLS culture with tumor necrosis factor alpha (TNFα) for 24 h and used for functional assay.  Results: IL-34 was expressed in the synovium, SF, and FLS from RA patients.  The prodn. of IL-34 in FLS was up-regulated by TNFα in RA samples compared with osteoarthritis (OA) patients.  Importantly, the preferential induction of IL-34 rather than M-CSF by TNFα in RAFLS was mediated by the transcription factor nuclear factor kappa B (NF-κB) and activation of c-Jun N-terminal kinase (JNK).  IL-34 elevation in plasma from RA patients was decreased after the administration of disease-modifying anti-rheumatic drugs (DMARDs) in accordance with a decrease in DAS28.  CM from RAFLS cultured with TNFα promoted chemotactic migration of human peripheral blood mononuclear cells (PBMCs) and subsequent osteoclast (OC) formation, effects that were attenuated by an anti-IL-34 antibody.  Conclusions: These data provide novel information about the prodn. of IL-34 in RA FLS and indicate that IL-34 is an addnl. osteoclastogenic factor regulated by TNFα in RA, suggesting a discrete role of IL-34 in inflammatory RA diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMSlra79yrVrVg90H21EOLACvtfcHk0liqDpBhHYRTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlSmsrg%253D&md5=ac340730d901349aae6b80bddca18233</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2Far3693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3693%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.-J.%26aulast%3DChoi%26aufirst%3DB.%26aulast%3DKang%26aufirst%3DS.-S.%26aulast%3DChang%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DY.-G.%26aulast%3DChung%26aufirst%3DY.-H.%26aulast%3DSohn%26aufirst%3DD.%2BH.%26aulast%3DSo%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DRobinson%26aufirst%3DW.%2BH.%26aulast%3DChang%26aufirst%3DE.%2BJ.%26atitle%3DInterleukin-34%2520produced%2520by%2520human%2520fibroblast-like%2520synovial%2520cells%2520in%2520rheumatoid%2520arthritis%2520supports%2520osteoclastogenesis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3DR14%26doi%3D10.1186%2Far3693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vääräniemi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Väänänen, H. K.</span></span> <span> </span><span class="NLM_article-title">The critical role of IL-34 in osteoclastogenesis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e18689</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0018689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0018689" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18689&author=Z.+Chenauthor=K.+Bukiauthor=J.+V%C3%A4%C3%A4r%C3%A4niemiauthor=G.+Guauthor=H.+K.+V%C3%A4%C3%A4n%C3%A4nen&title=The+critical+role+of+IL-34+in+osteoclastogenesis&doi=10.1371%2Fjournal.pone.0018689"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0018689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0018689%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DBuki%26aufirst%3DK.%26aulast%3DV%25C3%25A4%25C3%25A4r%25C3%25A4niemi%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DG.%26aulast%3DV%25C3%25A4%25C3%25A4n%25C3%25A4nen%26aufirst%3DH.%2BK.%26atitle%3DThe%2520critical%2520role%2520of%2520IL-34%2520in%2520osteoclastogenesis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De18689%26doi%3D10.1371%2Fjournal.pone.0018689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.2174/156802609789007327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.2174%2F156802609789007327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=19689368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=599-610&author=S.+Patelauthor=M.+R.+Player&title=Colony-stimulating+factor-1+receptor+inhibitors+for+the+treatment+of+cancer+and+inflammatory+disease&doi=10.2174%2F156802609789007327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease</span></div><div class="casAuthors">Patel, Sharmila; Player, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">599-610</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  FMS is the exclusive receptor tyrosine kinase for colony-stimulating factor-1 (CSF-1, also known as M-CSF), which regulates the survival, proliferation, differentiation, and function of macrophage lineage cells.  Since CSF-1 is overexpressed in many tumors and at sites of inflammation, small mol. inhibitors of CSF-1 appear to offer an attractive strategy for reducing macrophage nos. assocd. with cancer as well as autoimmune and inflammatory disease, such as rheumatoid arthritis (RA).  Numerous FMS inhibitors with structurally distinct chemotypes have been developed and exhibit potent in vitro activity, but only a limited no. of compds. have progressed clin. due to poor selectivity.  To date, only a handful of FMS inhibitors have been tested in models of metastatic bone disease and RA.  This review will summarize the biol. of FMS and its function in bone physiol., inflammation, immunity, and cancer.  In addn., efforts directed towards identifying FMS-selective small mol. inhibitors as well as the advancement of non-selective inhibitors in the clinic will be highlighted.  Furthermore, emerging monoclonal antibody-based therapeutic strategies specifically targeting M-CSF will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH40LdAlM5MrVg90H21EOLACvtfcHk0liqDpBhHYRTrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjO&md5=26bb4dd543b4b052df03aede1ec010b1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F156802609789007327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007327%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26atitle%3DColony-stimulating%2520factor-1%2520receptor%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%2520and%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D599%26epage%3D610%26doi%3D10.2174%2F156802609789007327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ginhoux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leboeuf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samokhvalov, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merad, M.</span></span> <span> </span><span class="NLM_article-title">Fate mapping analysis reveals that adult microglia derive from primitive macrophages</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">841</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1126/science.1194637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1126%2Fscience.1194637" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=841-845&author=F.+Ginhouxauthor=M.+Greterauthor=M.+Leboeufauthor=S.+Nandiauthor=P.+Seeauthor=S.+Gokhanauthor=M.+F.+Mehlerauthor=S.+J.+Conwayauthor=L.+G.+Ngauthor=E.+R.+Stanleyauthor=I.+M.+Samokhvalovauthor=M.+Merad&title=Fate+mapping+analysis+reveals+that+adult+microglia+derive+from+primitive+macrophages&doi=10.1126%2Fscience.1194637"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194637%26sid%3Dliteratum%253Aachs%26aulast%3DGinhoux%26aufirst%3DF.%26aulast%3DGreter%26aufirst%3DM.%26aulast%3DLeboeuf%26aufirst%3DM.%26aulast%3DNandi%26aufirst%3DS.%26aulast%3DSee%26aufirst%3DP.%26aulast%3DGokhan%26aufirst%3DS.%26aulast%3DMehler%26aufirst%3DM.%2BF.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DNg%26aufirst%3DL.%2BG.%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DSamokhvalov%26aufirst%3DI.%2BM.%26aulast%3DMerad%26aufirst%3DM.%26atitle%3DFate%2520mapping%2520analysis%2520reveals%2520that%2520adult%2520microglia%2520derive%2520from%2520primitive%2520macrophages%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D841%26epage%3D845%26doi%3D10.1126%2Fscience.1194637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erblich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etgen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrenis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J. W.</span></span> <span> </span><span class="NLM_article-title">Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e26317</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0026317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0026317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26317&author=B.+Erblichauthor=L.+Zhuauthor=A.+M.+Etgenauthor=K.+Dobrenisauthor=J.+W.+Pollard&title=Absence+of+colony+stimulation+factor-1+receptor+results+in+loss+of+microglia%2C+disrupted+brain+development+and+olfactory+deficits&doi=10.1371%2Fjournal.pone.0026317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026317%26sid%3Dliteratum%253Aachs%26aulast%3DErblich%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DEtgen%26aufirst%3DA.%2BM.%26aulast%3DDobrenis%26aufirst%3DK.%26aulast%3DPollard%26aufirst%3DJ.%2BW.%26atitle%3DAbsence%2520of%2520colony%2520stimulation%2520factor-1%2520receptor%2520results%2520in%2520loss%2520of%2520microglia%252C%2520disrupted%2520brain%2520development%2520and%2520olfactory%2520deficits%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26317%26doi%3D10.1371%2Fjournal.pone.0026317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, M. R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafi, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.neuron.2014.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24742461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=380-397&author=M.+R.+P.+Elmoreauthor=A.+R.+Najafiauthor=M.+A.+Koikeauthor=N.+N.+Dagherauthor=E.+E.+Spangenbergauthor=R.+A.+Riceauthor=M.+Kitazawaauthor=B.+Matusowauthor=H.+Nguyenauthor=B.+L.+Westauthor=K.+N.+Green&title=Colony-stimulating+factor+1+receptor+signaling+is+necessary+for+microglia+viability%2C+unmasking+a+microglia+progenitor+cell+in+the+adult+brain&doi=10.1016%2Fj.neuron.2014.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain</span></div><div class="casAuthors">Elmore, Monica R. P.; Najafi, Allison R.; Koike, Maya A.; Dagher, Nabil N.; Spangenberg, Elizabeth E.; Rice, Rachel A.; Kitazawa, Masashi; Matusow, Bernice; Nguyen, Hoa; West, Brian L.; Green, Kim N.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">380-397</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The colony-stimulating factor 1 receptor (CSF1R) is a key regulator of myeloid lineage cells.  Genetic loss of the CSF1R blocks the normal population of resident microglia in the brain that originates from the yolk sac during early development.  However, the role of CSF1R signaling in microglial homeostasis in the adult brain is largely unknown.  To this end, we tested the effects of selective CSF1R inhibitors on microglia in adult mice.  Surprisingly, extensive treatment results in elimination of ∼99% of all microglia brain-wide, showing that microglia in the adult brain are physiol. dependent upon CSF1R signaling.  Mice depleted of microglia show no behavioral or cognitive abnormalities, revealing that microglia are not necessary for these tasks.  Finally, we discovered that the microglia-depleted brain completely repopulates with new microglia within 1 wk of inhibitor cessation.  Microglial repopulation throughout the CNS occurs through proliferation of nestin-pos. cells that then differentiate into microglia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodzm1jC50Da7Vg90H21EOLACvtfcHk0lh-t5FGGmDPfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCntrs%253D&md5=144e568df88ec548687221d1b5b39084</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DElmore%26aufirst%3DM.%2BR.%2BP.%26aulast%3DNajafi%26aufirst%3DA.%2BR.%26aulast%3DKoike%26aufirst%3DM.%2BA.%26aulast%3DDagher%26aufirst%3DN.%2BN.%26aulast%3DSpangenberg%26aufirst%3DE.%2BE.%26aulast%3DRice%26aufirst%3DR.%2BA.%26aulast%3DKitazawa%26aufirst%3DM.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26atitle%3DColony-stimulating%2520factor%25201%2520receptor%2520signaling%2520is%2520necessary%2520for%2520microglia%2520viability%252C%2520unmasking%2520a%2520microglia%2520progenitor%2520cell%2520in%2520the%2520adult%2520brain%26jtitle%3DNeuron%26date%3D2014%26volume%3D82%26spage%3D380%26epage%3D397%26doi%3D10.1016%2Fj.neuron.2014.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikodemova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maklakova, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watters, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, L. S.</span></span> <span> </span><span class="NLM_article-title">CSF1 overexpression has pleiotropic effects on microglia in vivo</span>. <i>Glia.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1955</span>– <span class="NLM_lpage">1967</span>, <span class="refDoi"> DOI: 10.1002/glia.22717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fglia.22717" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=1955-1967&author=I.+Deauthor=M.+Nikodemovaauthor=M.+D.+Steffenauthor=E.+Soknauthor=V.+I.+Maklakovaauthor=J.+J.+Wattersauthor=L.+S.+Collier&title=CSF1+overexpression+has+pleiotropic+effects+on+microglia+in+vivo&doi=10.1002%2Fglia.22717"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fglia.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.22717%26sid%3Dliteratum%253Aachs%26aulast%3DDe%26aufirst%3DI.%26aulast%3DNikodemova%26aufirst%3DM.%26aulast%3DSteffen%26aufirst%3DM.%2BD.%26aulast%3DSokn%26aufirst%3DE.%26aulast%3DMaklakova%26aufirst%3DV.%2BI.%26aulast%3DWatters%26aufirst%3DJ.%2BJ.%26aulast%3DCollier%26aufirst%3DL.%2BS.%26atitle%3DCSF1%2520overexpression%2520has%2520pleiotropic%2520effects%2520on%2520microglia%2520in%2520vivo%26jtitle%3DGlia.%26date%3D2014%26volume%3D62%26spage%3D1955%26epage%3D1967%26doi%3D10.1002%2Fglia.22717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, F.-D.</span></span> <span> </span><span class="NLM_article-title">Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2383</span>– <span class="NLM_lpage">2395</span>, <span class="refDoi"> DOI: 10.1177/0271678X16666551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1177%2F0271678X16666551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27596835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=2383-2395&author=M.+Liauthor=Z.+Liauthor=H.+Renauthor=W.-N.+Jinauthor=K.+Woodauthor=Q.+Liuauthor=K.+N.+Shethauthor=F.-D.+Shi&title=Colony+stimulating+factor+1+receptor+inhibition+eliminates+microglia+and+attenuates+brain+injury+after+intracerebral+hemorrhage&doi=10.1177%2F0271678X16666551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage</span></div><div class="casAuthors">Li, Minshu; Li, Zhiguo; Ren, Honglei; Jin, Wei-Na; Wood, Kristofer; Liu, Qiang; Sheth, Kevin N.; Shi, Fu-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2383-2395</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Microglia are the first responders to intracerebral hemorrhage, but their precise role in intracerebral hemorrhage remains to be defined.  Microglia are the only type of brain cells expressing the colony-stimulating factor 1 receptor, a key regulator for myeloid lineage cells.  Here, we detd. the effects of a colony-stimulating factor 1 receptor inhibitor (PLX3397) on microglia and the outcome in the context of exptl. mouse intracerebral hemorrhage.  We show that PLX3397 effectively depleted microglia, and the depletion of microglia was sustained after intracerebral hemorrhage.  Importantly, colony-stimulating factor 1 receptor inhibition attenuated neurodeficits and brain edema in two exptl. models of intracerebral hemorrhage induced by injection of collagenase or autologous blood.  The benefit of colony-stimulating factor 1 receptor inhibition was assocd. with reduced leukocyte infiltration in the brain and improved blood-brain barrier integrity after intracerebral hemorrhage, and each observation was independent of lesion size or hematoma vol.  These results demonstrate that suppression of colony-stimulating factor 1 receptor signaling ablates microglia and confers protection after intracerebral hemorrhage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0E35okPweUbVg90H21EOLACvtfcHk0lh-t5FGGmDPfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKntbg%253D&md5=012ccb38351fe9ac0d750c37b1ab1d51</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1177%2F0271678X16666551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0271678X16666551%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DW.-N.%26aulast%3DWood%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSheth%26aufirst%3DK.%2BN.%26aulast%3DShi%26aufirst%3DF.-D.%26atitle%3DColony%2520stimulating%2520factor%25201%2520receptor%2520inhibition%2520eliminates%2520microglia%2520and%2520attenuates%2520brain%2520injury%2520after%2520intracerebral%2520hemorrhage%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2017%26volume%3D37%26spage%3D2383%26epage%3D2395%26doi%3D10.1177%2F0271678X16666551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erblich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etgen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrenis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J. W.</span></span> <span> </span><span class="NLM_article-title">Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e26317</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0026317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0026317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26317&author=B.+Erblichauthor=L.+Zhuauthor=A.+M.+Etgenauthor=K.+Dobrenisauthor=J.+W.+Pollard&title=Absence+of+colony+stimulation+factor-1+receptor+results+in+loss+of+microglia%2C+disrupted+brain+development+and+olfactory+deficits&doi=10.1371%2Fjournal.pone.0026317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026317%26sid%3Dliteratum%253Aachs%26aulast%3DErblich%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DEtgen%26aufirst%3DA.%2BM.%26aulast%3DDobrenis%26aufirst%3DK.%26aulast%3DPollard%26aufirst%3DJ.%2BW.%26atitle%3DAbsence%2520of%2520colony%2520stimulation%2520factor-1%2520receptor%2520results%2520in%2520loss%2520of%2520microglia%252C%2520disrupted%2520brain%2520development%2520and%2520olfactory%2520deficits%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26317%26doi%3D10.1371%2Fjournal.pone.0026317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chitu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span> <span> </span><span class="NLM_article-title">Emerging roles for CSF-1 receptor and its ligands in the nervous system</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.tins.2016.03.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=378-393&author=V.+Chituauthor=S.+Gokhanauthor=S.+Nandiauthor=M.+F.+Mehlerauthor=E.+R.+Stanley&title=Emerging+roles+for+CSF-1+receptor+and+its+ligands+in+the+nervous+system&doi=10.1016%2Fj.tins.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DChitu%26aufirst%3DV.%26aulast%3DGokhan%26aufirst%3DS.%26aulast%3DNandi%26aufirst%3DS.%26aulast%3DMehler%26aufirst%3DM.%2BF.%26aulast%3DStanley%26aufirst%3DE.%2BR.%26atitle%3DEmerging%2520roles%2520for%2520CSF-1%2520receptor%2520and%2520its%2520ligands%2520in%2520the%2520nervous%2520system%26jtitle%3DTrends%2520Neurosci.%26date%3D2016%26volume%3D39%26spage%3D378%26epage%3D393%26doi%3D10.1016%2Fj.tins.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fend, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kintz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Préville, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e73310</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0073310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0073310" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73310&author=L.+Fendauthor=N.+Accartauthor=J.+Kintzauthor=S.+Cochinauthor=C.+Reymannauthor=F.+Le+Pogamauthor=J.+B.+Marchandauthor=T.+Menguyauthor=P.+Slosauthor=R.+Rookeauthor=S.+Fournelauthor=J.+Y.+Bonnefoyauthor=X.+Pr%C3%A9villeauthor=H.+Haegel&title=Therapeutic+effects+of+anti-CD115+monoclonal+antibody+in+mouse+cancer+models+through+dual+inhibition+of+tumor-associated+macrophages+and+osteoclasts&doi=10.1371%2Fjournal.pone.0073310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073310%26sid%3Dliteratum%253Aachs%26aulast%3DFend%26aufirst%3DL.%26aulast%3DAccart%26aufirst%3DN.%26aulast%3DKintz%26aufirst%3DJ.%26aulast%3DCochin%26aufirst%3DS.%26aulast%3DReymann%26aufirst%3DC.%26aulast%3DLe%2BPogam%26aufirst%3DF.%26aulast%3DMarchand%26aufirst%3DJ.%2BB.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DSlos%26aufirst%3DP.%26aulast%3DRooke%26aufirst%3DR.%26aulast%3DFournel%26aufirst%3DS.%26aulast%3DBonnefoy%26aufirst%3DJ.%2BY.%26aulast%3DPr%25C3%25A9ville%26aufirst%3DX.%26aulast%3DHaegel%26aufirst%3DH.%26atitle%3DTherapeutic%2520effects%2520of%2520anti-CD115%2520monoclonal%2520antibody%2520in%2520mouse%2520cancer%2520models%2520through%2520dual%2520inhibition%2520of%2520tumor-associated%2520macrophages%2520and%2520osteoclasts%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73310%26doi%3D10.1371%2Fjournal.pone.0073310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakami, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano-Yamamoto, T.</span></span> <span> </span><span class="NLM_article-title">An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model</span>. <i>Oral Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1111/odi.12117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1111%2Fodi.12117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23651419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC3snhsFeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=319-324&author=K.+Kimuraauthor=H.+Kitauraauthor=T.+Fujiiauthor=M.+Ishidaauthor=Z.+W.+Hakamiauthor=T.+Takano-Yamamoto&title=An+anti-c-Fms+antibody+inhibits+osteoclastogenesis+in+a+mouse+periodontitis+model&doi=10.1111%2Fodi.12117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model</span></div><div class="casAuthors">Kimura K; Kitaura H; Fujii T; Ishida M; Hakami Z W; Takano-Yamamoto T</div><div class="citationInfo"><span class="NLM_cas:title">Oral diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Bacterial lipopolysaccharide (LPS) can induce inflammatory bone loss such as periodontal disease.  The formation of osteoclasts depends on macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kb ligand (RANKL).  It has recently been reported that administration of an antibody of the M-CSF receptor c-Fms completely blocked osteoclastogenesis and bone erosion induced by LPS in mouse calvaria.  In this study, the effect of antibody against c-Fms in the mouse periodontitis model by injection of LPS was investigated.  MATERIALS AND METHODS:  C57BL6/J mice were injected with LPS and anti-c-Fms antibody into the mesial gingiva of the first molar in the left mandible.  Histological sections of periodontal tissue were stained for tartrate-resistant acid phosphatase, and osteoclast numbers and ratio of alveolar bone resorption determined.  RESULTS:  The number of osteoclasts and ratio of alveolar bone resorption in mice administered both LPS and anti-c-Fms antibody was lower than those in mice administered LPS alone.  The expression of RANKL receptor, RANK, was inhibited by the anti-c-Fms antibody in periodontal tissue.  CONCLUSION:  M-CSF and/or its receptor are potential therapeutic targets for the treatment of bone resorption, caused by LPS, in periodontitis.  Injection of an anti-c-Fms antibody might be useful for inhibition of pathological bone resorption in periodontitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEM4WnxGgp5_h3YQQtAhNufW6udTcc2eaXie2I7LCS-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snhsFeksw%253D%253D&md5=052db4810d7f6558d89f8f76609a3e64</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fodi.12117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fodi.12117%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DM.%26aulast%3DHakami%26aufirst%3DZ.%2BW.%26aulast%3DTakano-Yamamoto%26aufirst%3DT.%26atitle%3DAn%2520anti-c-Fms%2520antibody%2520inhibits%2520osteoclastogenesis%2520in%2520a%2520mouse%2520periodontitis%2520model%26jtitle%3DOral%2520Dis.%26date%3D2014%26volume%3D20%26spage%3D319%26epage%3D324%26doi%3D10.1111%2Fodi.12117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanington, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belosevic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreda, D. R.</span></span> <span> </span><span class="NLM_article-title">Control of CSF-1 induced inflammation in teleost fish by a soluble form of the CSF-1 receptor</span>. <i>Fish Shellfish Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.fsi.2014.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.fsi.2014.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24726317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=45-51&author=A.+M.+Riegerauthor=P.+C.+Haningtonauthor=M.+Belosevicauthor=D.+R.+Barreda&title=Control+of+CSF-1+induced+inflammation+in+teleost+fish+by+a+soluble+form+of+the+CSF-1+receptor&doi=10.1016%2Fj.fsi.2014.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Control of CSF-1 induced inflammation in teleost fish by a soluble form of the CSF-1 receptor</span></div><div class="casAuthors">Rieger, Aja M.; Hanington, Patrick C.; Belosevic, Miodrag; Barreda, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Fish & Shellfish Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">FSIMEP</span>;
        ISSN:<span class="NLM_cas:issn">1050-4648</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The colony-stimulating factor-1 (CSF-1) is the principal regulator of the survival, proliferation, differentiation, and function of macrophages and their precursors, and has been shown to play a role in the etiol. of inflammation.  We recently identified a novel mechanism for the control of CSF-1 activity in teleost fish, through the prodn. of an inhibitory sol. form of the CSF-1 receptor (sCSF-1R).  Primary goldfish kidney macrophages selectively expressed sCSF-1R during the senescence phase, which corresponds to a defined stage of in vitro culture development where inhibition of macrophage proliferation and apoptotic cell death are prominent.  In contrast, primary macrophage cultures undergoing active proliferation displayed low levels of sCSF-1R expression.  Addn. of purified recombinant sCSF-1R to developing primary macrophage cultures leads to a dose-dependent decrease in macrophage proliferation and inhibits macrophage antimicrobial functions including chemotaxis, phagocytosis, and prodn. of reactive oxygen intermediates.  Using a goldfish in vivo model of self-resolving peritonitis, we found that sCSF-1R plays a role in the inhibition of inflammation, following an initial acute phase of antimicrobial responses within an inflammatory site.  Sol. CSF-1R inhibits pro-inflammatory cytokine prodn., inhibits leukocyte recruitment to the inflammatory site and decreases ROS prodn. in a dose-dependent manner.  This sCSF-1R-dependent regulation of inflammation appears to be an elegant mechanism for the control of macrophage nos. at inflammatory sites of lower vertebrates.  Overall, our results provide new insights into the evolutionary origins of the CSF-1 immune regulatory axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWR6y3FDzWTbVg90H21EOLACvtfcHk0lhRVD1PG_LV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvV2hsbY%253D&md5=a5a6b74143839127285e69365a246681</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.fsi.2014.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fsi.2014.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DA.%2BM.%26aulast%3DHanington%26aufirst%3DP.%2BC.%26aulast%3DBelosevic%26aufirst%3DM.%26aulast%3DBarreda%26aufirst%3DD.%2BR.%26atitle%3DControl%2520of%2520CSF-1%2520induced%2520inflammation%2520in%2520teleost%2520fish%2520by%2520a%2520soluble%2520form%2520of%2520the%2520CSF-1%2520receptor%26jtitle%3DFish%2520Shellfish%2520Immunol.%26date%3D2014%26volume%3D41%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.fsi.2014.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thioudellet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settelen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rissanen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayette, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J. Y.</span></span> <span> </span><span class="NLM_article-title">A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells</span>. <i>MAbs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.4161/mabs.25743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4161%2Fmabs.25743" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=736-747&author=H.+Haegelauthor=C.+Thioudelletauthor=R.+Halletauthor=M.+Geistauthor=T.+Menguyauthor=F.+Le+Pogamauthor=J.+B.+Marchandauthor=M.+L.+Tohauthor=V.+Duongauthor=A.+Calceiauthor=N.+Settelenauthor=X.+Previlleauthor=M.+Hennequiauthor=B.+Grellierauthor=P.+Ancianauthor=J.+Rissanenauthor=P.+Clayetteauthor=C.+Guillenauthor=R.+Rookeauthor=J.+Y.+Bonnefoy&title=A+unique+anti-CD115+monoclonal+antibody+which+inhibits+osteolysis+and+skews+human+monocyte+differentiation+from+M2-polarized+macrophages+toward+dendritic+cells&doi=10.4161%2Fmabs.25743"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.4161%2Fmabs.25743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.25743%26sid%3Dliteratum%253Aachs%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DThioudellet%26aufirst%3DC.%26aulast%3DHallet%26aufirst%3DR.%26aulast%3DGeist%26aufirst%3DM.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DLe%2BPogam%26aufirst%3DF.%26aulast%3DMarchand%26aufirst%3DJ.%2BB.%26aulast%3DToh%26aufirst%3DM.%2BL.%26aulast%3DDuong%26aufirst%3DV.%26aulast%3DCalcei%26aufirst%3DA.%26aulast%3DSettelen%26aufirst%3DN.%26aulast%3DPreville%26aufirst%3DX.%26aulast%3DHennequi%26aufirst%3DM.%26aulast%3DGrellier%26aufirst%3DB.%26aulast%3DAncian%26aufirst%3DP.%26aulast%3DRissanen%26aufirst%3DJ.%26aulast%3DClayette%26aufirst%3DP.%26aulast%3DGuillen%26aufirst%3DC.%26aulast%3DRooke%26aufirst%3DR.%26aulast%3DBonnefoy%26aufirst%3DJ.%2BY.%26atitle%3DA%2520unique%2520anti-CD115%2520monoclonal%2520antibody%2520which%2520inhibits%2520osteolysis%2520and%2520skews%2520human%2520monocyte%2520differentiation%2520from%2520M2-polarized%2520macrophages%2520toward%2520dendritic%2520cells%26jtitle%3DMAbs%26date%3D2013%26volume%3D5%26spage%3D736%26epage%3D747%26doi%3D10.4161%2Fmabs.25743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starck, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancian, P.</span></span> <span> </span><span class="NLM_article-title">3D modeling and characterization of the human CD115 monoclonal antibody H27K15 epitope and design of a chimeric CD115 target</span>. <i>MAbs</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.4161/mabs.27736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4161%2Fmabs.27736" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=533-546&author=B.+Grellierauthor=F.+Le+Pogamauthor=M.+Vitorinoauthor=J.-P.+Starckauthor=M.+Geistauthor=V.+Duongauthor=H.+Haegelauthor=T.+Menguyauthor=J.-Y.+Bonnefoyauthor=J.+B.+Marchandauthor=P.+Ancian&title=3D+modeling+and+characterization+of+the+human+CD115+monoclonal+antibody+H27K15+epitope+and+design+of+a+chimeric+CD115+target&doi=10.4161%2Fmabs.27736"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.4161%2Fmabs.27736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.27736%26sid%3Dliteratum%253Aachs%26aulast%3DGrellier%26aufirst%3DB.%26aulast%3DLe%2BPogam%26aufirst%3DF.%26aulast%3DVitorino%26aufirst%3DM.%26aulast%3DStarck%26aufirst%3DJ.-P.%26aulast%3DGeist%26aufirst%3DM.%26aulast%3DDuong%26aufirst%3DV.%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DBonnefoy%26aufirst%3DJ.-Y.%26aulast%3DMarchand%26aufirst%3DJ.%2BB.%26aulast%3DAncian%26aufirst%3DP.%26atitle%3D3D%2520modeling%2520and%2520characterization%2520of%2520the%2520human%2520CD115%2520monoclonal%2520antibody%2520H27K15%2520epitope%2520and%2520design%2520of%2520a%2520chimeric%2520CD115%2520target%26jtitle%3DMAbs%26date%3D2014%26volume%3D6%26spage%3D533%26epage%3D546%26doi%3D10.4161%2Fmabs.27736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ries, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannarile, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey-Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradel, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuerhake, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucknischke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiblich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluza, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorr, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Visser, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Italiano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tourneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delord, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blay, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüttinger, D.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ccr.2014.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24898549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=846-859&author=C.+H.+Riesauthor=M.+A.+Cannarileauthor=S.+Hovesauthor=J.+Benzauthor=K.+Warthaauthor=V.+Runzaauthor=F.+Rey-Giraudauthor=L.+P.+Pradelauthor=F.+Feuerhakeauthor=I.+Klamanauthor=T.+Jonesauthor=U.+Jucknischkeauthor=S.+Scheiblichauthor=K.+Kaluzaauthor=I.+H.+Gorrauthor=A.+Walzauthor=K.+Abirajauthor=P.+A.+Cassierauthor=A.+Sicaauthor=C.+Gomez-Rocaauthor=K.+E.+de+Visserauthor=A.+Italianoauthor=C.+Le+Tourneauauthor=J.+P.+Delordauthor=H.+Levitskyauthor=J.+Y.+Blayauthor=D.+R%C3%BCttinger&title=Targeting+tumor-associated+macrophages+with+anti-CSF-1R+antibody+reveals+a+strategy+for+cancer+therapy&doi=10.1016%2Fj.ccr.2014.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy</span></div><div class="casAuthors">Ries, Carola H.; Cannarile, Michael A.; Hoves, Sabine; Benz, Joerg; Wartha, Katharina; Runza, Valeria; Rey-Giraud, Flora; Pradel, Leon P.; Feuerhake, Friedrich; Klaman, Irina; Jones, Tobin; Jucknischke, Ute; Scheiblich, Stefan; Kaluza, Klaus; Gorr, Ingo H.; Walz, Antje; Abiraj, Keelara; Cassier, Philippe A.; Sica, Antonio; Gomez-Roca, Carlos; de Visser, Karin E.; Italiano, Antoine; Le Tourneau, Christophe; Delord, Jean-Pierre; Levitsky, Hyam; Blay, Jean-Yves; Ruettinger, Dominik</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Macrophage infiltration has been identified as an independent poor prognostic factor in several cancer types.  The major survival factor for these macrophages is macrophage colony-stimulating factor 1 (CSF-1).  We generated a monoclonal antibody (RG7155) that inhibits CSF-1 receptor (CSF-1R) activation.  In vitro RG7155 treatment results in cell death of CSF-1-differentiated macrophages.  In animal models, CSF-1R inhibition strongly reduces F4/80+ tumor-assocd. macrophages accompanied by an increase of the CD8+/CD4+ T cell ratio.  Administration of RG7155 to patients led to striking redns. of CSF-1R+CD163+ macrophages in tumor tissues, which translated into clin. objective responses in diffuse-type giant cell tumor (Dt-GCT) patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXw3weYo79F7Vg90H21EOLACvtfcHk0liXMWwvyPJMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCntrw%253D&md5=023e0585a753021f10b204c6aeb72d4b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DRies%26aufirst%3DC.%2BH.%26aulast%3DCannarile%26aufirst%3DM.%2BA.%26aulast%3DHoves%26aufirst%3DS.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DWartha%26aufirst%3DK.%26aulast%3DRunza%26aufirst%3DV.%26aulast%3DRey-Giraud%26aufirst%3DF.%26aulast%3DPradel%26aufirst%3DL.%2BP.%26aulast%3DFeuerhake%26aufirst%3DF.%26aulast%3DKlaman%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DT.%26aulast%3DJucknischke%26aufirst%3DU.%26aulast%3DScheiblich%26aufirst%3DS.%26aulast%3DKaluza%26aufirst%3DK.%26aulast%3DGorr%26aufirst%3DI.%2BH.%26aulast%3DWalz%26aufirst%3DA.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DCassier%26aufirst%3DP.%2BA.%26aulast%3DSica%26aufirst%3DA.%26aulast%3DGomez-Roca%26aufirst%3DC.%26aulast%3Dde%2BVisser%26aufirst%3DK.%2BE.%26aulast%3DItaliano%26aufirst%3DA.%26aulast%3DLe%2BTourneau%26aufirst%3DC.%26aulast%3DDelord%26aufirst%3DJ.%2BP.%26aulast%3DLevitsky%26aufirst%3DH.%26aulast%3DBlay%26aufirst%3DJ.%2BY.%26aulast%3DR%25C3%25BCttinger%26aufirst%3DD.%26atitle%3DTargeting%2520tumor-associated%2520macrophages%2520with%2520anti-CSF-1R%2520antibody%2520reveals%2520a%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D846%26epage%3D859%26doi%3D10.1016%2Fj.ccr.2014.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Italiano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Roca, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tourneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toulmonde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannarile, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillouet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jegg, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bröske, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray-French, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freilinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meneses-Lorente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratnayake, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gass, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christen, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukarma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bompas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delord, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blay, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüttinger, D.</span></span> <span> </span><span class="NLM_article-title">CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(15)00132-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2FS1470-2045%2815%2900132-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26179200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2isb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=949-956&author=P.+A.+Cassierauthor=A.+Italianoauthor=C.+A.+Gomez-Rocaauthor=C.+Le+Tourneauauthor=M.+Toulmondeauthor=M.+A.+Cannarileauthor=C.+Riesauthor=A.+Brillouetauthor=C.+M%C3%BCllerauthor=A.+M.+Jeggauthor=A.+M.+Br%C3%B6skeauthor=M.+Dembowskiauthor=K.+Bray-Frenchauthor=C.+Freilingerauthor=G.+Meneses-Lorenteauthor=M.+Baehnerauthor=R.+Hardingauthor=J.+Ratnayakeauthor=K.+Abirajauthor=N.+Gassauthor=K.+Nohauthor=R.+D.+Christenauthor=L.+Ukarmaauthor=E.+Bompasauthor=J.+P.+Delordauthor=J.+Y.+Blayauthor=D.+R%C3%BCttinger&title=CSF1R+inhibition+with+emactuzumab+in+locally+advanced+diffuse-type+tenosynovial+giant+cell+tumours+of+the+soft+tissue%3A+a+dose-escalation+and+dose-expansion+phase+1+study&doi=10.1016%2FS1470-2045%2815%2900132-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study</span></div><div class="casAuthors">Cassier, Philippe A.; Italiano, Antoine; Gomez-Roca, Carlos A.; Le Tourneau, Christophe; Toulmonde, Maud; Cannarile, Michael A.; Ries, Carola; Brillouet, Anne; Muller, Claudia; Jegg, Anna-Maria; Broske, Ann-Marie; Dembowski, Markus; Bray-French, Katharine; Freilinger, Christine; Meneses-Lorente, Georgina; Baehner, Monika; Harding, Ross; Ratnayake, Jayantha; Abiraj, Keelara; Gass, Nathalie; Noh, Karen; Christen, Randolph D.; Ukarma, Lidia; Bompas, Emmanuelle; Delord, Jean-Pierre; Blay, Jean-Yves; Ruttinger, Dominik</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">949-956</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Diffuse-type tenosynovial giant cell tumor (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan disease with unmet medical need, is characterized by an overexpression of colony-stimulating factor 1 (CSF1), and is usually caused by a chromosomal translocation involving CSF1.  CSF1 receptor (CSF1R) activation leads to the recruitment of CSF1R-expressing cells of the mononuclear phagocyte lineage that constitute the tumor mass in dt-GCT.  Emactuzumab (RG7155) is a novel monoclonal antibody that inhibits CSF1R activation.  We have assessed the safety, tolerability and activity of emactuzumab in patients with Dt-GCT of the soft tissue.  In this phase 1, first-in-human dose-escalation and dose-expansion study, eligible patients were aged 18 years or older with dt-GCT of the soft tissue with locally advanced disease or resectable tumors requiring extensive surgery, an Eastern Cooperative Oncol. Group performance status of 1 or less, measurable disease according to Response Evaluation Criteria In Solid Tumors version 1.1, and adequate end-organ function.  Patients with GCT of the bone were not eligible.  Patients received i.v. emactuzumab at 900 mg, 1350 mg, or 2000 mg every 2 wk in the dose-escalation phase and at the optimal biol. dose in a dose-expansion phase.  The primary objective was to evaluate the safety and tolerability of emactuzumab, and to det. the max. tolerated dose or optimal biol. dose.  All treated patients were included in the analyses.  Expansion cohorts are currently ongoing.  This study is registered with ClinicalTrials.gov, no. NCT01494688.  Between July 26, 2012, and Oct 21, 2013, 12 patients were enrolled in the dose-escalation phase.  No dose-limiting toxicities were noted in the dose-escalation cohort; on the basis of pharmacokinetic, pharmacodynamic, and safety information, we chose a dose of 1000 mg every 2 wk for the dose-expansion cohort, into which 17 patients were enrolled.  Owing to different cutoff dates for safety and efficacy readouts, the safety population comprised 25 patients.  Common adverse events after emactuzumab treatment were facial edema (16 [64%] of 25 patients), asthenia (14 [56%]), and pruritus (14 [56%]).  Five serious adverse events (periorbital edema, lupus erythematosus [occurring twice], erythema, and dermohypodermitis all experienced by one [4%] patient each) were reported in five patients.  Three of the five serious adverse events-periorbital edema (one [4%]), lupus erythematosus (one [4%]), and dermohypodermitis (one [4%])-were assessed as grade 3.  Two other grade 3 events were reported: mucositis (one [4%]) and fatigue (one [4%]). 24 (86%) of 28 patients achieved an objective response; two (7%) patients achieved a complete response.  Further study of dt-GCT is warranted and different possibilities, such as an international collaboration with cooperative groups to assure appropriate recruitment in this rare disease, are currently being assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYSYJLOewUJrVg90H21EOLACvtfcHk0liXMWwvyPJMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2isb%252FL&md5=7059e506871975477fef7cb8409e3c43</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2815%2900132-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252815%252900132-1%26sid%3Dliteratum%253Aachs%26aulast%3DCassier%26aufirst%3DP.%2BA.%26aulast%3DItaliano%26aufirst%3DA.%26aulast%3DGomez-Roca%26aufirst%3DC.%2BA.%26aulast%3DLe%2BTourneau%26aufirst%3DC.%26aulast%3DToulmonde%26aufirst%3DM.%26aulast%3DCannarile%26aufirst%3DM.%2BA.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DBrillouet%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DJegg%26aufirst%3DA.%2BM.%26aulast%3DBr%25C3%25B6ske%26aufirst%3DA.%2BM.%26aulast%3DDembowski%26aufirst%3DM.%26aulast%3DBray-French%26aufirst%3DK.%26aulast%3DFreilinger%26aufirst%3DC.%26aulast%3DMeneses-Lorente%26aufirst%3DG.%26aulast%3DBaehner%26aufirst%3DM.%26aulast%3DHarding%26aufirst%3DR.%26aulast%3DRatnayake%26aufirst%3DJ.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DGass%26aufirst%3DN.%26aulast%3DNoh%26aufirst%3DK.%26aulast%3DChristen%26aufirst%3DR.%2BD.%26aulast%3DUkarma%26aufirst%3DL.%26aulast%3DBompas%26aufirst%3DE.%26aulast%3DDelord%26aufirst%3DJ.%2BP.%26aulast%3DBlay%26aufirst%3DJ.%2BY.%26aulast%3DR%25C3%25BCttinger%26aufirst%3DD.%26atitle%3DCSF1R%2520inhibition%2520with%2520emactuzumab%2520in%2520locally%2520advanced%2520diffuse-type%2520tenosynovial%2520giant%2520cell%2520tumours%2520of%2520the%2520soft%2520tissue%253A%2520a%2520dose-escalation%2520and%2520dose-expansion%2520phase%25201%2520study%26jtitle%3DLancet%2520Oncol.%26date%3D2015%26volume%3D16%26spage%3D949%26epage%3D956%26doi%3D10.1016%2FS1470-2045%2815%2900132-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hambleton, J.</span>; <span class="NLM_string-name">Zhou, L.</span>; <span class="NLM_string-name">Rogers, S.</span>; <span class="NLM_string-name">Marle, S.
V.</span>; <span class="NLM_string-name">Iersel, T.
V.</span>; <span class="NLM_string-name">Zanghi, J.</span>; <span class="NLM_string-name">Masteller, E.</span>; <span class="NLM_string-name">Baker, K.</span>; <span class="NLM_string-name">Wong, B.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of FPA008, an anti-colony stimulating factor 1 receptor (anti-CSF1R) antibody in healthy volunteers and subjects with rheumatoid arthritis (RA): preliminary results</span>. In  <i>ACR/ARHP Annual Meeting: Rheumatoid Arthritis—Small Molecules, Biologics and Gene Therapy: Novel therapies, Biosimilars, Strategies and Mechanisms in Rheumatoid Arthritis, Boston, MA, 14–19 November 2014</i>; <span class="NLM_publisher-name">American College of Rheumatology</span>, <span class="NLM_year">2014</span>; <a href="http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-healthy-volunteers-and-subjects-with-rheumatoid-arthritis-ra-preliminary-results/" class="extLink">http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-healthy-volunteers-and-subjects-with-rheumatoid-arthritis-ra-preliminary-results/</a> (accessed December 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+Hambleton&author=L.+Zhou&author=S.+Rogers&author=S.%0AV.+Marle&author=T.%0AV.+Iersel&author=J.+Zanghi&author=E.+Masteller&author=K.+Baker&author=B.+Wong&title=A+phase+1+study+of+FPA008%2C+an+anti-colony+stimulating+factor+1+receptor+%28anti-CSF1R%29+antibody+in+healthy+volunteers+and+subjects+with+rheumatoid+arthritis+%28RA%29%3A+preliminary+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHambleton%26aufirst%3DJ.%26atitle%3DA%2520phase%25201%2520study%2520of%2520FPA008%252C%2520an%2520anti-colony%2520stimulating%2520factor%25201%2520receptor%2520%2528anti-CSF1R%2529%2520antibody%2520in%2520healthy%2520volunteers%2520and%2520subjects%2520with%2520rheumatoid%2520arthritis%2520%2528RA%2529%253A%2520preliminary%2520results%26jtitle%3DACR%252FARHP%2520Annual%2520Meeting%253A%2520Rheumatoid%2520Arthritis%25E2%2580%2594Small%2520Molecules%252C%2520Biologics%2520and%2520Gene%2520Therapy%253A%2520Novel%2520therapies%252C%2520Biosimilars%252C%2520Strategies%2520and%2520Mechanisms%2520in%2520Rheumatoid%2520Arthritis%252C%2520Boston%252C%2520MA%252C%252014%25E2%2580%259319%2520November%25202014%26pub%3DAmerican%2520College%2520of%2520Rheumatology%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span>; <span class="NLM_string-name">Sikorski, R.</span>; <span class="NLM_string-name">Rogers, S.</span>; <span class="NLM_string-name">Costin, S.</span>; <span class="NLM_string-name">Korkosz, M.</span>; <span class="NLM_string-name">Jaraczewska-Baumann, M.</span>; <span class="NLM_string-name">Éva, P.</span>; <span class="NLM_string-name">Rojkovich, B.</span>; <span class="NLM_string-name">Bartalos, J.</span>; <span class="NLM_string-name">Masteller, E.</span>; <span class="NLM_string-name">Xiang, H.</span>; <span class="NLM_string-name">Wong, B.</span>; <span class="NLM_string-name">Hambleton, J.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of FPA008, an anti-colony stimulating factor 1 receptor (anti-CSF1R) antibody in patients (pts) with rheumatoid arthritis (RA): preliminary results.</span> In  <i>ACR/ARHP Annual Meeting: Rheumatoid Arthritis—Small Molecules, Biologics and Gene Therapy Poster III, San Francisco, 6-11 November 2015</i>; <span class="NLM_publisher-name">American College of Rheumatology</span>, <span class="NLM_year">2015</span>;  <span class="NLM_fpage">67</span>, <a href="http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-patients-pts-with-rheumatoid-arthritis-ra-preliminary-results/" class="extLink">http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-patients-pts-with-rheumatoid-arthritis-ra-preliminary-results/</a> (accessed December 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=67&author=L.+Zhou&author=R.+Sikorski&author=S.+Rogers&author=S.+Costin&author=M.+Korkosz&author=M.+Jaraczewska-Baumann&author=P.+%C3%89va&author=B.+Rojkovich&author=J.+Bartalos&author=E.+Masteller&author=H.+Xiang&author=B.+Wong&author=J.+Hambleton&title=A+phase+1+study+of+FPA008%2C+an+anti-colony+stimulating+factor+1+receptor+%28anti-CSF1R%29+antibody+in+patients+%28pts%29+with+rheumatoid+arthritis+%28RA%29%3A+preliminary+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26atitle%3DA%2520phase%25201%2520study%2520of%2520FPA008%252C%2520an%2520anti-colony%2520stimulating%2520factor%25201%2520receptor%2520%2528anti-CSF1R%2529%2520antibody%2520in%2520patients%2520%2528pts%2529%2520with%2520rheumatoid%2520arthritis%2520%2528RA%2529%253A%2520preliminary%2520results.%26jtitle%3DACR%252FARHP%2520Annual%2520Meeting%253A%2520Rheumatoid%2520Arthritis%25E2%2580%2594Small%2520Molecules%252C%2520Biologics%2520and%2520Gene%2520Therapy%2520Poster%2520III%252C%2520San%2520Francisco%252C%25206-11%2520November%25202015%26pub%3DAmerican%2520College%2520of%2520Rheumatology%26date%3D2015%26spage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span> <i>Cabiralizumab
(FPA008)</i>; <span class="NLM_publisher-name">Five Prime Therapeutics</span>: <span class="NLM_publisher-loc">South San Francisco, CA</span>, <span class="NLM_year">2017</span>; <a href="http://www.fiveprime.com/pipeline/fpa008" class="extLink">http://www.fiveprime.com/pipeline/fpa008</a> (Accessed December 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Cabiralizumab%0A%28FPA008%29%3B+Five+Prime+Therapeutics%3A+South+San+Francisco%2C+CA%2C+2017%3B+http%3A%2F%2Fwww.fiveprime.com%2Fpipeline%2Ffpa008+%28Accessed+December+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCabiralizumab%250A%2528FPA008%2529%26pub%3DFive%2520Prime%2520Therapeutics%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziller-Rémy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraud, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thioudellet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Préville, X.</span></span> <span> </span><span class="NLM_article-title">TG3003, an immunomodulatory anti-CD115 mAb targeting M2-macrophage polarization in the tumor microenvironment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">288</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1538-7445.AM2015-288" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=288&author=H.+Haegelauthor=C.+Ziller-R%C3%A9myauthor=L.+Barraudauthor=J.-Y.+Bonnefoyauthor=S.+Cochinauthor=V.+Duongauthor=M.+Geistauthor=B.+Grellierauthor=R.+Halletauthor=J.-B.+Marchandauthor=T.+Menguyauthor=R.+Rookeauthor=C.+Thioudelletauthor=C.+Reymannauthor=X.+Pr%C3%A9ville&title=TG3003%2C+an+immunomodulatory+anti-CD115+mAb+targeting+M2-macrophage+polarization+in+the+tumor+microenvironment&doi=10.1158%2F1538-7445.AM2015-288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-288%26sid%3Dliteratum%253Aachs%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DZiller-R%25C3%25A9my%26aufirst%3DC.%26aulast%3DBarraud%26aufirst%3DL.%26aulast%3DBonnefoy%26aufirst%3DJ.-Y.%26aulast%3DCochin%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DV.%26aulast%3DGeist%26aufirst%3DM.%26aulast%3DGrellier%26aufirst%3DB.%26aulast%3DHallet%26aufirst%3DR.%26aulast%3DMarchand%26aufirst%3DJ.-B.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DRooke%26aufirst%3DR.%26aulast%3DThioudellet%26aufirst%3DC.%26aulast%3DReymann%26aufirst%3DC.%26aulast%3DPr%25C3%25A9ville%26aufirst%3DX.%26atitle%3DTG3003%252C%2520an%2520immunomodulatory%2520anti-CD115%2520mAb%2520targeting%2520M2-macrophage%2520polarization%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D288%26doi%3D10.1158%2F1538-7445.AM2015-288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkowski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masterson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurmond, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franks, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenspan, A.</span></span> <span> </span><span class="NLM_article-title">Results from a phase IIA parallel group study of JNJ-40346527, an oral CSF-1R inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy</span>. <i>J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.3899/jrheum.141580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3899%2Fjrheum.141580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26233509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyqsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1752-1761&author=M.+C.+Genoveseauthor=E.+Hsiaauthor=S.+M.+Belkowskiauthor=C.+Chienauthor=T.+Mastersonauthor=R.+L.+Thurmondauthor=C.+L.+Mantheyauthor=X.+D.+Yanauthor=T.+Geauthor=C.+Franksauthor=A.+Greenspan&title=Results+from+a+phase+IIA+parallel+group+study+of+JNJ-40346527%2C+an+oral+CSF-1R+inhibitor%2C+in+patients+with+active+rheumatoid+arthritis+despite+disease-modifying+antirheumatic+drug+therapy&doi=10.3899%2Fjrheum.141580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Results from a phase IIA parallel group study of JNJ-40346527, an oral CSF-1R inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy</span></div><div class="casAuthors">Genovese, Mark C.; Hsia, Elizabeth; Belkowski, Stanley M.; Chien, Caly; Masterson, Tara; Thurmond, Robin L.; Manthey, Carl L.; Yan, Xiaoyu; Ge, Tingting; Franks, Carol; Greenspan, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1752-1760</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">1499-2752</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">Objective.  To assess the efficacy and safety of JNJ-40346527, a selective inhibitor of colony-stimulating factor-1 (CSF-1) receptor kinase that acts to inhibit macrophage survival, proliferation, and differentiation in patients with active rheumatoid arthritis (RA) despite disease-modifying antirheumatic drug (DMARD) therapy.  In this randomized, double-blind, placebo-controlled, parallel group study, adults were randomized (2:1) to receive oral JNJ-40346527 100 mg or placebo twice daily through Week 12.  Patients with RA had disease activity [≥ 6 swollen/≥ 6 tender joints, C-reactive protein (CRP) ≥ 0.8 mg/dL] despite DMARD therapy for ≥ 6 mo.  The primary endpoint was change from baseline at Week 12 in the 28-joint Disease Activity Score with CRP (DAS28-CRP).  Pharmacokinetic/pharmacodynamic analyses were also performed, and safety was assessed through Week 16.  Ninety-five patients were treated (63 JNJ-40346527, 32 placebo); 8 patients discontinued treatment (6 JNJ-40346527, 2 placebo) through Week 12.  Mean improvements in DAS28-CRP from baseline to Week 12 were 1.15 for the JNJ-40346527 group and 1.42 for the placebo group (p = 0.30); thus, a statistically significant difference was not obsd. for the primary endpoint.  Pharmacokinetic exposure to JNJ-40346527 and its active metabolites was above the projected concn. needed for pharmacol. activity, and effective target engagement and proof of activity were demonstrated by increased levels of CSF-1 and decreased CD16+ monocytes in JNJ-40346527-treated, but not placebo-treated, patients.  Thirty-seven (58.7%) JNJ-40346527-treated and 16 (50.0%) placebo-treated patients reported ≥ 1 adverse event (AE); 1 (1.6%) JNJ-40346527-treated and 3 (9.4%) placebo-treated patients reported ≥ 1 serious AE.  Conclusion.  Although adequate exposure and effective peripheral target engagement were evident, JNJ-40346527 efficacy was not obsd. in patients with DMARD-refractory active RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYP703ihQxAbVg90H21EOLACvtfcHk0lhGE0-vhDEeeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyqsL7I&md5=691acfc23f3fdcb46c59da16c2d01455</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.141580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.141580%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DHsia%26aufirst%3DE.%26aulast%3DBelkowski%26aufirst%3DS.%2BM.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DMasterson%26aufirst%3DT.%26aulast%3DThurmond%26aufirst%3DR.%2BL.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DYan%26aufirst%3DX.%2BD.%26aulast%3DGe%26aufirst%3DT.%26aulast%3DFranks%26aufirst%3DC.%26aulast%3DGreenspan%26aufirst%3DA.%26atitle%3DResults%2520from%2520a%2520phase%2520IIA%2520parallel%2520group%2520study%2520of%2520JNJ-40346527%252C%2520an%2520oral%2520CSF-1R%2520inhibitor%252C%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520despite%2520disease-modifying%2520antirheumatic%2520drug%2520therapy%26jtitle%3DJ.%2520Rheumatol.%26date%3D2015%26volume%3D42%26spage%3D1752%26epage%3D1761%26doi%3D10.3899%2Fjrheum.141580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span> <span> </span><span class="NLM_article-title">The role of Kupffer cells in hepatic diseases</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.molimm.2017.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.molimm.2017.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=28314211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktl2iu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=222-229&author=P.+Liauthor=K.+Heauthor=J.+Liauthor=Z.+Liuauthor=J.+Gong&title=The+role+of+Kupffer+cells+in+hepatic+diseases&doi=10.1016%2Fj.molimm.2017.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Kupffer cells in hepatic diseases</span></div><div class="casAuthors">Li, Peizhi; He, Kun; Li, Jinzheng; Liu, Zuojin; Gong, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">222-229</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Kupffer cells (KCs) constitute 80-90% of the tissue macrophages present in the body.  Essential to innate and adaptive immunity, KCs are responsible for the swift containment and clearance of exogenous particulates and immunoreactive materials which are perceived as foreign and harmful to the body.  Similar to other macrophages, KCs also sense endogenous mol. signals that may result from perturbed homeostasis of the host.  KCs have been implicated in host defense and the pathogenesis of various hepatic diseases, including endotoxin tolerance, liver transplantation, nonalcoholic fatty liver disease, and alc. liver disease.  In this review, we summarized some novel findings assocd. with the role of KCs in hepatic diseases, such as the origin and mechanisms KCs polarization, mol. basis for caspase-1 activation called "non-canonical inflammasome pathway" involving the cleavage of Gsdmd by caspase-11, the important role of microRNA in liver transplantation, and so on.  A better understanding of KCs biol. characteristics and immunol. function in liver homeostasis and pathol. may pave the way to investigate new diagnostic and therapeutic approaches for hepatic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2BBu91uSf3bVg90H21EOLACvtfcHk0lhGE0-vhDEeeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktl2iu7Y%253D&md5=634a3d1b52153cc96841a82bead48fa5</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2017.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2017.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520Kupffer%2520cells%2520in%2520hepatic%2520diseases%26jtitle%3DMol.%2520Immunol.%26date%3D2017%26volume%3D85%26spage%3D222%26epage%3D229%26doi%3D10.1016%2Fj.molimm.2017.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Tresckow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribrag, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetharam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoulek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engert, A.</span></span> <span> </span><span class="NLM_article-title">An open-label, multicenter, phase I/II study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1850</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-1845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1078-0432.CCR-14-1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25628399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1843-1850&author=B.+von%0ATresckowauthor=F.+Morschhauserauthor=V.+Ribragauthor=M.+Toppauthor=C.+Chienauthor=S.+Seetharamauthor=R.+Aquinoauthor=S.+Kotoulekauthor=C.+J.+de+Boerauthor=A.+Engert&title=An+open-label%2C+multicenter%2C+phase+I%2FII+study+of+JNJ-40346527%2C+a+CSF-1R+inhibitor%2C+in+patients+with+relapsed+or+refractory+hodgkin+lymphoma&doi=10.1158%2F1078-0432.CCR-14-1845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma</span></div><div class="casAuthors">von Tresckow, Bastian; Morschhauser, Franck; Ribrag, Vincent; Topp, Max S.; Chien, Caly; Seetharam, Shobha; Aquino, Regina; Kotoulek, Sonja; de Boer, Carla J.; Engert, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1843-1850</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This phase I/II study investigated JNJ-40346527, a selective inhibitor of the colony-stimulating factor-1 receptor (CSF-1R) tyrosine kinase as treatment for relapsed or refractory classical Hodgkin lymphoma (cHL).  Patients ≥18 years with histopathol. confirmed initial diagnosis of cHL that had relapsed or was refractory after ≥1 appropriate therapies were assigned to sequential cohorts of oral daily doses of JNJ-40346527 (150, 300, 450, 600 mg every day, and 150 mg twice a day).  For the dose-escalation phase, the primary endpoint was to establish the recommended phase II dose.  Secondary endpoints included safety, pharmacokinetics, and pharmacodynamics.  Twenty-one patients [(150 mg: 3; 300 mg: 5; 450 mg: 3, 600 mg: 3) every day, and 150 mg twice a day: 7] were enrolled, 10 men, median age 40 (range, 19-75) years, median no. of prior systemic therapies 6 (range, 3-14).  No dose-limiting toxicities were obsd.; max.-tolerated dose was not established.  Best overall response was complete remission in 1 patient (duration, +352 days) and stable disease in 11 patients: (duration, 1.5-8 mo).  Median no. of cycles: 4 (range, 1-16).  Most common (≥20% patients) possibly drug-related adverse events (per investigator assessment) were nausea (n = 6), headache, and pyrexia (n = 5 each).  JNJ-40346527 exposure increased in near dose-proportional manner over a dose range of 150 to 450 mg every day, but plateaued at 600 mg every day.  Target engagement was confirmed (>80% inhibition of CSF-1R phosphorylation, 4 h after dosing).  JNJ-40346527, a selective inhibitor of CSF-1R was well tolerated, and preliminary antitumor results suggested limited activity in monotherapy for the treatment of cHL.  Clin Cancer Res; 21(8); 1843-50. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZuUy9-7MhLVg90H21EOLACvtfcHk0lhbwfExmax3MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D&md5=e3d4f2b2937078f85ef0ead51e093f82</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-1845%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BTresckow%26aufirst%3DB.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DRibrag%26aufirst%3DV.%26aulast%3DTopp%26aufirst%3DM.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DSeetharam%26aufirst%3DS.%26aulast%3DAquino%26aufirst%3DR.%26aulast%3DKotoulek%26aufirst%3DS.%26aulast%3Dde%2BBoer%26aufirst%3DC.%2BJ.%26aulast%3DEngert%26aufirst%3DA.%26atitle%3DAn%2520open-label%252C%2520multicenter%252C%2520phase%2520I%252FII%2520study%2520of%2520JNJ-40346527%252C%2520a%2520CSF-1R%2520inhibitor%252C%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520hodgkin%2520lymphoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D1843%26epage%3D1850%26doi%3D10.1158%2F1078-0432.CCR-14-1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tresckow, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribrag, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetharam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoulek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engert, A.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of JNJ-40346527, a colony stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with relapsed or refractory hodgkin lymphoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1812</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1812&author=B.+V.+Tresckowauthor=F.+Morschhauserauthor=V.+Ribragauthor=M.+S.+Toppauthor=C.+Chienauthor=S.+Seetharamauthor=R.+Aquinoauthor=S.+Kotoulekauthor=I.+Khanauthor=C.+J.+de+Boerauthor=A.+Engert&title=A+phase+1+study+of+JNJ-40346527%2C+a+colony+stimulating+factor-1+receptor+%28CSF-1R%29+inhibitor%2C+in+patients+with+relapsed+or+refractory+hodgkin+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresckow%26aufirst%3DB.%2BV.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DRibrag%26aufirst%3DV.%26aulast%3DTopp%26aufirst%3DM.%2BS.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DSeetharam%26aufirst%3DS.%26aulast%3DAquino%26aufirst%3DR.%26aulast%3DKotoulek%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DI.%26aulast%3Dde%2BBoer%26aufirst%3DC.%2BJ.%26aulast%3DEngert%26aufirst%3DA.%26atitle%3DA%2520phase%25201%2520study%2520of%2520JNJ-40346527%252C%2520a%2520colony%2520stimulating%2520factor-1%2520receptor%2520%2528CSF-1R%2529%2520inhibitor%252C%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520hodgkin%2520lymphoma%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meegalla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballentine, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desjarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomczuk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illig, C. R.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of a potent class of arylamide FMS inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3632</span>– <span class="NLM_lpage">3637</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bmcl.2008.04.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3632-3637&author=S.+K.+Meegallaauthor=M.+J.+Wallauthor=J.+Chenauthor=K.+J.+Wilsonauthor=S.+K.+Ballentineauthor=R.+L.+Desjarlaisauthor=C.+Schubertauthor=C.+S.+Cryslerauthor=Y.+Chenauthor=C.+J.+Molloyauthor=M.+A.+Chaikinauthor=C.+L.+Mantheyauthor=M.+R.+Playerauthor=B.+E.+Tomczukauthor=C.+R.+Illig&title=Structure-based+optimization+of+a+potent+class+of+arylamide+FMS+inhibitors&doi=10.1016%2Fj.bmcl.2008.04.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.059%26sid%3Dliteratum%253Aachs%26aulast%3DMeegalla%26aufirst%3DS.%2BK.%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DK.%2BJ.%26aulast%3DBallentine%26aufirst%3DS.%2BK.%26aulast%3DDesjarlais%26aufirst%3DR.%2BL.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DIllig%26aufirst%3DC.%2BR.%26atitle%3DStructure-based%2520optimization%2520of%2520a%2520potent%2520class%2520of%2520arylamide%2520FMS%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3632%26epage%3D3637%26doi%3D10.1016%2Fj.bmcl.2008.04.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Illig, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meegalla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DesJarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballentine, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomczuk, B. E.</span></span> <span> </span><span class="NLM_article-title">Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6363</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bmcl.2013.09.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6363-6369&author=C.+R.+Illigauthor=C.+L.+Mantheyauthor=S.+K.+Meegallaauthor=M.+J.+Wallauthor=J.+Chenauthor=K.+J.+Wilsonauthor=R.+L.+DesJarlaisauthor=S.+K.+Ballentineauthor=C.+Schubertauthor=C.+S.+Cryslerauthor=Y.+Chenauthor=C.+J.+Molloyauthor=M.+A.+Chaikinauthor=R.+R.+Donatelliauthor=E.+Yurkowauthor=Z.+Zhouauthor=M.+R.+Playerauthor=B.+E.+Tomczuk&title=Enhancement+of+kinase+selectivity+in+a+potent+class+of+arylamide+FMS+inhibitors&doi=10.1016%2Fj.bmcl.2013.09.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.061%26sid%3Dliteratum%253Aachs%26aulast%3DIllig%26aufirst%3DC.%2BR.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DMeegalla%26aufirst%3DS.%2BK.%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DK.%2BJ.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DBallentine%26aufirst%3DS.%2BK.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DR.%2BR.%26aulast%3DYurkow%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26atitle%3DEnhancement%2520of%2520kinase%2520selectivity%2520in%2520a%2520potent%2520class%2520of%2520arylamide%2520FMS%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6363%26epage%3D6369%26doi%3D10.1016%2Fj.bmcl.2013.09.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hembrough, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plum, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogler, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidor, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span> <span> </span><span class="NLM_article-title">ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of Action</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1535-7163.MCT-10-0574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=21177375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=126-137&author=G.+C.+Fletcherauthor=R.+D.+Brokxauthor=T.+A.+Dennyauthor=T.+A.+Hembroughauthor=S.+M.+Plumauthor=W.+E.+Foglerauthor=C.+F.+Sidorauthor=M.+R.+Bray&title=ENMD-2076+is+an+orally+active+kinase+inhibitor+with+antiangiogenic+and+antiproliferative+mechanisms+of+Action&doi=10.1158%2F1535-7163.MCT-10-0574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action</span></div><div class="casAuthors">Fletcher, Graham C.; Brokx, Richard D.; Denny, Trisha A.; Hembrough, Todd A.; Plum, Stacy M.; Fogler, William E.; Sidor, Carolyn F.; Bray, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-137</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ENMD-2076 is a novel orally active, small mol. kinase inhibitor with a mechanism of action involving several pathways key to tumor growth and survival: angiogenesis, proliferation, and the cell cycle.  ENMD-2076 has selective activity against the mitotic kinase Aurora A, as well as kinases involved in angiogenesis (VEGFRs, FGFRs).  ENMD-2076 inhibited the growth in vitro of a wide range of human solid tumor and hematopoietic cancer cell lines with IC50 values ranging from 0.025 to 0.7 μmol/L.  ENMD-2076 was also shown to induce regression or complete inhibition of tumor growth in vivo at well-tolerated doses in tumor xenograft models derived from breast, colon, melanoma, leukemia, and multiple myeloma cell lines.  Pharmacodynamic expts. in vivo showed that in addn. to inhibiting Aurora A, single doses of ENMD-2076 had sustained inhibitory effects on the activation of Flt3 as well as the angiogenic tyrosine kinases, VEGFR2/KDR and FGFR1 and 2.  ENMD-2076 was shown to prevent the formation of new blood vessels and regress formed vessels in vivo at doses equiv. to those that gave substantial activity in tumor xenograft models.  These results indicate that ENMD-2076 is a well-tolerated, orally active multitarget kinase inhibitor with a unique antiangiogenic/antiproliferative profile and provides strong preclin. support for use as a therapeutic for human cancers.  Several phase 1 studies involving ENMD-2076 have been recently completed, and the compd. is currently being evaluated in a phase 2 clin. trial in patients with platinum-resistant ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplPl3keBsSALVg90H21EOLACvtfcHk0lhbwfExmax3MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFeltQ%253D%253D&md5=069d96ad4ad3f0643ad4163036a5f4cd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0574%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DBrokx%26aufirst%3DR.%2BD.%26aulast%3DDenny%26aufirst%3DT.%2BA.%26aulast%3DHembrough%26aufirst%3DT.%2BA.%26aulast%3DPlum%26aufirst%3DS.%2BM.%26aulast%3DFogler%26aufirst%3DW.%2BE.%26aulast%3DSidor%26aufirst%3DC.%2BF.%26aulast%3DBray%26aufirst%3DM.%2BR.%26atitle%3DENMD-2076%2520is%2520an%2520orally%2520active%2520kinase%2520inhibitor%2520with%2520antiangiogenic%2520and%2520antiproliferative%2520mechanisms%2520of%2520Action%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D126%26epage%3D137%26doi%3D10.1158%2F1535-7163.MCT-10-0574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span> <i>ENMD-2076</i>; <span class="NLM_publisher-name">CASI Pharmaceuticals</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, <span class="NLM_year">2017</span>; <a href="http://www.casipharmaceuticals.com/product-pipeline/enmd-2076/" class="extLink">http://www.casipharmaceuticals.com/product-pipeline/enmd-2076/</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ENMD-2076%3B+CASI+Pharmaceuticals%3A+Rockville%2C+MD%2C+2017%3B+http%3A%2F%2Fwww.casipharmaceuticals.com%2Fproduct-pipeline%2Fenmd-2076%2F+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DENMD-2076%26pub%3DCASI%2520Pharmaceuticals%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">William, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span> <span> </span><span class="NLM_article-title">SB1578, a novel inhibitor of JAK2, FLT3, and c-Fms for the treatment of rheumatoid arthritis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4134</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1200675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4049%2Fjimmunol.1200675" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2012&pages=4123-4134&author=B.+Madanauthor=K.+Gohauthor=S.+Hartauthor=A.+Williamauthor=R.+Jayaramanauthor=K.+Ethirajuluauthor=B.+W.+Dymockauthor=J.+M.+Wood&title=SB1578%2C+a+novel+inhibitor+of+JAK2%2C+FLT3%2C+and+c-Fms+for+the+treatment+of+rheumatoid+arthritis&doi=10.4049%2Fjimmunol.1200675"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1200675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1200675%26sid%3Dliteratum%253Aachs%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DGoh%26aufirst%3DK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DWilliam%26aufirst%3DA.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3DSB1578%252C%2520a%2520novel%2520inhibitor%2520of%2520JAK2%252C%2520FLT3%252C%2520and%2520c-Fms%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D189%26spage%3D4123%26epage%3D4134%26doi%3D10.4049%2Fjimmunol.1200675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">William, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the macrocycle (9E)-15-(2-(pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a potent inhibitor of Janus kinase 2/Fms-LikeTyrosine Kinase-3 (JAK2/FLT3) for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2623</span>– <span class="NLM_lpage">2640</span>, <span class="refDoi"> DOI: 10.1021/jm201454n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201454n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2623-2640&author=A.+Williamauthor=A.+Leeauthor=A.+Poulsenauthor=K.+Gohauthor=B.+Madanauthor=S.+Hartauthor=E.+Tanauthor=H.+Wangauthor=H.+Nagarajauthor=D.+Chenauthor=C.+P.+Leeauthor=E.+T.+Sunauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+%289E%29-15-%282-%28pyrrolidin-1-yl%29ethoxy%29-7%2C12%2C25-trioxa-19%2C21%2C24-triaza-tetracyclo%5B18.3.1.1%282%2C5%29.1%2814%2C18%29%5Dhexacosa-1%2824%29%2C2%2C4%2C9%2C14%2826%29%2C15%2C17%2C20%2C22-nonaene+%28SB1578%29%2C+a+potent+inhibitor+of+Janus+kinase+2%2FFms-LikeTyrosine+Kinase-3+%28JAK2%2FFLT3%29+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Fjm201454n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm201454n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201454n%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DGoh%26aufirst%3DK.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DC.%2BP.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%2520%25289E%2529-15-%25282-%2528pyrrolidin-1-yl%2529ethoxy%2529-7%252C12%252C25-trioxa-19%252C21%252C24-triaza-tetracyclo%255B18.3.1.1%25282%252C5%2529.1%252814%252C18%2529%255Dhexacosa-1%252824%2529%252C2%252C4%252C9%252C14%252826%2529%252C15%252C17%252C20%252C22-nonaene%2520%2528SB1578%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520Janus%2520kinase%25202%252FFms-LikeTyrosine%2520Kinase-3%2520%2528JAK2%252FFLT3%2529%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2623%26epage%3D2640%26doi%3D10.1021%2Fjm201454n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conway, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusnak, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frick, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadepalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kull, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, J. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of colony stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">16078</span>– <span class="NLM_lpage">16083</span>, <span class="refDoi"> DOI: 10.1073/pnas.0502000102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1073%2Fpnas.0502000102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16078-16083&author=J.+G.+Conwayauthor=B.+McDonaldauthor=J.+Parhamauthor=B.+Keithauthor=D.+W.+Rusnakauthor=E.+Shawauthor=M.+Jansenauthor=P.+Linauthor=A.+Payneauthor=R.+M.+Crosbyauthor=J.+H.+Johnsonauthor=L.+Frickauthor=M.+H.+Linauthor=S.+Depeeauthor=S.+Tadepalliauthor=B.+Vottaauthor=I.+Jamesauthor=K.+Fullerauthor=T.+J.+Chambersauthor=F.+C.+Kullauthor=S.+D.+Chamberlainauthor=J.+T.+Hutchins&title=Inhibition+of+colony+stimulating-factor-1+signaling+in+vivo+with+the+orally+bioavailable+cFMS+kinase+inhibitor+GW2580&doi=10.1073%2Fpnas.0502000102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502000102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502000102%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DJ.%2BG.%26aulast%3DMcDonald%26aufirst%3DB.%26aulast%3DParham%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DShaw%26aufirst%3DE.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DFrick%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DDepee%26aufirst%3DS.%26aulast%3DTadepalli%26aufirst%3DS.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DJames%26aufirst%3DI.%26aulast%3DFuller%26aufirst%3DK.%26aulast%3DChambers%26aufirst%3DT.%2BJ.%26aulast%3DKull%26aufirst%3DF.%2BC.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DHutchins%26aufirst%3DJ.%2BT.%26atitle%3DInhibition%2520of%2520colony%2520stimulating-factor-1%2520signaling%2520in%2520vivo%2520with%2520the%2520orally%2520bioavailable%2520cFMS%2520kinase%2520inhibitor%2520GW2580%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D16078%26epage%3D16083%26doi%3D10.1073%2Fpnas.0502000102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinkert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caplice, N. M.</span></span> <span> </span><span class="NLM_article-title">Systemic and cardiac depletion of M2 macrophage through CSF-1R signaling inhibition alters cardiac function post myocardial infarction</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0137515</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0137515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0137515" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0137515&author=A.-L.+Leblondauthor=K.+Klinkertauthor=K.+Martinauthor=E.+C.+Turnerauthor=A.+H.+Kumarauthor=T.+Browneauthor=N.+M.+Caplice&title=Systemic+and+cardiac+depletion+of+M2+macrophage+through+CSF-1R+signaling+inhibition+alters+cardiac+function+post+myocardial+infarction&doi=10.1371%2Fjournal.pone.0137515"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0137515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0137515%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DA.-L.%26aulast%3DKlinkert%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DE.%2BC.%26aulast%3DKumar%26aufirst%3DA.%2BH.%26aulast%3DBrowne%26aufirst%3DT.%26aulast%3DCaplice%26aufirst%3DN.%2BM.%26atitle%3DSystemic%2520and%2520cardiac%2520depletion%2520of%2520M2%2520macrophage%2520through%2520CSF-1R%2520signaling%2520inhibition%2520alters%2520cardiac%2520function%2520post%2520myocardial%2520infarction%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0137515%26doi%3D10.1371%2Fjournal.pone.0137515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflimlin-Fritschy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, P.</span></span> <span> </span><span class="NLM_article-title">Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.3109/00498254.2014.945988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3109%2F00498254.2014.945988" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=107-123&author=J.+Krauserauthor=Y.+Jinauthor=M.+Wallesauthor=U.+Pfaarauthor=J.+Suttonauthor=M.+Wiesmannauthor=D.+Grafauthor=V.+Pflimlin-Fritschyauthor=T.+Wolfauthor=G.+Camenischauthor=P.+Swart&title=Phenotypic+and+metabolic+investigation+of+a+CSF-1R+kinase+receptor+inhibitor+%28BLZ945%29+and+its+pharmacologically+active+metabolite&doi=10.3109%2F00498254.2014.945988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.945988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.945988%26sid%3Dliteratum%253Aachs%26aulast%3DKrauser%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DPfaar%26aufirst%3DU.%26aulast%3DSutton%26aufirst%3DJ.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DGraf%26aufirst%3DD.%26aulast%3DPflimlin-Fritschy%26aufirst%3DV.%26aulast%3DWolf%26aufirst%3DT.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DSwart%26aufirst%3DP.%26atitle%3DPhenotypic%2520and%2520metabolic%2520investigation%2520of%2520a%2520CSF-1R%2520kinase%2520receptor%2520inhibitor%2520%2528BLZ945%2529%2520and%2520its%2520pharmacologically%2520active%2520metabolite%26jtitle%3DXenobiotica%26date%3D2015%26volume%3D45%26spage%3D107%26epage%3D123%26doi%3D10.3109%2F00498254.2014.945988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyonteck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijeiro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1038/nm.3337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1038%2Fnm.3337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24056773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1264-1272&author=S.+M.+Pyonteckauthor=L.+Akkariauthor=A.+J.+Schuhmacherauthor=R.+L.+Bowmanauthor=L.+Sevenichauthor=D.+F.+Quailauthor=O.+C.+Olsonauthor=M.+L.+Quickauthor=J.+T.+Huseauthor=V.+Teijeiroauthor=M.+Settyauthor=C.+S.+Leslieauthor=Y.+Oeiauthor=A.+Pedrazaauthor=J.+Zhangauthor=C.+W.+Brennanauthor=J.+C.+Suttonauthor=E.+C.+Hollandauthor=D.+Danielauthor=J.+A.+Joyce&title=CSF-1R+inhibition+alters+macrophage+polarization+and+blocks+glioma+progression&doi=10.1038%2Fnm.3337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span></div><div class="casAuthors">Pyonteck, Stephanie M.; Akkari, Leila; Schuhmacher, Alberto J.; Bowman, Robert L.; Sevenich, Lisa; Quail, Daniela F.; Olson, Oakley C.; Quick, Marsha L.; Huse, Jason T.; Teijeiro, Virginia; Setty, Manu; Leslie, Christina S.; Oei, Yoko; Pedraza, Alicia; Zhang, Jianan; Brennan, Cameron W.; Sutton, James C.; Holland, Eric C.; Daniel, Dylan; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1272</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) comprises several mol. subtypes, including proneural GBM.  Most therapeutic approaches targeting glioma cells have failed.  An alternative strategy is to target cells in the glioma microenvironment, such as tumor-assocd. macrophages and microglia (TAMs).  Macrophages depend on colony stimulating factor-1 (CSF-1) for differentiation and survival.  We used an inhibitor of the CSF-1 receptor (CSF-1R) to target TAMs in a mouse proneural GBM model, which significantly increased survival and regressed established tumors.  CSF-1R blockade addnl. slowed intracranial growth of patient-derived glioma xenografts.  Surprisingly, TAMs were not depleted in treated mice.  Instead, glioma-secreted factors, including granulocyte-macrophage CSF (GM-CSF) and interferon-γ (IFN-γ), facilitated TAM survival in the context of CSF-1R inhibition.  Expression of alternatively activated M2 markers decreased in surviving TAMs, which is consistent with impaired tumor-promoting functions.  These gene signatures were assocd. with enhanced survival in patients with proneural GBM.  Our results identify TAMs as a promising therapeutic target for proneural gliomas and establish the translational potential of CSF-1R inhibition for GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirwpRVIWUELVg90H21EOLACvtfcHk0lih2-enlFGBsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N&md5=9b908e86c4a7da35a009bf322d492214</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnm.3337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3337%26sid%3Dliteratum%253Aachs%26aulast%3DPyonteck%26aufirst%3DS.%2BM.%26aulast%3DAkkari%26aufirst%3DL.%26aulast%3DSchuhmacher%26aufirst%3DA.%2BJ.%26aulast%3DBowman%26aufirst%3DR.%2BL.%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DQuail%26aufirst%3DD.%2BF.%26aulast%3DOlson%26aufirst%3DO.%2BC.%26aulast%3DQuick%26aufirst%3DM.%2BL.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DTeijeiro%26aufirst%3DV.%26aulast%3DSetty%26aufirst%3DM.%26aulast%3DLeslie%26aufirst%3DC.%2BS.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DHolland%26aufirst%3DE.%2BC.%26aulast%3DDaniel%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DCSF-1R%2520inhibition%2520alters%2520macrophage%2520polarization%2520and%2520blocks%2520glioma%2520progression%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1264%26epage%3D1272%26doi%3D10.1038%2Fnm.3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruffell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span> <span> </span><span class="NLM_article-title">CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e26968</span>, <span class="refDoi"> DOI: 10.4161/onci.26968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4161%2Fonci.26968" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e26968&author=D.+C.+Strachanauthor=B.+Ruffellauthor=Y.+Oeiauthor=M.+J.+Bissellauthor=L.+M.+Coussensauthor=N.+Pryerauthor=D.+Daniel&title=CSF1R+inhibition+delays+cervical+and+mammary+tumor+growth+in+murine+models+by+attenuating+the+turnover+of+tumor-associated+macrophages+and+enhancing+infiltration+by+CD8+T+cells&doi=10.4161%2Fonci.26968"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.4161%2Fonci.26968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fonci.26968%26sid%3Dliteratum%253Aachs%26aulast%3DStrachan%26aufirst%3DD.%2BC.%26aulast%3DRuffell%26aufirst%3DB.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26aulast%3DPryer%26aufirst%3DN.%26aulast%3DDaniel%26aufirst%3DD.%26atitle%3DCSF1R%2520inhibition%2520delays%2520cervical%2520and%2520mammary%2520tumor%2520growth%2520in%2520murine%2520models%2520by%2520attenuating%2520the%2520turnover%2520of%2520tumor-associated%2520macrophages%2520and%2520enhancing%2520infiltration%2520by%2520CD8%2520T%2520cells%26jtitle%3DOncoimmunology%26date%3D2013%26volume%3D2%26spage%3De26968%26doi%3D10.4161%2Fonci.26968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carias, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesch, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5689</span>– <span class="NLM_lpage">5694</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219457110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1073%2Fpnas.1219457110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23493555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5689-5694&author=C.+Zhangauthor=P.+N.+Ibrahimauthor=J.+Zhangauthor=E.+A.+Burtonauthor=G.+Habetsauthor=Y.+Zhangauthor=B.+Powellauthor=B.+L.+Westauthor=B.+Matusowauthor=G.+Tsangauthor=R.+Shellooeauthor=H.+Cariasauthor=H.+Nguyenauthor=A.+Marimuthuauthor=K.+Y.+Zhangauthor=A.+Ohauthor=R.+Bremerauthor=C.+R.+Hurtauthor=D.+R.+Artisauthor=G.+Wuauthor=M.+Nespiauthor=W.+Spevakauthor=P.+Linauthor=K.+Nolopauthor=P.+Hirthauthor=G.+H.+Teschauthor=G.+Bollag&title=Design+and+pharmacology+of+a+highly+specific+dual+FMS+and+KIT+kinase+inhibitor&doi=10.1073%2Fpnas.1219457110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span></div><div class="casAuthors">Zhang, Chao; Ibrahim, Prabha N.; Zhang, Jiazhong; Burton, Elizabeth A.; Habets, Gaston; Zhang, Ying; Powell, Ben; West, Brian L.; Matusow, Bernice; Tsang, Garson; Shellooe, Rafe; Carias, Heidi; Nguyen, Hoa; Marimuthu, Adhirai; Zhang, Kam Y. J.; Oh, Angela; Bremer, Ryan; Hurt, Clarence R.; Artis, Dean R.; Wu, Guoxian; Nespi, Marika; Spevak, Wayne; Lin, Paul; Nolop, Keith; Hirth, Peter; Tesch, Greg H.; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5689-5694, S5689/1-S5689/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inflammation and cancer, two therapeutic areas historically addressed by sep. drug discovery efforts, are now coupled in treatment approaches by a growing understanding of the dynamic mol. dialogues between immune and cancer cells.  Agents that target specific compartments of the immune system, therefore, not only bring new disease modifying modalities to inflammatory diseases, but also offer a new avenue to cancer therapy by disrupting immune components of the microenvironment that foster tumor growth, progression, immune evasion, and treatment resistance.  McDonough feline sarcoma viral (v-fms) oncogene homolog (FMS) and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) are two hematopoietic cell surface receptors that regulate the development and function of macrophages and mast cells, resp.  The authors disclose a highly specific dual FMS and KIT kinase inhibitor developed from a multifaceted chem. scaffold.  As expected, this inhibitor blocks the activation of macrophages, osteoclasts, and mast cells controlled by these two receptors.  More importantly, the dual FMS and KIT inhibition profile has translated into a combination of benefits in preclin. disease models of inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofECnjzEONuLVg90H21EOLACvtfcHk0lih2-enlFGBsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D&md5=e4fbca9d41f95718a5119a08a54f5acc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219457110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219457110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCarias%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DHurt%26aufirst%3DC.%2BR.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTesch%26aufirst%3DG.%2BH.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDesign%2520and%2520pharmacology%2520of%2520a%2520highly%2520specific%2520dual%2520FMS%2520and%2520KIT%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D5689%26epage%3D5694%26doi%3D10.1073%2Fpnas.1219457110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">The azaindole framework in the design of kinase inhibitors</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">19935</span>– <span class="NLM_lpage">19979</span>, <span class="refDoi"> DOI: 10.3390/molecules191219935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3390%2Fmolecules191219935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25460315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=19935-19979&author=J.-Y.+M%C3%A9rourauthor=F.+Buronauthor=K.+Pl%C3%A9author=P.+Bonnetauthor=S.+Routier&title=The+azaindole+framework+in+the+design+of+kinase+inhibitors&doi=10.3390%2Fmolecules191219935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The azaindole framework in the design of kinase inhibitors</span></div><div class="casAuthors">Merour, Jean-Yves; Buron, Frederic; Ple, Karen; Bonnet, Pascal; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">19935-19979, 45 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This review article illustrates the growing use of azaindole derivs. as kinase inhibitors and their contribution to drug discovery and innovation.  The different protein kinases which have served as targets and the known mols. which have emerged from medicinal chem. and Fragment-Based Drug Discovery (FBDD) programs are presented.  The various synthetic routes used to access these compds. and the chem. pathways leading to their synthesis are also discussed.  An anal. of their mode of binding based on X-ray crystallog. data gives structural insights for the design of more potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLtZrGItBQbVg90H21EOLACvtfcHk0ljfoLiV6LN_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO&md5=7797450a99abb4a4c8e2492eb8a43dd7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191219935%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DPl%25C3%25A9%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DThe%2520azaindole%2520framework%2520in%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D19935%26epage%3D19979%26doi%3D10.3390%2Fmolecules191219935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Groot, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omuro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloughesy, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haidar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligon, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prados, M.</span></span> <span> </span><span class="NLM_article-title">Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an ivy foundation early phase clinical trials consortium phase II study</span>. <i>Neuro Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nov245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1093%2Fneuonc%2Fnov245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26449250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC28zgtVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=557-564&author=N.+Butowskiauthor=H.+Colmanauthor=J.+F.+De-Grootauthor=A.+M.+Omuroauthor=L.+Nayakauthor=P.+Y.+Wenauthor=T.+F.+Cloughesyauthor=A.+Marimuthuauthor=S.+Haidarauthor=A.+Perryauthor=J.+Huseauthor=J.+Phillipsauthor=B.+L.+Westauthor=K.+B.+Nolopauthor=H.+H.+Hsuauthor=K.+L.+Ligonauthor=A.+M.+Molinaroauthor=M.+Prados&title=Orally+administered+colony+stimulating+factor+1+receptor+inhibitor+PLX3397+in+recurrent+glioblastoma%3A+an+ivy+foundation+early+phase+clinical+trials+consortium+phase+II+study&doi=10.1093%2Fneuonc%2Fnov245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study</span></div><div class="casAuthors">Butowski Nicholas; Colman Howard; De Groot John F; Omuro Antonio M; Nayak Lakshmi; Wen Patrick Y; Cloughesy Timothy F; Marimuthu Adhirai; Haidar Sam; Perry Arie; Huse Jason; Phillips Joanna; West Brian L; Nolop Keith B; Hsu Henry H; Ligon Keith L; Molinaro Annette M; Prados Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">557-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The colony stimulating factor 1 receptor (CSF1R) ligands, CSF1 and interleukin-34, and the KIT ligand, stem cell factor, are expressed in glioblastoma (GB).  Microglia, macrophages, blood vessels, and tumor cells also express CSF1R, and depletion of the microglia reduces tumor burden and invasive capacity.  PLX3397 is an oral, small molecule that selectively inhibits CSF1R and KIT, penetrates the blood-brain barrier in model systems, and represents a novel approach for clinical development.  METHODS:  We conducted a phase II study in patients with recurrent GB.  The primary endpoint was 6-month progression-free survival (PFS6).  Secondary endpoints included overall survival response rate, safety, and plasma/tumor tissue pharmacokinetics.  Exploratory endpoints included pharmacodynamic measures of drug effect in blood and tumor tissue.  RESULTS:  A total of 37 patients were enrolled, with 13 treated prior to a planned surgical resection (Cohort 1) and 24 treated without surgery (Cohort 2).  PLX3397 was given at an oral dose of 1000 mg daily and was well tolerated.  The primary efficacy endpoint of PFS6 was only 8.6%, with no objective responses.  Pharmacokinetic endpoints revealed a median maximal concentration (Cmax) of 8090 ng/mL, with a time to attain Cmax of 2 hour in plasma.  Tumor tissue obtained after 7 days of drug exposure revealed a median drug level of 5500 ng/g.  Pharmacodynamic changes included an increase in colony stimulating factor 1 and reduced CD14(dim)/CD16+ monocytes in plasma compared with pretreatment baseline values.  CONCLUSION:  PLX3397 was well tolerated and readily crossed the blood-tumor barrier but showed no efficacy.  Additional studies are ongoing, testing combination strategies and potential biomarkers to identify patients with greater likelihood of response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMYyE8XOr7HrBItaL1WaVAfW6udTcc2eb6DXi7Y54AlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zgtVOgsA%253D%253D&md5=0c56fb5d3fabf8da99529f1311f9bb2d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnov245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnov245%26sid%3Dliteratum%253Aachs%26aulast%3DButowski%26aufirst%3DN.%26aulast%3DColman%26aufirst%3DH.%26aulast%3DDe-Groot%26aufirst%3DJ.%2BF.%26aulast%3DOmuro%26aufirst%3DA.%2BM.%26aulast%3DNayak%26aufirst%3DL.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DHaidar%26aufirst%3DS.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DHuse%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DJ.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DNolop%26aufirst%3DK.%2BB.%26aulast%3DHsu%26aufirst%3DH.%2BH.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DMolinaro%26aufirst%3DA.%2BM.%26aulast%3DPrados%26aufirst%3DM.%26atitle%3DOrally%2520administered%2520colony%2520stimulating%2520factor%25201%2520receptor%2520inhibitor%2520PLX3397%2520in%2520recurrent%2520glioblastoma%253A%2520an%2520ivy%2520foundation%2520early%2520phase%2520clinical%2520trials%2520consortium%2520phase%2520II%2520study%26jtitle%3DNeuro%2520Oncol.%26date%3D2016%26volume%3D18%26spage%3D557%26epage%3D564%26doi%3D10.1093%2Fneuonc%2Fnov245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tap, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainberg, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healey, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmielowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staddon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanftner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterfy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong-Starksen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1411366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1056%2FNEJMoa1411366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26222558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=428-437&author=W.+D.+Tapauthor=Z.+A.+Wainbergauthor=S.+P.+Anthonyauthor=P.+N.+Ibrahimauthor=C.+Zhangauthor=J.+H.+Healeyauthor=B.+Chmielowskiauthor=A.+P.+Staddonauthor=A.+L.+Cohnauthor=G.+I.+Shapiroauthor=V.+L.+Keedyauthor=A.+S.+Singhauthor=I.+Puzanovauthor=E.+L.+Kwakauthor=A.+J.+Wagnerauthor=D.+D.+Von+Hoffauthor=G.+J.+Weissauthor=R.+K.+Ramanathanauthor=J.+Zhangauthor=G.+Habetsauthor=Y.+Zhangauthor=E.+A.+Burtonauthor=G.+Visorauthor=L.+Sanftnerauthor=P.+Seversonauthor=H.+Nguyenauthor=M.+J.+Kimauthor=A.+Marimuthuauthor=G.+Tsangauthor=R.+Shellooeauthor=C.+Geeauthor=B.+L.+Westauthor=P.+Hirthauthor=K.+Nolopauthor=M.+van+de+Rijnauthor=H.+H.+Hsuauthor=C.+Peterfyauthor=P.+S.+Linauthor=S.+Tong-Starksenauthor=G.+Bollag&title=Structure-guided+blockade+of+CSF1R+kinase+in+tenosynovial+giant-cell+tumor&doi=10.1056%2FNEJMoa1411366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span></div><div class="casAuthors">Tap, W. D.; Wainberg, Z. A.; Anthony, S. P.; Ibrahim, P. N.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Staddon, A. P.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; Singh, A. S.; Puzanov, I.; Kwak, E. L.; Wagner, A. J.; Von Hoff, D. D.; Weiss, G. J.; Ramanathan, R. K.; Zhang, J.; Habets, G.; Zhang, Y.; Burton, E. A.; Visor, G.; Sanftner, L.; Severson, P.; Nguyen, H.; Kim, M. J.; Marimuthu, A.; Tsang, G.; Shellooe, R.; Gee, C.; West, B. L.; Hirth, P.; Nolop, K.; van de Rijn, M.; Hsu, H. H.; Peterfy, C.; Lin, P. S.; Tong-Starksen, S.; Bollag, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-437</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Expression of the colony-stimulating factor 1 (CSF1) gene is elevated in most tenosynovial giant-cell tumors.  This observation has led to the discovery and clin. development of therapy targeting the CSF1 receptor (CSF1R).  METHODS Using x-ray co-crystallog. to guide our drug-discovery research, we generated a potent, selective CSF1R inhibitor, PLX3397, that traps the kinase in the autoinhibited conformation.  We then conducted a multicenter, phase 1 trial in two parts to analyze this compd.  In the first part, we evaluated escalations in the dose of PLX3397 that was administered orally in patients with solid tumors (doseescalation study).  In the second part, we evaluated PLX3397 at the chosen phase 2 dose in an extension cohort of patients with tenosynovial giant-cell tumors (extension study).  Pharmacokinetic and tumor responses in the enrolled patients were assessed, and CSF1 in situ hybridization was performed to confirm the mechanism of action of PLX3397 and that the pattern of CSF1 expression was consistent with the pathol. features of tenosynovial giant-cell tumor.  RESULTS A total of 41 patients were enrolled in the dose-escalation study, and an addnl. 23 patients were enrolled in the extension study.  The chosen phase 2 dose of PLX3397 was 1000 mg per day.  In the extension study, 12 patients with tenosynovial giant-cell tumors had a partial response and 7 patients had stable disease.  Responses usually occurred within the first 4 mo of treatment, and the median duration of response exceeded 8 mo.  The most common adverse events included fatigue, change in hair color, nausea, dysgeusia, and periorbital edema; adverse events rarely led to discontinuation of treatment.  CONCLUSIONS Treatment of tenosynovial giant-cell tumors with PLX3397 resulted in a prolonged regression in tumor vol. in most patients. (Funded by Plexxikon; ClinicalTrials.gov no., NCT01004861.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgftPP4lKlQrVg90H21EOLACvtfcHk0ljiUU9Etcz5RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN&md5=5e822a87786aca7495222e3d18f82bdb</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1411366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1411366%26sid%3Dliteratum%253Aachs%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DChmielowski%26aufirst%3DB.%26aulast%3DStaddon%26aufirst%3DA.%2BP.%26aulast%3DCohn%26aufirst%3DA.%2BL.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DKeedy%26aufirst%3DV.%2BL.%26aulast%3DSingh%26aufirst%3DA.%2BS.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DVisor%26aufirst%3DG.%26aulast%3DSanftner%26aufirst%3DL.%26aulast%3DSeverson%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DGee%26aufirst%3DC.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DH.%2BH.%26aulast%3DPeterfy%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DTong-Starksen%26aufirst%3DS.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DStructure-guided%2520blockade%2520of%2520CSF1R%2520kinase%2520in%2520tenosynovial%2520giant-cell%2520tumor%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D428%26epage%3D437%26doi%3D10.1056%2FNEJMoa1411366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chabner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richon, V.</span></span> <span> </span><span class="NLM_article-title">Structural approaches to cancer drug development</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1056/NEJMp1503567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1056%2FNEJMp1503567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26222556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=402-403&author=B.+Chabnerauthor=V.+Richon&title=Structural+approaches+to+cancer+drug+development&doi=10.1056%2FNEJMp1503567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structural approaches to cancer drug development</span></div><div class="casAuthors">Chabner, Bruce; Richon, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">402-403</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZO7m2NM9v5bVg90H21EOLACvtfcHk0ljiUU9Etcz5RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvP&md5=7d242767e6a378e972fabae3233393fe</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1503567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1503567%26sid%3Dliteratum%253Aachs%26aulast%3DChabner%26aufirst%3DB.%26aulast%3DRichon%26aufirst%3DV.%26atitle%3DStructural%2520approaches%2520to%2520cancer%2520drug%2520development%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D402%26epage%3D403%26doi%3D10.1056%2FNEJMp1503567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coniglio, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugenin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrenis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segall, J. E.</span></span> <span> </span><span class="NLM_article-title">Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.2119/molmed.2011.00217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.2119%2Fmolmed.2011.00217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22294205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFent7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=519-527&author=S.+J.+Coniglioauthor=E.+Eugeninauthor=K.+Dobrenisauthor=E.+R.+Stanleyauthor=B.+L.+Westauthor=M.+H.+Symonsauthor=J.+E.+Segall&title=Microglial+stimulation+of+glioblastoma+invasion+involves+epidermal+growth+factor+receptor+%28EGFR%29+and+colony+stimulating+factor+1+receptor+%28CSF-1R%29+signaling&doi=10.2119%2Fmolmed.2011.00217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling</span></div><div class="casAuthors">Coniglio, Salvatore J.; Eugenin, Eliseo; Dobrenis, Kostantin; Stanley, E. Richard; West, Brian L.; Symons, Marc H.; Segall, Jeffrey E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Glioblastoma multiforme is a deadly cancer for which current treatment options are limited.  The ability of glioblastoma tumor cells to infiltrate the surrounding brain parenchyma critically limits the effectiveness of current treatments.  We investigated how microglia, the resident macrophages of the brain, stimulate glioblastoma cell invasion.  We first examd. the ability of normal microglia from C57Bl/6J mice to stimulate GL261 glioblastoma cell invasion in vitro.  We found that microglia stimulate the invasion of GL261 glioblastoma cells by approx. 8-fold in an in vitro invasion assay.  Pharmacol. inhibition of epidermal growth factor receptor (EGFR) strongly inhibited microglia-stimulated invasion.  Furthermore, blockade of colony stimulating factor 1 receptor (CSF-1R) signaling using RNA interference or pharmacol. inhibitors completely inhibited microglial enhancement of glioblastoma invasion.  GL261 cells were found to constitutively secrete CSF-1, the levels of which were unaffected by epidermal growth factor (EGF) stimulation, EGFR inhibition or coculture with microglia.  CSF-1 only stimulated microglia invasion, whereas EGF only stimulated glioblastoma cell migration, demonstrating a synergistic interaction between these 2 cell types.  Finally, using PLX3397 (a CSF-1R inhibitor that can cross the blood-brain barrier) in live animals, we discovered that blockade of CSF-1R signaling in vivo reduced the no. of tumor-assocd. microglia and glioblastoma invasion.  These data indicate that glioblastoma and microglia interactions mediated by EGF and CSF-1 can enhance glioblastoma invasion and demonstrate the possibility of inhibiting glioblastoma invasion by targeting glioblastoma-assocd. microglia via inhibition of the CSF-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWCOfXV2VsbVg90H21EOLACvtfcHk0ljiUU9Etcz5RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFent7Y%253D&md5=eab4e226beff6aeeabc138961b597cdc</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00217%26sid%3Dliteratum%253Aachs%26aulast%3DConiglio%26aufirst%3DS.%2BJ.%26aulast%3DEugenin%26aufirst%3DE.%26aulast%3DDobrenis%26aufirst%3DK.%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DSymons%26aufirst%3DM.%2BH.%26aulast%3DSegall%26aufirst%3DJ.%2BE.%26atitle%3DMicroglial%2520stimulation%2520of%2520glioblastoma%2520invasion%2520involves%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520colony%2520stimulating%2520factor%25201%2520receptor%2520%2528CSF-1R%2529%2520signaling%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D519%26epage%3D527%26doi%3D10.2119%2Fmolmed.2011.00217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drew, L.</span>; <span class="NLM_string-name">Bell, K.</span>; <span class="NLM_string-name">Dakin, L.</span>; <span class="NLM_string-name">Hattersley, M.</span>; <span class="NLM_string-name">Lawson, D.</span>; <span class="NLM_string-name">Repik, G.</span>; <span class="NLM_string-name">Scott, D.</span>; <span class="NLM_string-name">Shen, M.</span>; <span class="NLM_string-name">Omer, C.</span></span> <span> </span><span class="NLM_article-title">The selective CSF-1R inhibitor AZ683 reduces tumor associated macrophages and inhibits growth of breast cancer xenograft models</span>. In  <i>AACR Annual Meeting: Tumor Biology, 2009, Apr 18–22, Denver, CO</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2009</span>;  <span class="NLM_fpage">259</span>, <a href="http://cancerres.aacrjournals.org/content/69/9_Supplement/259" class="extLink">http://cancerres.aacrjournals.org/content/69/9_Supplement/259</a> (accessed Dec 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=259&author=L.+Drew&author=K.+Bell&author=L.+Dakin&author=M.+Hattersley&author=D.+Lawson&author=G.+Repik&author=D.+Scott&author=M.+Shen&author=C.+Omer&title=The+selective+CSF-1R+inhibitor+AZ683+reduces+tumor+associated+macrophages+and+inhibits+growth+of+breast+cancer+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDrew%26aufirst%3DL.%26atitle%3DThe%2520selective%2520CSF-1R%2520inhibitor%2520AZ683%2520reduces%2520tumor%2520associated%2520macrophages%2520and%2520inhibits%2520growth%2520of%2520breast%2520cancer%2520xenograft%2520models%26jtitle%3DAACR%2520Annual%2520Meeting%253A%2520Tumor%2520Biology%252C%25202009%252C%2520Apr%252018%25E2%2580%259322%252C%2520Denver%252C%2520CO%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2009%26spage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Valle, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezhuthachan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogoe, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmond, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span> <span> </span><span class="NLM_article-title">Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4591</span>– <span class="NLM_lpage">4596</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bmcl.2013.06.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23842474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ltbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4591-4596&author=D.+A.+Scottauthor=L.+A.+Dakinauthor=K.+Dalyauthor=D.+J.+Del+Valleauthor=R.+B.+Dieboldauthor=L.+Drewauthor=J.+Ezhuthachanauthor=T.+W.+Geroauthor=C.+A.+Ogoeauthor=C.+A.+Omerauthor=S.+P.+Redmondauthor=G.+Repikauthor=K.+Thakurauthor=Q.+Yeauthor=X.+Zheng&title=Mitigation+of+cardiovascular+toxicity+in+a+series+of+CSF-1R+inhibitors%2C+and+the+identification+of+AZD7507&doi=10.1016%2Fj.bmcl.2013.06.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507</span></div><div class="casAuthors">Scott, David A.; Dakin, Les A.; Daly, Kevin; Del Valle, David J.; Diebold, R. Bruce; Drew, Lisa; Ezhuthachan, Jayachandran; Gero, Thomas W.; Ogoe, Claude A.; Omer, Charles A.; Redmond, Sean P.; Repik, Galina; Thakur, Kumar; Ye, Qing; Zheng, Xiaolan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4591-4596</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The potent and selective 3-amido-4-anilinoquinoline CSF-1R inhibitor AZ683 suffered from cardiovascular liabilities, which were linked to the off-target activities of the compd. and ion channel activity in particular.  Less basic and less lipophilic examples from both the quinoline and cinnoline series demonstrated cleaner secondary pharmacol. profiles.  Cinnoline 31 retained the required potency and oral PK profile, and was progressed through the safety screening cascade to be nominated into development as AZD7507.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBUarwHmu2-rVg90H21EOLACvtfcHk0li149qzt8dh2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ltbjO&md5=7ffab262014fea03ff82233b1b45e21a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.031%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDaly%26aufirst%3DK.%26aulast%3DDel%2BValle%26aufirst%3DD.%2BJ.%26aulast%3DDiebold%26aufirst%3DR.%2BB.%26aulast%3DDrew%26aufirst%3DL.%26aulast%3DEzhuthachan%26aufirst%3DJ.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DOgoe%26aufirst%3DC.%2BA.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DRedmond%26aufirst%3DS.%2BP.%26aulast%3DRepik%26aufirst%3DG.%26aulast%3DThakur%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26atitle%3DMitigation%2520of%2520cardiovascular%2520toxicity%2520in%2520a%2520series%2520of%2520CSF-1R%2520inhibitors%252C%2520and%2520the%2520identification%2520of%2520AZD7507%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4591%26epage%3D4596%26doi%3D10.1016%2Fj.bmcl.2013.06.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boulter, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtacha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgway, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rooijen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigmore, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, S. J.</span></span> <span> </span><span class="NLM_article-title">WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1172/JCI76452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1172%2FJCI76452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1269-1285&author=L.+Boulterauthor=R.+V.+Guestauthor=T.+J.+Kendallauthor=D.+H.+Wilsonauthor=D.+Wojtachaauthor=A.+J.+Robsonauthor=R.+A.+Ridgwayauthor=K.+Samuelauthor=N.+Van+Rooijenauthor=S.+T.+Barryauthor=S.+J.+Wigmoreauthor=O.+J.+Sansomauthor=S.+J.+Forbes&title=WNT+signaling+drives+cholangiocarcinoma+growth+and+can+be+pharmacologically+inhibited&doi=10.1172%2FJCI76452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1172%2FJCI76452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI76452%26sid%3Dliteratum%253Aachs%26aulast%3DBoulter%26aufirst%3DL.%26aulast%3DGuest%26aufirst%3DR.%2BV.%26aulast%3DKendall%26aufirst%3DT.%2BJ.%26aulast%3DWilson%26aufirst%3DD.%2BH.%26aulast%3DWojtacha%26aufirst%3DD.%26aulast%3DRobson%26aufirst%3DA.%2BJ.%26aulast%3DRidgway%26aufirst%3DR.%2BA.%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DVan%2BRooijen%26aufirst%3DN.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DWigmore%26aufirst%3DS.%2BJ.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DForbes%26aufirst%3DS.%2BJ.%26atitle%3DWNT%2520signaling%2520drives%2520cholangiocarcinoma%2520growth%2520and%2520can%2520be%2520pharmacologically%2520inhibited%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26spage%3D1269%26epage%3D1285%26doi%3D10.1172%2FJCI76452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepomuceno, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, A. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooks, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMannus, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holladay, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Abstract 903: AC708 is a potent and selective inhibitor of CSF1R and reduces tumor associated macrophage infiltration in a breast tumor model</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">903</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2013-903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1538-7445.AM2013-903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=903&author=R.+C.+Armstrongauthor=B.+Belliauthor=M.+W.+Rowbottomauthor=R.+R.+Nepomucenoauthor=A.+Q.+Daoauthor=A.+M.+Rooksauthor=D.+Brighamauthor=C.+W.+McMannusauthor=M.+D.+Hockerauthor=M.+W.+Holladayauthor=G.+Liu&title=Abstract+903%3A+AC708+is+a+potent+and+selective+inhibitor+of+CSF1R+and+reduces+tumor+associated+macrophage+infiltration+in+a+breast+tumor+model&doi=10.1158%2F1538-7445.AM2013-903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2013-903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2013-903%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DBelli%26aufirst%3DB.%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DNepomuceno%26aufirst%3DR.%2BR.%26aulast%3DDao%26aufirst%3DA.%2BQ.%26aulast%3DRooks%26aufirst%3DA.%2BM.%26aulast%3DBrigham%26aufirst%3DD.%26aulast%3DMcMannus%26aufirst%3DC.%2BW.%26aulast%3DHocker%26aufirst%3DM.%2BD.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DAbstract%2520903%253A%2520AC708%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520CSF1R%2520and%2520reduces%2520tumor%2520associated%2520macrophage%2520infiltration%2520in%2520a%2520breast%2520tumor%2520model%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D903%26doi%3D10.1158%2F1538-7445.AM2013-903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, Y. A.</span>; <span class="NLM_string-name">Pradeep, S.</span>; <span class="NLM_string-name">Hansen, J. M.</span>; <span class="NLM_string-name">Wagner, M. J.</span>; <span class="NLM_string-name">Dood, R. L.</span>; <span class="NLM_string-name">Wu, S.
Y.</span>; <span class="NLM_string-name">Previs, R.
A.</span>; <span class="NLM_string-name">Hu, W.</span>; <span class="NLM_string-name">Coleman, R. L.</span>; <span class="NLM_string-name">Sood, A. K.</span></span> <span> </span><span class="NLM_article-title">Less is more: macrophage depletion via CSF1/CSF1R pathway improves anti-VEGF therapy after adaptive resistance</span>. In  <i>AACR Annual Meeting: Tumor Biology, 2017 April 1–5, Washington, DC</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2017</span>;  <span class="NLM_fpage">788</span>, <a href="http://cancerres.aacrjournals.org/content/77/13_Supplement/788" class="extLink">http://cancerres.aacrjournals.org/content/77/13_Supplement/788</a> (Accessed Dec 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=788&author=Y.+A.+Lyons&author=S.+Pradeep&author=J.+M.+Hansen&author=M.+J.+Wagner&author=R.+L.+Dood&author=S.%0AY.+Wu&author=R.%0AA.+Previs&author=W.+Hu&author=R.+L.+Coleman&author=A.+K.+Sood&title=Less+is+more%3A+macrophage+depletion+via+CSF1%2FCSF1R+pathway+improves+anti-VEGF+therapy+after+adaptive+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DLyons%26aufirst%3DY.%2BA.%26atitle%3DLess%2520is%2520more%253A%2520macrophage%2520depletion%2520via%2520CSF1%252FCSF1R%2520pathway%2520improves%2520anti-VEGF%2520therapy%2520after%2520adaptive%2520resistance%26jtitle%3DAACR%2520Annual%2520Meeting%253A%2520Tumor%2520Biology%252C%25202017%2520April%25201%25E2%2580%25935%252C%2520Washington%252C%2520DC%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2017%26spage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span> </span><span class="NLM_article-title">ARRY-382</span>.  <i>ClinicalTrials.gov</i>: <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=ARRY-382&amp;cntry1=&amp;state1=&amp;Search=Search" class="extLink">hhttps://clinicaltrials.gov/ct2/results?cond=&term=ARRY-382&cntry=&state=&city=&dist=</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ARRY-382.+ClinicalTrials.gov%3A+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3B+hhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fcond%3D%26term%3DARRY-382%26cntry%3D%26state%3D%26city%3D%26dist%3D+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DARRY-382%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J.</span>; <span class="NLM_string-name">Tolcher, A. W.</span>; <span class="NLM_string-name">Jones, S.</span>; <span class="NLM_string-name">Beeram, M.</span>; <span class="NLM_string-name">Infante, J.</span>; <span class="NLM_string-name">Larsen, P.</span>; <span class="NLM_string-name">Rasor, K.</span>; <span class="NLM_string-name">Garrus, J. E.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Cable, P. L.</span>; <span class="NLM_string-name">Eberhardt, C.</span>; <span class="NLM_string-name">Schreiber, J.</span>; <span class="NLM_string-name">Rush, S.</span>; <span class="NLM_string-name">Wood, K. W.</span>; <span class="NLM_string-name">Barrett, E.</span>; <span class="NLM_string-name">Patnaik, A.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers</span>. In  <i>AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Boston, MA, October 19–23 2013</i>; <span class="NLM_publisher-name">Array Biopharma</span>: <span class="NLM_publisher-loc">Boulder, CO</span>, <span class="NLM_year">2013</span>; <a href="http://www.arraybiopharma.com/files/3014/4501/8593/382-101_AACR-NCI-EORTC_poster.pdf" class="extLink">http://www.arraybiopharma.com/files/3014/4501/8593/382-101_AACR-NCI-EORTC_poster.pdf</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+Bendell&author=A.+W.+Tolcher&author=S.+Jones&author=M.+Beeram&author=J.+Infante&author=P.+Larsen&author=K.+Rasor&author=J.+E.+Garrus&author=J.+Li&author=P.+L.+Cable&author=C.+Eberhardt&author=J.+Schreiber&author=S.+Rush&author=K.+W.+Wood&author=E.+Barrett&author=A.+Patnaik&title=A+phase+1+study+of+ARRY-382%2C+an+oral+inhibitor+of+colony-stimulating+factor-1+receptor+%28CSF1R%29%2C+in+patients+with+advanced+or+metastatic+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBendell%26aufirst%3DJ.%26atitle%3DA%2520phase%25201%2520study%2520of%2520ARRY-382%252C%2520an%2520oral%2520inhibitor%2520of%2520colony-stimulating%2520factor-1%2520receptor%2520%2528CSF1R%2529%252C%2520in%2520patients%2520with%2520advanced%2520or%2520metastatic%2520cancers%26jtitle%3DAACR-NCI-EORTC%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%252C%2520Boston%252C%2520MA%252C%2520October%252019%25E2%2580%259323%25202013%26pub%3DArray%2520Biopharma%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, N.
N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafi, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayala, K. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, M. R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">139</span>, <span class="refDoi"> DOI: 10.1186/s12974-015-0366-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1186%2Fs12974-015-0366-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26232154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FpsFOltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=139&author=N.%0AN.+Dagherauthor=A.+R.+Najafiauthor=K.+M.+N.+Kayalaauthor=M.+R.+P.+Elmoreauthor=T.+E.+Whiteauthor=R.+Medeirosauthor=B.+L.+Westauthor=K.+N.+Green&title=Colony-stimulating+factor+1+receptor+inhibition+prevents+microglial+plaque+association+and+improves+cognition+in+3xTg-AD+mice&doi=10.1186%2Fs12974-015-0366-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice</span></div><div class="casAuthors">Dagher Nabil N; Najafi Allison R; Kayala Kara M Neely; Elmore Monica R P; White Terra E; Medeiros Rodrigo; Green Kim N; West Brian L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">139</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Microglia are dependent upon colony-stimulating factor 1 receptor (CSF1R) signaling for their survival in the adult brain, with administration of the dual CSF1R/c-kit inhibitor PLX3397 leading to the near-complete elimination of all microglia brainwide.  Here, we determined the dose-dependent effects of a specific CSF1R inhibitor (PLX5622) on microglia in both wild-type and the 3xTg-AD mouse model of Alzheimer's disease.  METHODS:  Wild-type mice were treated with PLX5622 for up to 21 days, and the effects on microglial numbers were assessed. 3xTg-AD mice were treated with PLX5622 for 6 or 12 weeks and effects on microglial numbers and pathology subsequently assessed.  RESULTS:  High doses of CSF1R inhibitor eliminate most microglia from the brain, but a 75% lower-dose results in sustained elimination of ~30 of microglia in both wild-type and 3xTg-AD mice.  No behavioral or cognitive deficits were found in mice either depleted of microglia or treated with lower CSF1R inhibitor concentrations.  Aged 3xTg-AD mice treated for 6 or 12 weeks with lower levels of PLX5622 resulted in improved learning and memory.  Aβ levels and plaque loads were not altered, but microglia in treated mice no longer associated with plaques, revealing a role for the CSF1R in the microglial reaction to plaques, as well as in mediating cognitive deficits.  CONCLUSIONS:  We find that inhibition of CSF1R alone is sufficient to eliminate microglia and that sustained microglial elimination is concentration-dependent.  Inhibition of the CSF1R at lower levels in 3xTg-AD mice prevents microglial association with plaques and improves cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCV4bMy2gP3Rjv2lLSLOxFfW6udTcc2eb7JgXHw08l17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FpsFOltg%253D%253D&md5=2622ddfc1dcdef4cdb98333711138875</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1186%2Fs12974-015-0366-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-015-0366-9%26sid%3Dliteratum%253Aachs%26aulast%3DDagher%26aufirst%3DN.%2BN.%26aulast%3DNajafi%26aufirst%3DA.%2BR.%26aulast%3DKayala%26aufirst%3DK.%2BM.%2BN.%26aulast%3DElmore%26aufirst%3DM.%2BR.%2BP.%26aulast%3DWhite%26aufirst%3DT.%2BE.%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26atitle%3DColony-stimulating%2520factor%25201%2520receptor%2520inhibition%2520prevents%2520microglial%2520plaque%2520association%2520and%2520improves%2520cognition%2520in%25203xTg-AD%2520mice%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2015%26volume%3D12%26spage%3D139%26doi%3D10.1186%2Fs12974-015-0366-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valdearcos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robblee, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koliwad, S. K.</span></span> <span> </span><span class="NLM_article-title">Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2124</span>– <span class="NLM_lpage">2138</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.celrep.2014.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25497089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKnurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2124-2138&author=M.+Valdearcosauthor=M.+M.+Robbleeauthor=D.+I.+Benjaminauthor=D.+K.+Nomuraauthor=A.+W.+Xuauthor=S.+K.+Koliwad&title=Microglia+dictate+the+impact+of+saturated+fat+consumption+on+hypothalamic+inflammation+and+neuronal+function&doi=10.1016%2Fj.celrep.2014.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia Dictate the Impact of Saturated Fat Consumption on Hypothalamic Inflammation and Neuronal Function</span></div><div class="casAuthors">Valdearcos, Martin; Robblee, Megan M.; Benjamin, Daniel I.; Nomura, Daniel K.; Xu, Allison W.; Koliwad, Suneil K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2124-2138</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diets rich in satd. fat produce inflammation, gliosis, and neuronal stress in the mediobasal hypothalamus (MBH).  Here, we show that microglia mediate this process and its functional impact.  Although microglia and astrocytes accumulate in the MBH of mice fed a diet rich in satd. fatty acids (SFAs), only the microglia undergo inflammatory activation, along with a buildup of hypothalamic SFAs.  Enteric gavage specifically with SFAs reproduces microglial activation and neuronal stress in the MBH, and SFA treatment activates murine microglia, but not astrocytes, in culture.  Moreover, depleting microglia abrogates SFA-induced inflammation in hypothalamic slices.  Remarkably, depleting microglia from the MBH of mice abolishes inflammation and neuronal stress induced by excess SFA consumption, and in this context, microglial depletion enhances leptin signaling and reduces food intake.  We thus show that microglia sense SFAs and orchestrate an inflammatory process in the MBH that alters neuronal function when SFA consumption is high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYJWfvoB64Q7Vg90H21EOLACvtfcHk0ljxrmLRnR3pQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKnurnN&md5=a4172f43ff9120bc468717a9637c0a33</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DValdearcos%26aufirst%3DM.%26aulast%3DRobblee%26aufirst%3DM.%2BM.%26aulast%3DBenjamin%26aufirst%3DD.%2BI.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DXu%26aufirst%3DA.%2BW.%26aulast%3DKoliwad%26aufirst%3DS.%2BK.%26atitle%3DMicroglia%2520dictate%2520the%2520impact%2520of%2520saturated%2520fat%2520consumption%2520on%2520hypothalamic%2520inflammation%2520and%2520neuronal%2520function%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D2124%26epage%3D2138%26doi%3D10.1016%2Fj.celrep.2014.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosi, S.</span></span> <span> </span><span class="NLM_article-title">Targeting colony stimulating factor 1 receptor to prevent cognitive deficits induced by fractionated whole-brain irradiation</span>. <i>Neural Regener. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.4103/1673-5374.202940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4103%2F1673-5374.202940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=28469650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC1crjvValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=399-400&author=X.+Fengauthor=S.+Rosi&title=Targeting+colony+stimulating+factor+1+receptor+to+prevent+cognitive+deficits+induced+by+fractionated+whole-brain+irradiation&doi=10.4103%2F1673-5374.202940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting colony stimulating factor 1 receptor to prevent cognitive deficits induced by fractionated whole-brain irradiation</span></div><div class="casAuthors">Feng Xi; Rosi Susanna</div><div class="citationInfo"><span class="NLM_cas:title">Neural regeneration research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-400</span>
        ISSN:<span class="NLM_cas:issn">1673-5374</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTR7Fmzqo3OT3WEEzDrymxmfW6udTcc2eaLCt2RThkufbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjvValuw%253D%253D&md5=b07ff72f5c3be20b5a7486bad359f38f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.4103%2F1673-5374.202940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F1673-5374.202940%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DRosi%26aufirst%3DS.%26atitle%3DTargeting%2520colony%2520stimulating%2520factor%25201%2520receptor%2520to%2520prevent%2520cognitive%2520deficits%2520induced%2520by%2520fractionated%2520whole-brain%2520irradiation%26jtitle%3DNeural%2520Regener.%2520Res.%26date%3D2017%26volume%3D12%26spage%3D399%26epage%3D400%26doi%3D10.4103%2F1673-5374.202940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span>; <span class="NLM_string-name">Leary, C. B.</span>; <span class="NLM_string-name">Lu, W.-P.</span>; <span class="NLM_string-name">Kaufman, M. D.</span>; <span class="NLM_string-name">Flynn, D. L.</span></span> <span> </span><span class="NLM_article-title">The highly specific CSF1R inhibitor DCC-3014 exhibits immunomodulatory and anti-invasive activities in cancer models</span>. In  <i>AACR Annual Meeting: Cancer Chemistry 2016, April 16–20, New Orleans, LA</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span> <span class="NLM_year">2016</span>;  <span class="NLM_fpage">76</span>, <a href="http://cancerres.aacrjournals.org/content/76/14_Supplement/4889" class="extLink">http://cancerres.aacrjournals.org/content/76/14_Supplement/4889</a> (accessed Oct 21, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=76&author=B.+D.+Smith&author=C.+B.+Leary&author=W.-P.+Lu&author=M.+D.+Kaufman&author=D.+L.+Flynn&title=The+highly+specific+CSF1R+inhibitor+DCC-3014+exhibits+immunomodulatory+and+anti-invasive+activities+in+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BD.%26atitle%3DThe%2520highly%2520specific%2520CSF1R%2520inhibitor%2520DCC-3014%2520exhibits%2520immunomodulatory%2520and%2520anti-invasive%2520activities%2520in%2520cancer%2520models%26jtitle%3DAACR%2520Annual%2520Meeting%253A%2520Cancer%2520Chemistry%25202016%252C%2520April%252016%25E2%2580%259320%252C%2520New%2520Orleans%252C%2520LA%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2016%26spage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span> </span><span class="NLM_article-title">Study of DCC-3014
in Patients With Advanced Malignancies</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03069469" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03069469</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+DCC-3014%0Ain+Patients+With+Advanced+Malignancies.+ClinicalTrials.gov%3B+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03069469+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520of%2520DCC-3014%250Ain%2520Patients%2520With%2520Advanced%2520Malignancies%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waltham, M. A.</span></span> <i>Deciphera Pharmaceuticals Initiates a Phase 1 Clinical Trial of DCC-3014</i>; <span class="NLM_publisher-name">Deciphera Pharmaceuticals</span>: <span class="NLM_publisher-loc">Waltham, MA</span>, <span class="NLM_year">2014</span>; <a href="https://www.deciphera.com/?s=dcc-3014" class="extLink">https://www.deciphera.com/?s=dcc-3014</a> (Accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+A.+Waltham&title=Deciphera+Pharmaceuticals+Initiates+a+Phase+1+Clinical+Trial+of+DCC-3014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DWaltham%26aufirst%3DM.%2BA.%26jtitle%3DDeciphera%2520Pharmaceuticals%2520Initiates%2520a%2520Phase%25201%2520Clinical%2520Trial%2520of%2520DCC-3014%26pub%3DDeciphera%2520Pharmaceuticals%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Barbara Czako, Joseph. R. Marszalek, Jason P. Burke, Pijus Mandal, Paul G. Leonard, Jason B. Cross, Faika Mseeh, Yongying Jiang, Edward Q. Chang, Erika Suzuki, Jeffrey J. Kovacs, Ningping Feng, Sonal Gera, Angela L. Harris, Zhen Liu, Robert A. Mullinax, Jihai Pang, Connor A. Parker, Nakia D. Spencer, Simon S. Yu, Qi Wu, Martin R. Tremblay, Keith Mikule, Keith Wilcoxen, Timothy P. Heffernan, Giulio F. Draetta, <span class="NLM_string-name hlFld-ContribAuthor">Philip Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1R. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9888-9911. <a href="https://doi.org/10.1021/acs.jmedchem.0c00936" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00936</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00936%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BIACS-9439%25252C%252Ba%252BPotent%25252C%252BExquisitely%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitor%252Bof%252BCSF1R%26aulast%3DCzako%26aufirst%3DBarbara%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18062020%26date%3D18082020%26date%3D29072020%26volume%3D63%26issue%3D17%26spage%3D9888%26epage%3D9911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhicheng Xie, Bing Wu, Yingqiang Liu, Wenming Ren, Linjiang Tong, Caigui Xiang, Aihuan Wei, Yuanzhuo Gao, Limin Zeng, Hua Xie, Wei Tang, <span class="NLM_string-name hlFld-ContribAuthor">Youhong Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1397-1414. <a href="https://doi.org/10.1021/acs.jmedchem.9b01912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BClass%252Bof%252BColony-Stimulating%252BFactor%252B1%252BReceptor%252BKinase%252BInhibitors%252BBased%252Bon%252Ban%252Bo-Aminopyridyl%252BAlkynyl%252BScaffold%252Bas%252BPotential%252BTreatment%252Bfor%252BInflammatory%252BDisorders%26aulast%3DXie%26aufirst%3DZhicheng%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26112019%26date%3D14012020%26volume%3D63%26issue%3D3%26spage%3D1397%26epage%3D1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masamitsu  Tsukamoto</span>, <span class="hlFld-ContribAuthor ">Tadashi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hirohiko  Kimura</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Nakayama</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and application of trifluoromethylpyridines as a key structural motif in active agrochemical and pharmaceutical ingredients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pesticide Science</span><span> <strong>2021,</strong> <em>46 </em>
                                    (2)
                                     , 125-142. <a href="https://doi.org/10.1584/jpestics.D21-012" title="DOI URL">https://doi.org/10.1584/jpestics.D21-012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1584/jpestics.D21-012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1584%2Fjpestics.D21-012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pesticide%2520Science%26atitle%3DSynthesis%252Band%252Bapplication%252Bof%252Btrifluoromethylpyridines%252Bas%252Ba%252Bkey%252Bstructural%252Bmotif%252Bin%252Bactive%252Bagrochemical%252Band%252Bpharmaceutical%252Bingredients%26aulast%3DTsukamoto%26aufirst%3DMasamitsu%26date%3D2021%26volume%3D46%26issue%3D2%26spage%3D125%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoqing  Yang</span>, <span class="hlFld-ContribAuthor ">Yuqing  He</span>, <span class="hlFld-ContribAuthor ">Hao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">The involvement of bioactive factors in the self-renewal and stemness maintenance of spermatogonial stem cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biochemistry</span><span> <strong>2021,</strong> <em>476 </em>
                                    (4)
                                     , 1813-1823. <a href="https://doi.org/10.1007/s11010-020-04028-7" title="DOI URL">https://doi.org/10.1007/s11010-020-04028-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11010-020-04028-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11010-020-04028-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biochemistry%26atitle%3DThe%252Binvolvement%252Bof%252Bbioactive%252Bfactors%252Bin%252Bthe%252Bself-renewal%252Band%252Bstemness%252Bmaintenance%252Bof%252Bspermatogonial%252Bstem%252Bcells%26aulast%3DYang%26aufirst%3DGuoqing%26date%3D2021%26date%3D2021%26volume%3D476%26issue%3D4%26spage%3D1813%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Freuchet</span>, <span class="hlFld-ContribAuthor ">Apolline  Salama</span>, <span class="hlFld-ContribAuthor ">Séverine  Remy</span>, <span class="hlFld-ContribAuthor ">Carole  Guillonneau</span>, <span class="hlFld-ContribAuthor ">Ignacio  Anegon</span>. </span><span class="cited-content_cbyCitation_article-title">IL‐34 and CSF‐1, deciphering similarities and differences at steady state and in diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Leukocyte Biology</span><span> <strong>2021,</strong> <em>29 </em><a href="https://doi.org/10.1002/JLB.3RU1120-773R" title="DOI URL">https://doi.org/10.1002/JLB.3RU1120-773R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/JLB.3RU1120-773R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2FJLB.3RU1120-773R%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Leukocyte%2520Biology%26atitle%3DIL%2525E2%252580%25259034%252Band%252BCSF%2525E2%252580%2525901%25252C%252Bdeciphering%252Bsimilarities%252Band%252Bdifferences%252Bat%252Bsteady%252Bstate%252Band%252Bin%252Bdiseases%26aulast%3DFreuchet%26aufirst%3DAntoine%26date%3D2021%26date%3D2021%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule CSF1R kinase inhibitors; review of patents 2015-present. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (2)
                                     , 107-117. <a href="https://doi.org/10.1080/13543776.2021.1839414" title="DOI URL">https://doi.org/10.1080/13543776.2021.1839414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1839414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1839414%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BCSF1R%252Bkinase%252Binhibitors%25253B%252Breview%252Bof%252Bpatents%252B2015-present%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D2%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neng  Wang</span>, <span class="hlFld-ContribAuthor ">Shengqi  Wang</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yifeng  Zheng</span>, <span class="hlFld-ContribAuthor ">Bowen  Yang</span>, <span class="hlFld-ContribAuthor ">Juping  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Pan</span>, <span class="hlFld-ContribAuthor ">Jianli  Gao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Research trends in pharmacological modulation of tumor‐associated macrophages. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Medicine</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/ctm2.288" title="DOI URL">https://doi.org/10.1002/ctm2.288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ctm2.288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fctm2.288%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Medicine%26atitle%3DResearch%252Btrends%252Bin%252Bpharmacological%252Bmodulation%252Bof%252Btumor%2525E2%252580%252590associated%252Bmacrophages%26aulast%3DWang%26aufirst%3DNeng%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rawan M.  Sbenati</span>, <span class="hlFld-ContribAuthor ">Seyed-Omar  Zaraei</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Hamadeh  Tarazi</span>, <span class="hlFld-ContribAuthor ">Malaka M.  Zoghbor</span>, <span class="hlFld-ContribAuthor ">Najma A.  Mohamood</span>, <span class="hlFld-ContribAuthor ">Mahta M.  Khakpour</span>, <span class="hlFld-ContribAuthor ">Dana M.  Zaher</span>, <span class="hlFld-ContribAuthor ">Hany A.  Omar</span>, <span class="hlFld-ContribAuthor ">Nour N.  Alach</span>, <span class="hlFld-ContribAuthor ">Mahmoud K.  Shehata</span>, <span class="hlFld-ContribAuthor ">Randa  El-Gamal</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 113081. <a href="https://doi.org/10.1016/j.ejmech.2020.113081" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113081%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmodeling%252Bstudies%252Bof%252Bnovel%252Bconformationally-restricted%252Banalogues%252Bof%252Bsorafenib%252Bas%252Bselective%252Bkinase-inhibitory%252Bantiproliferative%252Bagents%252Bagainst%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DSbenati%26aufirst%3DRawan%2BM.%26date%3D2021%26volume%3D210%26spage%3D113081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huaqing  Mo</span>, <span class="hlFld-ContribAuthor ">Yanrong  Hao</span>, <span class="hlFld-ContribAuthor ">Yanru  Lv</span>, <span class="hlFld-ContribAuthor ">Zenan  Chen</span>, <span class="hlFld-ContribAuthor ">Jingyi  Shen</span>, <span class="hlFld-ContribAuthor ">Shu  Zhou</span>, <span class="hlFld-ContribAuthor ">MengJie  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer. </span><span class="cited-content_cbyCitation_journal-name">Medicine</span><span> <strong>2021,</strong> <em>100 </em>
                                    (12)
                                     , e25218. <a href="https://doi.org/10.1097/MD.0000000000025218" title="DOI URL">https://doi.org/10.1097/MD.0000000000025218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MD.0000000000025218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMD.0000000000025218%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%26atitle%3DOverexpression%252Bof%252Bmacrophage-colony%252Bstimulating%252Bfactor-1%252Breceptor%252Bas%252Ba%252Bprognostic%252Bfactor%252Bfor%252Bsurvival%252Bin%252Bcancer%26aulast%3DMo%26aufirst%3DHuaqing%26date%3D2021%26date%3D2021%26volume%3D100%26issue%3D12%26spage%3De25218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arisaí  Martínez-Martínez</span>, <span class="hlFld-ContribAuthor ">Enriqueta  Muñoz-Islas</span>, <span class="hlFld-ContribAuthor ">Martha B.  Ramírez-Rosas</span>, <span class="hlFld-ContribAuthor ">Rosa I.  Acosta-González</span>, <span class="hlFld-ContribAuthor ">Héctor F.  Torres-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Juan M.  Jiménez-Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Blockade of the colony-stimulating factor-1 receptor reverses bone loss in osteoporosis mouse models. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2020,</strong> <em>72 </em>
                                    (6)
                                     , 1614-1626. <a href="https://doi.org/10.1007/s43440-020-00091-5" title="DOI URL">https://doi.org/10.1007/s43440-020-00091-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s43440-020-00091-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs43440-020-00091-5%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DBlockade%252Bof%252Bthe%252Bcolony-stimulating%252Bfactor-1%252Breceptor%252Breverses%252Bbone%252Bloss%252Bin%252Bosteoporosis%252Bmouse%252Bmodels%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DArisa%25C3%25AD%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D6%26spage%3D1614%26epage%3D1626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naofumi  Uesato</span>, <span class="hlFld-ContribAuthor ">Koji  Inagaki</span>, <span class="hlFld-ContribAuthor ">Naoki  Miyagawa</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Kitagawa</span>, <span class="hlFld-ContribAuthor ">Reina  Kakefuda</span>, <span class="hlFld-ContribAuthor ">Yushi  Matsuo</span>, <span class="hlFld-ContribAuthor ">Takayuki  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Takahiro  Hata</span>, <span class="hlFld-ContribAuthor ">Kazutaka  Ikegashira</span>, <span class="hlFld-ContribAuthor ">Mutsuyoshi  Matsushita</span>. </span><span class="cited-content_cbyCitation_article-title">JTE-952 Suppresses Bone Destruction in Collagen-Induced Arthritis in Mice by Inhibiting Colony Stimulating Factor 1 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Biological and Pharmaceutical Bulletin</span><span> <strong>2020,</strong> <em>43 </em>
                                    (12)
                                     , 1884-1892. <a href="https://doi.org/10.1248/bpb.b20-00517" title="DOI URL">https://doi.org/10.1248/bpb.b20-00517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/bpb.b20-00517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fbpb.b20-00517%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DJTE-952%252BSuppresses%252BBone%252BDestruction%252Bin%252BCollagen-Induced%252BArthritis%252Bin%252BMice%252Bby%252BInhibiting%252BColony%252BStimulating%252BFactor%252B1%252BReceptor%26aulast%3DUesato%26aufirst%3DNaofumi%26date%3D2020%26volume%3D43%26issue%3D12%26spage%3D1884%26epage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olus  Uyar</span>, <span class="hlFld-ContribAuthor ">Nataly  Laflamme</span>, <span class="hlFld-ContribAuthor ">Jocelyne  Piret</span>, <span class="hlFld-ContribAuthor ">Marie-Christine  Venable</span>, <span class="hlFld-ContribAuthor ">Julie  Carbonneau</span>, <span class="hlFld-ContribAuthor ">Karima  Zarrouk</span>, <span class="hlFld-ContribAuthor ">Serge  Rivest</span>, <span class="hlFld-ContribAuthor ">Guy  Boivin</span>, . </span><span class="cited-content_cbyCitation_article-title">An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2020,</strong> <em>94 </em>
                                    (23)
                                     <a href="https://doi.org/10.1128/JVI.01428-20" title="DOI URL">https://doi.org/10.1128/JVI.01428-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.01428-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.01428-20%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DAn%252BEarly%252BMicroglial%252BResponse%252BIs%252BNeeded%252BTo%252BEfficiently%252BControl%252BHerpes%252BSimplex%252BVirus%252BEncephalitis%26aulast%3DUyar%26aufirst%3DOlus%26date%3D2020%26volume%3D94%26issue%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliane  Obst</span>, <span class="hlFld-ContribAuthor ">Emilie  Simon</span>, <span class="hlFld-ContribAuthor ">Maria  Martin-Estebane</span>, <span class="hlFld-ContribAuthor ">Elena  Pipi</span>, <span class="hlFld-ContribAuthor ">Liana M.  Barkwill</span>, <span class="hlFld-ContribAuthor ">Ivette  Gonzalez-Rivera</span>, <span class="hlFld-ContribAuthor ">Fergus  Buchanan</span>, <span class="hlFld-ContribAuthor ">Alan R.  Prescott</span>, <span class="hlFld-ContribAuthor ">Dorte  Faust</span>, <span class="hlFld-ContribAuthor ">Simon  Fox</span>, <span class="hlFld-ContribAuthor ">Janet  Brownlees</span>, <span class="hlFld-ContribAuthor ">Debra  Taylor</span>, <span class="hlFld-ContribAuthor ">V. Hugh  Perry</span>, <span class="hlFld-ContribAuthor ">Hugh  Nuthall</span>, <span class="hlFld-ContribAuthor ">Peter J.  Atkinson</span>, <span class="hlFld-ContribAuthor ">Eric  Karran</span>, <span class="hlFld-ContribAuthor ">Carol  Routledge</span>, <span class="hlFld-ContribAuthor ">Diego  Gomez-Nicola</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.579000" title="DOI URL">https://doi.org/10.3389/fimmu.2020.579000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.579000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.579000%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DInhibition%252Bof%252BIL-34%252BUnveils%252BTissue-Selectivity%252Band%252BIs%252BSufficient%252Bto%252BReduce%252BMicroglial%252BProliferation%252Bin%252Ba%252BModel%252Bof%252BChronic%252BNeurodegeneration%26aulast%3DObst%26aufirst%3DJuliane%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline L.  Benn</span>, <span class="hlFld-ContribAuthor ">Lee A.  Dawson</span>. </span><span class="cited-content_cbyCitation_article-title">Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnagi.2020.00242" title="DOI URL">https://doi.org/10.3389/fnagi.2020.00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2020.00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2020.00242%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DClinically%252BPrecedented%252BProtein%252BKinases%25253A%252BRationale%252Bfor%252BTheir%252BUse%252Bin%252BNeurodegenerative%252BDisease%26aulast%3DBenn%26aufirst%3DCaroline%2BL.%26date%3D2020%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Martin-Estebane</span>, <span class="hlFld-ContribAuthor ">Diego  Gomez-Nicola</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Microglial Population Dynamics in Alzheimer’s Disease: Are We Ready for a Potential Impact on Immune Function?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fncel.2020.00149" title="DOI URL">https://doi.org/10.3389/fncel.2020.00149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fncel.2020.00149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffncel.2020.00149%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520Neuroscience%26atitle%3DTargeting%252BMicroglial%252BPopulation%252BDynamics%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BAre%252BWe%252BReady%252Bfor%252Ba%252BPotential%252BImpact%252Bon%252BImmune%252BFunction%25253F%26aulast%3DMartin-Estebane%26aufirst%3DMaria%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Singleton</span>, <span class="hlFld-ContribAuthor ">Hussein  Bdair</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Sangho  Choi</span>, <span class="hlFld-ContribAuthor ">Arturo  Aliaga</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient radiosynthesis and preclinical evaluation of [
              18
              F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 144-150. <a href="https://doi.org/10.1002/jlcr.3827" title="DOI URL">https://doi.org/10.1002/jlcr.3827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3827%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DEfficient%252Bradiosynthesis%252Band%252Bpreclinical%252Bevaluation%252Bof%252B%25255B%252B18%252BF%25255DFOMPyD%252Bas%252Ba%252Bpositron%252Bemission%252Btomography%252Btracer%252Bcandidate%252Bfor%252BTrkB%25252FC%252Breceptor%252Bimaging%26aulast%3DSingleton%26aufirst%3DThomas%2BA.%26date%3D2020%26date%3D2020%26volume%3D63%26issue%3D3%26spage%3D144%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Li</span>, <span class="hlFld-ContribAuthor ">Shiqi  Kong</span>, <span class="hlFld-ContribAuthor ">Yingxiao  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">miR‐1254 inhibits progression of glioma in vivo and in vitro by targeting CSF‐1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2020,</strong> <em>24 </em>
                                    (5)
                                     , 3128-3138. <a href="https://doi.org/10.1111/jcmm.14981" title="DOI URL">https://doi.org/10.1111/jcmm.14981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.14981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.14981%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DmiR%2525E2%252580%2525901254%252Binhibits%252Bprogression%252Bof%252Bglioma%252Bin%252Bvivo%252Band%252Bin%252Bvitro%252Bby%252Btargeting%252BCSF%2525E2%252580%2525901%26aulast%3DLi%26aufirst%3DXin%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D5%26spage%3D3128%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anujan  Ramesh</span>, <span class="hlFld-ContribAuthor ">Sahana  Kumar</span>, <span class="hlFld-ContribAuthor ">Dipika  Nandi</span>, <span class="hlFld-ContribAuthor ">Ashish  Kulkarni</span>. </span><span class="cited-content_cbyCitation_article-title">CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials</span><span> <strong>2019,</strong> <em>31 </em>
                                    (51)
                                     , 1904364. <a href="https://doi.org/10.1002/adma.201904364" title="DOI URL">https://doi.org/10.1002/adma.201904364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adma.201904364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadma.201904364%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%26atitle%3DCSF1R%2525E2%252580%252590%252Band%252BSHP2%2525E2%252580%252590Inhibitor%2525E2%252580%252590Loaded%252BNanoparticles%252BEnhance%252BCytotoxic%252BActivity%252Band%252BPhagocytosis%252Bin%252BTumor%2525E2%252580%252590Associated%252BMacrophages%26aulast%3DRamesh%26aufirst%3DAnujan%26date%3D2019%26date%3D2019%26volume%3D31%26issue%3D51%26spage%3D1904364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed  El-Gamal</span>. </span><span class="cited-content_cbyCitation_article-title">Meet Our Editorial Board Member. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (8)
                                     , 961-961. <a href="https://doi.org/10.2174/187152061908190715141829" title="DOI URL">https://doi.org/10.2174/187152061908190715141829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/187152061908190715141829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F187152061908190715141829%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DMeet%252BOur%252BEditorial%252BBoard%252BMember%26aulast%3DEl-Gamal%26aufirst%3DMohammed%26date%3D2019%26volume%3D19%26issue%3D8%26spage%3D961%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin-fang  Wang</span>, <span class="hlFld-ContribAuthor ">Ya-juan  Wang</span>, <span class="hlFld-ContribAuthor ">Tong-ying  Li</span>, <span class="hlFld-ContribAuthor ">Jiang-xue  Guo</span>, <span class="hlFld-ContribAuthor ">Fang  Lv</span>, <span class="hlFld-ContribAuthor ">Cheng-li  Li</span>, <span class="hlFld-ContribAuthor ">Xing-tao  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2019,</strong> <em>115 </em>, 108916. <a href="https://doi.org/10.1016/j.biopha.2019.108916" title="DOI URL">https://doi.org/10.1016/j.biopha.2019.108916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2019.108916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2019.108916%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DColony-stimulating%252Bfactor%252B1%252Breceptor%252Binhibition%252Bprevents%252Bagainst%252Blipopolysaccharide%252B-induced%252Bosteoporosis%252Bby%252Binhibiting%252Bosteoclast%252Bformation%26aulast%3DWang%26aufirst%3DXin-fang%26date%3D2019%26volume%3D115%26spage%3D108916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.F.  Rai</span>, <span class="hlFld-ContribAuthor ">E.D.  Tycksen</span>, <span class="hlFld-ContribAuthor ">L.  Cai</span>, <span class="hlFld-ContribAuthor ">J.  Yu</span>, <span class="hlFld-ContribAuthor ">R.W.  Wright</span>, <span class="hlFld-ContribAuthor ">R.H.  Brophy</span>. </span><span class="cited-content_cbyCitation_article-title">Distinct degenerative phenotype of articular cartilage from knees with meniscus tear compared to knees with osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name">Osteoarthritis and Cartilage</span><span> <strong>2019,</strong> <em>27 </em>
                                    (6)
                                     , 945-955. <a href="https://doi.org/10.1016/j.joca.2019.02.792" title="DOI URL">https://doi.org/10.1016/j.joca.2019.02.792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.joca.2019.02.792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.joca.2019.02.792%26sid%3Dliteratum%253Aachs%26jtitle%3DOsteoarthritis%2520and%2520Cartilage%26atitle%3DDistinct%252Bdegenerative%252Bphenotype%252Bof%252Barticular%252Bcartilage%252Bfrom%252Bknees%252Bwith%252Bmeniscus%252Btear%252Bcompared%252Bto%252Bknees%252Bwith%252Bosteoarthritis%26aulast%3DRai%26aufirst%3DM.F.%26date%3D2019%26volume%3D27%26issue%3D6%26spage%3D945%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morgan A.  Alford</span>, <span class="hlFld-ContribAuthor ">Zhenlin  Tian</span>, <span class="hlFld-ContribAuthor ">Frederic  Menard</span>, <span class="hlFld-ContribAuthor ">Andis  Klegeris</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of novel kainic acid analogs as inhibitors of select microglial functions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>851 </em>, 25-35. <a href="https://doi.org/10.1016/j.ejphar.2019.02.025" title="DOI URL">https://doi.org/10.1016/j.ejphar.2019.02.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2019.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2019.02.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DCharacterization%252Bof%252Bnovel%252Bkainic%252Bacid%252Banalogs%252Bas%252Binhibitors%252Bof%252Bselect%252Bmicroglial%252Bfunctions%26aulast%3DAlford%26aufirst%3DMorgan%2BA.%26date%3D2019%26volume%3D851%26spage%3D25%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcel Alexander  Heinrich</span>, <span class="hlFld-ContribAuthor ">Ruchi  Bansal</span>, <span class="hlFld-ContribAuthor ">Twan  Lammers</span>, <span class="hlFld-ContribAuthor ">Yu Shrike  Zhang</span>, <span class="hlFld-ContribAuthor ">Raymond  Michel Schiffelers</span>, <span class="hlFld-ContribAuthor ">Jai  Prakash</span>. </span><span class="cited-content_cbyCitation_article-title">3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials</span><span> <strong>2019,</strong> <em>31 </em>
                                    (14)
                                     , 1806590. <a href="https://doi.org/10.1002/adma.201806590" title="DOI URL">https://doi.org/10.1002/adma.201806590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adma.201806590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadma.201806590%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%26atitle%3D3D%2525E2%252580%252590Bioprinted%252BMini%2525E2%252580%252590Brain%25253A%252BA%252BGlioblastoma%252BModel%252Bto%252BStudy%252BCellular%252BInteractions%252Band%252BTherapeutics%26aulast%3DHeinrich%26aufirst%3DMarcel%2BAlexander%26date%3D2019%26date%3D2019%26volume%3D31%26issue%3D14%26spage%3D1806590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>, <span class="hlFld-ContribAuthor ">Ravi  Naik</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Foss</span>, <span class="hlFld-ContribAuthor ">Il  Minn</span>, <span class="hlFld-ContribAuthor ">Varia  Misheneva</span>, <span class="hlFld-ContribAuthor ">Yong  Du</span>, <span class="hlFld-ContribAuthor ">Yuchuan  Wang</span>, <span class="hlFld-ContribAuthor ">William B.  Mathews</span>, <span class="hlFld-ContribAuthor ">Yunkou  Wu</span>, <span class="hlFld-ContribAuthor ">Andrew  Hall</span>, <span class="hlFld-ContribAuthor ">Catherine  LaCourse</span>, <span class="hlFld-ContribAuthor ">Hye-Hyun  Ahn</span>, <span class="hlFld-ContribAuthor ">Hwanhee  Nam</span>, <span class="hlFld-ContribAuthor ">Wojciech G.  Lesniak</span>, <span class="hlFld-ContribAuthor ">Heather  Valentine</span>, <span class="hlFld-ContribAuthor ">Olga  Pletnikova</span>, <span class="hlFld-ContribAuthor ">Juan C.  Troncoso</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Smith</span>, <span class="hlFld-ContribAuthor ">Peter A.  Calabresi</span>, <span class="hlFld-ContribAuthor ">Alena V.  Savonenko</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Mikhail V.  Pletnikov</span>, <span class="hlFld-ContribAuthor ">Martin G.  Pomper</span>. </span><span class="cited-content_cbyCitation_article-title">PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (5)
                                     , 1686-1691. <a href="https://doi.org/10.1073/pnas.1812155116" title="DOI URL">https://doi.org/10.1073/pnas.1812155116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1812155116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1812155116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DPET%252Bimaging%252Bof%252Bmicroglia%252Bby%252Btargeting%252Bmacrophage%252Bcolony-stimulating%252Bfactor%252B1%252Breceptor%252B%252528CSF1R%252529%26aulast%3DHorti%26aufirst%3DAndrew%2BG.%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D5%26spage%3D1686%26epage%3D1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Wesolowski</span>, <span class="hlFld-ContribAuthor ">Neelesh  Sharma</span>, <span class="hlFld-ContribAuthor ">Laura  Reebel</span>, <span class="hlFld-ContribAuthor ">Mary Beth  Rodal</span>, <span class="hlFld-ContribAuthor ">Alexandra  Peck</span>, <span class="hlFld-ContribAuthor ">Brian L.  West</span>, <span class="hlFld-ContribAuthor ">Adhirai  Marimuthu</span>, <span class="hlFld-ContribAuthor ">Paul  Severson</span>, <span class="hlFld-ContribAuthor ">David A.  Karlin</span>, <span class="hlFld-ContribAuthor ">Afshin  Dowlati</span>, <span class="hlFld-ContribAuthor ">Mai H.  Le</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Coussens</span>, <span class="hlFld-ContribAuthor ">Hope S.  Rugo</span>. </span><span class="cited-content_cbyCitation_article-title">Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Medical Oncology</span><span> <strong>2019,</strong> <em>11 </em>, 175883591985423. <a href="https://doi.org/10.1177/1758835919854238" title="DOI URL">https://doi.org/10.1177/1758835919854238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1758835919854238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1758835919854238%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Medical%2520Oncology%26atitle%3DPhase%252BIb%252Bstudy%252Bof%252Bthe%252Bcombination%252Bof%252Bpexidartinib%252B%252528PLX3397%252529%25252C%252Ba%252BCSF-1R%252Binhibitor%25252C%252Band%252Bpaclitaxel%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumors%26aulast%3DWesolowski%26aufirst%3DRobert%26date%3D2019%26date%3D2019%26volume%3D11%26spage%3D175883591985423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean  Tanzey</span>, <span class="hlFld-ContribAuthor ">Xia  Shao</span>, <span class="hlFld-ContribAuthor ">Jenelle  Stauff</span>, <span class="hlFld-ContribAuthor ">Janna  Arteaga</span>, <span class="hlFld-ContribAuthor ">Phillip  Sherman</span>, <span class="hlFld-ContribAuthor ">Peter  Scott</span>, <span class="hlFld-ContribAuthor ">Andrew  Mossine</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Initial In Vivo Evaluation of [11C]AZ683—A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R). </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2018,</strong> <em>11 </em>
                                    (4)
                                     , 136. <a href="https://doi.org/10.3390/ph11040136" title="DOI URL">https://doi.org/10.3390/ph11040136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph11040136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph11040136%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DSynthesis%252Band%252BInitial%252BIn%252BVivo%252BEvaluation%252Bof%252B%25255B11C%25255DAZ683%2525E2%252580%252594A%252BNovel%252BPET%252BRadiotracer%252Bfor%252BColony%252BStimulating%252BFactor%252B1%252BReceptor%252B%252528CSF1R%252529%26aulast%3DTanzey%26aufirst%3DSean%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D4%26spage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan V.  Pham</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Pogue</span>, <span class="hlFld-ContribAuthor ">Richard J.  Ford</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2018,</strong> <em>8 </em><a href="https://doi.org/10.3389/fonc.2018.00147" title="DOI URL">https://doi.org/10.3389/fonc.2018.00147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2018.00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2018.00147%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DThe%252BRole%252Bof%252BMacrophage%25252FB-Cell%252BInteractions%252Bin%252Bthe%252BPathophysiology%252Bof%252BB-Cell%252BLymphomas%26aulast%3DPham%26aufirst%3DLan%2BV.%26date%3D2018%26date%3D2018%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[3,2-
              c
              ]pyridine derivatives with potential inhibitory effect against FMS kinase:
              in vitro
              biological studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1160-1166. <a href="https://doi.org/10.1080/14756366.2018.1491563" title="DOI URL">https://doi.org/10.1080/14756366.2018.1491563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1491563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1491563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DPyrrolo%25255B3%25252C2-%252Bc%252B%25255Dpyridine%252Bderivatives%252Bwith%252Bpotential%252Binhibitory%252Beffect%252Bagainst%252BFMS%252Bkinase%25253A%252Bin%252Bvitro%252Bbiological%252Bstudies%26aulast%3DEl-Gamal%26aufirst%3DMohammed%2BI.%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1160%26epage%3D1166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Cyanoimidazolecarboxamide and cyanofurancarboxamide CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Aminopyrimidine CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of BLZ945 and its active metabolite.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of the 7-azaindole-containing pyridine analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Conformation-specific inhibition of CSF-1R kinase by PLX3397 (<b>16</b>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Reprinted with permission from <span class="references__authors"><span class="NLM_string-name">Tap, W. D.</span></span>   <cite><i>New England Journal of Medicine</i></cite> <span class="NLM_year">2015</span>, <em>373</em>, 428–437.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Copyright 2015 Massachusetts Medical Socieity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of the quinoline and cinnoline derivatives reported as CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of the 4-arylamido-5-methylisoxazole analogues reported as CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/medium/jm-2017-00873f_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding mode of compound <b>20a</b> docked into CSF-1R (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCO">3LCO</a>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Reprinted with permission from <span class="references__authors"><span class="NLM_string-name">Im, D.</span></span>,   <cite><i>European Journal of Medicinal Chemistry</i></cite> <span class="NLM_year">2015</span>, <em>102</em>, 600.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Copyright 2015 Elsevier Masson SAS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-13/acs.jmedchem.7b00873/20180706/images/large/jm-2017-00873f_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00873&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18448" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18448" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 96 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. T.</span></span> <span> </span><span class="NLM_article-title">Receptor tyrosine kinases: mechanisms of activation and signaling</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.ceb.2007.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ceb.2007.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=17306972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=117-123&author=S.+R.+Hubbardauthor=W.+T.+Miller&title=Receptor+tyrosine+kinases%3A+mechanisms+of+activation+and+signaling&doi=10.1016%2Fj.ceb.2007.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases: mechanisms of activation and signaling</span></div><div class="casAuthors">Hubbard, Stevan R.; Miller, W. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-123</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases (RTKs) are essential components of signal transduction pathways that mediate cell-to-cell communication.  These single-pass transmembrane receptors, which bind polypeptide ligands - mainly growth factors - play key roles in processes such as cellular growth, differentiation, metab. and motility.  Recent progress has been achieved towards an understanding of the precise (and varied) mechanisms by which RTKs are activated by ligand binding and by which signals are propagated from the activated receptors to downstream targets in the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg3ej9ekC3hLVg90H21EOLACvtfcHk0liWT7f7exn3Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Slu78%253D&md5=254110135c0f1a5642441c551d379bef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2007.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2007.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26atitle%3DReceptor%2520tyrosine%2520kinases%253A%2520mechanisms%2520of%2520activation%2520and%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2007%26volume%3D19%26spage%3D117%26epage%3D123%26doi%3D10.1016%2Fj.ceb.2007.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebaï, A.</span></span> <span> </span><span class="NLM_article-title">Receptor tyrosine kinases: from biology to pathology</span>. <i>J. Recept. Signal Transduction Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.3109/10799893.2011.625425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3109%2F10799893.2011.625425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22040163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbot1KhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=387-394&author=M.+Chouraauthor=A.+Reba%C3%AF&title=Receptor+tyrosine+kinases%3A+from+biology+to+pathology&doi=10.3109%2F10799893.2011.625425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinases: from biology to pathology</span></div><div class="casAuthors">Choura Mouna; Rebai Ahmed</div><div class="citationInfo"><span class="NLM_cas:title">Journal of receptor and signal transduction research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">387-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Receptor tyrosine kinases (RTKs) are transmembrane proteins involved in the control of fundamental cellular processes in metazoans.  RTKs possess a general structure that includes an extracellular domain, a transmembrane domain and a highly conserved tyrosine kinase domain.  RTKs are classified according to their variable extracellular ligand-binding domain.  Studies of human RTK members have yielded a wealth of information elucidating their importance.  Improper functioning of these enzymes due to mutations, mainly in the kinase domain, is often manifested in various human diseases and is known to be involved in several types of cancer.  Here we summarize most of human RTKs, their cognate ligands, as well as related diseases and discuss the eventual use of certain RTKs as new therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQs7acWT79Owg5nADWVYHg1fW6udTcc2eYWElGBLCNYZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbot1KhsQ%253D%253D&md5=ba6dc2f354598801af9a8f2947a6f1cb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3109%2F10799893.2011.625425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10799893.2011.625425%26sid%3Dliteratum%253Aachs%26aulast%3DChoura%26aufirst%3DM.%26aulast%3DReba%25C3%25AF%26aufirst%3DA.%26atitle%3DReceptor%2520tyrosine%2520kinases%253A%2520from%2520biology%2520to%2520pathology%26jtitle%3DJ.%2520Recept.%2520Signal%2520Transduction%2520Res.%26date%3D2011%26volume%3D31%26spage%3D387%26epage%3D394%26doi%3D10.3109%2F10799893.2011.625425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Im, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hah, J. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">600</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ejmech.2015.08.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2015&pages=600-610&author=D.+Imauthor=K.+Jungauthor=S.+Yangauthor=W.+Amanauthor=J.+M.+Hah&title=Discovery+of+4-arylamido+3-methyl+isoxazole+derivatives+as+novel+FMS+kinase+inhibitors&doi=10.1016%2Fj.ejmech.2015.08.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAman%26aufirst%3DW.%26aulast%3DHah%26aufirst%3DJ.%2BM.%26atitle%3DDiscovery%2520of%25204-arylamido%25203-methyl%2520isoxazole%2520derivatives%2520as%2520novel%2520FMS%2520kinase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D102%26spage%3D600%26epage%3D610%26doi%3D10.1016%2Fj.ejmech.2015.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitu, V.</span></span> <span> </span><span class="NLM_article-title">CSF-1 receptor signaling in myeloid cells</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">a021857</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a021857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1101%2Fcshperspect.a021857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24890514" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=a021857&author=E.+R.+Stanleyauthor=V.+Chitu&title=CSF-1+receptor+signaling+in+myeloid+cells&doi=10.1101%2Fcshperspect.a021857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a021857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a021857%26sid%3Dliteratum%253Aachs%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DChitu%26aufirst%3DV.%26atitle%3DCSF-1%2520receptor%2520signaling%2520in%2520myeloid%2520cells%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2014%26volume%3D6%26spage%3Da021857%26doi%3D10.1101%2Fcshperspect.a021857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Gamal, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anbar, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.-H.</span></span> <span> </span><span class="NLM_article-title">FMS kinase inhibitors: current status and future prospects</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1002/med.21258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fmed.21258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22434539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVyrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=599-636&author=M.+I.+El-Gamalauthor=H.+S.+Anbarauthor=K.+H.+Yooauthor=C.-H.+Oh&title=FMS+kinase+inhibitors%3A+current+status+and+future+prospects&doi=10.1002%2Fmed.21258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">FMS Kinase Inhibitors: Current Status and Future Prospects</span></div><div class="casAuthors">El-Gamal, Mohammed I.; Anbar, Hanan S.; Yoo, Kyung Ho; Oh, Chang-Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">599-636</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  FMS, first discovered as the oncogene responsible for Feline McDonough Sarcoma, is a type III receptor tyrosine kinase that binds to the macrophage or monocyte colony-stimulating factor (M-CSF or CSF-1).  Signal transduction through that binding results in survival, proliferation, and differentiation of monocyte/macrophage lineage.  Overexpression of CSF-1 and/or FMS has been implicated in a no. of disease states such as the growth of metastasis of certain types of cancer, in promoting osteoclast proliferation in bone osteolysis, and many inflammatory disorders.  Inhibition of CSF-1 and/or FMS may help treat these pathol. conditions.  This article reviews FMS gene, FMS kinase, CSF-1, IL-34, and their roles in bone osteolysis, cancer biol., and inflammation.  Monoclonal antibodies, FMS crystal structure, and small mol. FMS kinase inhibitors of different chem. scaffolds are also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqclLKowsJFbVg90H21EOLACvtfcHk0ljh1xXWd20ZuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVyrsbs%253D&md5=779bb21f27a2d89670b0ac1655c1d47b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fmed.21258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21258%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Gamal%26aufirst%3DM.%2BI.%26aulast%3DAnbar%26aufirst%3DH.%2BS.%26aulast%3DYoo%26aufirst%3DK.%2BH.%26aulast%3DOh%26aufirst%3DC.-H.%26atitle%3DFMS%2520kinase%2520inhibitors%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D599%26epage%3D636%26doi%3D10.1002%2Fmed.21258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khol, M. P.</span></span> <span> </span><span class="NLM_article-title">The effects of recombinant osteoactivin on murine osteoclastogenesis</span>. Thesis. <span class="NLM_publisher-name">Northeast Ohio Medical University</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+P.+Khol&title=The+effects+of+recombinant+osteoactivin+on+murine+osteoclastogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhol%26aufirst%3DM.%2BP.%26atitle%3DThe%2520effects%2520of%2520recombinant%2520osteoactivin%2520on%2520murine%2520osteoclastogenesis%26pub%3DNortheast%2520Ohio%2520Medical%2520University%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, R.</span>; <span class="NLM_string-name">Feldman, D.</span>; <span class="NLM_string-name">Dempster, D. W.</span>; <span class="NLM_string-name">Luckey, M.</span>; <span class="NLM_string-name">Cauley, J. A.</span></span> <i>Osteoporosis</i>, <span class="NLM_edition">4th</span> ed., <span class="NLM_year">2014</span>; <a href="https://www.elsevier.com/books/osteoporosis/marcus/978-0-12-415853-5" class="extLink">https://www.elsevier.com/books/osteoporosis/marcus/978-0-12-415853-5</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+Marcus&author=D.+Feldman&author=D.+W.+Dempster&author=M.+Luckey&author=J.+A.+Cauley&title=Osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMarcus%26aufirst%3DR.%26btitle%3DOsteoporosis%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chockalingam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S. S.</span></span> <span> </span><span class="NLM_article-title">Macrophage colony stimulating factor and cancer: a review</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">10635</span>– <span class="NLM_lpage">10644</span>, <span class="refDoi"> DOI: 10.1007/s13277-014-2627-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1007%2Fs13277-014-2627-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=10635-10644&author=S.+Chockalingamauthor=S.+S.+Ghosh&title=Macrophage+colony+stimulating+factor+and+cancer%3A+a+review&doi=10.1007%2Fs13277-014-2627-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage colony-stimulating factor and cancer: a review</span></div><div class="casAuthors">Chockalingam, S.; Ghosh, Siddhartha Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10635-10644</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor growth is influenced by a wide variety of external and internal factors.  One of the most important mediators of tumor development is our immune system.  The nonstop surveillance of the immune system was originally expected to clear the transformed cells from the body and guard against the development of tumor.  But contradictory evidences are reported to show the involvement of immune system in supporting the growth and spread of tumor.  Tumor infiltrating immune cells, in addn. to harboring immunosuppressive activities, also promote angiogenesis and metastasis of tumor.  Many growth factors and cytokines are involved in shaping this complex immune microenvironment of the tumor.  Macrophage colony-stimulating factor (MCSF) is one such growth factor which is overexpressed in many tumors.  In this review, we summarize the basic biol. of MCSF, its role in cancer and discuss the involvement of tumor-assocd. macrophages (TAMs) in tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonrRt-ocMfhrVg90H21EOLACvtfcHk0lgUXDlSYdOdmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM&md5=01055b227ccf55ef96e8d9a4a3ec1277</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs13277-014-2627-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-014-2627-0%26sid%3Dliteratum%253Aachs%26aulast%3DChockalingam%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DS.%2BS.%26atitle%3DMacrophage%2520colony%2520stimulating%2520factor%2520and%2520cancer%253A%2520a%2520review%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D10635%26epage%3D10644%26doi%3D10.1007%2Fs13277-014-2627-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeengar, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramavat, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, V. G.</span></span> <span> </span><span class="NLM_article-title">Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2015.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.phrs.2015.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26022736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt12ht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2015&pages=63-73&author=D.+Thummuriauthor=M.+K.+Jeengarauthor=S.+Shrivastavaauthor=H.+Nemaniauthor=R.+N.+Ramavatauthor=P.+Chaudhariauthor=V.+G.+Naidu&title=Thymoquinone+prevents+RANKL-induced+osteoclastogenesis+activation+and+osteolysis+in+an+in+vivo+model+of+inflammation+by+suppressing+NF-KB+and+MAPK+Signalling&doi=10.1016%2Fj.phrs.2015.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling</span></div><div class="casAuthors">Thummuri, Dinesh; Jeengar, Manish Kumar; Shrivastava, Shweta; Nemani, Harishankar; Ramavat, Ravindar Naik; Chaudhari, Pradip; Naidu, V. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Osteoclasts are multinuclear giant cells responsible for bone resorption in inflammatory bone diseases such as osteoporosis, rheumatoid arthritis and periodontitis.  Because of deleterious side effects with currently available drugs the search continues for novel effective and safe therapies.  Thymoquinone (TQ), the major bioactive component of Nigella sativa has been investigated for its anti-inflammatory, antioxidant and anticancer activities.  However, its effects in osteoclastogenesis have not been reported.  In the present study we show for the first time that TQ inhibits nuclear factor-KB ligand (RANKL) induced osteoclastogenesis in RAW 264.7 and primary bone marrow derived macrophages (BMMs) cells.  RANKL induced osteoclastogenesis is assocd. with increased expression of multiple transcription factors via activation of NF-KB, MAPKs signalling and reactive oxygen species (ROS).  Mechanistically TQ blocked the RANKL induced NF-KB activation by attenuating the phosphorylation of IkB kinase (IKKα/β).  Interestingly, in RAW 264.7 cells TQ inhibited the RANKL induced phosphorylation of MAPKs and mRNA expression of osteoclastic specific genes such as TRAP, DC-STAMP, NFATc1 and c-Fos.  In addn., TQ also decreased the RANKL stimulated ROS generation in macropahges (RAW 264.7) and H2O2 induced ROS generation in osteoblasts (MC-3T3-E1).  Consistent with in vitro results, TQ inhibited lipopolysaccharide (LPS) induced bone resorption by suppressing the osteoclastogenesis.  Indeed, micro-CT anal. showed that bone mineral d. (BMD) and bone architecture parameters were pos. modulated by TQ.  Taken together our data demonstrate that TQ has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-KB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre7jXayHxqlbVg90H21EOLACvtfcHk0lgUXDlSYdOdmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt12ht74%253D&md5=3bb4cd59e7dc807794a2dc296d510687</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DJeengar%26aufirst%3DM.%2BK.%26aulast%3DShrivastava%26aufirst%3DS.%26aulast%3DNemani%26aufirst%3DH.%26aulast%3DRamavat%26aufirst%3DR.%2BN.%26aulast%3DChaudhari%26aufirst%3DP.%26aulast%3DNaidu%26aufirst%3DV.%2BG.%26atitle%3DThymoquinone%2520prevents%2520RANKL-induced%2520osteoclastogenesis%2520activation%2520and%2520osteolysis%2520in%2520an%2520in%2520vivo%2520model%2520of%2520inflammation%2520by%2520suppressing%2520NF-KB%2520and%2520MAPK%2520Signalling%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D99%26spage%3D63%26epage%3D73%26doi%3D10.1016%2Fj.phrs.2015.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Papp, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, L. T.</span></span> <span> </span><span class="NLM_article-title">The osteoclast, bone remodelling and treatment of metabolic bone disease</span>. <i>Eur. J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1341</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2362.2012.02717.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1111%2Fj.1365-2362.2012.02717.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1332-1341&author=B.+F.+Boyceauthor=E.+Rosenbergauthor=A.+E.+de+Pappauthor=L.+T.+Duong&title=The+osteoclast%2C+bone+remodelling+and+treatment+of+metabolic+bone+disease&doi=10.1111%2Fj.1365-2362.2012.02717.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2362.2012.02717.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2362.2012.02717.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DB.%2BF.%26aulast%3DRosenberg%26aufirst%3DE.%26aulast%3Dde%2BPapp%26aufirst%3DA.%2BE.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26atitle%3DThe%2520osteoclast%252C%2520bone%2520remodelling%2520and%2520treatment%2520of%2520metabolic%2520bone%2520disease%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D42%26spage%3D1332%26epage%3D1341%26doi%3D10.1111%2Fj.1365-2362.2012.02717.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodruff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebel, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fajardo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluhak-Heinrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud Werner, S.</span></span> <span> </span><span class="NLM_article-title">Abboud Werner, S.. Meox2Cre-mediated disruption of CSF-1 leads to osteopetrosis and osteocyte defects</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2011.09.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bone.2011.09.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2012&pages=42-53&author=S.+E.+Harrisauthor=M.+Macdougallauthor=D.+Hornauthor=K.+Woodruffauthor=S.+N.+Zimmerauthor=V.+I.+Rebelauthor=R.+Fajardoauthor=J.+Q.+Fengauthor=J.+Gluhak-Heinrichauthor=M.+A.+Harrisauthor=S.+Abboud+Werner&title=Abboud+Werner%2C+S..+Meox2Cre-mediated+disruption+of+CSF-1+leads+to+osteopetrosis+and+osteocyte+defects&doi=10.1016%2Fj.bone.2011.09.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.09.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.09.038%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DS.%2BE.%26aulast%3DMacdougall%26aufirst%3DM.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DWoodruff%26aufirst%3DK.%26aulast%3DZimmer%26aufirst%3DS.%2BN.%26aulast%3DRebel%26aufirst%3DV.%2BI.%26aulast%3DFajardo%26aufirst%3DR.%26aulast%3DFeng%26aufirst%3DJ.%2BQ.%26aulast%3DGluhak-Heinrich%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DM.%2BA.%26aulast%3DAbboud%2BWerner%26aufirst%3DS.%26atitle%3DAbboud%2520Werner%252C%2520S..%2520Meox2Cre-mediated%2520disruption%2520of%2520CSF-1%2520leads%2520to%2520osteopetrosis%2520and%2520osteocyte%2520defects%26jtitle%3DBone%26date%3D2012%26volume%3D50%26spage%3D42%26epage%3D53%26doi%3D10.1016%2Fj.bone.2011.09.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegal, G. P.</span></span> <span> </span><span class="NLM_article-title">Mechanisms modulating inflammatory osteolysis: A review with insights into therapeutic targets</span>. <i>Pathol., Res. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1016/j.prp.2008.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.prp.2008.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=18757139" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOku7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2008&pages=695-706&author=S.+Weiauthor=G.+P.+Siegal&title=Mechanisms+modulating+inflammatory+osteolysis%3A+A+review+with+insights+into+therapeutic+targets&doi=10.1016%2Fj.prp.2008.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets</span></div><div class="casAuthors">Wei, Shi; Siegal, Gene P.</div><div class="citationInfo"><span class="NLM_cas:title">Pathology, Research and Practice</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">695-706</span>CODEN:
                <span class="NLM_cas:coden">PARPDS</span>;
        ISSN:<span class="NLM_cas:issn">0344-0338</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">A review.  Inflammatory osteolysis is a relatively frequent and incapacitating complication of rheumatoid arthritis and multiple other inflammation-assocd. bone diseases.  It is thought to operate through an ultimate common pathway of accelerated osteoclast recruitment and activation under the control of cytokines produced in the inflammatory environment.  Over the past decade, there have been major advances in our understanding of the mechanisms of osteoclastogenesis.  It is now clear that the interaction of receptor activator NF-κB (RANK) and its ligand, RANKL, plays a central role in osteoclast formation and activity.  Therefore, understanding osteoclastogenesis offers new pathways for potential therapeutic intervention in inflammatory osteolysis.  The success of anti-tumor necrosis factor-α and interleukin-1 therapy highlights the central role that these specific cytokines play in this disease.  This review outlines our current understanding of the mechanisms mediating inflammatory osteolysis and highlights potential therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojz5UoKcSsvrVg90H21EOLACvtfcHk0lgeBrKgMcOj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOku7fO&md5=a245bf8522c9b35081325e461b2b3b4a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.prp.2008.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prp.2008.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DS.%26aulast%3DSiegal%26aufirst%3DG.%2BP.%26atitle%3DMechanisms%2520modulating%2520inflammatory%2520osteolysis%253A%2520A%2520review%2520with%2520insights%2520into%2520therapeutic%2520targets%26jtitle%3DPathol.%252C%2520Res.%2520Pract.%26date%3D2008%26volume%3D204%26spage%3D695%26epage%3D706%26doi%3D10.1016%2Fj.prp.2008.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimoldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Macrophages polarization in tumor progression</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.semcancer.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=18467122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=349-355&author=A.+Sicaauthor=P.+Larghiauthor=A.+Mancinoauthor=L.+Rubinoauthor=C.+Portaauthor=M.+G.+Totaroauthor=M.+Rimoldiauthor=S.+K.+Biswasauthor=P.+Allavenaauthor=A.+Mantovani&title=Macrophages+polarization+in+tumor+progression&doi=10.1016%2Fj.semcancer.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage polarization in tumour progression</span></div><div class="casAuthors">Sica, Antonio; Larghi, Paola; Mancino, Alessandra; Rubino, Luca; Porta, Chiara; Totaro, Maria Grazia; Rimoldi, Monica; Biswas, Subhra Kumar; Allavena, Paola; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Macrophages are a fundamental part of the innate defense mechanisms, which can promote specific immunity by inducing T cell recruitment and activation.  Despite this, their presence within the tumor microenvironment has been assocd. with enhanced tumor progression and shown to promote cancer cell growth and spread, angiogenesis and immunosuppression.  This paradoxical role of macrophages in cancer finds an explanation in their functional plasticity, that may result in the polarized expression of either pro- or anti-tumoral functions.  Key players in the setting of their phenotype are the microenvironmental signals to which macrophages are exposed, which selectively tune their functions within a functional spectrum encompassing the M1 and M2 extremes.  Here, we discuss recent findings suggesting that targeting tumor-assocd. macrophages (TAMs) polarization may represent a novel therapeutic strategy against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphZcYy9ySqx7Vg90H21EOLACvtfcHk0lgeBrKgMcOj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D&md5=a786b03442ac65bb774e8b87ea84e0b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DLarghi%26aufirst%3DP.%26aulast%3DMancino%26aufirst%3DA.%26aulast%3DRubino%26aufirst%3DL.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DTotaro%26aufirst%3DM.%2BG.%26aulast%3DRimoldi%26aufirst%3DM.%26aulast%3DBiswas%26aufirst%3DS.%2BK.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DMacrophages%2520polarization%2520in%2520tumor%2520progression%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2008%26volume%3D18%26spage%3D349%26epage%3D355%26doi%3D10.1016%2Fj.semcancer.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schioppa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span> <span> </span><span class="NLM_article-title">Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">717</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2006.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ejca.2006.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=16520032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Grt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=717-727&author=A.+Sicaauthor=T.+Schioppaauthor=A.+Mantovaniauthor=P.+Allavena&title=Tumour-associated+macrophages+are+a+distinct+M2+polarised+population+promoting+tumour+progression%3A+Potential+targets+of+anti-cancer+therapy&doi=10.1016%2Fj.ejca.2006.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy</span></div><div class="casAuthors">Sica, Antonio; Schioppa, Tiziana; Mantovani, Alberto; Allavena, Paola</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAM) represent the major inflammatory component of the stroma of many tumors, and can affect different aspects of the neoplastic tissue.  Many observations indicate that TAM express several M2-assocd. pro-tumoral functions, including promotion of angiogenesis, matrix remodelling and suppression of adaptive immunity.  The pro-tumoral role of TAM in cancer is further supported by clin. studies that found a correlation between the high macrophage content of tumors and poor patient prognosis.  Evidence is presented here supporting the view that TAM represent a unique and distinct M2-skewed myeloid population and are a potential target for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2BRvs8GA_9bVg90H21EOLACvtfcHk0lgeBrKgMcOj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Grt78%253D&md5=5df82a5fe77ad15b687a31aeda826205</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2006.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2006.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DSchioppa%26aufirst%3DT.%26aulast%3DMantovani%26aufirst%3DA.%26aulast%3DAllavena%26aufirst%3DP.%26atitle%3DTumour-associated%2520macrophages%2520are%2520a%2520distinct%2520M2%2520polarised%2520population%2520promoting%2520tumour%2520progression%253A%2520Potential%2520targets%2520of%2520anti-cancer%2520therapy%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26spage%3D717%26epage%3D727%26doi%3D10.1016%2Fj.ejca.2006.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Achkova, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span> <span> </span><span class="NLM_article-title">Role of the colony stimulating factor 1 (CSF-1)/CSF-1 receptor axis in cancer</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1042/BST20150245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1042%2FBST20150245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27068937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslyqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=333-341&author=D.+Achkovaauthor=J.+Maher&title=Role+of+the+colony+stimulating+factor+1+%28CSF-1%29%2FCSF-1+receptor+axis+in+cancer&doi=10.1042%2FBST20150245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer</span></div><div class="casAuthors">Achkova, Daniela; Maher, John</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">333-341</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Cancer cells employ a variety of mechanisms to evade apoptosis and senescence.  Pre-eminent among these is the aberrant co-expression of growth factors and their ligands, forming an autocrine growth loop that promotes tumor formation and progression.  One growth loop whose transforming potential has been repeatedly demonstrated is the CSF-1/CSF-1R axis.  Expression of CSF-1 and/or CSF-1R has been documented in a no. of human malignancies, including breast, prostate and ovarian cancer and classical Hodgkin's lymphoma (cHL).  This review summarizes the large body of work undertaken to study the role of this cytokine receptor system in malignant transformation.  These studies have attributed a key role to the CSF-1/CSF-1R axis in supporting tumor cell survival, proliferation and enhanced motility.  Moreover, increasing evidence implicates paracrine interactions between CSF-1 and its receptor in defining a tumor-permissive and immunosuppressive tumor-assocd. stroma.  Against this background, we briefly consider the prospects for therapeutic targeting of this system in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohsPnqZfR7n7Vg90H21EOLACvtfcHk0lhwgjEtf6CmzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslyqs7w%253D&md5=3155b29184a36c189f8704e25e896cc1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1042%2FBST20150245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150245%26sid%3Dliteratum%253Aachs%26aulast%3DAchkova%26aufirst%3DD.%26aulast%3DMaher%26aufirst%3DJ.%26atitle%3DRole%2520of%2520the%2520colony%2520stimulating%2520factor%25201%2520%2528CSF-1%2529%252FCSF-1%2520receptor%2520axis%2520in%2520cancer%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2016%26volume%3D44%26spage%3D333%26epage%3D341%26doi%3D10.1042%2FBST20150245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morandi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riverso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dello Sbarba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovida, E.</span></span> <span> </span><span class="NLM_article-title">The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e27450</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0027450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0027450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e27450&author=A.+Morandiauthor=V.+Barbettiauthor=M.+Riversoauthor=P.+Dello+Sbarbaauthor=E.+Rovida&title=The+colony-stimulating+factor-1+%28CSF-1%29+receptor+sustains+ERK1%2F2+activation+and+proliferation+in+breast+cancer+cell+lines&doi=10.1371%2Fjournal.pone.0027450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0027450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0027450%26sid%3Dliteratum%253Aachs%26aulast%3DMorandi%26aufirst%3DA.%26aulast%3DBarbetti%26aufirst%3DV.%26aulast%3DRiverso%26aufirst%3DM.%26aulast%3DDello%2BSbarba%26aufirst%3DP.%26aulast%3DRovida%26aufirst%3DE.%26atitle%3DThe%2520colony-stimulating%2520factor-1%2520%2528CSF-1%2529%2520receptor%2520sustains%2520ERK1%252F2%2520activation%2520and%2520proliferation%2520in%2520breast%2520cancer%2520cell%2520lines%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De27450%26doi%3D10.1371%2Fjournal.pone.0027450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swierczak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, J. A.</span></span> <span> </span><span class="NLM_article-title">The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1158/2326-6066.CIR-13-0190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F2326-6066.CIR-13-0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25005824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlSrur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=765-776&author=A.+Swierczakauthor=A.+Cookauthor=J.+Lenzoauthor=C.+Restallauthor=J.+Dohertyauthor=R.+Andersonauthor=J.+A.+Hamilton&title=The+promotion+of+breast+cancer+metastasis+caused+by+inhibition+of+CSF-1R%2FCSF-1+signaling+is+blocked+by+targeting+the+G-CSF+receptor&doi=10.1158%2F2326-6066.CIR-13-0190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor</span></div><div class="casAuthors">Swierczak, Agnieszka; Cook, Andrew D.; Lenzo, Jason C.; Restall, Christina M.; Doherty, Judy P.; Anderson, Robin L.; Hamilton, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-776</span>CODEN:
                <span class="NLM_cas:coden">CIRACV</span>;
        ISSN:<span class="NLM_cas:issn">2326-6066</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Swierczak and colleagues show that blockade of CSF-1R signaling promoted metastasis in two mouse mammary tumor models, with increases in serum G-CSF and neutrophils, which can be overcome by anti-G-CSFR antibodies, raising concerns about targeting CSF-1R as breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJjtH5QPlxgbVg90H21EOLACvtfcHk0lhwgjEtf6CmzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlSrur7J&md5=d22a84794043ca0337187af822aa7107</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F2326-6066.CIR-13-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2326-6066.CIR-13-0190%26sid%3Dliteratum%253Aachs%26aulast%3DSwierczak%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DA.%26aulast%3DLenzo%26aufirst%3DJ.%26aulast%3DRestall%26aufirst%3DC.%26aulast%3DDoherty%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DR.%26aulast%3DHamilton%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520promotion%2520of%2520breast%2520cancer%2520metastasis%2520caused%2520by%2520inhibition%2520of%2520CSF-1R%252FCSF-1%2520signaling%2520is%2520blocked%2520by%2520targeting%2520the%2520G-CSF%2520receptor%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2014%26volume%3D2%26spage%3D765%26epage%3D776%26doi%3D10.1158%2F2326-6066.CIR-13-0190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pixley, F. J.</span></span> <span> </span><span class="NLM_article-title">CSF-1R signaling in health and disease: a focus on the mammary gland</span>. <i>J. Mammary Gland Biol. Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1007/s10911-014-9320-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1007%2Fs10911-014-9320-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24912655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC2cfgslWkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=149-159&author=A.+R.+Sullivanauthor=F.+J.+Pixley&title=CSF-1R+signaling+in+health+and+disease%3A+a+focus+on+the+mammary+gland&doi=10.1007%2Fs10911-014-9320-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">CSF-1R signaling in health and disease: a focus on the mammary gland</span></div><div class="casAuthors">Sullivan Amy Renee; Pixley Fiona Jane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of mammary gland biology and neoplasia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-59</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colony-stimulating factor-1 (CSF-1), also known as macrophage-colony stimulating factor (M-CSF), is the primary growth factor regulating survival, proliferation and differentiation of macrophages.  It is also a potent chemokine for macrophages and monocytes.  Signaling via the CSF-1 receptor (CSF-1R) is necessary for the production of almost all tissue resident macrophage populations and these macrophages participate, via trophic mechanisms, in the normal development and homeostasis of tissues and organs in which they reside, including the mammary gland.  The drawback of this close interaction between macrophages and parenchymal cells is that dysregulation of macrophage trophic functions assists in the development and progression of many cancers, including breast cancer.  Furthermore, tumour cells secrete CSF-1 to attract more macrophages to the tumour microenvironment where CSF-1R signaling frequently drives the behaviour of these tumour-associated macrophages (TAMs) to promote tumour progression and metastasis.  Evidence is mounting that treated tumours secrete more CSF-1 and the increased recruitment of TAMs limits treatment efficacy.  Thus, therapeutic targeting of the CSF-1R to inhibit TAM function is likely to enhance tumour response and improve patient outcomes in the treatment of cancer, including breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwf4vn3sGFXS-bLEOO4dYpfW6udTcc2eY8561fznoTObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfgslWkug%253D%253D&md5=26e33f74139721dccff408dbf8b86e62</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs10911-014-9320-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10911-014-9320-1%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DA.%2BR.%26aulast%3DPixley%26aufirst%3DF.%2BJ.%26atitle%3DCSF-1R%2520signaling%2520in%2520health%2520and%2520disease%253A%2520a%2520focus%2520on%2520the%2520mammary%2520gland%26jtitle%3DJ.%2520Mammary%2520Gland%2520Biol.%2520Neoplasia%26date%3D2014%26volume%3D19%26spage%3D149%26epage%3D159%26doi%3D10.1007%2Fs10911-014-9320-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Escudier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux-Leclercq, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruenvald, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwich, A.</span></span> <span> </span><span class="NLM_article-title">Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">v58</span>– <span class="NLM_lpage">v68</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdw328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1093%2Fannonc%2Fmdw328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27664262" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=v58-v68&author=B.+Escudierauthor=C.+Portaauthor=M.+Schmidingerauthor=N.+Rioux-Leclercqauthor=A.+Bexauthor=V.+Khooauthor=V.+Gruenvaldauthor=A.+Horwich&title=Renal+cell+carcinoma%3A+ESMO+clinical+practice+guidelines+for+diagnosis%2C+treatment+and+follow-up&doi=10.1093%2Fannonc%2Fmdw328"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdw328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdw328%26sid%3Dliteratum%253Aachs%26aulast%3DEscudier%26aufirst%3DB.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DSchmidinger%26aufirst%3DM.%26aulast%3DRioux-Leclercq%26aufirst%3DN.%26aulast%3DBex%26aufirst%3DA.%26aulast%3DKhoo%26aufirst%3DV.%26aulast%3DGruenvald%26aufirst%3DV.%26aulast%3DHorwich%26aufirst%3DA.%26atitle%3DRenal%2520cell%2520carcinoma%253A%2520ESMO%2520clinical%2520practice%2520guidelines%2520for%2520diagnosis%252C%2520treatment%2520and%2520follow-up%26jtitle%3DAnn.%2520Oncol.%26date%3D2016%26volume%3D27%26spage%3Dv58%26epage%3Dv68%26doi%3D10.1093%2Fannonc%2Fmdw328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriegsmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimanski, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarting, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, V. R.</span></span> <span> </span><span class="NLM_article-title">Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F0008-5472.CAN-11-1232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=187-200&author=J.+Menkeauthor=J.+Kriegsmannauthor=C.+C.+Schimanskiauthor=M.+M.+Schwartzauthor=A.+Schwartingauthor=V.+R.+Kelley&title=Autocrine+CSF-1+and+CSF-1+receptor+coexpression+promotes+renal+cell+carcinoma+growth&doi=10.1158%2F0008-5472.CAN-11-1232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1232%26sid%3Dliteratum%253Aachs%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DKriegsmann%26aufirst%3DJ.%26aulast%3DSchimanski%26aufirst%3DC.%2BC.%26aulast%3DSchwartz%26aufirst%3DM.%2BM.%26aulast%3DSchwarting%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DV.%2BR.%26atitle%3DAutocrine%2520CSF-1%2520and%2520CSF-1%2520receptor%2520coexpression%2520promotes%2520renal%2520cell%2520carcinoma%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D187%26epage%3D200%26doi%3D10.1158%2F0008-5472.CAN-11-1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burattini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montironi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascinu, S.</span></span> <span> </span><span class="NLM_article-title">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1007/s00262-013-1487-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1007%2Fs00262-013-1487-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24132754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1757-1768&author=M.+Santoniauthor=F.+Massariauthor=C.+Amantiniauthor=M.+Nabissiauthor=F.+Mainesauthor=L.+Burattiniauthor=R.+Berardiauthor=G.+Santoniauthor=R.+Montironiauthor=G.+Tortoraauthor=S.+Cascinu&title=Emerging+role+of+tumor-associated+macrophages+as+therapeutic+targets+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1007%2Fs00262-013-1487-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Santoni, Matteo; Massari, Francesco; Amantini, Consuelo; Nabissi, Massimo; Maines, Francesca; Burattini, Luciano; Berardi, Rossana; Santoni, Giorgio; Montironi, Rodolfo; Tortora, Giampaolo; Cascinu, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1757-1768</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAMs) derived from peripheral blood monocytes recruited into the renal cell carcinoma (RCC) microenvironment.  In response to inflammatory stimuli, macrophages undergo M1 (classical) or M2 (alternative) activation.  M1 cells produce high levels of inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-12, IL-23 and IL-6, while M2 cells produce anti-inflammatory cytokines, such as IL-10, thus contributing to RCC-related immune dysfunction.  The presence of extensive TAM infiltration in RCC microenvironment contributes to cancer progression and metastasis by stimulating angiogenesis, tumor growth, and cellular migration and invasion.  Moreover, TAMs are involved in epithelial-mesenchymal transition of RCC cancer cells and in the development of tumor resistance to targeted agents.  Interestingly, macrophage autophagy seems to play an important role in RCC.  Based on this scenario, TAMs represent a promising and effective target for cancer therapy in RCC.  Several strategies have been proposed to suppress TAM recruitment, to deplete their no., to switch M2 TAMs into antitumor M1 phenotype and to inhibit TAM-assocd. mols.  In this review, we summarize current data on the essential role of TAMs in RCC angiogenesis, invasion, impaired anti-tumor immune response and development of drug resistance, thus describing the emerging TAM-centered therapies for RCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolZG976wpuQbVg90H21EOLACvtfcHk0lhTLA_FkQ-TPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF&md5=1160c0890450df83400121069c437a24</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00262-013-1487-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-013-1487-6%26sid%3Dliteratum%253Aachs%26aulast%3DSantoni%26aufirst%3DM.%26aulast%3DMassari%26aufirst%3DF.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMaines%26aufirst%3DF.%26aulast%3DBurattini%26aufirst%3DL.%26aulast%3DBerardi%26aufirst%3DR.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DMontironi%26aufirst%3DR.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DCascinu%26aufirst%3DS.%26atitle%3DEmerging%2520role%2520of%2520tumor-associated%2520macrophages%2520as%2520therapeutic%2520targets%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2013%26volume%3D62%26spage%3D1757%26epage%3D1768%26doi%3D10.1007%2Fs00262-013-1487-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. H.</span></span> <span> </span><span class="NLM_article-title">Optimal dose reduction of Folfirinox for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2017.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ejca.2017.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=125-133&author=J.+C.+Leeauthor=J.+W.+Kimauthor=S.+Ahnauthor=H.+W.+Kimauthor=J.+Leeauthor=Y.+H.+Kimauthor=K.+H.+Paikauthor=J.+Kimauthor=J.+H.+Hwang&title=Optimal+dose+reduction+of+Folfirinox+for+preserving+tumour+response+in+advanced+pancreatic+cancer%3A+Using+cumulative+relative+dose+intensity&doi=10.1016%2Fj.ejca.2017.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2017.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2017.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DH.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DPaik%26aufirst%3DK.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DJ.%2BH.%26atitle%3DOptimal%2520dose%2520reduction%2520of%2520Folfirinox%2520for%2520preserving%2520tumour%2520response%2520in%2520advanced%2520pancreatic%2520cancer%253A%2520Using%2520cumulative%2520relative%2520dose%2520intensity%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2017%26volume%3D76%26spage%3D125%26epage%3D133%26doi%3D10.1016%2Fj.ejca.2017.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knolhoff, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nywening, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang-Gillam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedegebuure, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linehan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNardo, D. G.</span></span> <span> </span><span class="NLM_article-title">CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">5057</span>– <span class="NLM_lpage">5069</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-3723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F0008-5472.CAN-13-3723" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=5057-5069&author=Y.+Zhuauthor=B.+L.+Knolhoffauthor=M.+A.+Meyerauthor=T.+M.+Nyweningauthor=B.+L.+Westauthor=J.+Luoauthor=A.+Wang-Gillamauthor=S.+P.+Goedegebuureauthor=D.+C.+Linehanauthor=D.+G.+DeNardo&title=CSF1%2FCSF1R+blockade+reprograms+tumor-infiltrating+macrophages+and+improves+response+to+T-cell+checkpoint+immunotherapy+in+pancreatic+cancer+models&doi=10.1158%2F0008-5472.CAN-13-3723"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-3723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-3723%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DKnolhoff%26aufirst%3DB.%2BL.%26aulast%3DMeyer%26aufirst%3DM.%2BA.%26aulast%3DNywening%26aufirst%3DT.%2BM.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DWang-Gillam%26aufirst%3DA.%26aulast%3DGoedegebuure%26aufirst%3DS.%2BP.%26aulast%3DLinehan%26aufirst%3DD.%2BC.%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26atitle%3DCSF1%252FCSF1R%2520blockade%2520reprograms%2520tumor-infiltrating%2520macrophages%2520and%2520improves%2520response%2520to%2520T-cell%2520checkpoint%2520immunotherapy%2520in%2520pancreatic%2520cancer%2520models%26jtitle%3DCancer%2520Res.%26date%3D2014%26volume%3D74%26spage%3D5057%26epage%3D5069%26doi%3D10.1158%2F0008-5472.CAN-13-3723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayne, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beatty, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanger, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonderheide, R. H.</span></span> <span> </span><span class="NLM_article-title">Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ccr.2012.04.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=822-835&author=L.+J.+Bayneauthor=G.+L.+Beattyauthor=N.+Jhalaauthor=C.+E.+Clarkauthor=A.+D.+Rhimauthor=B.+Z.+Stangerauthor=R.+H.+Vonderheide&title=Tumor-derived+granulocyte-macrophage+colony-stimulating+factor+regulates+myeloid+inflammation+and+T+cell+immunity+in+pancreatic+cancer&doi=10.1016%2Fj.ccr.2012.04.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DBayne%26aufirst%3DL.%2BJ.%26aulast%3DBeatty%26aufirst%3DG.%2BL.%26aulast%3DJhala%26aufirst%3DN.%26aulast%3DClark%26aufirst%3DC.%2BE.%26aulast%3DRhim%26aufirst%3DA.%2BD.%26aulast%3DStanger%26aufirst%3DB.%2BZ.%26aulast%3DVonderheide%26aufirst%3DR.%2BH.%26atitle%3DTumor-derived%2520granulocyte-macrophage%2520colony-stimulating%2520factor%2520regulates%2520myeloid%2520inflammation%2520and%2520T%2520cell%2520immunity%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D822%26epage%3D835%26doi%3D10.1016%2Fj.ccr.2012.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louzoun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesinski, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span> <span> </span><span class="NLM_article-title">A mathematical model for pancreatic cancer growth and treatments</span>. <i>J. Theor. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1016/j.jtbi.2014.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.jtbi.2014.02.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=74-82&author=Y.+Louzounauthor=C.+Xueauthor=G.+B.+Lesinskiauthor=A.+Friedman&title=A+mathematical+model+for+pancreatic+cancer+growth+and+treatments&doi=10.1016%2Fj.jtbi.2014.02.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jtbi.2014.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtbi.2014.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DLouzoun%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DC.%26aulast%3DLesinski%26aufirst%3DG.%2BB.%26aulast%3DFriedman%26aufirst%3DA.%26atitle%3DA%2520mathematical%2520model%2520for%2520pancreatic%2520cancer%2520growth%2520and%2520treatments%26jtitle%3DJ.%2520Theor.%2520Biol.%26date%3D2014%26volume%3D351%26spage%3D74%26epage%3D82%26doi%3D10.1016%2Fj.jtbi.2014.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmgaard, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamarin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesokhin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merghoub, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolchok, J. D.</span></span> <span> </span><span class="NLM_article-title">Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2, 3-dioxygenase-expressing tumors</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2016.02.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ebiom.2016.02.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=50-58&author=R.+B.+Holmgaardauthor=D.+Zamarinauthor=A.+Lesokhinauthor=T.+Merghoubauthor=J.+D.+Wolchok&title=Targeting+myeloid-derived+suppressor+cells+with+colony+stimulating+factor-1+receptor+blockade+can+reverse+immune+resistance+to+immunotherapy+in+indoleamine+2%2C+3-dioxygenase-expressing+tumors&doi=10.1016%2Fj.ebiom.2016.02.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2016.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2016.02.024%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgaard%26aufirst%3DR.%2BB.%26aulast%3DZamarin%26aufirst%3DD.%26aulast%3DLesokhin%26aufirst%3DA.%26aulast%3DMerghoub%26aufirst%3DT.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26atitle%3DTargeting%2520myeloid-derived%2520suppressor%2520cells%2520with%2520colony%2520stimulating%2520factor-1%2520receptor%2520blockade%2520can%2520reverse%2520immune%2520resistance%2520to%2520immunotherapy%2520in%2520indoleamine%25202%252C%25203-dioxygenase-expressing%2520tumors%26jtitle%3DEBioMedicine%26date%3D2016%26volume%3D6%26spage%3D50%26epage%3D58%26doi%3D10.1016%2Fj.ebiom.2016.02.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodruff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prihoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeSaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboud-Werner, S. L.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor 1 potentiates lung cancer bone metastasis</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2014.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1038%2Flabinvest.2014.1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=371-381&author=J.+Y.+Hungauthor=D.+Hornauthor=K.+Woodruffauthor=T.+Prihodaauthor=C.+LeSauxauthor=J.+Petersauthor=F.+Tioauthor=S.+L.+Abboud-Werner&title=Colony-stimulating+factor+1+potentiates+lung+cancer+bone+metastasis&doi=10.1038%2Flabinvest.2014.1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2014.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2014.1%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DJ.%2BY.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DWoodruff%26aufirst%3DK.%26aulast%3DPrihoda%26aufirst%3DT.%26aulast%3DLeSaux%26aufirst%3DC.%26aulast%3DPeters%26aufirst%3DJ.%26aulast%3DTio%26aufirst%3DF.%26aulast%3DAbboud-Werner%26aufirst%3DS.%2BL.%26atitle%3DColony-stimulating%2520factor%25201%2520potentiates%2520lung%2520cancer%2520bone%2520metastasis%26jtitle%3DLab.%2520Invest.%26date%3D2014%26volume%3D94%26spage%3D371%26epage%3D381%26doi%3D10.1038%2Flabinvest.2014.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ettinger, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akerley, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheney, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chirieac, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demmy, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganti, A. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grannis, F. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanzeb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kris, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennes, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Malley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osarogiagbon, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otterson, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinder-Schenck, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisters, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reckamp, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riely, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HUghes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, K. M.</span></span> <span> </span><span class="NLM_article-title">Non-small cell lung cancer clinical practice guidelines in oncology</span>. <i>J. Natl. Compr. Cancer Network</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.6004/jnccn.2012.0130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.6004%2Fjnccn.2012.0130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23054877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslynsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1236-1271&author=D.+S.+Ettingerauthor=W.+Akerleyauthor=H.+Borghaeiauthor=A.+C.+Changauthor=R.+T.+Cheneyauthor=L.+R.+Chirieacauthor=T.+A.+D%E2%80%99Amicoauthor=T.+L.+Demmyauthor=A.+K.+P.+Gantiauthor=R.+Govindanauthor=F.+W.+Grannisauthor=L.+Hornauthor=T.+M.+Jahanauthor=M.+Jahanzebauthor=A.+Kessingerauthor=R.+Komakiauthor=F.-M.+Kongauthor=M.+G.+Krisauthor=L.+M.+Krugauthor=I.+T.+Lennesauthor=B.+W.+Looauthor=R.+Martinsauthor=J.+O%27Malleyauthor=R.+U.+Osarogiagbonauthor=G.+A.+Ottersonauthor=J.+D.+Patelauthor=M.+C.+Pinder-Schenckauthor=K.+M.+Pistersauthor=K.+Reckampauthor=G.+J.+Rielyauthor=E.+Rohrenauthor=S.+J.+Swansonauthor=D.+E.+Woodauthor=S.+C.+Yangauthor=M.+HUghesauthor=K.+M.+Gregory&title=Non-small+cell+lung+cancer+clinical+practice+guidelines+in+oncology&doi=10.6004%2Fjnccn.2012.0130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Non-small cell lung cancer: clinical practice guidelines in oncology</span></div><div class="casAuthors">Ettinger, David S.; Akerley, Wallace; Borghaei, Hossein; Chang, Andrew C.; Cheney, Richard T.; Chirieac, Lucian R.; D'Amico, Thomas A.; Demmy, Todd L.; Ganti, Apar Kishor P.; Govindan, Ramaswamy; Grannis, Frederic W., Jr.; Horn, Leora; Jahan, Thierry M.; Jahanzeb, Mohammad; Kessinger, Anne; Komaki, Ritsuko; Kong, Feng-Ming; Kris, Mark G.; Krug, Lee M.; Lennes, Inga T.; Loo, Billy W., Jr.; Martins, Renato; O'Malley, Janis; Osarogiagbon, Raymond U.; Otterson, Gregory A.; Patel, Jyoti D.; Pinder-Schenck, Mary C.; Pisters, Katherine M.; Reckhamp, Karen; Riely, Gregory J.; Rohren, Eric; Swanson, Scott J.; Wood, Douglas E.; Yang, Stephen C.; Hughes, Miranda; Gregory, Kristina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Comprehensive Cancer Network</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1236-1271</span>CODEN:
                <span class="NLM_cas:coden">JNCCA4</span>;
        ISSN:<span class="NLM_cas:issn">1540-1405</span>.
    
            (<span class="NLM_cas:orgname">Harborside Press</span>)
        </div><div class="casAbstract">A review.  Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer.  These guidelines only include information about stage IV NSCLC.  Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clin. trials, and/or palliative treatment.  The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment.  If metastatic disease is discovered during surgery, then extensive surgery is often aborted.  Decisions about treatment should be based on multidisciplinary discussion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGPB2lS5HTrVg90H21EOLACvtfcHk0ljyFCShX1g-qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslynsrrL&md5=7c12bc6563fb96f5ce5515a068394eeb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.6004%2Fjnccn.2012.0130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6004%252Fjnccn.2012.0130%26sid%3Dliteratum%253Aachs%26aulast%3DEttinger%26aufirst%3DD.%2BS.%26aulast%3DAkerley%26aufirst%3DW.%26aulast%3DBorghaei%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DA.%2BC.%26aulast%3DCheney%26aufirst%3DR.%2BT.%26aulast%3DChirieac%26aufirst%3DL.%2BR.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DT.%2BA.%26aulast%3DDemmy%26aufirst%3DT.%2BL.%26aulast%3DGanti%26aufirst%3DA.%2BK.%2BP.%26aulast%3DGovindan%26aufirst%3DR.%26aulast%3DGrannis%26aufirst%3DF.%2BW.%26aulast%3DHorn%26aufirst%3DL.%26aulast%3DJahan%26aufirst%3DT.%2BM.%26aulast%3DJahanzeb%26aufirst%3DM.%26aulast%3DKessinger%26aufirst%3DA.%26aulast%3DKomaki%26aufirst%3DR.%26aulast%3DKong%26aufirst%3DF.-M.%26aulast%3DKris%26aufirst%3DM.%2BG.%26aulast%3DKrug%26aufirst%3DL.%2BM.%26aulast%3DLennes%26aufirst%3DI.%2BT.%26aulast%3DLoo%26aufirst%3DB.%2BW.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3DO%2527Malley%26aufirst%3DJ.%26aulast%3DOsarogiagbon%26aufirst%3DR.%2BU.%26aulast%3DOtterson%26aufirst%3DG.%2BA.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DPinder-Schenck%26aufirst%3DM.%2BC.%26aulast%3DPisters%26aufirst%3DK.%2BM.%26aulast%3DReckamp%26aufirst%3DK.%26aulast%3DRiely%26aufirst%3DG.%2BJ.%26aulast%3DRohren%26aufirst%3DE.%26aulast%3DSwanson%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DD.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DHUghes%26aufirst%3DM.%26aulast%3DGregory%26aufirst%3DK.%2BM.%26atitle%3DNon-small%2520cell%2520lung%2520cancer%2520clinical%2520practice%2520guidelines%2520in%2520oncology%26jtitle%3DJ.%2520Natl.%2520Compr.%2520Cancer%2520Network%26date%3D2012%26volume%3D10%26spage%3D1236%26epage%3D1271%26doi%3D10.6004%2Fjnccn.2012.0130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adah, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2016.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.phrs.2016.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27157248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFemtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2016&pages=25-34&author=D.+Adahauthor=M.+Hussainauthor=L.+Qinauthor=L.+Qinauthor=J.+Zhangauthor=X.+Chen&title=Implications+of+MDSCs-targeting+in+lung+cancer+chemo-immunotherapeutics&doi=10.1016%2Fj.phrs.2016.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics</span></div><div class="casAuthors">Adah, Dickson; Hussain, Muzammal; Qin, Limei; Qin, Li; Zhang, Jiancun; Chen, Xiaoping</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Despite advances in chemotherapy and immunotherapy, advanced lung cancer remains an incurable disease.  Novel trends in anticancer therapeutics focus on harnessing the therapeutically-targeted tumor-related immune suppression.  In this respect, myeloid-derived suppressor cells (MDSCs) have captured considerable attention in the last few years, as they are vividly implicated in tumor immune escape mechanisms.  In this review, we specifically discuss the multifaceted roles of MDSCs in lung tumor microenvironment, encompassing lung tumor growth and progression via suppression of anti-tumor immunity, assocn. with worse prognosis, and hampering the efficacy of lung cancer chemotherapy and immunotherapy.  In addn., we also discuss that therapeutic manipulation of MDSCs-targeting, either alone or in combination with chemo- and/or immune-therapeutic regimens, may not only have tumor growth inhibition, anti-angiogenesis and anti-metastasis effects, but may also have the potential to enhance the efficacy of lung cancer chemotherapy and immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobpVR72xV93rVg90H21EOLACvtfcHk0ljyFCShX1g-qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFemtL0%253D&md5=79630ef8a0be79ae52e7fb38049fcbcb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DAdah%26aufirst%3DD.%26aulast%3DHussain%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DImplications%2520of%2520MDSCs-targeting%2520in%2520lung%2520cancer%2520chemo-immunotherapeutics%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D110%26spage%3D25%26epage%3D34%26doi%3D10.1016%2Fj.phrs.2016.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span> <span> </span><span class="NLM_article-title">MiR-1207–5p suppresses lung cancer growth and metastasis by targeting CSF1</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">32421</span>– <span class="NLM_lpage">32432</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.8718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.18632%2Foncotarget.8718" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=32421-32432&author=W.+Dangauthor=Z.+Qinauthor=S.+Fanauthor=Q.+Wenauthor=Y.+Luauthor=J.+Wangauthor=X.+Zhangauthor=L.+Weiauthor=W.+Heauthor=Q.+Yeauthor=Q.+Yanauthor=G.+Liauthor=J.+Ma&title=MiR-1207%E2%80%935p+suppresses+lung+cancer+growth+and+metastasis+by+targeting+CSF1&doi=10.18632%2Foncotarget.8718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.8718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.8718%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DWen%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DJ.%26atitle%3DMiR-1207%25E2%2580%25935p%2520suppresses%2520lung%2520cancer%2520growth%2520and%2520metastasis%2520by%2520targeting%2520CSF1%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D32421%26epage%3D32432%26doi%3D10.18632%2Foncotarget.8718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panni, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linehan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNardo, D. G.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor-infiltrating macrophages to combat cancer</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.2217/imt.13.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.2217%2Fimt.13.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24088077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCrtr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1075-1087&author=R.+Z.+Panniauthor=D.+C.+Linehanauthor=D.+G.+DeNardo&title=Targeting+tumor-infiltrating+macrophages+to+combat+cancer&doi=10.2217%2Fimt.13.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor-infiltrating macrophages to combat cancer</span></div><div class="casAuthors">Panni, Roheena Z.; Linehan, David C.; DeNardo, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1075-1087</span>CODEN:
                <span class="NLM_cas:coden">IMMUCO</span>;
        ISSN:<span class="NLM_cas:issn">1750-743X</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages are one of the major constituents of tumor stroma in many solid tumors and there is compelling preclin. and clin. evidence that macrophages promote cancer initiation and malignant progression.  Therefore, these cells represent potential targets for therapeutic benefit.  In this review, we will summarize macrophage phenotypic heterogeneity, the current understanding of how tumors take advantage of macrophage plasticity to generate immunosuppression, and how manipulation of specific macrophage populations can be used for therapeutic purposes through translational approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhoXbRjxrVErVg90H21EOLACvtfcHk0ljYTGqNz0hD8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCrtr7K&md5=c1be67329f872a65c7d326233cc225e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2217%2Fimt.13.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt.13.102%26sid%3Dliteratum%253Aachs%26aulast%3DPanni%26aufirst%3DR.%2BZ.%26aulast%3DLinehan%26aufirst%3DD.%2BC.%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26atitle%3DTargeting%2520tumor-infiltrating%2520macrophages%2520to%2520combat%2520cancer%26jtitle%3DImmunotherapy%26date%3D2013%26volume%3D5%26spage%3D1075%26epage%3D1087%26doi%3D10.2217%2Fimt.13.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J. H.</span></span> <span> </span><span class="NLM_article-title">Cytokine-mediated bone destruction in rheumatoid arthritis</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2014</i></span>,  <span class="NLM_fpage">263625</span>, <span class="refDoi"> DOI: 10.1155/2014/263625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1155%2F2014%2F263625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25295284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC2M3msVOmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2014&publication_year=2014&pages=263625&author=S.+M.+Jungauthor=K.+W.+Kimauthor=C.-W.+Yangauthor=S.-H.+Parkauthor=J.+H.+Ju&title=Cytokine-mediated+bone+destruction+in+rheumatoid+arthritis&doi=10.1155%2F2014%2F263625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine-mediated bone destruction in rheumatoid arthritis</span></div><div class="casAuthors">Jung Seung Min; Park Sung-Hwan; Kim Kyoung Woon; Yang Chul-Woo; Ju Ji Hyeon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">263625</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bone homeostasis, which involves formation and resorption, is an important process for maintaining adequate bone mass in humans.  Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation and bone loss, leading to joint destruction and deformity, and is a representative disease of disrupted bone homeostasis.  The bone loss and joint destruction are mediated by immunological insults by proinflammatory cytokines and various immune cells.  The connection between bone and immunity has been intensely studied and comprises the emerging field of osteoimmunology.  Osteoimmunology is an interdisciplinary science investigating the interplay between the skeletal and the immune systems.  The main contributors in osteoimmunology are the bone effector cells, such as osteoclasts or osteoblasts, and the immune cells, particularly lymphocytes and monocytes.  Physiologically, osteoclasts originate from immune cells, and immune cells regulate osteoblasts and vice versa.  Pathological conditions such as RA might affect these interactions, thereby altering bone homeostasis, resulting in the unfavorable outcome of bone destruction.  In this review, we describe the osteoclastogenic roles of the proinflammatory cytokines and immune cells that are important in the pathophysiology of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdPpzEjzv6SLHHuJhbyicZfW6udTcc2eYjYJVXKsPppbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3msVOmtA%253D%253D&md5=b710905e9cdf0315fba9b9410681a2d6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1155%2F2014%2F263625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2014%252F263625%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DYang%26aufirst%3DC.-W.%26aulast%3DPark%26aufirst%3DS.-H.%26aulast%3DJu%26aufirst%3DJ.%2BH.%26atitle%3DCytokine-mediated%2520bone%2520destruction%2520in%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2014%26volume%3D2014%26spage%3D263625%26doi%3D10.1155%2F2014%2F263625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. R.</span></span> <span> </span><span class="NLM_article-title">Treatment options for rheumatoid arthritis</span>. <i>Drug Topics</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1999&pages=53-62&author=D.+R.+Miller&title=Treatment+options+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BR.%26atitle%3DTreatment%2520options%2520for%2520rheumatoid%2520arthritis%26jtitle%3DDrug%2520Topics%26date%3D1999%26volume%3D143%26spage%3D53%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartkamp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malvar-Fernandez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanghi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masteller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radstake, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedquist, K. A.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">75</span>, <span class="refDoi"> DOI: 10.1186/s13075-016-0973-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1186%2Fs13075-016-0973-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27036883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVyjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=75&author=S.+Garciaauthor=L.+Hartkampauthor=B.+Malvar-Fernandezauthor=I.+E.+van+Esauthor=H.+Linauthor=J.+Wongauthor=L.+Longauthor=J.+A.+Zanghiauthor=A.+L.+Rankinauthor=E.+L.+Mastellerauthor=B.+R.+Wongauthor=T.+R.+Radstakeauthor=P.+P.+Takauthor=K.+A.+Reedquist&title=Colony-stimulating+factor+%28CSF%29+1+receptor+blockade+reduces+inflammation+in+human+and+murine+models+of+rheumatoid+arthritis&doi=10.1186%2Fs13075-016-0973-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis</span></div><div class="casAuthors">Garcia, Samuel; Hartkamp, Linda M.; Malvar-Fernandez, B.; van Es, Inge E.; Lin, Haishan; Wong, Justin; Long, Li; Zanghi, James A.; Rankin, Andrew L.; Masteller, Emma L.; Wong, Brian R.; Radstake, Timothy R. D. J.; Tak, Paul P.; Reedquist, Kris A.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75/1-75/14</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: CSF-1 or IL-34 stimulation of CSF1R promotes macrophage differentiation, activation and osteoclastogenesis, and pharmacol. inhibition of CSF1R is beneficial in animal models of arthritis.  The objective of this study was to det. the relative contributions of CSF-1 and IL-34 signaling to CSF1R in RA.  Methods: CSF-1 and IL-34 were detected by immunohistochem. and digital image anal. in synovial tissue from 15 biol.-naive rheumatoid arthritis (RA), 15 psoriatic arthritis (PsA) and 7 osteoarthritis (OA) patients.  Gene expression in CSF-1- and IL-34-differentiated human macrophages was assessed by FACS anal. and quant. PCR.  RA synovial explants were incubated with CSF-1, IL-34, control antibody (Ab), or neutralizing/blocking Abs targeting CSF-1, IL-34, or CSF1R.  The effect of a CSF1R-blocking Ab was examd. in murine collagen-induced arthritis (CIA).  Results: CSF-1 (also known as M-CSF) and IL-34 expression was similar in RA and PsA synovial tissue, but lower in controls (P < 0.05).  CSF-1 expression was obsd. in the synovial sublining, and IL-34 in the sublining and the intimal lining layer.  CSF-1 and IL-34 differentially regulated the expression of 17 of 336 inflammation-assocd. genes in macrophages, including chemokines, extra-cellular matrix components, and matrix metalloproteinases.  Exogenous CSF-1 or IL-34, or their independent neutralization, had no effect on RA synovial explant IL-6 prodn.  Anti-CSF1R Ab significantly reduced IL-6 and other inflammatory mediator prodn. in RA synovial explants, and paw swelling and joint destruction in CIA.  Conclusions: Simultaneous inhibition of CSF1R interactions with both CSF-1 and IL-34 suppresses inflammatory activation of RA synovial tissue and pathol. in CIA, suggesting a novel therapeutic strategy for RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeozGQWNoAnLVg90H21EOLACvtfcHk0ljYTGqNz0hD8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVyjsbY%253D&md5=12c52f2156d063843efe928153dcd22c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1186%2Fs13075-016-0973-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-016-0973-6%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DS.%26aulast%3DHartkamp%26aufirst%3DL.%26aulast%3DMalvar-Fernandez%26aufirst%3DB.%26aulast%3Dvan%2BEs%26aufirst%3DI.%2BE.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DL.%26aulast%3DZanghi%26aufirst%3DJ.%2BA.%26aulast%3DRankin%26aufirst%3DA.%2BL.%26aulast%3DMasteller%26aufirst%3DE.%2BL.%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DRadstake%26aufirst%3DT.%2BR.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DReedquist%26aufirst%3DK.%2BA.%26atitle%3DColony-stimulating%2520factor%2520%2528CSF%2529%25201%2520receptor%2520blockade%2520reduces%2520inflammation%2520in%2520human%2520and%2520murine%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2016%26volume%3D18%26spage%3D75%26doi%3D10.1186%2Fs13075-016-0973-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zemmour, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thioudellet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehnert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nimmerjahn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span> <span> </span><span class="NLM_article-title">Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3000</span>, <span class="refDoi"> DOI: 10.1002/art.38624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fart.38624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24623505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVOhtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=2989-3000&author=M.+L.+Tohauthor=J.+Y.+Bonnefoyauthor=N.+Accartauthor=S.+Cochinauthor=S.+Pohleauthor=H.+Haegelauthor=M.+De+Meyerauthor=C.+Zemmourauthor=X.+Previlleauthor=C.+Guillenauthor=C.+Thioudelletauthor=P.+Ancianauthor=A.+Luxauthor=B.+Sehnertauthor=F.+Nimmerjahnauthor=R.+E.+Vollauthor=G.+Schett&title=Bone-+and+cartilage-protective+effects+of+a+monoclonal+antibody+against+colony-stimulating+factor+1+receptor+in+experimental+arthritis&doi=10.1002%2Fart.38624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis</span></div><div class="casAuthors">Toh, Myew-Ling; Bonnefoy, Jean-Yves; Accart, Nathalie; Cochin, Sandrine; Pohle, Sandy; Haegel, Helene; De Meyer, Micael; Zemmour, Christophe; Preville, Xavier; Guillen, Christine; Thioudellet, Christine; Ancian, Philippe; Lux, Anja; Sehnert, Bettina; Nimmerjahn, Falk; Voll, Reinhard E.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2989-3000</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Colony-stimulating factor 1 receptor (CSF-1R) essentially modulates monocyte proliferation, migration, and activation, which are considered important for the pathogenesis of rheumatoid arthritis (RA).  We undertook this study to det. CSF-1R expression in human RA as well as the efficacy of a specific anti-CSF-1R monoclonal antibody (AFS98) in 2 different animal models of RA.  Methods: CSF-1R expression was examd. in blood, synovium, and bone samples from RA patients, osteoarthritis (OA) patients, and healthy subjects.  The efficacy of AFS98 was examd. by clin. assessment, histol., and bone histomorphometry in collagen-induced arthritis (CIA) and serum-transfer arthritis.  Results: CSF-1R expression was increased in the synovium of RA patients compared to OA patients and healthy controls in fibroblast-like synoviocytes, follicular dendritic cells, macrophages, and osteoclasts.  Circulating RA monocytes and neutrophils but not lymphocytes were CSF-1R+.  In mice, blockade of CSF-1R abrogated cartilage damage, bone erosion, and systemic bone loss, and this was assocd. with the depletion of osteoclasts in both models.  While blockade of CSF-1R did not affect inflammation in passive serum-transfer arthritis, it significantly reduced inflammation in CIA, and this was assocd. with the absence of synovial macrophages and reduced splenic CD11b+Gr-1-monocytes.  Conclusion: CSF-1R was broadly expressed in human RA.  Blockade of CSF-1R protected against bone and cartilage destruction in both mouse models and also showed significant antiinflammatory effects in the CIA model.  These data provide evidence for CSF-1R as a therapeutic target in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ8ZxPzKmL4rVg90H21EOLACvtfcHk0lj4BjGqHYPJRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVOhtbnF&md5=4ba72d8cf97bc11a568026c2a480e1dc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fart.38624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.38624%26sid%3Dliteratum%253Aachs%26aulast%3DToh%26aufirst%3DM.%2BL.%26aulast%3DBonnefoy%26aufirst%3DJ.%2BY.%26aulast%3DAccart%26aufirst%3DN.%26aulast%3DCochin%26aufirst%3DS.%26aulast%3DPohle%26aufirst%3DS.%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DDe%2BMeyer%26aufirst%3DM.%26aulast%3DZemmour%26aufirst%3DC.%26aulast%3DPreville%26aufirst%3DX.%26aulast%3DGuillen%26aufirst%3DC.%26aulast%3DThioudellet%26aufirst%3DC.%26aulast%3DAncian%26aufirst%3DP.%26aulast%3DLux%26aufirst%3DA.%26aulast%3DSehnert%26aufirst%3DB.%26aulast%3DNimmerjahn%26aufirst%3DF.%26aulast%3DVoll%26aufirst%3DR.%2BE.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DBone-%2520and%2520cartilage-protective%2520effects%2520of%2520a%2520monoclonal%2520antibody%2520against%2520colony-stimulating%2520factor%25201%2520receptor%2520in%2520experimental%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2014%26volume%3D66%26spage%3D2989%26epage%3D3000%26doi%3D10.1002%2Fart.38624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado-Vazquez, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morado-Urbina, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castãneda-Corral, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta-Gonzalez, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano-Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Andrade, J. M.</span></span> <span> </span><span class="NLM_article-title">Intra-articular administration of an antibody against CSF-1 receptor reduces pain-related behaviors and inflammation in CFA-induced knee arthritis</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>584</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2014.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.neulet.2014.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2015&pages=39-44&author=P.+A.+Alvarado-Vazquezauthor=C.+E.+Morado-Urbinaauthor=G.+Cast%C3%A3neda-Corralauthor=R.+I.+Acosta-Gonzalezauthor=H.+Kitauraauthor=K.+Kimuraauthor=T.+Takano-Yamamotoauthor=J.+M.+Jim%C3%A9nez-Andrade&title=Intra-articular+administration+of+an+antibody+against+CSF-1+receptor+reduces+pain-related+behaviors+and+inflammation+in+CFA-induced+knee+arthritis&doi=10.1016%2Fj.neulet.2014.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2014.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2014.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarado-Vazquez%26aufirst%3DP.%2BA.%26aulast%3DMorado-Urbina%26aufirst%3DC.%2BE.%26aulast%3DCast%25C3%25A3neda-Corral%26aufirst%3DG.%26aulast%3DAcosta-Gonzalez%26aufirst%3DR.%2BI.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DTakano-Yamamoto%26aufirst%3DT.%26aulast%3DJim%25C3%25A9nez-Andrade%26aufirst%3DJ.%2BM.%26atitle%3DIntra-articular%2520administration%2520of%2520an%2520antibody%2520against%2520CSF-1%2520receptor%2520reduces%2520pain-related%2520behaviors%2520and%2520inflammation%2520in%2520CFA-induced%2520knee%2520arthritis%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D584%26spage%3D39%26epage%3D44%26doi%3D10.1016%2Fj.neulet.2014.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stawicki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhyala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.str.2012.02.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=676-687&author=X.+Maauthor=W.+Y.+Linauthor=Y.+Chenauthor=S.+Stawickiauthor=K.+Mukhyalaauthor=Y.+Wuauthor=F.+Martinauthor=J.+F.+Bazanauthor=M.+A.+Starovasnik&title=Structural+basis+for+the+dual+recognition+of+helical+cytokines+IL-34+and+CSF-1+by+CSF-1R&doi=10.1016%2Fj.str.2012.02.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DW.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DStawicki%26aufirst%3DS.%26aulast%3DMukhyala%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DF.%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26atitle%3DStructural%2520basis%2520for%2520the%2520dual%2520recognition%2520of%2520helical%2520cytokines%2520IL-34%2520and%2520CSF-1%2520by%2520CSF-1R%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D676%26epage%3D687%26doi%3D10.1016%2Fj.str.2012.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garceau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapetanovic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sester, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fici, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelly, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, D. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and expression of porcine colony stimulating factor-1 (CSF-1) and colony stimulating factor-1 receptor (CSF-1R) and analysis of the species specificity of stimulation by CSF-1 and Interleukin 34</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">793</span>– <span class="NLM_lpage">805</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2012.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.cyto.2012.08.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=793-805&author=D.+J.+Gowauthor=V.+Garceauauthor=R.+Kapetanovicauthor=D.+P.+Sesterauthor=G.+J.+Ficiauthor=J.+A.+Shellyauthor=T.+L.+Wilsonauthor=D.+A.+Hume&title=Cloning+and+expression+of+porcine+colony+stimulating+factor-1+%28CSF-1%29+and+colony+stimulating+factor-1+receptor+%28CSF-1R%29+and+analysis+of+the+species+specificity+of+stimulation+by+CSF-1+and+Interleukin+34&doi=10.1016%2Fj.cyto.2012.08.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2012.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2012.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DGow%26aufirst%3DD.%2BJ.%26aulast%3DGarceau%26aufirst%3DV.%26aulast%3DKapetanovic%26aufirst%3DR.%26aulast%3DSester%26aufirst%3DD.%2BP.%26aulast%3DFici%26aufirst%3DG.%2BJ.%26aulast%3DShelly%26aufirst%3DJ.%2BA.%26aulast%3DWilson%26aufirst%3DT.%2BL.%26aulast%3DHume%26aufirst%3DD.%2BA.%26atitle%3DCloning%2520and%2520expression%2520of%2520porcine%2520colony%2520stimulating%2520factor-1%2520%2528CSF-1%2529%2520and%2520colony%2520stimulating%2520factor-1%2520receptor%2520%2528CSF-1R%2529%2520and%2520analysis%2520of%2520the%2520species%2520specificity%2520of%2520stimulation%2520by%2520CSF-1%2520and%2520Interleukin%252034%26jtitle%3DCytokine%26date%3D2012%26volume%3D60%26spage%3D793%26epage%3D805%26doi%3D10.1016%2Fj.cyto.2012.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gow, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garceau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pridans, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gow, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, D. A.</span></span> <span> </span><span class="NLM_article-title">Cloning and expression of feline colony stimulating factor receptor (CSF-1R) and analysis of the species specificity of stimulation by colony stimulating factor-1 (CSF-1) and interleukin-34 (IL-34)</span>. <i>Cytokine</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.cyto.2012.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.cyto.2012.11.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=630-638&author=D.+J.+Gowauthor=V.+Garceauauthor=C.+Pridansauthor=A.+G.+Gowauthor=K.+E.+Simpsonauthor=D.+Gunn-Mooreauthor=D.+A.+Hume&title=Cloning+and+expression+of+feline+colony+stimulating+factor+receptor+%28CSF-1R%29+and+analysis+of+the+species+specificity+of+stimulation+by+colony+stimulating+factor-1+%28CSF-1%29+and+interleukin-34+%28IL-34%29&doi=10.1016%2Fj.cyto.2012.11.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cyto.2012.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cyto.2012.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DGow%26aufirst%3DD.%2BJ.%26aulast%3DGarceau%26aufirst%3DV.%26aulast%3DPridans%26aufirst%3DC.%26aulast%3DGow%26aufirst%3DA.%2BG.%26aulast%3DSimpson%26aufirst%3DK.%2BE.%26aulast%3DGunn-Moore%26aufirst%3DD.%26aulast%3DHume%26aufirst%3DD.%2BA.%26atitle%3DCloning%2520and%2520expression%2520of%2520feline%2520colony%2520stimulating%2520factor%2520receptor%2520%2528CSF-1R%2529%2520and%2520analysis%2520of%2520the%2520species%2520specificity%2520of%2520stimulation%2520by%2520colony%2520stimulating%2520factor-1%2520%2528CSF-1%2529%2520and%2520interleukin-34%2520%2528IL-34%2529%26jtitle%3DCytokine%26date%3D2013%26volume%3D61%26spage%3D630%26epage%3D638%26doi%3D10.1016%2Fj.cyto.2012.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masteller, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. R.</span></span> <span> </span><span class="NLM_article-title">Targeting IL-34 in chronic inflammation</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1212</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.drudis.2014.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24906044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1212-1216&author=E.+L.+Mastellerauthor=B.+R.+Wong&title=Targeting+IL-34+in+chronic+inflammation&doi=10.1016%2Fj.drudis.2014.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-34 in chronic inflammation</span></div><div class="casAuthors">Masteller, Emma L.; Wong, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1212-1216</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  A second ligand for colony-stimulating factor-1 receptor (CSF-1R) with distinct biol. activities had long been implicated but not appreciated until the recent discovery of interleukin (IL)-34.  IL-34 and CSF-1 signal through this common receptor to mediate the biol. of mononuclear phagocytic cells.  Aberrant macrophage activation by CSF-1 and/or IL-34 is assocd. with numerous diseases, and clin. therapies targeting this pathway are being tested.  Although IL-34 and CSF-1 have distinct activities under physiol. conditions, they appear functionally redundant in various disease states.  Thus, blocking the activity of both might be necessary for maximal efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRSYJn2BakBbVg90H21EOLACvtfcHk0lhbdB5Lw45eYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShur3I&md5=e673220555f583d447e5e8585ba869f3</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DMasteller%26aufirst%3DE.%2BL.%26aulast%3DWong%26aufirst%3DB.%2BR.%26atitle%3DTargeting%2520IL-34%2520in%2520chronic%2520inflammation%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1212%26epage%3D1216%26doi%3D10.1016%2Fj.drudis.2014.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ségaliny, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohamadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dizier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokajczyk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisson-Vidal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymann, D.</span></span> <span> </span><span class="NLM_article-title">Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1002/ijc.29376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fijc.29376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25471534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyjt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=73-85&author=A.+I.+S%C3%A9galinyauthor=A.+Mohamadiauthor=B.+Dizierauthor=A.+Lokajczykauthor=R.+Brionauthor=R.+Lanelauthor=J.+Amiaudauthor=C.+Charrierauthor=C.+Boisson-Vidalauthor=D.+Heymann&title=Interleukin-34+promotes+tumor+progression+and+metastatic+process+in+osteosarcoma+through+induction+of+angiogenesis+and+macrophage+recruitment&doi=10.1002%2Fijc.29376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment</span></div><div class="casAuthors">Segaliny, Aude I.; Mohamadi, Amel; Dizier, Blandine; Lokajczyk, Anna; Brion, Regis; Lanel, Rachel; Amiaud, Jerome; Charrier, Celine; Boisson-Vidal, Catherine; Heymann, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-85</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Interleukin-34 (IL-34) was recently characterized as the M-CSF "twin" cytokine, regulating the proliferation/differentiation/survival of myeloid cells.  The implication of M-CSF in oncol. was initially suspected by the reduced metastatic dissemination in knock-out mice, due to angiogenesis impairment.  Based on this observation, our work studied the involvement of IL-34 in the pathogenesis of osteosarcoma.  The in vivo effects of IL-34 were assessed on tissue vasculature and macrophage infiltration in a murine preclin. model based on a paratibial inoculation of human osteosarcoma cells overexpressing or not IL-34 or M-CSF.  In vitro investigations using endothelial cell precursors and mature HUVEC cells were performed to analyze the involvement of IL-34 in angiogenesis and myeloid cell adhesion.  The data revealed that IL-34 overexpression was assocd. with the progression of osteosarcoma (tumor growth, lung metastases) and an increase of neo-angiogenesis.  In vitro analyses demonstrated that IL-34 stimulated endothelial cell proliferation and vascular cord formation.  Pre-treatment of endothelial cells by chondroitinases/heparinases reduced the formation of vascular tubes and abolished the assocd. cell signalling.  In addn., IL-34 increased the in vivo recruitment of M2 tumor-assocd. macrophages into the tumor tissue.  IL-34 increased in vitro monocyte/CD34+ cell adhesion to activated HUVEC monolayers under physiol. shear stress conditions.  This work also demonstrates that IL-34 is expressed by osteosarcoma cells, is regulated by TNF-α, IL-1β, and contributes to osteosarcoma growth by increasing the neo-angiogenesis and the recruitment of M2 macrophages.  By promoting new vessel formation and extravasation of immune cells, IL-34 may play a key role in tumor development and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroMj1wADvl57Vg90H21EOLACvtfcHk0lhbdB5Lw45eYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyjt73E&md5=065a3257b00a059065c35812033be8ab</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fijc.29376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29376%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A9galiny%26aufirst%3DA.%2BI.%26aulast%3DMohamadi%26aufirst%3DA.%26aulast%3DDizier%26aufirst%3DB.%26aulast%3DLokajczyk%26aufirst%3DA.%26aulast%3DBrion%26aufirst%3DR.%26aulast%3DLanel%26aufirst%3DR.%26aulast%3DAmiaud%26aufirst%3DJ.%26aulast%3DCharrier%26aufirst%3DC.%26aulast%3DBoisson-Vidal%26aufirst%3DC.%26aulast%3DHeymann%26aufirst%3DD.%26atitle%3DInterleukin-34%2520promotes%2520tumor%2520progression%2520and%2520metastatic%2520process%2520in%2520osteosarcoma%2520through%2520induction%2520of%2520angiogenesis%2520and%2520macrophage%2520recruitment%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D137%26spage%3D73%26epage%3D85%26doi%3D10.1002%2Fijc.29376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. J.</span></span> <span> </span><span class="NLM_article-title">Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis</span>. <i>Arthritis Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">R14</span>, <span class="refDoi"> DOI: 10.1186/ar3693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1186%2Far3693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22264405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlSmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R14&author=S.-J.+Hwangauthor=B.+Choiauthor=S.-S.+Kangauthor=J.-H.+Changauthor=Y.-G.+Kimauthor=Y.-H.+Chungauthor=D.+H.+Sohnauthor=M.+W.+Soauthor=C.+K.+Leeauthor=W.+H.+Robinsonauthor=E.+J.+Chang&title=Interleukin-34+produced+by+human+fibroblast-like+synovial+cells+in+rheumatoid+arthritis+supports+osteoclastogenesis&doi=10.1186%2Far3693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis</span></div><div class="casAuthors">Hwang, Seung-Jun; Choi, Bongkun; Kang, Soon-Suk; Chang, Jae-Ho; Kim, Yong-Gil; Chung, Yeon-Ho; Sohn, Dong Hyun; So, Min Wook; Lee, Chang-Keun; Robinson, William H.; Chang, Eun-Ju</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">R14</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Introduction: Interleukin-34 (IL-34) is a recently defined cytokine, showing a functional overlap with macrophage colony stimulating factor (M-CSF).  This study was undertaken to address the expression of IL-34 in rheumatoid arthritis (RA) patients and to investigate its regulation and pathogenic role in RA.  Methods: IL-34 levels were detd. in the RA synovium, synovial fluid (SF) and fibroblast-like synovial cells (FLS) by immunohistochem., real-time PCR, ELISA and immunoblotting.  RA activity was assessed using Disease Activity Score 28 (DAS28) activity in the plasma collected at baseline and one year after treatment.  Conditioned media (CM) were prepd. from RA FLS culture with tumor necrosis factor alpha (TNFα) for 24 h and used for functional assay.  Results: IL-34 was expressed in the synovium, SF, and FLS from RA patients.  The prodn. of IL-34 in FLS was up-regulated by TNFα in RA samples compared with osteoarthritis (OA) patients.  Importantly, the preferential induction of IL-34 rather than M-CSF by TNFα in RAFLS was mediated by the transcription factor nuclear factor kappa B (NF-κB) and activation of c-Jun N-terminal kinase (JNK).  IL-34 elevation in plasma from RA patients was decreased after the administration of disease-modifying anti-rheumatic drugs (DMARDs) in accordance with a decrease in DAS28.  CM from RAFLS cultured with TNFα promoted chemotactic migration of human peripheral blood mononuclear cells (PBMCs) and subsequent osteoclast (OC) formation, effects that were attenuated by an anti-IL-34 antibody.  Conclusions: These data provide novel information about the prodn. of IL-34 in RA FLS and indicate that IL-34 is an addnl. osteoclastogenic factor regulated by TNFα in RA, suggesting a discrete role of IL-34 in inflammatory RA diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMSlra79yrVrVg90H21EOLACvtfcHk0lhbdB5Lw45eYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlSmsrg%253D&md5=ac340730d901349aae6b80bddca18233</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2Far3693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3693%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.-J.%26aulast%3DChoi%26aufirst%3DB.%26aulast%3DKang%26aufirst%3DS.-S.%26aulast%3DChang%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DY.-G.%26aulast%3DChung%26aufirst%3DY.-H.%26aulast%3DSohn%26aufirst%3DD.%2BH.%26aulast%3DSo%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DRobinson%26aufirst%3DW.%2BH.%26aulast%3DChang%26aufirst%3DE.%2BJ.%26atitle%3DInterleukin-34%2520produced%2520by%2520human%2520fibroblast-like%2520synovial%2520cells%2520in%2520rheumatoid%2520arthritis%2520supports%2520osteoclastogenesis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3DR14%26doi%3D10.1186%2Far3693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vääräniemi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Väänänen, H. K.</span></span> <span> </span><span class="NLM_article-title">The critical role of IL-34 in osteoclastogenesis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e18689</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0018689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0018689" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18689&author=Z.+Chenauthor=K.+Bukiauthor=J.+V%C3%A4%C3%A4r%C3%A4niemiauthor=G.+Guauthor=H.+K.+V%C3%A4%C3%A4n%C3%A4nen&title=The+critical+role+of+IL-34+in+osteoclastogenesis&doi=10.1371%2Fjournal.pone.0018689"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0018689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0018689%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DBuki%26aufirst%3DK.%26aulast%3DV%25C3%25A4%25C3%25A4r%25C3%25A4niemi%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DG.%26aulast%3DV%25C3%25A4%25C3%25A4n%25C3%25A4nen%26aufirst%3DH.%2BK.%26atitle%3DThe%2520critical%2520role%2520of%2520IL-34%2520in%2520osteoclastogenesis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De18689%26doi%3D10.1371%2Fjournal.pone.0018689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.2174/156802609789007327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.2174%2F156802609789007327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=19689368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=599-610&author=S.+Patelauthor=M.+R.+Player&title=Colony-stimulating+factor-1+receptor+inhibitors+for+the+treatment+of+cancer+and+inflammatory+disease&doi=10.2174%2F156802609789007327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease</span></div><div class="casAuthors">Patel, Sharmila; Player, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">599-610</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  FMS is the exclusive receptor tyrosine kinase for colony-stimulating factor-1 (CSF-1, also known as M-CSF), which regulates the survival, proliferation, differentiation, and function of macrophage lineage cells.  Since CSF-1 is overexpressed in many tumors and at sites of inflammation, small mol. inhibitors of CSF-1 appear to offer an attractive strategy for reducing macrophage nos. assocd. with cancer as well as autoimmune and inflammatory disease, such as rheumatoid arthritis (RA).  Numerous FMS inhibitors with structurally distinct chemotypes have been developed and exhibit potent in vitro activity, but only a limited no. of compds. have progressed clin. due to poor selectivity.  To date, only a handful of FMS inhibitors have been tested in models of metastatic bone disease and RA.  This review will summarize the biol. of FMS and its function in bone physiol., inflammation, immunity, and cancer.  In addn., efforts directed towards identifying FMS-selective small mol. inhibitors as well as the advancement of non-selective inhibitors in the clinic will be highlighted.  Furthermore, emerging monoclonal antibody-based therapeutic strategies specifically targeting M-CSF will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH40LdAlM5MrVg90H21EOLACvtfcHk0liIt5E_S-8nxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFehsLjO&md5=26bb4dd543b4b052df03aede1ec010b1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F156802609789007327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789007327%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26atitle%3DColony-stimulating%2520factor-1%2520receptor%2520inhibitors%2520for%2520the%2520treatment%2520of%2520cancer%2520and%2520inflammatory%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D599%26epage%3D610%26doi%3D10.2174%2F156802609789007327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ginhoux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leboeuf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samokhvalov, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merad, M.</span></span> <span> </span><span class="NLM_article-title">Fate mapping analysis reveals that adult microglia derive from primitive macrophages</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">841</span>– <span class="NLM_lpage">845</span>, <span class="refDoi"> DOI: 10.1126/science.1194637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1126%2Fscience.1194637" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=841-845&author=F.+Ginhouxauthor=M.+Greterauthor=M.+Leboeufauthor=S.+Nandiauthor=P.+Seeauthor=S.+Gokhanauthor=M.+F.+Mehlerauthor=S.+J.+Conwayauthor=L.+G.+Ngauthor=E.+R.+Stanleyauthor=I.+M.+Samokhvalovauthor=M.+Merad&title=Fate+mapping+analysis+reveals+that+adult+microglia+derive+from+primitive+macrophages&doi=10.1126%2Fscience.1194637"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194637%26sid%3Dliteratum%253Aachs%26aulast%3DGinhoux%26aufirst%3DF.%26aulast%3DGreter%26aufirst%3DM.%26aulast%3DLeboeuf%26aufirst%3DM.%26aulast%3DNandi%26aufirst%3DS.%26aulast%3DSee%26aufirst%3DP.%26aulast%3DGokhan%26aufirst%3DS.%26aulast%3DMehler%26aufirst%3DM.%2BF.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DNg%26aufirst%3DL.%2BG.%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DSamokhvalov%26aufirst%3DI.%2BM.%26aulast%3DMerad%26aufirst%3DM.%26atitle%3DFate%2520mapping%2520analysis%2520reveals%2520that%2520adult%2520microglia%2520derive%2520from%2520primitive%2520macrophages%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D841%26epage%3D845%26doi%3D10.1126%2Fscience.1194637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erblich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etgen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrenis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J. W.</span></span> <span> </span><span class="NLM_article-title">Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e26317</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0026317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0026317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26317&author=B.+Erblichauthor=L.+Zhuauthor=A.+M.+Etgenauthor=K.+Dobrenisauthor=J.+W.+Pollard&title=Absence+of+colony+stimulation+factor-1+receptor+results+in+loss+of+microglia%2C+disrupted+brain+development+and+olfactory+deficits&doi=10.1371%2Fjournal.pone.0026317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026317%26sid%3Dliteratum%253Aachs%26aulast%3DErblich%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DEtgen%26aufirst%3DA.%2BM.%26aulast%3DDobrenis%26aufirst%3DK.%26aulast%3DPollard%26aufirst%3DJ.%2BW.%26atitle%3DAbsence%2520of%2520colony%2520stimulation%2520factor-1%2520receptor%2520results%2520in%2520loss%2520of%2520microglia%252C%2520disrupted%2520brain%2520development%2520and%2520olfactory%2520deficits%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26317%26doi%3D10.1371%2Fjournal.pone.0026317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, M. R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafi, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koike, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2014.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.neuron.2014.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24742461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFCntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=380-397&author=M.+R.+P.+Elmoreauthor=A.+R.+Najafiauthor=M.+A.+Koikeauthor=N.+N.+Dagherauthor=E.+E.+Spangenbergauthor=R.+A.+Riceauthor=M.+Kitazawaauthor=B.+Matusowauthor=H.+Nguyenauthor=B.+L.+Westauthor=K.+N.+Green&title=Colony-stimulating+factor+1+receptor+signaling+is+necessary+for+microglia+viability%2C+unmasking+a+microglia+progenitor+cell+in+the+adult+brain&doi=10.1016%2Fj.neuron.2014.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain</span></div><div class="casAuthors">Elmore, Monica R. P.; Najafi, Allison R.; Koike, Maya A.; Dagher, Nabil N.; Spangenberg, Elizabeth E.; Rice, Rachel A.; Kitazawa, Masashi; Matusow, Bernice; Nguyen, Hoa; West, Brian L.; Green, Kim N.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">380-397</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The colony-stimulating factor 1 receptor (CSF1R) is a key regulator of myeloid lineage cells.  Genetic loss of the CSF1R blocks the normal population of resident microglia in the brain that originates from the yolk sac during early development.  However, the role of CSF1R signaling in microglial homeostasis in the adult brain is largely unknown.  To this end, we tested the effects of selective CSF1R inhibitors on microglia in adult mice.  Surprisingly, extensive treatment results in elimination of ∼99% of all microglia brain-wide, showing that microglia in the adult brain are physiol. dependent upon CSF1R signaling.  Mice depleted of microglia show no behavioral or cognitive abnormalities, revealing that microglia are not necessary for these tasks.  Finally, we discovered that the microglia-depleted brain completely repopulates with new microglia within 1 wk of inhibitor cessation.  Microglial repopulation throughout the CNS occurs through proliferation of nestin-pos. cells that then differentiate into microglia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodzm1jC50Da7Vg90H21EOLACvtfcHk0liIt5E_S-8nxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFCntrs%253D&md5=144e568df88ec548687221d1b5b39084</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DElmore%26aufirst%3DM.%2BR.%2BP.%26aulast%3DNajafi%26aufirst%3DA.%2BR.%26aulast%3DKoike%26aufirst%3DM.%2BA.%26aulast%3DDagher%26aufirst%3DN.%2BN.%26aulast%3DSpangenberg%26aufirst%3DE.%2BE.%26aulast%3DRice%26aufirst%3DR.%2BA.%26aulast%3DKitazawa%26aufirst%3DM.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26atitle%3DColony-stimulating%2520factor%25201%2520receptor%2520signaling%2520is%2520necessary%2520for%2520microglia%2520viability%252C%2520unmasking%2520a%2520microglia%2520progenitor%2520cell%2520in%2520the%2520adult%2520brain%26jtitle%3DNeuron%26date%3D2014%26volume%3D82%26spage%3D380%26epage%3D397%26doi%3D10.1016%2Fj.neuron.2014.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikodemova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maklakova, V. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watters, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, L. S.</span></span> <span> </span><span class="NLM_article-title">CSF1 overexpression has pleiotropic effects on microglia in vivo</span>. <i>Glia.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1955</span>– <span class="NLM_lpage">1967</span>, <span class="refDoi"> DOI: 10.1002/glia.22717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1002%2Fglia.22717" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=1955-1967&author=I.+Deauthor=M.+Nikodemovaauthor=M.+D.+Steffenauthor=E.+Soknauthor=V.+I.+Maklakovaauthor=J.+J.+Wattersauthor=L.+S.+Collier&title=CSF1+overexpression+has+pleiotropic+effects+on+microglia+in+vivo&doi=10.1002%2Fglia.22717"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fglia.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.22717%26sid%3Dliteratum%253Aachs%26aulast%3DDe%26aufirst%3DI.%26aulast%3DNikodemova%26aufirst%3DM.%26aulast%3DSteffen%26aufirst%3DM.%2BD.%26aulast%3DSokn%26aufirst%3DE.%26aulast%3DMaklakova%26aufirst%3DV.%2BI.%26aulast%3DWatters%26aufirst%3DJ.%2BJ.%26aulast%3DCollier%26aufirst%3DL.%2BS.%26atitle%3DCSF1%2520overexpression%2520has%2520pleiotropic%2520effects%2520on%2520microglia%2520in%2520vivo%26jtitle%3DGlia.%26date%3D2014%26volume%3D62%26spage%3D1955%26epage%3D1967%26doi%3D10.1002%2Fglia.22717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, W.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, F.-D.</span></span> <span> </span><span class="NLM_article-title">Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">2383</span>– <span class="NLM_lpage">2395</span>, <span class="refDoi"> DOI: 10.1177/0271678X16666551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1177%2F0271678X16666551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=27596835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=2383-2395&author=M.+Liauthor=Z.+Liauthor=H.+Renauthor=W.-N.+Jinauthor=K.+Woodauthor=Q.+Liuauthor=K.+N.+Shethauthor=F.-D.+Shi&title=Colony+stimulating+factor+1+receptor+inhibition+eliminates+microglia+and+attenuates+brain+injury+after+intracerebral+hemorrhage&doi=10.1177%2F0271678X16666551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage</span></div><div class="casAuthors">Li, Minshu; Li, Zhiguo; Ren, Honglei; Jin, Wei-Na; Wood, Kristofer; Liu, Qiang; Sheth, Kevin N.; Shi, Fu-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2383-2395</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Microglia are the first responders to intracerebral hemorrhage, but their precise role in intracerebral hemorrhage remains to be defined.  Microglia are the only type of brain cells expressing the colony-stimulating factor 1 receptor, a key regulator for myeloid lineage cells.  Here, we detd. the effects of a colony-stimulating factor 1 receptor inhibitor (PLX3397) on microglia and the outcome in the context of exptl. mouse intracerebral hemorrhage.  We show that PLX3397 effectively depleted microglia, and the depletion of microglia was sustained after intracerebral hemorrhage.  Importantly, colony-stimulating factor 1 receptor inhibition attenuated neurodeficits and brain edema in two exptl. models of intracerebral hemorrhage induced by injection of collagenase or autologous blood.  The benefit of colony-stimulating factor 1 receptor inhibition was assocd. with reduced leukocyte infiltration in the brain and improved blood-brain barrier integrity after intracerebral hemorrhage, and each observation was independent of lesion size or hematoma vol.  These results demonstrate that suppression of colony-stimulating factor 1 receptor signaling ablates microglia and confers protection after intracerebral hemorrhage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0E35okPweUbVg90H21EOLACvtfcHk0li0GXhm7nFqEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKntbg%253D&md5=012ccb38351fe9ac0d750c37b1ab1d51</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1177%2F0271678X16666551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0271678X16666551%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DW.-N.%26aulast%3DWood%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSheth%26aufirst%3DK.%2BN.%26aulast%3DShi%26aufirst%3DF.-D.%26atitle%3DColony%2520stimulating%2520factor%25201%2520receptor%2520inhibition%2520eliminates%2520microglia%2520and%2520attenuates%2520brain%2520injury%2520after%2520intracerebral%2520hemorrhage%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2017%26volume%3D37%26spage%3D2383%26epage%3D2395%26doi%3D10.1177%2F0271678X16666551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erblich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Etgen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrenis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J. W.</span></span> <span> </span><span class="NLM_article-title">Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e26317</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0026317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0026317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26317&author=B.+Erblichauthor=L.+Zhuauthor=A.+M.+Etgenauthor=K.+Dobrenisauthor=J.+W.+Pollard&title=Absence+of+colony+stimulation+factor-1+receptor+results+in+loss+of+microglia%2C+disrupted+brain+development+and+olfactory+deficits&doi=10.1371%2Fjournal.pone.0026317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026317%26sid%3Dliteratum%253Aachs%26aulast%3DErblich%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DEtgen%26aufirst%3DA.%2BM.%26aulast%3DDobrenis%26aufirst%3DK.%26aulast%3DPollard%26aufirst%3DJ.%2BW.%26atitle%3DAbsence%2520of%2520colony%2520stimulation%2520factor-1%2520receptor%2520results%2520in%2520loss%2520of%2520microglia%252C%2520disrupted%2520brain%2520development%2520and%2520olfactory%2520deficits%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26317%26doi%3D10.1371%2Fjournal.pone.0026317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chitu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokhan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span> <span> </span><span class="NLM_article-title">Emerging roles for CSF-1 receptor and its ligands in the nervous system</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">393</span>, <span class="refDoi"> DOI: 10.1016/j.tins.2016.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.tins.2016.03.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=378-393&author=V.+Chituauthor=S.+Gokhanauthor=S.+Nandiauthor=M.+F.+Mehlerauthor=E.+R.+Stanley&title=Emerging+roles+for+CSF-1+receptor+and+its+ligands+in+the+nervous+system&doi=10.1016%2Fj.tins.2016.03.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2016.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2016.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DChitu%26aufirst%3DV.%26aulast%3DGokhan%26aufirst%3DS.%26aulast%3DNandi%26aufirst%3DS.%26aulast%3DMehler%26aufirst%3DM.%2BF.%26aulast%3DStanley%26aufirst%3DE.%2BR.%26atitle%3DEmerging%2520roles%2520for%2520CSF-1%2520receptor%2520and%2520its%2520ligands%2520in%2520the%2520nervous%2520system%26jtitle%3DTrends%2520Neurosci.%26date%3D2016%26volume%3D39%26spage%3D378%26epage%3D393%26doi%3D10.1016%2Fj.tins.2016.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fend, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Accart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kintz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Préville, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e73310</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0073310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0073310" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73310&author=L.+Fendauthor=N.+Accartauthor=J.+Kintzauthor=S.+Cochinauthor=C.+Reymannauthor=F.+Le+Pogamauthor=J.+B.+Marchandauthor=T.+Menguyauthor=P.+Slosauthor=R.+Rookeauthor=S.+Fournelauthor=J.+Y.+Bonnefoyauthor=X.+Pr%C3%A9villeauthor=H.+Haegel&title=Therapeutic+effects+of+anti-CD115+monoclonal+antibody+in+mouse+cancer+models+through+dual+inhibition+of+tumor-associated+macrophages+and+osteoclasts&doi=10.1371%2Fjournal.pone.0073310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073310%26sid%3Dliteratum%253Aachs%26aulast%3DFend%26aufirst%3DL.%26aulast%3DAccart%26aufirst%3DN.%26aulast%3DKintz%26aufirst%3DJ.%26aulast%3DCochin%26aufirst%3DS.%26aulast%3DReymann%26aufirst%3DC.%26aulast%3DLe%2BPogam%26aufirst%3DF.%26aulast%3DMarchand%26aufirst%3DJ.%2BB.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DSlos%26aufirst%3DP.%26aulast%3DRooke%26aufirst%3DR.%26aulast%3DFournel%26aufirst%3DS.%26aulast%3DBonnefoy%26aufirst%3DJ.%2BY.%26aulast%3DPr%25C3%25A9ville%26aufirst%3DX.%26aulast%3DHaegel%26aufirst%3DH.%26atitle%3DTherapeutic%2520effects%2520of%2520anti-CD115%2520monoclonal%2520antibody%2520in%2520mouse%2520cancer%2520models%2520through%2520dual%2520inhibition%2520of%2520tumor-associated%2520macrophages%2520and%2520osteoclasts%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73310%26doi%3D10.1371%2Fjournal.pone.0073310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hakami, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano-Yamamoto, T.</span></span> <span> </span><span class="NLM_article-title">An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model</span>. <i>Oral Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1111/odi.12117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1111%2Fodi.12117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23651419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC3snhsFeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=319-324&author=K.+Kimuraauthor=H.+Kitauraauthor=T.+Fujiiauthor=M.+Ishidaauthor=Z.+W.+Hakamiauthor=T.+Takano-Yamamoto&title=An+anti-c-Fms+antibody+inhibits+osteoclastogenesis+in+a+mouse+periodontitis+model&doi=10.1111%2Fodi.12117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model</span></div><div class="casAuthors">Kimura K; Kitaura H; Fujii T; Ishida M; Hakami Z W; Takano-Yamamoto T</div><div class="citationInfo"><span class="NLM_cas:title">Oral diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Bacterial lipopolysaccharide (LPS) can induce inflammatory bone loss such as periodontal disease.  The formation of osteoclasts depends on macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kb ligand (RANKL).  It has recently been reported that administration of an antibody of the M-CSF receptor c-Fms completely blocked osteoclastogenesis and bone erosion induced by LPS in mouse calvaria.  In this study, the effect of antibody against c-Fms in the mouse periodontitis model by injection of LPS was investigated.  MATERIALS AND METHODS:  C57BL6/J mice were injected with LPS and anti-c-Fms antibody into the mesial gingiva of the first molar in the left mandible.  Histological sections of periodontal tissue were stained for tartrate-resistant acid phosphatase, and osteoclast numbers and ratio of alveolar bone resorption determined.  RESULTS:  The number of osteoclasts and ratio of alveolar bone resorption in mice administered both LPS and anti-c-Fms antibody was lower than those in mice administered LPS alone.  The expression of RANKL receptor, RANK, was inhibited by the anti-c-Fms antibody in periodontal tissue.  CONCLUSION:  M-CSF and/or its receptor are potential therapeutic targets for the treatment of bone resorption, caused by LPS, in periodontitis.  Injection of an anti-c-Fms antibody might be useful for inhibition of pathological bone resorption in periodontitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEM4WnxGgp5_h3YQQtAhNufW6udTcc2eYcNrmgNi3pTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snhsFeksw%253D%253D&md5=052db4810d7f6558d89f8f76609a3e64</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fodi.12117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fodi.12117%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DM.%26aulast%3DHakami%26aufirst%3DZ.%2BW.%26aulast%3DTakano-Yamamoto%26aufirst%3DT.%26atitle%3DAn%2520anti-c-Fms%2520antibody%2520inhibits%2520osteoclastogenesis%2520in%2520a%2520mouse%2520periodontitis%2520model%26jtitle%3DOral%2520Dis.%26date%3D2014%26volume%3D20%26spage%3D319%26epage%3D324%26doi%3D10.1111%2Fodi.12117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanington, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belosevic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreda, D. R.</span></span> <span> </span><span class="NLM_article-title">Control of CSF-1 induced inflammation in teleost fish by a soluble form of the CSF-1 receptor</span>. <i>Fish Shellfish Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.fsi.2014.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.fsi.2014.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24726317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=45-51&author=A.+M.+Riegerauthor=P.+C.+Haningtonauthor=M.+Belosevicauthor=D.+R.+Barreda&title=Control+of+CSF-1+induced+inflammation+in+teleost+fish+by+a+soluble+form+of+the+CSF-1+receptor&doi=10.1016%2Fj.fsi.2014.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Control of CSF-1 induced inflammation in teleost fish by a soluble form of the CSF-1 receptor</span></div><div class="casAuthors">Rieger, Aja M.; Hanington, Patrick C.; Belosevic, Miodrag; Barreda, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Fish & Shellfish Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">FSIMEP</span>;
        ISSN:<span class="NLM_cas:issn">1050-4648</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The colony-stimulating factor-1 (CSF-1) is the principal regulator of the survival, proliferation, differentiation, and function of macrophages and their precursors, and has been shown to play a role in the etiol. of inflammation.  We recently identified a novel mechanism for the control of CSF-1 activity in teleost fish, through the prodn. of an inhibitory sol. form of the CSF-1 receptor (sCSF-1R).  Primary goldfish kidney macrophages selectively expressed sCSF-1R during the senescence phase, which corresponds to a defined stage of in vitro culture development where inhibition of macrophage proliferation and apoptotic cell death are prominent.  In contrast, primary macrophage cultures undergoing active proliferation displayed low levels of sCSF-1R expression.  Addn. of purified recombinant sCSF-1R to developing primary macrophage cultures leads to a dose-dependent decrease in macrophage proliferation and inhibits macrophage antimicrobial functions including chemotaxis, phagocytosis, and prodn. of reactive oxygen intermediates.  Using a goldfish in vivo model of self-resolving peritonitis, we found that sCSF-1R plays a role in the inhibition of inflammation, following an initial acute phase of antimicrobial responses within an inflammatory site.  Sol. CSF-1R inhibits pro-inflammatory cytokine prodn., inhibits leukocyte recruitment to the inflammatory site and decreases ROS prodn. in a dose-dependent manner.  This sCSF-1R-dependent regulation of inflammation appears to be an elegant mechanism for the control of macrophage nos. at inflammatory sites of lower vertebrates.  Overall, our results provide new insights into the evolutionary origins of the CSF-1 immune regulatory axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWR6y3FDzWTbVg90H21EOLACvtfcHk0ljbL-jxnLtSUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvV2hsbY%253D&md5=a5a6b74143839127285e69365a246681</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.fsi.2014.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fsi.2014.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DA.%2BM.%26aulast%3DHanington%26aufirst%3DP.%2BC.%26aulast%3DBelosevic%26aufirst%3DM.%26aulast%3DBarreda%26aufirst%3DD.%2BR.%26atitle%3DControl%2520of%2520CSF-1%2520induced%2520inflammation%2520in%2520teleost%2520fish%2520by%2520a%2520soluble%2520form%2520of%2520the%2520CSF-1%2520receptor%26jtitle%3DFish%2520Shellfish%2520Immunol.%26date%3D2014%26volume%3D41%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.fsi.2014.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thioudellet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settelen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rissanen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayette, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J. Y.</span></span> <span> </span><span class="NLM_article-title">A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells</span>. <i>MAbs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.4161/mabs.25743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4161%2Fmabs.25743" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=736-747&author=H.+Haegelauthor=C.+Thioudelletauthor=R.+Halletauthor=M.+Geistauthor=T.+Menguyauthor=F.+Le+Pogamauthor=J.+B.+Marchandauthor=M.+L.+Tohauthor=V.+Duongauthor=A.+Calceiauthor=N.+Settelenauthor=X.+Previlleauthor=M.+Hennequiauthor=B.+Grellierauthor=P.+Ancianauthor=J.+Rissanenauthor=P.+Clayetteauthor=C.+Guillenauthor=R.+Rookeauthor=J.+Y.+Bonnefoy&title=A+unique+anti-CD115+monoclonal+antibody+which+inhibits+osteolysis+and+skews+human+monocyte+differentiation+from+M2-polarized+macrophages+toward+dendritic+cells&doi=10.4161%2Fmabs.25743"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.4161%2Fmabs.25743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.25743%26sid%3Dliteratum%253Aachs%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DThioudellet%26aufirst%3DC.%26aulast%3DHallet%26aufirst%3DR.%26aulast%3DGeist%26aufirst%3DM.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DLe%2BPogam%26aufirst%3DF.%26aulast%3DMarchand%26aufirst%3DJ.%2BB.%26aulast%3DToh%26aufirst%3DM.%2BL.%26aulast%3DDuong%26aufirst%3DV.%26aulast%3DCalcei%26aufirst%3DA.%26aulast%3DSettelen%26aufirst%3DN.%26aulast%3DPreville%26aufirst%3DX.%26aulast%3DHennequi%26aufirst%3DM.%26aulast%3DGrellier%26aufirst%3DB.%26aulast%3DAncian%26aufirst%3DP.%26aulast%3DRissanen%26aufirst%3DJ.%26aulast%3DClayette%26aufirst%3DP.%26aulast%3DGuillen%26aufirst%3DC.%26aulast%3DRooke%26aufirst%3DR.%26aulast%3DBonnefoy%26aufirst%3DJ.%2BY.%26atitle%3DA%2520unique%2520anti-CD115%2520monoclonal%2520antibody%2520which%2520inhibits%2520osteolysis%2520and%2520skews%2520human%2520monocyte%2520differentiation%2520from%2520M2-polarized%2520macrophages%2520toward%2520dendritic%2520cells%26jtitle%3DMAbs%26date%3D2013%26volume%3D5%26spage%3D736%26epage%3D747%26doi%3D10.4161%2Fmabs.25743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Pogam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starck, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancian, P.</span></span> <span> </span><span class="NLM_article-title">3D modeling and characterization of the human CD115 monoclonal antibody H27K15 epitope and design of a chimeric CD115 target</span>. <i>MAbs</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.4161/mabs.27736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4161%2Fmabs.27736" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=533-546&author=B.+Grellierauthor=F.+Le+Pogamauthor=M.+Vitorinoauthor=J.-P.+Starckauthor=M.+Geistauthor=V.+Duongauthor=H.+Haegelauthor=T.+Menguyauthor=J.-Y.+Bonnefoyauthor=J.+B.+Marchandauthor=P.+Ancian&title=3D+modeling+and+characterization+of+the+human+CD115+monoclonal+antibody+H27K15+epitope+and+design+of+a+chimeric+CD115+target&doi=10.4161%2Fmabs.27736"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.4161%2Fmabs.27736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.27736%26sid%3Dliteratum%253Aachs%26aulast%3DGrellier%26aufirst%3DB.%26aulast%3DLe%2BPogam%26aufirst%3DF.%26aulast%3DVitorino%26aufirst%3DM.%26aulast%3DStarck%26aufirst%3DJ.-P.%26aulast%3DGeist%26aufirst%3DM.%26aulast%3DDuong%26aufirst%3DV.%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DBonnefoy%26aufirst%3DJ.-Y.%26aulast%3DMarchand%26aufirst%3DJ.%2BB.%26aulast%3DAncian%26aufirst%3DP.%26atitle%3D3D%2520modeling%2520and%2520characterization%2520of%2520the%2520human%2520CD115%2520monoclonal%2520antibody%2520H27K15%2520epitope%2520and%2520design%2520of%2520a%2520chimeric%2520CD115%2520target%26jtitle%3DMAbs%26date%3D2014%26volume%3D6%26spage%3D533%26epage%3D546%26doi%3D10.4161%2Fmabs.27736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ries, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannarile, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartha, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey-Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradel, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuerhake, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucknischke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiblich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluza, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorr, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Visser, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Italiano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tourneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delord, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blay, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüttinger, D.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2014.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.ccr.2014.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24898549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=846-859&author=C.+H.+Riesauthor=M.+A.+Cannarileauthor=S.+Hovesauthor=J.+Benzauthor=K.+Warthaauthor=V.+Runzaauthor=F.+Rey-Giraudauthor=L.+P.+Pradelauthor=F.+Feuerhakeauthor=I.+Klamanauthor=T.+Jonesauthor=U.+Jucknischkeauthor=S.+Scheiblichauthor=K.+Kaluzaauthor=I.+H.+Gorrauthor=A.+Walzauthor=K.+Abirajauthor=P.+A.+Cassierauthor=A.+Sicaauthor=C.+Gomez-Rocaauthor=K.+E.+de+Visserauthor=A.+Italianoauthor=C.+Le+Tourneauauthor=J.+P.+Delordauthor=H.+Levitskyauthor=J.+Y.+Blayauthor=D.+R%C3%BCttinger&title=Targeting+tumor-associated+macrophages+with+anti-CSF-1R+antibody+reveals+a+strategy+for+cancer+therapy&doi=10.1016%2Fj.ccr.2014.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy</span></div><div class="casAuthors">Ries, Carola H.; Cannarile, Michael A.; Hoves, Sabine; Benz, Joerg; Wartha, Katharina; Runza, Valeria; Rey-Giraud, Flora; Pradel, Leon P.; Feuerhake, Friedrich; Klaman, Irina; Jones, Tobin; Jucknischke, Ute; Scheiblich, Stefan; Kaluza, Klaus; Gorr, Ingo H.; Walz, Antje; Abiraj, Keelara; Cassier, Philippe A.; Sica, Antonio; Gomez-Roca, Carlos; de Visser, Karin E.; Italiano, Antoine; Le Tourneau, Christophe; Delord, Jean-Pierre; Levitsky, Hyam; Blay, Jean-Yves; Ruettinger, Dominik</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Macrophage infiltration has been identified as an independent poor prognostic factor in several cancer types.  The major survival factor for these macrophages is macrophage colony-stimulating factor 1 (CSF-1).  We generated a monoclonal antibody (RG7155) that inhibits CSF-1 receptor (CSF-1R) activation.  In vitro RG7155 treatment results in cell death of CSF-1-differentiated macrophages.  In animal models, CSF-1R inhibition strongly reduces F4/80+ tumor-assocd. macrophages accompanied by an increase of the CD8+/CD4+ T cell ratio.  Administration of RG7155 to patients led to striking redns. of CSF-1R+CD163+ macrophages in tumor tissues, which translated into clin. objective responses in diffuse-type giant cell tumor (Dt-GCT) patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXw3weYo79F7Vg90H21EOLACvtfcHk0lifANO8Oh832w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCntrw%253D&md5=023e0585a753021f10b204c6aeb72d4b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2014.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2014.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DRies%26aufirst%3DC.%2BH.%26aulast%3DCannarile%26aufirst%3DM.%2BA.%26aulast%3DHoves%26aufirst%3DS.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DWartha%26aufirst%3DK.%26aulast%3DRunza%26aufirst%3DV.%26aulast%3DRey-Giraud%26aufirst%3DF.%26aulast%3DPradel%26aufirst%3DL.%2BP.%26aulast%3DFeuerhake%26aufirst%3DF.%26aulast%3DKlaman%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DT.%26aulast%3DJucknischke%26aufirst%3DU.%26aulast%3DScheiblich%26aufirst%3DS.%26aulast%3DKaluza%26aufirst%3DK.%26aulast%3DGorr%26aufirst%3DI.%2BH.%26aulast%3DWalz%26aufirst%3DA.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DCassier%26aufirst%3DP.%2BA.%26aulast%3DSica%26aufirst%3DA.%26aulast%3DGomez-Roca%26aufirst%3DC.%26aulast%3Dde%2BVisser%26aufirst%3DK.%2BE.%26aulast%3DItaliano%26aufirst%3DA.%26aulast%3DLe%2BTourneau%26aufirst%3DC.%26aulast%3DDelord%26aufirst%3DJ.%2BP.%26aulast%3DLevitsky%26aufirst%3DH.%26aulast%3DBlay%26aufirst%3DJ.%2BY.%26aulast%3DR%25C3%25BCttinger%26aufirst%3DD.%26atitle%3DTargeting%2520tumor-associated%2520macrophages%2520with%2520anti-CSF-1R%2520antibody%2520reveals%2520a%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DCancer%2520Cell%26date%3D2014%26volume%3D25%26spage%3D846%26epage%3D859%26doi%3D10.1016%2Fj.ccr.2014.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Italiano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Roca, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tourneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toulmonde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannarile, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillouet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jegg, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bröske, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray-French, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freilinger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meneses-Lorente, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baehner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratnayake, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gass, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christen, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukarma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bompas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delord, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blay, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüttinger, D.</span></span> <span> </span><span class="NLM_article-title">CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(15)00132-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2FS1470-2045%2815%2900132-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26179200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2isb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=949-956&author=P.+A.+Cassierauthor=A.+Italianoauthor=C.+A.+Gomez-Rocaauthor=C.+Le+Tourneauauthor=M.+Toulmondeauthor=M.+A.+Cannarileauthor=C.+Riesauthor=A.+Brillouetauthor=C.+M%C3%BCllerauthor=A.+M.+Jeggauthor=A.+M.+Br%C3%B6skeauthor=M.+Dembowskiauthor=K.+Bray-Frenchauthor=C.+Freilingerauthor=G.+Meneses-Lorenteauthor=M.+Baehnerauthor=R.+Hardingauthor=J.+Ratnayakeauthor=K.+Abirajauthor=N.+Gassauthor=K.+Nohauthor=R.+D.+Christenauthor=L.+Ukarmaauthor=E.+Bompasauthor=J.+P.+Delordauthor=J.+Y.+Blayauthor=D.+R%C3%BCttinger&title=CSF1R+inhibition+with+emactuzumab+in+locally+advanced+diffuse-type+tenosynovial+giant+cell+tumours+of+the+soft+tissue%3A+a+dose-escalation+and+dose-expansion+phase+1+study&doi=10.1016%2FS1470-2045%2815%2900132-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study</span></div><div class="casAuthors">Cassier, Philippe A.; Italiano, Antoine; Gomez-Roca, Carlos A.; Le Tourneau, Christophe; Toulmonde, Maud; Cannarile, Michael A.; Ries, Carola; Brillouet, Anne; Muller, Claudia; Jegg, Anna-Maria; Broske, Ann-Marie; Dembowski, Markus; Bray-French, Katharine; Freilinger, Christine; Meneses-Lorente, Georgina; Baehner, Monika; Harding, Ross; Ratnayake, Jayantha; Abiraj, Keelara; Gass, Nathalie; Noh, Karen; Christen, Randolph D.; Ukarma, Lidia; Bompas, Emmanuelle; Delord, Jean-Pierre; Blay, Jean-Yves; Ruttinger, Dominik</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">949-956</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Diffuse-type tenosynovial giant cell tumor (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan disease with unmet medical need, is characterized by an overexpression of colony-stimulating factor 1 (CSF1), and is usually caused by a chromosomal translocation involving CSF1.  CSF1 receptor (CSF1R) activation leads to the recruitment of CSF1R-expressing cells of the mononuclear phagocyte lineage that constitute the tumor mass in dt-GCT.  Emactuzumab (RG7155) is a novel monoclonal antibody that inhibits CSF1R activation.  We have assessed the safety, tolerability and activity of emactuzumab in patients with Dt-GCT of the soft tissue.  In this phase 1, first-in-human dose-escalation and dose-expansion study, eligible patients were aged 18 years or older with dt-GCT of the soft tissue with locally advanced disease or resectable tumors requiring extensive surgery, an Eastern Cooperative Oncol. Group performance status of 1 or less, measurable disease according to Response Evaluation Criteria In Solid Tumors version 1.1, and adequate end-organ function.  Patients with GCT of the bone were not eligible.  Patients received i.v. emactuzumab at 900 mg, 1350 mg, or 2000 mg every 2 wk in the dose-escalation phase and at the optimal biol. dose in a dose-expansion phase.  The primary objective was to evaluate the safety and tolerability of emactuzumab, and to det. the max. tolerated dose or optimal biol. dose.  All treated patients were included in the analyses.  Expansion cohorts are currently ongoing.  This study is registered with ClinicalTrials.gov, no. NCT01494688.  Between July 26, 2012, and Oct 21, 2013, 12 patients were enrolled in the dose-escalation phase.  No dose-limiting toxicities were noted in the dose-escalation cohort; on the basis of pharmacokinetic, pharmacodynamic, and safety information, we chose a dose of 1000 mg every 2 wk for the dose-expansion cohort, into which 17 patients were enrolled.  Owing to different cutoff dates for safety and efficacy readouts, the safety population comprised 25 patients.  Common adverse events after emactuzumab treatment were facial edema (16 [64%] of 25 patients), asthenia (14 [56%]), and pruritus (14 [56%]).  Five serious adverse events (periorbital edema, lupus erythematosus [occurring twice], erythema, and dermohypodermitis all experienced by one [4%] patient each) were reported in five patients.  Three of the five serious adverse events-periorbital edema (one [4%]), lupus erythematosus (one [4%]), and dermohypodermitis (one [4%])-were assessed as grade 3.  Two other grade 3 events were reported: mucositis (one [4%]) and fatigue (one [4%]). 24 (86%) of 28 patients achieved an objective response; two (7%) patients achieved a complete response.  Further study of dt-GCT is warranted and different possibilities, such as an international collaboration with cooperative groups to assure appropriate recruitment in this rare disease, are currently being assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYSYJLOewUJrVg90H21EOLACvtfcHk0lifANO8Oh832w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2isb%252FL&md5=7059e506871975477fef7cb8409e3c43</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2815%2900132-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252815%252900132-1%26sid%3Dliteratum%253Aachs%26aulast%3DCassier%26aufirst%3DP.%2BA.%26aulast%3DItaliano%26aufirst%3DA.%26aulast%3DGomez-Roca%26aufirst%3DC.%2BA.%26aulast%3DLe%2BTourneau%26aufirst%3DC.%26aulast%3DToulmonde%26aufirst%3DM.%26aulast%3DCannarile%26aufirst%3DM.%2BA.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DBrillouet%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DJegg%26aufirst%3DA.%2BM.%26aulast%3DBr%25C3%25B6ske%26aufirst%3DA.%2BM.%26aulast%3DDembowski%26aufirst%3DM.%26aulast%3DBray-French%26aufirst%3DK.%26aulast%3DFreilinger%26aufirst%3DC.%26aulast%3DMeneses-Lorente%26aufirst%3DG.%26aulast%3DBaehner%26aufirst%3DM.%26aulast%3DHarding%26aufirst%3DR.%26aulast%3DRatnayake%26aufirst%3DJ.%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DGass%26aufirst%3DN.%26aulast%3DNoh%26aufirst%3DK.%26aulast%3DChristen%26aufirst%3DR.%2BD.%26aulast%3DUkarma%26aufirst%3DL.%26aulast%3DBompas%26aufirst%3DE.%26aulast%3DDelord%26aufirst%3DJ.%2BP.%26aulast%3DBlay%26aufirst%3DJ.%2BY.%26aulast%3DR%25C3%25BCttinger%26aufirst%3DD.%26atitle%3DCSF1R%2520inhibition%2520with%2520emactuzumab%2520in%2520locally%2520advanced%2520diffuse-type%2520tenosynovial%2520giant%2520cell%2520tumours%2520of%2520the%2520soft%2520tissue%253A%2520a%2520dose-escalation%2520and%2520dose-expansion%2520phase%25201%2520study%26jtitle%3DLancet%2520Oncol.%26date%3D2015%26volume%3D16%26spage%3D949%26epage%3D956%26doi%3D10.1016%2FS1470-2045%2815%2900132-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hambleton, J.</span>; <span class="NLM_string-name">Zhou, L.</span>; <span class="NLM_string-name">Rogers, S.</span>; <span class="NLM_string-name">Marle, S.
V.</span>; <span class="NLM_string-name">Iersel, T.
V.</span>; <span class="NLM_string-name">Zanghi, J.</span>; <span class="NLM_string-name">Masteller, E.</span>; <span class="NLM_string-name">Baker, K.</span>; <span class="NLM_string-name">Wong, B.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of FPA008, an anti-colony stimulating factor 1 receptor (anti-CSF1R) antibody in healthy volunteers and subjects with rheumatoid arthritis (RA): preliminary results</span>. In  <i>ACR/ARHP Annual Meeting: Rheumatoid Arthritis—Small Molecules, Biologics and Gene Therapy: Novel therapies, Biosimilars, Strategies and Mechanisms in Rheumatoid Arthritis, Boston, MA, 14–19 November 2014</i>; <span class="NLM_publisher-name">American College of Rheumatology</span>, <span class="NLM_year">2014</span>; <a href="http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-healthy-volunteers-and-subjects-with-rheumatoid-arthritis-ra-preliminary-results/" class="extLink">http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-healthy-volunteers-and-subjects-with-rheumatoid-arthritis-ra-preliminary-results/</a> (accessed December 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+Hambleton&author=L.+Zhou&author=S.+Rogers&author=S.%0AV.+Marle&author=T.%0AV.+Iersel&author=J.+Zanghi&author=E.+Masteller&author=K.+Baker&author=B.+Wong&title=A+phase+1+study+of+FPA008%2C+an+anti-colony+stimulating+factor+1+receptor+%28anti-CSF1R%29+antibody+in+healthy+volunteers+and+subjects+with+rheumatoid+arthritis+%28RA%29%3A+preliminary+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHambleton%26aufirst%3DJ.%26atitle%3DA%2520phase%25201%2520study%2520of%2520FPA008%252C%2520an%2520anti-colony%2520stimulating%2520factor%25201%2520receptor%2520%2528anti-CSF1R%2529%2520antibody%2520in%2520healthy%2520volunteers%2520and%2520subjects%2520with%2520rheumatoid%2520arthritis%2520%2528RA%2529%253A%2520preliminary%2520results%26jtitle%3DACR%252FARHP%2520Annual%2520Meeting%253A%2520Rheumatoid%2520Arthritis%25E2%2580%2594Small%2520Molecules%252C%2520Biologics%2520and%2520Gene%2520Therapy%253A%2520Novel%2520therapies%252C%2520Biosimilars%252C%2520Strategies%2520and%2520Mechanisms%2520in%2520Rheumatoid%2520Arthritis%252C%2520Boston%252C%2520MA%252C%252014%25E2%2580%259319%2520November%25202014%26pub%3DAmerican%2520College%2520of%2520Rheumatology%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span>; <span class="NLM_string-name">Sikorski, R.</span>; <span class="NLM_string-name">Rogers, S.</span>; <span class="NLM_string-name">Costin, S.</span>; <span class="NLM_string-name">Korkosz, M.</span>; <span class="NLM_string-name">Jaraczewska-Baumann, M.</span>; <span class="NLM_string-name">Éva, P.</span>; <span class="NLM_string-name">Rojkovich, B.</span>; <span class="NLM_string-name">Bartalos, J.</span>; <span class="NLM_string-name">Masteller, E.</span>; <span class="NLM_string-name">Xiang, H.</span>; <span class="NLM_string-name">Wong, B.</span>; <span class="NLM_string-name">Hambleton, J.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of FPA008, an anti-colony stimulating factor 1 receptor (anti-CSF1R) antibody in patients (pts) with rheumatoid arthritis (RA): preliminary results.</span> In  <i>ACR/ARHP Annual Meeting: Rheumatoid Arthritis—Small Molecules, Biologics and Gene Therapy Poster III, San Francisco, 6-11 November 2015</i>; <span class="NLM_publisher-name">American College of Rheumatology</span>, <span class="NLM_year">2015</span>;  <span class="NLM_fpage">67</span>, <a href="http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-patients-pts-with-rheumatoid-arthritis-ra-preliminary-results/" class="extLink">http://acrabstracts.org/abstract/a-phase-1-study-of-fpa008-an-anti-colony-stimulating-factor-1-receptor-anti-csf1r-antibody-in-patients-pts-with-rheumatoid-arthritis-ra-preliminary-results/</a> (accessed December 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=67&author=L.+Zhou&author=R.+Sikorski&author=S.+Rogers&author=S.+Costin&author=M.+Korkosz&author=M.+Jaraczewska-Baumann&author=P.+%C3%89va&author=B.+Rojkovich&author=J.+Bartalos&author=E.+Masteller&author=H.+Xiang&author=B.+Wong&author=J.+Hambleton&title=A+phase+1+study+of+FPA008%2C+an+anti-colony+stimulating+factor+1+receptor+%28anti-CSF1R%29+antibody+in+patients+%28pts%29+with+rheumatoid+arthritis+%28RA%29%3A+preliminary+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26atitle%3DA%2520phase%25201%2520study%2520of%2520FPA008%252C%2520an%2520anti-colony%2520stimulating%2520factor%25201%2520receptor%2520%2528anti-CSF1R%2529%2520antibody%2520in%2520patients%2520%2528pts%2529%2520with%2520rheumatoid%2520arthritis%2520%2528RA%2529%253A%2520preliminary%2520results.%26jtitle%3DACR%252FARHP%2520Annual%2520Meeting%253A%2520Rheumatoid%2520Arthritis%25E2%2580%2594Small%2520Molecules%252C%2520Biologics%2520and%2520Gene%2520Therapy%2520Poster%2520III%252C%2520San%2520Francisco%252C%25206-11%2520November%25202015%26pub%3DAmerican%2520College%2520of%2520Rheumatology%26date%3D2015%26spage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span> <i>Cabiralizumab
(FPA008)</i>; <span class="NLM_publisher-name">Five Prime Therapeutics</span>: <span class="NLM_publisher-loc">South San Francisco, CA</span>, <span class="NLM_year">2017</span>; <a href="http://www.fiveprime.com/pipeline/fpa008" class="extLink">http://www.fiveprime.com/pipeline/fpa008</a> (Accessed December 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Cabiralizumab%0A%28FPA008%29%3B+Five+Prime+Therapeutics%3A+South+San+Francisco%2C+CA%2C+2017%3B+http%3A%2F%2Fwww.fiveprime.com%2Fpipeline%2Ffpa008+%28Accessed+December+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DCabiralizumab%250A%2528FPA008%2529%26pub%3DFive%2520Prime%2520Therapeutics%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haegel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziller-Rémy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraud, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefoy, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grellier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, J.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menguy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thioudellet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Préville, X.</span></span> <span> </span><span class="NLM_article-title">TG3003, an immunomodulatory anti-CD115 mAb targeting M2-macrophage polarization in the tumor microenvironment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">288</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2015-288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1538-7445.AM2015-288" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=288&author=H.+Haegelauthor=C.+Ziller-R%C3%A9myauthor=L.+Barraudauthor=J.-Y.+Bonnefoyauthor=S.+Cochinauthor=V.+Duongauthor=M.+Geistauthor=B.+Grellierauthor=R.+Halletauthor=J.-B.+Marchandauthor=T.+Menguyauthor=R.+Rookeauthor=C.+Thioudelletauthor=C.+Reymannauthor=X.+Pr%C3%A9ville&title=TG3003%2C+an+immunomodulatory+anti-CD115+mAb+targeting+M2-macrophage+polarization+in+the+tumor+microenvironment&doi=10.1158%2F1538-7445.AM2015-288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2015-288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2015-288%26sid%3Dliteratum%253Aachs%26aulast%3DHaegel%26aufirst%3DH.%26aulast%3DZiller-R%25C3%25A9my%26aufirst%3DC.%26aulast%3DBarraud%26aufirst%3DL.%26aulast%3DBonnefoy%26aufirst%3DJ.-Y.%26aulast%3DCochin%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DV.%26aulast%3DGeist%26aufirst%3DM.%26aulast%3DGrellier%26aufirst%3DB.%26aulast%3DHallet%26aufirst%3DR.%26aulast%3DMarchand%26aufirst%3DJ.-B.%26aulast%3DMenguy%26aufirst%3DT.%26aulast%3DRooke%26aufirst%3DR.%26aulast%3DThioudellet%26aufirst%3DC.%26aulast%3DReymann%26aufirst%3DC.%26aulast%3DPr%25C3%25A9ville%26aufirst%3DX.%26atitle%3DTG3003%252C%2520an%2520immunomodulatory%2520anti-CD115%2520mAb%2520targeting%2520M2-macrophage%2520polarization%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D288%26doi%3D10.1158%2F1538-7445.AM2015-288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkowski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masterson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurmond, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franks, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenspan, A.</span></span> <span> </span><span class="NLM_article-title">Results from a phase IIA parallel group study of JNJ-40346527, an oral CSF-1R inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy</span>. <i>J. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1752</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.3899/jrheum.141580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3899%2Fjrheum.141580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26233509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyqsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1752-1761&author=M.+C.+Genoveseauthor=E.+Hsiaauthor=S.+M.+Belkowskiauthor=C.+Chienauthor=T.+Mastersonauthor=R.+L.+Thurmondauthor=C.+L.+Mantheyauthor=X.+D.+Yanauthor=T.+Geauthor=C.+Franksauthor=A.+Greenspan&title=Results+from+a+phase+IIA+parallel+group+study+of+JNJ-40346527%2C+an+oral+CSF-1R+inhibitor%2C+in+patients+with+active+rheumatoid+arthritis+despite+disease-modifying+antirheumatic+drug+therapy&doi=10.3899%2Fjrheum.141580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Results from a phase IIA parallel group study of JNJ-40346527, an oral CSF-1R inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy</span></div><div class="casAuthors">Genovese, Mark C.; Hsia, Elizabeth; Belkowski, Stanley M.; Chien, Caly; Masterson, Tara; Thurmond, Robin L.; Manthey, Carl L.; Yan, Xiaoyu; Ge, Tingting; Franks, Carol; Greenspan, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1752-1760</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">1499-2752</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">Objective.  To assess the efficacy and safety of JNJ-40346527, a selective inhibitor of colony-stimulating factor-1 (CSF-1) receptor kinase that acts to inhibit macrophage survival, proliferation, and differentiation in patients with active rheumatoid arthritis (RA) despite disease-modifying antirheumatic drug (DMARD) therapy.  In this randomized, double-blind, placebo-controlled, parallel group study, adults were randomized (2:1) to receive oral JNJ-40346527 100 mg or placebo twice daily through Week 12.  Patients with RA had disease activity [≥ 6 swollen/≥ 6 tender joints, C-reactive protein (CRP) ≥ 0.8 mg/dL] despite DMARD therapy for ≥ 6 mo.  The primary endpoint was change from baseline at Week 12 in the 28-joint Disease Activity Score with CRP (DAS28-CRP).  Pharmacokinetic/pharmacodynamic analyses were also performed, and safety was assessed through Week 16.  Ninety-five patients were treated (63 JNJ-40346527, 32 placebo); 8 patients discontinued treatment (6 JNJ-40346527, 2 placebo) through Week 12.  Mean improvements in DAS28-CRP from baseline to Week 12 were 1.15 for the JNJ-40346527 group and 1.42 for the placebo group (p = 0.30); thus, a statistically significant difference was not obsd. for the primary endpoint.  Pharmacokinetic exposure to JNJ-40346527 and its active metabolites was above the projected concn. needed for pharmacol. activity, and effective target engagement and proof of activity were demonstrated by increased levels of CSF-1 and decreased CD16+ monocytes in JNJ-40346527-treated, but not placebo-treated, patients.  Thirty-seven (58.7%) JNJ-40346527-treated and 16 (50.0%) placebo-treated patients reported ≥ 1 adverse event (AE); 1 (1.6%) JNJ-40346527-treated and 3 (9.4%) placebo-treated patients reported ≥ 1 serious AE.  Conclusion.  Although adequate exposure and effective peripheral target engagement were evident, JNJ-40346527 efficacy was not obsd. in patients with DMARD-refractory active RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYP703ihQxAbVg90H21EOLACvtfcHk0liDPLXxSg0yng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyqsL7I&md5=691acfc23f3fdcb46c59da16c2d01455</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.141580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.141580%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DHsia%26aufirst%3DE.%26aulast%3DBelkowski%26aufirst%3DS.%2BM.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DMasterson%26aufirst%3DT.%26aulast%3DThurmond%26aufirst%3DR.%2BL.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DYan%26aufirst%3DX.%2BD.%26aulast%3DGe%26aufirst%3DT.%26aulast%3DFranks%26aufirst%3DC.%26aulast%3DGreenspan%26aufirst%3DA.%26atitle%3DResults%2520from%2520a%2520phase%2520IIA%2520parallel%2520group%2520study%2520of%2520JNJ-40346527%252C%2520an%2520oral%2520CSF-1R%2520inhibitor%252C%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520despite%2520disease-modifying%2520antirheumatic%2520drug%2520therapy%26jtitle%3DJ.%2520Rheumatol.%26date%3D2015%26volume%3D42%26spage%3D1752%26epage%3D1761%26doi%3D10.3899%2Fjrheum.141580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span> <span> </span><span class="NLM_article-title">The role of Kupffer cells in hepatic diseases</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/j.molimm.2017.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.molimm.2017.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=28314211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktl2iu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=222-229&author=P.+Liauthor=K.+Heauthor=J.+Liauthor=Z.+Liuauthor=J.+Gong&title=The+role+of+Kupffer+cells+in+hepatic+diseases&doi=10.1016%2Fj.molimm.2017.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Kupffer cells in hepatic diseases</span></div><div class="casAuthors">Li, Peizhi; He, Kun; Li, Jinzheng; Liu, Zuojin; Gong, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">222-229</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Kupffer cells (KCs) constitute 80-90% of the tissue macrophages present in the body.  Essential to innate and adaptive immunity, KCs are responsible for the swift containment and clearance of exogenous particulates and immunoreactive materials which are perceived as foreign and harmful to the body.  Similar to other macrophages, KCs also sense endogenous mol. signals that may result from perturbed homeostasis of the host.  KCs have been implicated in host defense and the pathogenesis of various hepatic diseases, including endotoxin tolerance, liver transplantation, nonalcoholic fatty liver disease, and alc. liver disease.  In this review, we summarized some novel findings assocd. with the role of KCs in hepatic diseases, such as the origin and mechanisms KCs polarization, mol. basis for caspase-1 activation called "non-canonical inflammasome pathway" involving the cleavage of Gsdmd by caspase-11, the important role of microRNA in liver transplantation, and so on.  A better understanding of KCs biol. characteristics and immunol. function in liver homeostasis and pathol. may pave the way to investigate new diagnostic and therapeutic approaches for hepatic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2BBu91uSf3bVg90H21EOLACvtfcHk0liDPLXxSg0yng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktl2iu7Y%253D&md5=634a3d1b52153cc96841a82bead48fa5</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2017.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2017.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520Kupffer%2520cells%2520in%2520hepatic%2520diseases%26jtitle%3DMol.%2520Immunol.%26date%3D2017%26volume%3D85%26spage%3D222%26epage%3D229%26doi%3D10.1016%2Fj.molimm.2017.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Tresckow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribrag, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetharam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoulek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engert, A.</span></span> <span> </span><span class="NLM_article-title">An open-label, multicenter, phase I/II study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1850</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-1845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1078-0432.CCR-14-1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25628399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1843-1850&author=B.+von%0ATresckowauthor=F.+Morschhauserauthor=V.+Ribragauthor=M.+Toppauthor=C.+Chienauthor=S.+Seetharamauthor=R.+Aquinoauthor=S.+Kotoulekauthor=C.+J.+de+Boerauthor=A.+Engert&title=An+open-label%2C+multicenter%2C+phase+I%2FII+study+of+JNJ-40346527%2C+a+CSF-1R+inhibitor%2C+in+patients+with+relapsed+or+refractory+hodgkin+lymphoma&doi=10.1158%2F1078-0432.CCR-14-1845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma</span></div><div class="casAuthors">von Tresckow, Bastian; Morschhauser, Franck; Ribrag, Vincent; Topp, Max S.; Chien, Caly; Seetharam, Shobha; Aquino, Regina; Kotoulek, Sonja; de Boer, Carla J.; Engert, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1843-1850</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This phase I/II study investigated JNJ-40346527, a selective inhibitor of the colony-stimulating factor-1 receptor (CSF-1R) tyrosine kinase as treatment for relapsed or refractory classical Hodgkin lymphoma (cHL).  Patients ≥18 years with histopathol. confirmed initial diagnosis of cHL that had relapsed or was refractory after ≥1 appropriate therapies were assigned to sequential cohorts of oral daily doses of JNJ-40346527 (150, 300, 450, 600 mg every day, and 150 mg twice a day).  For the dose-escalation phase, the primary endpoint was to establish the recommended phase II dose.  Secondary endpoints included safety, pharmacokinetics, and pharmacodynamics.  Twenty-one patients [(150 mg: 3; 300 mg: 5; 450 mg: 3, 600 mg: 3) every day, and 150 mg twice a day: 7] were enrolled, 10 men, median age 40 (range, 19-75) years, median no. of prior systemic therapies 6 (range, 3-14).  No dose-limiting toxicities were obsd.; max.-tolerated dose was not established.  Best overall response was complete remission in 1 patient (duration, +352 days) and stable disease in 11 patients: (duration, 1.5-8 mo).  Median no. of cycles: 4 (range, 1-16).  Most common (≥20% patients) possibly drug-related adverse events (per investigator assessment) were nausea (n = 6), headache, and pyrexia (n = 5 each).  JNJ-40346527 exposure increased in near dose-proportional manner over a dose range of 150 to 450 mg every day, but plateaued at 600 mg every day.  Target engagement was confirmed (>80% inhibition of CSF-1R phosphorylation, 4 h after dosing).  JNJ-40346527, a selective inhibitor of CSF-1R was well tolerated, and preliminary antitumor results suggested limited activity in monotherapy for the treatment of cHL.  Clin Cancer Res; 21(8); 1843-50. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZuUy9-7MhLVg90H21EOLACvtfcHk0liDT5HgWJAtRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D&md5=e3d4f2b2937078f85ef0ead51e093f82</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-1845%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BTresckow%26aufirst%3DB.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DRibrag%26aufirst%3DV.%26aulast%3DTopp%26aufirst%3DM.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DSeetharam%26aufirst%3DS.%26aulast%3DAquino%26aufirst%3DR.%26aulast%3DKotoulek%26aufirst%3DS.%26aulast%3Dde%2BBoer%26aufirst%3DC.%2BJ.%26aulast%3DEngert%26aufirst%3DA.%26atitle%3DAn%2520open-label%252C%2520multicenter%252C%2520phase%2520I%252FII%2520study%2520of%2520JNJ-40346527%252C%2520a%2520CSF-1R%2520inhibitor%252C%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520hodgkin%2520lymphoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D1843%26epage%3D1850%26doi%3D10.1158%2F1078-0432.CCR-14-1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tresckow, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribrag, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetharam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoulek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engert, A.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of JNJ-40346527, a colony stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with relapsed or refractory hodgkin lymphoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1812</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1812&author=B.+V.+Tresckowauthor=F.+Morschhauserauthor=V.+Ribragauthor=M.+S.+Toppauthor=C.+Chienauthor=S.+Seetharamauthor=R.+Aquinoauthor=S.+Kotoulekauthor=I.+Khanauthor=C.+J.+de+Boerauthor=A.+Engert&title=A+phase+1+study+of+JNJ-40346527%2C+a+colony+stimulating+factor-1+receptor+%28CSF-1R%29+inhibitor%2C+in+patients+with+relapsed+or+refractory+hodgkin+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresckow%26aufirst%3DB.%2BV.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DRibrag%26aufirst%3DV.%26aulast%3DTopp%26aufirst%3DM.%2BS.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DSeetharam%26aufirst%3DS.%26aulast%3DAquino%26aufirst%3DR.%26aulast%3DKotoulek%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DI.%26aulast%3Dde%2BBoer%26aufirst%3DC.%2BJ.%26aulast%3DEngert%26aufirst%3DA.%26atitle%3DA%2520phase%25201%2520study%2520of%2520JNJ-40346527%252C%2520a%2520colony%2520stimulating%2520factor-1%2520receptor%2520%2528CSF-1R%2529%2520inhibitor%252C%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520hodgkin%2520lymphoma%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meegalla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballentine, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desjarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomczuk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illig, C. R.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of a potent class of arylamide FMS inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3632</span>– <span class="NLM_lpage">3637</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bmcl.2008.04.059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3632-3637&author=S.+K.+Meegallaauthor=M.+J.+Wallauthor=J.+Chenauthor=K.+J.+Wilsonauthor=S.+K.+Ballentineauthor=R.+L.+Desjarlaisauthor=C.+Schubertauthor=C.+S.+Cryslerauthor=Y.+Chenauthor=C.+J.+Molloyauthor=M.+A.+Chaikinauthor=C.+L.+Mantheyauthor=M.+R.+Playerauthor=B.+E.+Tomczukauthor=C.+R.+Illig&title=Structure-based+optimization+of+a+potent+class+of+arylamide+FMS+inhibitors&doi=10.1016%2Fj.bmcl.2008.04.059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.059%26sid%3Dliteratum%253Aachs%26aulast%3DMeegalla%26aufirst%3DS.%2BK.%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DK.%2BJ.%26aulast%3DBallentine%26aufirst%3DS.%2BK.%26aulast%3DDesjarlais%26aufirst%3DR.%2BL.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DIllig%26aufirst%3DC.%2BR.%26atitle%3DStructure-based%2520optimization%2520of%2520a%2520potent%2520class%2520of%2520arylamide%2520FMS%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3632%26epage%3D3637%26doi%3D10.1016%2Fj.bmcl.2008.04.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Illig, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meegalla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DesJarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballentine, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomczuk, B. E.</span></span> <span> </span><span class="NLM_article-title">Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6363</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bmcl.2013.09.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6363-6369&author=C.+R.+Illigauthor=C.+L.+Mantheyauthor=S.+K.+Meegallaauthor=M.+J.+Wallauthor=J.+Chenauthor=K.+J.+Wilsonauthor=R.+L.+DesJarlaisauthor=S.+K.+Ballentineauthor=C.+Schubertauthor=C.+S.+Cryslerauthor=Y.+Chenauthor=C.+J.+Molloyauthor=M.+A.+Chaikinauthor=R.+R.+Donatelliauthor=E.+Yurkowauthor=Z.+Zhouauthor=M.+R.+Playerauthor=B.+E.+Tomczuk&title=Enhancement+of+kinase+selectivity+in+a+potent+class+of+arylamide+FMS+inhibitors&doi=10.1016%2Fj.bmcl.2013.09.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.061%26sid%3Dliteratum%253Aachs%26aulast%3DIllig%26aufirst%3DC.%2BR.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DMeegalla%26aufirst%3DS.%2BK.%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DK.%2BJ.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DBallentine%26aufirst%3DS.%2BK.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DR.%2BR.%26aulast%3DYurkow%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26atitle%3DEnhancement%2520of%2520kinase%2520selectivity%2520in%2520a%2520potent%2520class%2520of%2520arylamide%2520FMS%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6363%26epage%3D6369%26doi%3D10.1016%2Fj.bmcl.2013.09.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hembrough, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plum, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogler, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidor, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span> <span> </span><span class="NLM_article-title">ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of Action</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1535-7163.MCT-10-0574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=21177375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=126-137&author=G.+C.+Fletcherauthor=R.+D.+Brokxauthor=T.+A.+Dennyauthor=T.+A.+Hembroughauthor=S.+M.+Plumauthor=W.+E.+Foglerauthor=C.+F.+Sidorauthor=M.+R.+Bray&title=ENMD-2076+is+an+orally+active+kinase+inhibitor+with+antiangiogenic+and+antiproliferative+mechanisms+of+Action&doi=10.1158%2F1535-7163.MCT-10-0574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action</span></div><div class="casAuthors">Fletcher, Graham C.; Brokx, Richard D.; Denny, Trisha A.; Hembrough, Todd A.; Plum, Stacy M.; Fogler, William E.; Sidor, Carolyn F.; Bray, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-137</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ENMD-2076 is a novel orally active, small mol. kinase inhibitor with a mechanism of action involving several pathways key to tumor growth and survival: angiogenesis, proliferation, and the cell cycle.  ENMD-2076 has selective activity against the mitotic kinase Aurora A, as well as kinases involved in angiogenesis (VEGFRs, FGFRs).  ENMD-2076 inhibited the growth in vitro of a wide range of human solid tumor and hematopoietic cancer cell lines with IC50 values ranging from 0.025 to 0.7 μmol/L.  ENMD-2076 was also shown to induce regression or complete inhibition of tumor growth in vivo at well-tolerated doses in tumor xenograft models derived from breast, colon, melanoma, leukemia, and multiple myeloma cell lines.  Pharmacodynamic expts. in vivo showed that in addn. to inhibiting Aurora A, single doses of ENMD-2076 had sustained inhibitory effects on the activation of Flt3 as well as the angiogenic tyrosine kinases, VEGFR2/KDR and FGFR1 and 2.  ENMD-2076 was shown to prevent the formation of new blood vessels and regress formed vessels in vivo at doses equiv. to those that gave substantial activity in tumor xenograft models.  These results indicate that ENMD-2076 is a well-tolerated, orally active multitarget kinase inhibitor with a unique antiangiogenic/antiproliferative profile and provides strong preclin. support for use as a therapeutic for human cancers.  Several phase 1 studies involving ENMD-2076 have been recently completed, and the compd. is currently being evaluated in a phase 2 clin. trial in patients with platinum-resistant ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplPl3keBsSALVg90H21EOLACvtfcHk0liDT5HgWJAtRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFeltQ%253D%253D&md5=069d96ad4ad3f0643ad4163036a5f4cd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0574%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DBrokx%26aufirst%3DR.%2BD.%26aulast%3DDenny%26aufirst%3DT.%2BA.%26aulast%3DHembrough%26aufirst%3DT.%2BA.%26aulast%3DPlum%26aufirst%3DS.%2BM.%26aulast%3DFogler%26aufirst%3DW.%2BE.%26aulast%3DSidor%26aufirst%3DC.%2BF.%26aulast%3DBray%26aufirst%3DM.%2BR.%26atitle%3DENMD-2076%2520is%2520an%2520orally%2520active%2520kinase%2520inhibitor%2520with%2520antiangiogenic%2520and%2520antiproliferative%2520mechanisms%2520of%2520Action%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D126%26epage%3D137%26doi%3D10.1158%2F1535-7163.MCT-10-0574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span> <i>ENMD-2076</i>; <span class="NLM_publisher-name">CASI Pharmaceuticals</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, <span class="NLM_year">2017</span>; <a href="http://www.casipharmaceuticals.com/product-pipeline/enmd-2076/" class="extLink">http://www.casipharmaceuticals.com/product-pipeline/enmd-2076/</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ENMD-2076%3B+CASI+Pharmaceuticals%3A+Rockville%2C+MD%2C+2017%3B+http%3A%2F%2Fwww.casipharmaceuticals.com%2Fproduct-pipeline%2Fenmd-2076%2F+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DENMD-2076%26pub%3DCASI%2520Pharmaceuticals%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">William, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span> <span> </span><span class="NLM_article-title">SB1578, a novel inhibitor of JAK2, FLT3, and c-Fms for the treatment of rheumatoid arthritis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>189</i></span>,  <span class="NLM_fpage">4123</span>– <span class="NLM_lpage">4134</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1200675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4049%2Fjimmunol.1200675" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=189&publication_year=2012&pages=4123-4134&author=B.+Madanauthor=K.+Gohauthor=S.+Hartauthor=A.+Williamauthor=R.+Jayaramanauthor=K.+Ethirajuluauthor=B.+W.+Dymockauthor=J.+M.+Wood&title=SB1578%2C+a+novel+inhibitor+of+JAK2%2C+FLT3%2C+and+c-Fms+for+the+treatment+of+rheumatoid+arthritis&doi=10.4049%2Fjimmunol.1200675"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1200675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1200675%26sid%3Dliteratum%253Aachs%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DGoh%26aufirst%3DK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DWilliam%26aufirst%3DA.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26atitle%3DSB1578%252C%2520a%2520novel%2520inhibitor%2520of%2520JAK2%252C%2520FLT3%252C%2520and%2520c-Fms%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2012%26volume%3D189%26spage%3D4123%26epage%3D4134%26doi%3D10.4049%2Fjimmunol.1200675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">William, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the macrocycle (9E)-15-(2-(pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a potent inhibitor of Janus kinase 2/Fms-LikeTyrosine Kinase-3 (JAK2/FLT3) for the treatment of rheumatoid arthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2623</span>– <span class="NLM_lpage">2640</span>, <span class="refDoi"> DOI: 10.1021/jm201454n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201454n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2623-2640&author=A.+Williamauthor=A.+Leeauthor=A.+Poulsenauthor=K.+Gohauthor=B.+Madanauthor=S.+Hartauthor=E.+Tanauthor=H.+Wangauthor=H.+Nagarajauthor=D.+Chenauthor=C.+P.+Leeauthor=E.+T.+Sunauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+%289E%29-15-%282-%28pyrrolidin-1-yl%29ethoxy%29-7%2C12%2C25-trioxa-19%2C21%2C24-triaza-tetracyclo%5B18.3.1.1%282%2C5%29.1%2814%2C18%29%5Dhexacosa-1%2824%29%2C2%2C4%2C9%2C14%2826%29%2C15%2C17%2C20%2C22-nonaene+%28SB1578%29%2C+a+potent+inhibitor+of+Janus+kinase+2%2FFms-LikeTyrosine+Kinase-3+%28JAK2%2FFLT3%29+for+the+treatment+of+rheumatoid+arthritis&doi=10.1021%2Fjm201454n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm201454n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201454n%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DGoh%26aufirst%3DK.%26aulast%3DMadan%26aufirst%3DB.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DC.%2BP.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%2520%25289E%2529-15-%25282-%2528pyrrolidin-1-yl%2529ethoxy%2529-7%252C12%252C25-trioxa-19%252C21%252C24-triaza-tetracyclo%255B18.3.1.1%25282%252C5%2529.1%252814%252C18%2529%255Dhexacosa-1%252824%2529%252C2%252C4%252C9%252C14%252826%2529%252C15%252C17%252C20%252C22-nonaene%2520%2528SB1578%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520Janus%2520kinase%25202%252FFms-LikeTyrosine%2520Kinase-3%2520%2528JAK2%252FFLT3%2529%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2623%26epage%3D2640%26doi%3D10.1021%2Fjm201454n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conway, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusnak, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frick, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadepalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kull, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, J. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of colony stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">16078</span>– <span class="NLM_lpage">16083</span>, <span class="refDoi"> DOI: 10.1073/pnas.0502000102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1073%2Fpnas.0502000102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16078-16083&author=J.+G.+Conwayauthor=B.+McDonaldauthor=J.+Parhamauthor=B.+Keithauthor=D.+W.+Rusnakauthor=E.+Shawauthor=M.+Jansenauthor=P.+Linauthor=A.+Payneauthor=R.+M.+Crosbyauthor=J.+H.+Johnsonauthor=L.+Frickauthor=M.+H.+Linauthor=S.+Depeeauthor=S.+Tadepalliauthor=B.+Vottaauthor=I.+Jamesauthor=K.+Fullerauthor=T.+J.+Chambersauthor=F.+C.+Kullauthor=S.+D.+Chamberlainauthor=J.+T.+Hutchins&title=Inhibition+of+colony+stimulating-factor-1+signaling+in+vivo+with+the+orally+bioavailable+cFMS+kinase+inhibitor+GW2580&doi=10.1073%2Fpnas.0502000102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0502000102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0502000102%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DJ.%2BG.%26aulast%3DMcDonald%26aufirst%3DB.%26aulast%3DParham%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DShaw%26aufirst%3DE.%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DCrosby%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%2BH.%26aulast%3DFrick%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DDepee%26aufirst%3DS.%26aulast%3DTadepalli%26aufirst%3DS.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DJames%26aufirst%3DI.%26aulast%3DFuller%26aufirst%3DK.%26aulast%3DChambers%26aufirst%3DT.%2BJ.%26aulast%3DKull%26aufirst%3DF.%2BC.%26aulast%3DChamberlain%26aufirst%3DS.%2BD.%26aulast%3DHutchins%26aufirst%3DJ.%2BT.%26atitle%3DInhibition%2520of%2520colony%2520stimulating-factor-1%2520signaling%2520in%2520vivo%2520with%2520the%2520orally%2520bioavailable%2520cFMS%2520kinase%2520inhibitor%2520GW2580%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D16078%26epage%3D16083%26doi%3D10.1073%2Fpnas.0502000102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinkert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caplice, N. M.</span></span> <span> </span><span class="NLM_article-title">Systemic and cardiac depletion of M2 macrophage through CSF-1R signaling inhibition alters cardiac function post myocardial infarction</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0137515</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0137515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1371%2Fjournal.pone.0137515" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0137515&author=A.-L.+Leblondauthor=K.+Klinkertauthor=K.+Martinauthor=E.+C.+Turnerauthor=A.+H.+Kumarauthor=T.+Browneauthor=N.+M.+Caplice&title=Systemic+and+cardiac+depletion+of+M2+macrophage+through+CSF-1R+signaling+inhibition+alters+cardiac+function+post+myocardial+infarction&doi=10.1371%2Fjournal.pone.0137515"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0137515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0137515%26sid%3Dliteratum%253Aachs%26aulast%3DLeblond%26aufirst%3DA.-L.%26aulast%3DKlinkert%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DE.%2BC.%26aulast%3DKumar%26aufirst%3DA.%2BH.%26aulast%3DBrowne%26aufirst%3DT.%26aulast%3DCaplice%26aufirst%3DN.%2BM.%26atitle%3DSystemic%2520and%2520cardiac%2520depletion%2520of%2520M2%2520macrophage%2520through%2520CSF-1R%2520signaling%2520inhibition%2520alters%2520cardiac%2520function%2520post%2520myocardial%2520infarction%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0137515%26doi%3D10.1371%2Fjournal.pone.0137515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walles, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflimlin-Fritschy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camenisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swart, P.</span></span> <span> </span><span class="NLM_article-title">Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.3109/00498254.2014.945988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3109%2F00498254.2014.945988" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=107-123&author=J.+Krauserauthor=Y.+Jinauthor=M.+Wallesauthor=U.+Pfaarauthor=J.+Suttonauthor=M.+Wiesmannauthor=D.+Grafauthor=V.+Pflimlin-Fritschyauthor=T.+Wolfauthor=G.+Camenischauthor=P.+Swart&title=Phenotypic+and+metabolic+investigation+of+a+CSF-1R+kinase+receptor+inhibitor+%28BLZ945%29+and+its+pharmacologically+active+metabolite&doi=10.3109%2F00498254.2014.945988"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.3109%2F00498254.2014.945988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2014.945988%26sid%3Dliteratum%253Aachs%26aulast%3DKrauser%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DWalles%26aufirst%3DM.%26aulast%3DPfaar%26aufirst%3DU.%26aulast%3DSutton%26aufirst%3DJ.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DGraf%26aufirst%3DD.%26aulast%3DPflimlin-Fritschy%26aufirst%3DV.%26aulast%3DWolf%26aufirst%3DT.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DSwart%26aufirst%3DP.%26atitle%3DPhenotypic%2520and%2520metabolic%2520investigation%2520of%2520a%2520CSF-1R%2520kinase%2520receptor%2520inhibitor%2520%2528BLZ945%2529%2520and%2520its%2520pharmacologically%2520active%2520metabolite%26jtitle%3DXenobiotica%26date%3D2015%26volume%3D45%26spage%3D107%26epage%3D123%26doi%3D10.3109%2F00498254.2014.945988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyonteck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijeiro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1038/nm.3337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1038%2Fnm.3337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=24056773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1264-1272&author=S.+M.+Pyonteckauthor=L.+Akkariauthor=A.+J.+Schuhmacherauthor=R.+L.+Bowmanauthor=L.+Sevenichauthor=D.+F.+Quailauthor=O.+C.+Olsonauthor=M.+L.+Quickauthor=J.+T.+Huseauthor=V.+Teijeiroauthor=M.+Settyauthor=C.+S.+Leslieauthor=Y.+Oeiauthor=A.+Pedrazaauthor=J.+Zhangauthor=C.+W.+Brennanauthor=J.+C.+Suttonauthor=E.+C.+Hollandauthor=D.+Danielauthor=J.+A.+Joyce&title=CSF-1R+inhibition+alters+macrophage+polarization+and+blocks+glioma+progression&doi=10.1038%2Fnm.3337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span></div><div class="casAuthors">Pyonteck, Stephanie M.; Akkari, Leila; Schuhmacher, Alberto J.; Bowman, Robert L.; Sevenich, Lisa; Quail, Daniela F.; Olson, Oakley C.; Quick, Marsha L.; Huse, Jason T.; Teijeiro, Virginia; Setty, Manu; Leslie, Christina S.; Oei, Yoko; Pedraza, Alicia; Zhang, Jianan; Brennan, Cameron W.; Sutton, James C.; Holland, Eric C.; Daniel, Dylan; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1272</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) comprises several mol. subtypes, including proneural GBM.  Most therapeutic approaches targeting glioma cells have failed.  An alternative strategy is to target cells in the glioma microenvironment, such as tumor-assocd. macrophages and microglia (TAMs).  Macrophages depend on colony stimulating factor-1 (CSF-1) for differentiation and survival.  We used an inhibitor of the CSF-1 receptor (CSF-1R) to target TAMs in a mouse proneural GBM model, which significantly increased survival and regressed established tumors.  CSF-1R blockade addnl. slowed intracranial growth of patient-derived glioma xenografts.  Surprisingly, TAMs were not depleted in treated mice.  Instead, glioma-secreted factors, including granulocyte-macrophage CSF (GM-CSF) and interferon-γ (IFN-γ), facilitated TAM survival in the context of CSF-1R inhibition.  Expression of alternatively activated M2 markers decreased in surviving TAMs, which is consistent with impaired tumor-promoting functions.  These gene signatures were assocd. with enhanced survival in patients with proneural GBM.  Our results identify TAMs as a promising therapeutic target for proneural gliomas and establish the translational potential of CSF-1R inhibition for GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirwpRVIWUELVg90H21EOLACvtfcHk0liOWbKucCf63A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N&md5=9b908e86c4a7da35a009bf322d492214</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnm.3337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3337%26sid%3Dliteratum%253Aachs%26aulast%3DPyonteck%26aufirst%3DS.%2BM.%26aulast%3DAkkari%26aufirst%3DL.%26aulast%3DSchuhmacher%26aufirst%3DA.%2BJ.%26aulast%3DBowman%26aufirst%3DR.%2BL.%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DQuail%26aufirst%3DD.%2BF.%26aulast%3DOlson%26aufirst%3DO.%2BC.%26aulast%3DQuick%26aufirst%3DM.%2BL.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DTeijeiro%26aufirst%3DV.%26aulast%3DSetty%26aufirst%3DM.%26aulast%3DLeslie%26aufirst%3DC.%2BS.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DHolland%26aufirst%3DE.%2BC.%26aulast%3DDaniel%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DCSF-1R%2520inhibition%2520alters%2520macrophage%2520polarization%2520and%2520blocks%2520glioma%2520progression%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1264%26epage%3D1272%26doi%3D10.1038%2Fnm.3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruffell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pryer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span> <span> </span><span class="NLM_article-title">CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e26968</span>, <span class="refDoi"> DOI: 10.4161/onci.26968</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4161%2Fonci.26968" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e26968&author=D.+C.+Strachanauthor=B.+Ruffellauthor=Y.+Oeiauthor=M.+J.+Bissellauthor=L.+M.+Coussensauthor=N.+Pryerauthor=D.+Daniel&title=CSF1R+inhibition+delays+cervical+and+mammary+tumor+growth+in+murine+models+by+attenuating+the+turnover+of+tumor-associated+macrophages+and+enhancing+infiltration+by+CD8+T+cells&doi=10.4161%2Fonci.26968"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.4161%2Fonci.26968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fonci.26968%26sid%3Dliteratum%253Aachs%26aulast%3DStrachan%26aufirst%3DD.%2BC.%26aulast%3DRuffell%26aufirst%3DB.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DBissell%26aufirst%3DM.%2BJ.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26aulast%3DPryer%26aufirst%3DN.%26aulast%3DDaniel%26aufirst%3DD.%26atitle%3DCSF1R%2520inhibition%2520delays%2520cervical%2520and%2520mammary%2520tumor%2520growth%2520in%2520murine%2520models%2520by%2520attenuating%2520the%2520turnover%2520of%2520tumor-associated%2520macrophages%2520and%2520enhancing%2520infiltration%2520by%2520CD8%2520T%2520cells%26jtitle%3DOncoimmunology%26date%3D2013%26volume%3D2%26spage%3De26968%26doi%3D10.4161%2Fonci.26968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carias, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesch, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5689</span>– <span class="NLM_lpage">5694</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219457110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1073%2Fpnas.1219457110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23493555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5689-5694&author=C.+Zhangauthor=P.+N.+Ibrahimauthor=J.+Zhangauthor=E.+A.+Burtonauthor=G.+Habetsauthor=Y.+Zhangauthor=B.+Powellauthor=B.+L.+Westauthor=B.+Matusowauthor=G.+Tsangauthor=R.+Shellooeauthor=H.+Cariasauthor=H.+Nguyenauthor=A.+Marimuthuauthor=K.+Y.+Zhangauthor=A.+Ohauthor=R.+Bremerauthor=C.+R.+Hurtauthor=D.+R.+Artisauthor=G.+Wuauthor=M.+Nespiauthor=W.+Spevakauthor=P.+Linauthor=K.+Nolopauthor=P.+Hirthauthor=G.+H.+Teschauthor=G.+Bollag&title=Design+and+pharmacology+of+a+highly+specific+dual+FMS+and+KIT+kinase+inhibitor&doi=10.1073%2Fpnas.1219457110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span></div><div class="casAuthors">Zhang, Chao; Ibrahim, Prabha N.; Zhang, Jiazhong; Burton, Elizabeth A.; Habets, Gaston; Zhang, Ying; Powell, Ben; West, Brian L.; Matusow, Bernice; Tsang, Garson; Shellooe, Rafe; Carias, Heidi; Nguyen, Hoa; Marimuthu, Adhirai; Zhang, Kam Y. J.; Oh, Angela; Bremer, Ryan; Hurt, Clarence R.; Artis, Dean R.; Wu, Guoxian; Nespi, Marika; Spevak, Wayne; Lin, Paul; Nolop, Keith; Hirth, Peter; Tesch, Greg H.; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5689-5694, S5689/1-S5689/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inflammation and cancer, two therapeutic areas historically addressed by sep. drug discovery efforts, are now coupled in treatment approaches by a growing understanding of the dynamic mol. dialogues between immune and cancer cells.  Agents that target specific compartments of the immune system, therefore, not only bring new disease modifying modalities to inflammatory diseases, but also offer a new avenue to cancer therapy by disrupting immune components of the microenvironment that foster tumor growth, progression, immune evasion, and treatment resistance.  McDonough feline sarcoma viral (v-fms) oncogene homolog (FMS) and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) are two hematopoietic cell surface receptors that regulate the development and function of macrophages and mast cells, resp.  The authors disclose a highly specific dual FMS and KIT kinase inhibitor developed from a multifaceted chem. scaffold.  As expected, this inhibitor blocks the activation of macrophages, osteoclasts, and mast cells controlled by these two receptors.  More importantly, the dual FMS and KIT inhibition profile has translated into a combination of benefits in preclin. disease models of inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofECnjzEONuLVg90H21EOLACvtfcHk0liOWbKucCf63A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D&md5=e4fbca9d41f95718a5119a08a54f5acc</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219457110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219457110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCarias%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DHurt%26aufirst%3DC.%2BR.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTesch%26aufirst%3DG.%2BH.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDesign%2520and%2520pharmacology%2520of%2520a%2520highly%2520specific%2520dual%2520FMS%2520and%2520KIT%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D5689%26epage%3D5694%26doi%3D10.1073%2Fpnas.1219457110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span> <span> </span><span class="NLM_article-title">The azaindole framework in the design of kinase inhibitors</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">19935</span>– <span class="NLM_lpage">19979</span>, <span class="refDoi"> DOI: 10.3390/molecules191219935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.3390%2Fmolecules191219935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25460315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=19935-19979&author=J.-Y.+M%C3%A9rourauthor=F.+Buronauthor=K.+Pl%C3%A9author=P.+Bonnetauthor=S.+Routier&title=The+azaindole+framework+in+the+design+of+kinase+inhibitors&doi=10.3390%2Fmolecules191219935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The azaindole framework in the design of kinase inhibitors</span></div><div class="casAuthors">Merour, Jean-Yves; Buron, Frederic; Ple, Karen; Bonnet, Pascal; Routier, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">19935-19979, 45 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This review article illustrates the growing use of azaindole derivs. as kinase inhibitors and their contribution to drug discovery and innovation.  The different protein kinases which have served as targets and the known mols. which have emerged from medicinal chem. and Fragment-Based Drug Discovery (FBDD) programs are presented.  The various synthetic routes used to access these compds. and the chem. pathways leading to their synthesis are also discussed.  An anal. of their mode of binding based on X-ray crystallog. data gives structural insights for the design of more potent and selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLtZrGItBQbVg90H21EOLACvtfcHk0lh-VbL2fFv9dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVymtLbO&md5=7797450a99abb4a4c8e2492eb8a43dd7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.3390%2Fmolecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules191219935%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DBuron%26aufirst%3DF.%26aulast%3DPl%25C3%25A9%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DP.%26aulast%3DRoutier%26aufirst%3DS.%26atitle%3DThe%2520azaindole%2520framework%2520in%2520the%2520design%2520of%2520kinase%2520inhibitors%26jtitle%3DMolecules%26date%3D2014%26volume%3D19%26spage%3D19935%26epage%3D19979%26doi%3D10.3390%2Fmolecules191219935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Groot, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omuro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloughesy, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haidar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligon, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prados, M.</span></span> <span> </span><span class="NLM_article-title">Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an ivy foundation early phase clinical trials consortium phase II study</span>. <i>Neuro Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nov245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1093%2Fneuonc%2Fnov245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26449250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC28zgtVOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=557-564&author=N.+Butowskiauthor=H.+Colmanauthor=J.+F.+De-Grootauthor=A.+M.+Omuroauthor=L.+Nayakauthor=P.+Y.+Wenauthor=T.+F.+Cloughesyauthor=A.+Marimuthuauthor=S.+Haidarauthor=A.+Perryauthor=J.+Huseauthor=J.+Phillipsauthor=B.+L.+Westauthor=K.+B.+Nolopauthor=H.+H.+Hsuauthor=K.+L.+Ligonauthor=A.+M.+Molinaroauthor=M.+Prados&title=Orally+administered+colony+stimulating+factor+1+receptor+inhibitor+PLX3397+in+recurrent+glioblastoma%3A+an+ivy+foundation+early+phase+clinical+trials+consortium+phase+II+study&doi=10.1093%2Fneuonc%2Fnov245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study</span></div><div class="casAuthors">Butowski Nicholas; Colman Howard; De Groot John F; Omuro Antonio M; Nayak Lakshmi; Wen Patrick Y; Cloughesy Timothy F; Marimuthu Adhirai; Haidar Sam; Perry Arie; Huse Jason; Phillips Joanna; West Brian L; Nolop Keith B; Hsu Henry H; Ligon Keith L; Molinaro Annette M; Prados Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">557-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The colony stimulating factor 1 receptor (CSF1R) ligands, CSF1 and interleukin-34, and the KIT ligand, stem cell factor, are expressed in glioblastoma (GB).  Microglia, macrophages, blood vessels, and tumor cells also express CSF1R, and depletion of the microglia reduces tumor burden and invasive capacity.  PLX3397 is an oral, small molecule that selectively inhibits CSF1R and KIT, penetrates the blood-brain barrier in model systems, and represents a novel approach for clinical development.  METHODS:  We conducted a phase II study in patients with recurrent GB.  The primary endpoint was 6-month progression-free survival (PFS6).  Secondary endpoints included overall survival response rate, safety, and plasma/tumor tissue pharmacokinetics.  Exploratory endpoints included pharmacodynamic measures of drug effect in blood and tumor tissue.  RESULTS:  A total of 37 patients were enrolled, with 13 treated prior to a planned surgical resection (Cohort 1) and 24 treated without surgery (Cohort 2).  PLX3397 was given at an oral dose of 1000 mg daily and was well tolerated.  The primary efficacy endpoint of PFS6 was only 8.6%, with no objective responses.  Pharmacokinetic endpoints revealed a median maximal concentration (Cmax) of 8090 ng/mL, with a time to attain Cmax of 2 hour in plasma.  Tumor tissue obtained after 7 days of drug exposure revealed a median drug level of 5500 ng/g.  Pharmacodynamic changes included an increase in colony stimulating factor 1 and reduced CD14(dim)/CD16+ monocytes in plasma compared with pretreatment baseline values.  CONCLUSION:  PLX3397 was well tolerated and readily crossed the blood-tumor barrier but showed no efficacy.  Additional studies are ongoing, testing combination strategies and potential biomarkers to identify patients with greater likelihood of response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMYyE8XOr7HrBItaL1WaVAfW6udTcc2eYfI-IjVebIZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zgtVOgsA%253D%253D&md5=0c56fb5d3fabf8da99529f1311f9bb2d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnov245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnov245%26sid%3Dliteratum%253Aachs%26aulast%3DButowski%26aufirst%3DN.%26aulast%3DColman%26aufirst%3DH.%26aulast%3DDe-Groot%26aufirst%3DJ.%2BF.%26aulast%3DOmuro%26aufirst%3DA.%2BM.%26aulast%3DNayak%26aufirst%3DL.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DHaidar%26aufirst%3DS.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DHuse%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DJ.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DNolop%26aufirst%3DK.%2BB.%26aulast%3DHsu%26aufirst%3DH.%2BH.%26aulast%3DLigon%26aufirst%3DK.%2BL.%26aulast%3DMolinaro%26aufirst%3DA.%2BM.%26aulast%3DPrados%26aufirst%3DM.%26atitle%3DOrally%2520administered%2520colony%2520stimulating%2520factor%25201%2520receptor%2520inhibitor%2520PLX3397%2520in%2520recurrent%2520glioblastoma%253A%2520an%2520ivy%2520foundation%2520early%2520phase%2520clinical%2520trials%2520consortium%2520phase%2520II%2520study%26jtitle%3DNeuro%2520Oncol.%26date%3D2016%26volume%3D18%26spage%3D557%26epage%3D564%26doi%3D10.1093%2Fneuonc%2Fnov245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tap, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainberg, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healey, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmielowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staddon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanftner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterfy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong-Starksen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1411366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1056%2FNEJMoa1411366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26222558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=428-437&author=W.+D.+Tapauthor=Z.+A.+Wainbergauthor=S.+P.+Anthonyauthor=P.+N.+Ibrahimauthor=C.+Zhangauthor=J.+H.+Healeyauthor=B.+Chmielowskiauthor=A.+P.+Staddonauthor=A.+L.+Cohnauthor=G.+I.+Shapiroauthor=V.+L.+Keedyauthor=A.+S.+Singhauthor=I.+Puzanovauthor=E.+L.+Kwakauthor=A.+J.+Wagnerauthor=D.+D.+Von+Hoffauthor=G.+J.+Weissauthor=R.+K.+Ramanathanauthor=J.+Zhangauthor=G.+Habetsauthor=Y.+Zhangauthor=E.+A.+Burtonauthor=G.+Visorauthor=L.+Sanftnerauthor=P.+Seversonauthor=H.+Nguyenauthor=M.+J.+Kimauthor=A.+Marimuthuauthor=G.+Tsangauthor=R.+Shellooeauthor=C.+Geeauthor=B.+L.+Westauthor=P.+Hirthauthor=K.+Nolopauthor=M.+van+de+Rijnauthor=H.+H.+Hsuauthor=C.+Peterfyauthor=P.+S.+Linauthor=S.+Tong-Starksenauthor=G.+Bollag&title=Structure-guided+blockade+of+CSF1R+kinase+in+tenosynovial+giant-cell+tumor&doi=10.1056%2FNEJMoa1411366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span></div><div class="casAuthors">Tap, W. D.; Wainberg, Z. A.; Anthony, S. P.; Ibrahim, P. N.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Staddon, A. P.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; Singh, A. S.; Puzanov, I.; Kwak, E. L.; Wagner, A. J.; Von Hoff, D. D.; Weiss, G. J.; Ramanathan, R. K.; Zhang, J.; Habets, G.; Zhang, Y.; Burton, E. A.; Visor, G.; Sanftner, L.; Severson, P.; Nguyen, H.; Kim, M. J.; Marimuthu, A.; Tsang, G.; Shellooe, R.; Gee, C.; West, B. L.; Hirth, P.; Nolop, K.; van de Rijn, M.; Hsu, H. H.; Peterfy, C.; Lin, P. S.; Tong-Starksen, S.; Bollag, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-437</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Expression of the colony-stimulating factor 1 (CSF1) gene is elevated in most tenosynovial giant-cell tumors.  This observation has led to the discovery and clin. development of therapy targeting the CSF1 receptor (CSF1R).  METHODS Using x-ray co-crystallog. to guide our drug-discovery research, we generated a potent, selective CSF1R inhibitor, PLX3397, that traps the kinase in the autoinhibited conformation.  We then conducted a multicenter, phase 1 trial in two parts to analyze this compd.  In the first part, we evaluated escalations in the dose of PLX3397 that was administered orally in patients with solid tumors (doseescalation study).  In the second part, we evaluated PLX3397 at the chosen phase 2 dose in an extension cohort of patients with tenosynovial giant-cell tumors (extension study).  Pharmacokinetic and tumor responses in the enrolled patients were assessed, and CSF1 in situ hybridization was performed to confirm the mechanism of action of PLX3397 and that the pattern of CSF1 expression was consistent with the pathol. features of tenosynovial giant-cell tumor.  RESULTS A total of 41 patients were enrolled in the dose-escalation study, and an addnl. 23 patients were enrolled in the extension study.  The chosen phase 2 dose of PLX3397 was 1000 mg per day.  In the extension study, 12 patients with tenosynovial giant-cell tumors had a partial response and 7 patients had stable disease.  Responses usually occurred within the first 4 mo of treatment, and the median duration of response exceeded 8 mo.  The most common adverse events included fatigue, change in hair color, nausea, dysgeusia, and periorbital edema; adverse events rarely led to discontinuation of treatment.  CONCLUSIONS Treatment of tenosynovial giant-cell tumors with PLX3397 resulted in a prolonged regression in tumor vol. in most patients. (Funded by Plexxikon; ClinicalTrials.gov no., NCT01004861.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgftPP4lKlQrVg90H21EOLACvtfcHk0lh-VbL2fFv9dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN&md5=5e822a87786aca7495222e3d18f82bdb</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1411366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1411366%26sid%3Dliteratum%253Aachs%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DChmielowski%26aufirst%3DB.%26aulast%3DStaddon%26aufirst%3DA.%2BP.%26aulast%3DCohn%26aufirst%3DA.%2BL.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DKeedy%26aufirst%3DV.%2BL.%26aulast%3DSingh%26aufirst%3DA.%2BS.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DVisor%26aufirst%3DG.%26aulast%3DSanftner%26aufirst%3DL.%26aulast%3DSeverson%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DGee%26aufirst%3DC.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DH.%2BH.%26aulast%3DPeterfy%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DTong-Starksen%26aufirst%3DS.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DStructure-guided%2520blockade%2520of%2520CSF1R%2520kinase%2520in%2520tenosynovial%2520giant-cell%2520tumor%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D428%26epage%3D437%26doi%3D10.1056%2FNEJMoa1411366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chabner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richon, V.</span></span> <span> </span><span class="NLM_article-title">Structural approaches to cancer drug development</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1056/NEJMp1503567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1056%2FNEJMp1503567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26222556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=402-403&author=B.+Chabnerauthor=V.+Richon&title=Structural+approaches+to+cancer+drug+development&doi=10.1056%2FNEJMp1503567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Structural approaches to cancer drug development</span></div><div class="casAuthors">Chabner, Bruce; Richon, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">402-403</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZO7m2NM9v5bVg90H21EOLACvtfcHk0licE3pNi_tsYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvP&md5=7d242767e6a378e972fabae3233393fe</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1056%2FNEJMp1503567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp1503567%26sid%3Dliteratum%253Aachs%26aulast%3DChabner%26aufirst%3DB.%26aulast%3DRichon%26aufirst%3DV.%26atitle%3DStructural%2520approaches%2520to%2520cancer%2520drug%2520development%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D402%26epage%3D403%26doi%3D10.1056%2FNEJMp1503567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coniglio, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugenin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrenis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segall, J. E.</span></span> <span> </span><span class="NLM_article-title">Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.2119/molmed.2011.00217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.2119%2Fmolmed.2011.00217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=22294205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFent7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=519-527&author=S.+J.+Coniglioauthor=E.+Eugeninauthor=K.+Dobrenisauthor=E.+R.+Stanleyauthor=B.+L.+Westauthor=M.+H.+Symonsauthor=J.+E.+Segall&title=Microglial+stimulation+of+glioblastoma+invasion+involves+epidermal+growth+factor+receptor+%28EGFR%29+and+colony+stimulating+factor+1+receptor+%28CSF-1R%29+signaling&doi=10.2119%2Fmolmed.2011.00217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling</span></div><div class="casAuthors">Coniglio, Salvatore J.; Eugenin, Eliseo; Dobrenis, Kostantin; Stanley, E. Richard; West, Brian L.; Symons, Marc H.; Segall, Jeffrey E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Glioblastoma multiforme is a deadly cancer for which current treatment options are limited.  The ability of glioblastoma tumor cells to infiltrate the surrounding brain parenchyma critically limits the effectiveness of current treatments.  We investigated how microglia, the resident macrophages of the brain, stimulate glioblastoma cell invasion.  We first examd. the ability of normal microglia from C57Bl/6J mice to stimulate GL261 glioblastoma cell invasion in vitro.  We found that microglia stimulate the invasion of GL261 glioblastoma cells by approx. 8-fold in an in vitro invasion assay.  Pharmacol. inhibition of epidermal growth factor receptor (EGFR) strongly inhibited microglia-stimulated invasion.  Furthermore, blockade of colony stimulating factor 1 receptor (CSF-1R) signaling using RNA interference or pharmacol. inhibitors completely inhibited microglial enhancement of glioblastoma invasion.  GL261 cells were found to constitutively secrete CSF-1, the levels of which were unaffected by epidermal growth factor (EGF) stimulation, EGFR inhibition or coculture with microglia.  CSF-1 only stimulated microglia invasion, whereas EGF only stimulated glioblastoma cell migration, demonstrating a synergistic interaction between these 2 cell types.  Finally, using PLX3397 (a CSF-1R inhibitor that can cross the blood-brain barrier) in live animals, we discovered that blockade of CSF-1R signaling in vivo reduced the no. of tumor-assocd. microglia and glioblastoma invasion.  These data indicate that glioblastoma and microglia interactions mediated by EGF and CSF-1 can enhance glioblastoma invasion and demonstrate the possibility of inhibiting glioblastoma invasion by targeting glioblastoma-assocd. microglia via inhibition of the CSF-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRWCOfXV2VsbVg90H21EOLACvtfcHk0lgscGr_mPqUyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFent7Y%253D&md5=eab4e226beff6aeeabc138961b597cdc</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00217%26sid%3Dliteratum%253Aachs%26aulast%3DConiglio%26aufirst%3DS.%2BJ.%26aulast%3DEugenin%26aufirst%3DE.%26aulast%3DDobrenis%26aufirst%3DK.%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DSymons%26aufirst%3DM.%2BH.%26aulast%3DSegall%26aufirst%3DJ.%2BE.%26atitle%3DMicroglial%2520stimulation%2520of%2520glioblastoma%2520invasion%2520involves%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520colony%2520stimulating%2520factor%25201%2520receptor%2520%2528CSF-1R%2529%2520signaling%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D519%26epage%3D527%26doi%3D10.2119%2Fmolmed.2011.00217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drew, L.</span>; <span class="NLM_string-name">Bell, K.</span>; <span class="NLM_string-name">Dakin, L.</span>; <span class="NLM_string-name">Hattersley, M.</span>; <span class="NLM_string-name">Lawson, D.</span>; <span class="NLM_string-name">Repik, G.</span>; <span class="NLM_string-name">Scott, D.</span>; <span class="NLM_string-name">Shen, M.</span>; <span class="NLM_string-name">Omer, C.</span></span> <span> </span><span class="NLM_article-title">The selective CSF-1R inhibitor AZ683 reduces tumor associated macrophages and inhibits growth of breast cancer xenograft models</span>. In  <i>AACR Annual Meeting: Tumor Biology, 2009, Apr 18–22, Denver, CO</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2009</span>;  <span class="NLM_fpage">259</span>, <a href="http://cancerres.aacrjournals.org/content/69/9_Supplement/259" class="extLink">http://cancerres.aacrjournals.org/content/69/9_Supplement/259</a> (accessed Dec 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=259&author=L.+Drew&author=K.+Bell&author=L.+Dakin&author=M.+Hattersley&author=D.+Lawson&author=G.+Repik&author=D.+Scott&author=M.+Shen&author=C.+Omer&title=The+selective+CSF-1R+inhibitor+AZ683+reduces+tumor+associated+macrophages+and+inhibits+growth+of+breast+cancer+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDrew%26aufirst%3DL.%26atitle%3DThe%2520selective%2520CSF-1R%2520inhibitor%2520AZ683%2520reduces%2520tumor%2520associated%2520macrophages%2520and%2520inhibits%2520growth%2520of%2520breast%2520cancer%2520xenograft%2520models%26jtitle%3DAACR%2520Annual%2520Meeting%253A%2520Tumor%2520Biology%252C%25202009%252C%2520Apr%252018%25E2%2580%259322%252C%2520Denver%252C%2520CO%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2009%26spage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daly, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Valle, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diebold, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drew, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezhuthachan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gero, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogoe, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redmond, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thakur, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span> <span> </span><span class="NLM_article-title">Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4591</span>– <span class="NLM_lpage">4596</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.06.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.bmcl.2013.06.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=23842474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2ltbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4591-4596&author=D.+A.+Scottauthor=L.+A.+Dakinauthor=K.+Dalyauthor=D.+J.+Del+Valleauthor=R.+B.+Dieboldauthor=L.+Drewauthor=J.+Ezhuthachanauthor=T.+W.+Geroauthor=C.+A.+Ogoeauthor=C.+A.+Omerauthor=S.+P.+Redmondauthor=G.+Repikauthor=K.+Thakurauthor=Q.+Yeauthor=X.+Zheng&title=Mitigation+of+cardiovascular+toxicity+in+a+series+of+CSF-1R+inhibitors%2C+and+the+identification+of+AZD7507&doi=10.1016%2Fj.bmcl.2013.06.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507</span></div><div class="casAuthors">Scott, David A.; Dakin, Les A.; Daly, Kevin; Del Valle, David J.; Diebold, R. Bruce; Drew, Lisa; Ezhuthachan, Jayachandran; Gero, Thomas W.; Ogoe, Claude A.; Omer, Charles A.; Redmond, Sean P.; Repik, Galina; Thakur, Kumar; Ye, Qing; Zheng, Xiaolan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4591-4596</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The potent and selective 3-amido-4-anilinoquinoline CSF-1R inhibitor AZ683 suffered from cardiovascular liabilities, which were linked to the off-target activities of the compd. and ion channel activity in particular.  Less basic and less lipophilic examples from both the quinoline and cinnoline series demonstrated cleaner secondary pharmacol. profiles.  Cinnoline 31 retained the required potency and oral PK profile, and was progressed through the safety screening cascade to be nominated into development as AZD7507.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBUarwHmu2-rVg90H21EOLACvtfcHk0lgXI7rDlBxYxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2ltbjO&md5=7ffab262014fea03ff82233b1b45e21a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.031%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDaly%26aufirst%3DK.%26aulast%3DDel%2BValle%26aufirst%3DD.%2BJ.%26aulast%3DDiebold%26aufirst%3DR.%2BB.%26aulast%3DDrew%26aufirst%3DL.%26aulast%3DEzhuthachan%26aufirst%3DJ.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DOgoe%26aufirst%3DC.%2BA.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DRedmond%26aufirst%3DS.%2BP.%26aulast%3DRepik%26aufirst%3DG.%26aulast%3DThakur%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26atitle%3DMitigation%2520of%2520cardiovascular%2520toxicity%2520in%2520a%2520series%2520of%2520CSF-1R%2520inhibitors%252C%2520and%2520the%2520identification%2520of%2520AZD7507%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4591%26epage%3D4596%26doi%3D10.1016%2Fj.bmcl.2013.06.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boulter, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendall, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtacha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgway, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Rooijen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigmore, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, S. J.</span></span> <span> </span><span class="NLM_article-title">WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1172/JCI76452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1172%2FJCI76452" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=1269-1285&author=L.+Boulterauthor=R.+V.+Guestauthor=T.+J.+Kendallauthor=D.+H.+Wilsonauthor=D.+Wojtachaauthor=A.+J.+Robsonauthor=R.+A.+Ridgwayauthor=K.+Samuelauthor=N.+Van+Rooijenauthor=S.+T.+Barryauthor=S.+J.+Wigmoreauthor=O.+J.+Sansomauthor=S.+J.+Forbes&title=WNT+signaling+drives+cholangiocarcinoma+growth+and+can+be+pharmacologically+inhibited&doi=10.1172%2FJCI76452"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1172%2FJCI76452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI76452%26sid%3Dliteratum%253Aachs%26aulast%3DBoulter%26aufirst%3DL.%26aulast%3DGuest%26aufirst%3DR.%2BV.%26aulast%3DKendall%26aufirst%3DT.%2BJ.%26aulast%3DWilson%26aufirst%3DD.%2BH.%26aulast%3DWojtacha%26aufirst%3DD.%26aulast%3DRobson%26aufirst%3DA.%2BJ.%26aulast%3DRidgway%26aufirst%3DR.%2BA.%26aulast%3DSamuel%26aufirst%3DK.%26aulast%3DVan%2BRooijen%26aufirst%3DN.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26aulast%3DWigmore%26aufirst%3DS.%2BJ.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DForbes%26aufirst%3DS.%2BJ.%26atitle%3DWNT%2520signaling%2520drives%2520cholangiocarcinoma%2520growth%2520and%2520can%2520be%2520pharmacologically%2520inhibited%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2015%26volume%3D125%26spage%3D1269%26epage%3D1285%26doi%3D10.1172%2FJCI76452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepomuceno, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, A. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooks, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMannus, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holladay, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Abstract 903: AC708 is a potent and selective inhibitor of CSF1R and reduces tumor associated macrophage infiltration in a breast tumor model</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">903</span>, <span class="refDoi"> DOI: 10.1158/1538-7445.AM2013-903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1158%2F1538-7445.AM2013-903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=903&author=R.+C.+Armstrongauthor=B.+Belliauthor=M.+W.+Rowbottomauthor=R.+R.+Nepomucenoauthor=A.+Q.+Daoauthor=A.+M.+Rooksauthor=D.+Brighamauthor=C.+W.+McMannusauthor=M.+D.+Hockerauthor=M.+W.+Holladayauthor=G.+Liu&title=Abstract+903%3A+AC708+is+a+potent+and+selective+inhibitor+of+CSF1R+and+reduces+tumor+associated+macrophage+infiltration+in+a+breast+tumor+model&doi=10.1158%2F1538-7445.AM2013-903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1158%2F1538-7445.AM2013-903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1538-7445.AM2013-903%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DBelli%26aufirst%3DB.%26aulast%3DRowbottom%26aufirst%3DM.%2BW.%26aulast%3DNepomuceno%26aufirst%3DR.%2BR.%26aulast%3DDao%26aufirst%3DA.%2BQ.%26aulast%3DRooks%26aufirst%3DA.%2BM.%26aulast%3DBrigham%26aufirst%3DD.%26aulast%3DMcMannus%26aufirst%3DC.%2BW.%26aulast%3DHocker%26aufirst%3DM.%2BD.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DAbstract%2520903%253A%2520AC708%2520is%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520CSF1R%2520and%2520reduces%2520tumor%2520associated%2520macrophage%2520infiltration%2520in%2520a%2520breast%2520tumor%2520model%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D903%26doi%3D10.1158%2F1538-7445.AM2013-903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, Y. A.</span>; <span class="NLM_string-name">Pradeep, S.</span>; <span class="NLM_string-name">Hansen, J. M.</span>; <span class="NLM_string-name">Wagner, M. J.</span>; <span class="NLM_string-name">Dood, R. L.</span>; <span class="NLM_string-name">Wu, S.
Y.</span>; <span class="NLM_string-name">Previs, R.
A.</span>; <span class="NLM_string-name">Hu, W.</span>; <span class="NLM_string-name">Coleman, R. L.</span>; <span class="NLM_string-name">Sood, A. K.</span></span> <span> </span><span class="NLM_article-title">Less is more: macrophage depletion via CSF1/CSF1R pathway improves anti-VEGF therapy after adaptive resistance</span>. In  <i>AACR Annual Meeting: Tumor Biology, 2017 April 1–5, Washington, DC</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2017</span>;  <span class="NLM_fpage">788</span>, <a href="http://cancerres.aacrjournals.org/content/77/13_Supplement/788" class="extLink">http://cancerres.aacrjournals.org/content/77/13_Supplement/788</a> (Accessed Dec 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=788&author=Y.+A.+Lyons&author=S.+Pradeep&author=J.+M.+Hansen&author=M.+J.+Wagner&author=R.+L.+Dood&author=S.%0AY.+Wu&author=R.%0AA.+Previs&author=W.+Hu&author=R.+L.+Coleman&author=A.+K.+Sood&title=Less+is+more%3A+macrophage+depletion+via+CSF1%2FCSF1R+pathway+improves+anti-VEGF+therapy+after+adaptive+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DLyons%26aufirst%3DY.%2BA.%26atitle%3DLess%2520is%2520more%253A%2520macrophage%2520depletion%2520via%2520CSF1%252FCSF1R%2520pathway%2520improves%2520anti-VEGF%2520therapy%2520after%2520adaptive%2520resistance%26jtitle%3DAACR%2520Annual%2520Meeting%253A%2520Tumor%2520Biology%252C%25202017%2520April%25201%25E2%2580%25935%252C%2520Washington%252C%2520DC%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2017%26spage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span> </span><span class="NLM_article-title">ARRY-382</span>.  <i>ClinicalTrials.gov</i>: <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=ARRY-382&amp;cntry1=&amp;state1=&amp;Search=Search" class="extLink">hhttps://clinicaltrials.gov/ct2/results?cond=&term=ARRY-382&cntry=&state=&city=&dist=</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ARRY-382.+ClinicalTrials.gov%3A+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3B+hhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fcond%3D%26term%3DARRY-382%26cntry%3D%26state%3D%26city%3D%26dist%3D+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DARRY-382%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J.</span>; <span class="NLM_string-name">Tolcher, A. W.</span>; <span class="NLM_string-name">Jones, S.</span>; <span class="NLM_string-name">Beeram, M.</span>; <span class="NLM_string-name">Infante, J.</span>; <span class="NLM_string-name">Larsen, P.</span>; <span class="NLM_string-name">Rasor, K.</span>; <span class="NLM_string-name">Garrus, J. E.</span>; <span class="NLM_string-name">Li, J.</span>; <span class="NLM_string-name">Cable, P. L.</span>; <span class="NLM_string-name">Eberhardt, C.</span>; <span class="NLM_string-name">Schreiber, J.</span>; <span class="NLM_string-name">Rush, S.</span>; <span class="NLM_string-name">Wood, K. W.</span>; <span class="NLM_string-name">Barrett, E.</span>; <span class="NLM_string-name">Patnaik, A.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers</span>. In  <i>AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Boston, MA, October 19–23 2013</i>; <span class="NLM_publisher-name">Array Biopharma</span>: <span class="NLM_publisher-loc">Boulder, CO</span>, <span class="NLM_year">2013</span>; <a href="http://www.arraybiopharma.com/files/3014/4501/8593/382-101_AACR-NCI-EORTC_poster.pdf" class="extLink">http://www.arraybiopharma.com/files/3014/4501/8593/382-101_AACR-NCI-EORTC_poster.pdf</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+Bendell&author=A.+W.+Tolcher&author=S.+Jones&author=M.+Beeram&author=J.+Infante&author=P.+Larsen&author=K.+Rasor&author=J.+E.+Garrus&author=J.+Li&author=P.+L.+Cable&author=C.+Eberhardt&author=J.+Schreiber&author=S.+Rush&author=K.+W.+Wood&author=E.+Barrett&author=A.+Patnaik&title=A+phase+1+study+of+ARRY-382%2C+an+oral+inhibitor+of+colony-stimulating+factor-1+receptor+%28CSF1R%29%2C+in+patients+with+advanced+or+metastatic+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBendell%26aufirst%3DJ.%26atitle%3DA%2520phase%25201%2520study%2520of%2520ARRY-382%252C%2520an%2520oral%2520inhibitor%2520of%2520colony-stimulating%2520factor-1%2520receptor%2520%2528CSF1R%2529%252C%2520in%2520patients%2520with%2520advanced%2520or%2520metastatic%2520cancers%26jtitle%3DAACR-NCI-EORTC%2520Molecular%2520Targets%2520and%2520Cancer%2520Therapeutics%252C%2520Boston%252C%2520MA%252C%2520October%252019%25E2%2580%259323%25202013%26pub%3DArray%2520Biopharma%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, N.
N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafi, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayala, K. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, M. R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span> <span> </span><span class="NLM_article-title">Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">139</span>, <span class="refDoi"> DOI: 10.1186/s12974-015-0366-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1186%2Fs12974-015-0366-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=26232154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FpsFOltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=139&author=N.%0AN.+Dagherauthor=A.+R.+Najafiauthor=K.+M.+N.+Kayalaauthor=M.+R.+P.+Elmoreauthor=T.+E.+Whiteauthor=R.+Medeirosauthor=B.+L.+Westauthor=K.+N.+Green&title=Colony-stimulating+factor+1+receptor+inhibition+prevents+microglial+plaque+association+and+improves+cognition+in+3xTg-AD+mice&doi=10.1186%2Fs12974-015-0366-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice</span></div><div class="casAuthors">Dagher Nabil N; Najafi Allison R; Kayala Kara M Neely; Elmore Monica R P; White Terra E; Medeiros Rodrigo; Green Kim N; West Brian L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">139</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Microglia are dependent upon colony-stimulating factor 1 receptor (CSF1R) signaling for their survival in the adult brain, with administration of the dual CSF1R/c-kit inhibitor PLX3397 leading to the near-complete elimination of all microglia brainwide.  Here, we determined the dose-dependent effects of a specific CSF1R inhibitor (PLX5622) on microglia in both wild-type and the 3xTg-AD mouse model of Alzheimer's disease.  METHODS:  Wild-type mice were treated with PLX5622 for up to 21 days, and the effects on microglial numbers were assessed. 3xTg-AD mice were treated with PLX5622 for 6 or 12 weeks and effects on microglial numbers and pathology subsequently assessed.  RESULTS:  High doses of CSF1R inhibitor eliminate most microglia from the brain, but a 75% lower-dose results in sustained elimination of ~30 of microglia in both wild-type and 3xTg-AD mice.  No behavioral or cognitive deficits were found in mice either depleted of microglia or treated with lower CSF1R inhibitor concentrations.  Aged 3xTg-AD mice treated for 6 or 12 weeks with lower levels of PLX5622 resulted in improved learning and memory.  Aβ levels and plaque loads were not altered, but microglia in treated mice no longer associated with plaques, revealing a role for the CSF1R in the microglial reaction to plaques, as well as in mediating cognitive deficits.  CONCLUSIONS:  We find that inhibition of CSF1R alone is sufficient to eliminate microglia and that sustained microglial elimination is concentration-dependent.  Inhibition of the CSF1R at lower levels in 3xTg-AD mice prevents microglial association with plaques and improves cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCV4bMy2gP3Rjv2lLSLOxFfW6udTcc2eY_d3gcOTt2iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FpsFOltg%253D%253D&md5=2622ddfc1dcdef4cdb98333711138875</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1186%2Fs12974-015-0366-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-015-0366-9%26sid%3Dliteratum%253Aachs%26aulast%3DDagher%26aufirst%3DN.%2BN.%26aulast%3DNajafi%26aufirst%3DA.%2BR.%26aulast%3DKayala%26aufirst%3DK.%2BM.%2BN.%26aulast%3DElmore%26aufirst%3DM.%2BR.%2BP.%26aulast%3DWhite%26aufirst%3DT.%2BE.%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26atitle%3DColony-stimulating%2520factor%25201%2520receptor%2520inhibition%2520prevents%2520microglial%2520plaque%2520association%2520and%2520improves%2520cognition%2520in%25203xTg-AD%2520mice%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2015%26volume%3D12%26spage%3D139%26doi%3D10.1186%2Fs12974-015-0366-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valdearcos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robblee, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koliwad, S. K.</span></span> <span> </span><span class="NLM_article-title">Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2124</span>– <span class="NLM_lpage">2138</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.1016%2Fj.celrep.2014.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=25497089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKnurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2124-2138&author=M.+Valdearcosauthor=M.+M.+Robbleeauthor=D.+I.+Benjaminauthor=D.+K.+Nomuraauthor=A.+W.+Xuauthor=S.+K.+Koliwad&title=Microglia+dictate+the+impact+of+saturated+fat+consumption+on+hypothalamic+inflammation+and+neuronal+function&doi=10.1016%2Fj.celrep.2014.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia Dictate the Impact of Saturated Fat Consumption on Hypothalamic Inflammation and Neuronal Function</span></div><div class="casAuthors">Valdearcos, Martin; Robblee, Megan M.; Benjamin, Daniel I.; Nomura, Daniel K.; Xu, Allison W.; Koliwad, Suneil K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2124-2138</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diets rich in satd. fat produce inflammation, gliosis, and neuronal stress in the mediobasal hypothalamus (MBH).  Here, we show that microglia mediate this process and its functional impact.  Although microglia and astrocytes accumulate in the MBH of mice fed a diet rich in satd. fatty acids (SFAs), only the microglia undergo inflammatory activation, along with a buildup of hypothalamic SFAs.  Enteric gavage specifically with SFAs reproduces microglial activation and neuronal stress in the MBH, and SFA treatment activates murine microglia, but not astrocytes, in culture.  Moreover, depleting microglia abrogates SFA-induced inflammation in hypothalamic slices.  Remarkably, depleting microglia from the MBH of mice abolishes inflammation and neuronal stress induced by excess SFA consumption, and in this context, microglial depletion enhances leptin signaling and reduces food intake.  We thus show that microglia sense SFAs and orchestrate an inflammatory process in the MBH that alters neuronal function when SFA consumption is high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYJWfvoB64Q7Vg90H21EOLACvtfcHk0ljxusEJDtOvAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKnurnN&md5=a4172f43ff9120bc468717a9637c0a33</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DValdearcos%26aufirst%3DM.%26aulast%3DRobblee%26aufirst%3DM.%2BM.%26aulast%3DBenjamin%26aufirst%3DD.%2BI.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DXu%26aufirst%3DA.%2BW.%26aulast%3DKoliwad%26aufirst%3DS.%2BK.%26atitle%3DMicroglia%2520dictate%2520the%2520impact%2520of%2520saturated%2520fat%2520consumption%2520on%2520hypothalamic%2520inflammation%2520and%2520neuronal%2520function%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D2124%26epage%3D2138%26doi%3D10.1016%2Fj.celrep.2014.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosi, S.</span></span> <span> </span><span class="NLM_article-title">Targeting colony stimulating factor 1 receptor to prevent cognitive deficits induced by fractionated whole-brain irradiation</span>. <i>Neural Regener. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.4103/1673-5374.202940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=10.4103%2F1673-5374.202940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=28469650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;key=1%3ACAS%3A280%3ADC%252BC1crjvValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=399-400&author=X.+Fengauthor=S.+Rosi&title=Targeting+colony+stimulating+factor+1+receptor+to+prevent+cognitive+deficits+induced+by+fractionated+whole-brain+irradiation&doi=10.4103%2F1673-5374.202940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting colony stimulating factor 1 receptor to prevent cognitive deficits induced by fractionated whole-brain irradiation</span></div><div class="casAuthors">Feng Xi; Rosi Susanna</div><div class="citationInfo"><span class="NLM_cas:title">Neural regeneration research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-400</span>
        ISSN:<span class="NLM_cas:issn">1673-5374</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTR7Fmzqo3OT3WEEzDrymxmfW6udTcc2eY_d3gcOTt2iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjvValuw%253D%253D&md5=b07ff72f5c3be20b5a7486bad359f38f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.4103%2F1673-5374.202940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F1673-5374.202940%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DRosi%26aufirst%3DS.%26atitle%3DTargeting%2520colony%2520stimulating%2520factor%25201%2520receptor%2520to%2520prevent%2520cognitive%2520deficits%2520induced%2520by%2520fractionated%2520whole-brain%2520irradiation%26jtitle%3DNeural%2520Regener.%2520Res.%26date%3D2017%26volume%3D12%26spage%3D399%26epage%3D400%26doi%3D10.4103%2F1673-5374.202940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B. D.</span>; <span class="NLM_string-name">Leary, C. B.</span>; <span class="NLM_string-name">Lu, W.-P.</span>; <span class="NLM_string-name">Kaufman, M. D.</span>; <span class="NLM_string-name">Flynn, D. L.</span></span> <span> </span><span class="NLM_article-title">The highly specific CSF1R inhibitor DCC-3014 exhibits immunomodulatory and anti-invasive activities in cancer models</span>. In  <i>AACR Annual Meeting: Cancer Chemistry 2016, April 16–20, New Orleans, LA</i>; <span class="NLM_publisher-name">American Association for Cancer Research</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span> <span class="NLM_year">2016</span>;  <span class="NLM_fpage">76</span>, <a href="http://cancerres.aacrjournals.org/content/76/14_Supplement/4889" class="extLink">http://cancerres.aacrjournals.org/content/76/14_Supplement/4889</a> (accessed Oct 21, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=76&author=B.+D.+Smith&author=C.+B.+Leary&author=W.-P.+Lu&author=M.+D.+Kaufman&author=D.+L.+Flynn&title=The+highly+specific+CSF1R+inhibitor+DCC-3014+exhibits+immunomodulatory+and+anti-invasive+activities+in+cancer+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BD.%26atitle%3DThe%2520highly%2520specific%2520CSF1R%2520inhibitor%2520DCC-3014%2520exhibits%2520immunomodulatory%2520and%2520anti-invasive%2520activities%2520in%2520cancer%2520models%26jtitle%3DAACR%2520Annual%2520Meeting%253A%2520Cancer%2520Chemistry%25202016%252C%2520April%252016%25E2%2580%259320%252C%2520New%2520Orleans%252C%2520LA%26pub%3DAmerican%2520Association%2520for%2520Cancer%2520Research%26date%3D2016%26spage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span> </span><span class="NLM_article-title">Study of DCC-3014
in Patients With Advanced Malignancies</span>.  <i>ClinicalTrials.gov</i>; <span class="NLM_publisher-name">U.S. National
Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03069469" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03069469</a> (accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+DCC-3014%0Ain+Patients+With+Advanced+Malignancies.+ClinicalTrials.gov%3B+U.S.+National%0AInstitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03069469+%28accessed+Dec.+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520of%2520DCC-3014%250Ain%2520Patients%2520With%2520Advanced%2520Malignancies%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%250AInstitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waltham, M. A.</span></span> <i>Deciphera Pharmaceuticals Initiates a Phase 1 Clinical Trial of DCC-3014</i>; <span class="NLM_publisher-name">Deciphera Pharmaceuticals</span>: <span class="NLM_publisher-loc">Waltham, MA</span>, <span class="NLM_year">2014</span>; <a href="https://www.deciphera.com/?s=dcc-3014" class="extLink">https://www.deciphera.com/?s=dcc-3014</a> (Accessed Dec. 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+A.+Waltham&title=Deciphera+Pharmaceuticals+Initiates+a+Phase+1+Clinical+Trial+of+DCC-3014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DWaltham%26aufirst%3DM.%2BA.%26jtitle%3DDeciphera%2520Pharmaceuticals%2520Initiates%2520a%2520Phase%25201%2520Clinical%2520Trial%2520of%2520DCC-3014%26pub%3DDeciphera%2520Pharmaceuticals%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCO','PDB','3LCO'); return false;">PDB: 3LCO</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-13%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00873%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00873" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66798016bd3a1243","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
